data_2lcp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.448 -0.575 . . . . 3.02 109.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.41 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.26 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 3.14 108.11 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 3.25 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 18' ' ' ARG . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.94 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.37 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.37 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.17 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 3.52 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 4.31 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.56 109.771 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.98 110.097 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 4.19 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 4.09 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 6.1 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.516 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 3.45 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.54 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 3.04 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 4.62 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.83 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 6.06 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 5.26 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.53 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 3.02 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.51 109.204 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 3.27 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 2.25 109.197 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.35 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.17 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 3.39 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.9 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.8 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 3.46 108.606 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.54 107.874 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 4.05 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.67 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.74 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 7.19 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.99 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.8 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 4.22 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 5.03 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.84 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.77 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.9 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 2.18 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.4 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 3.11 109.177 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 72' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 2.09 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 5.03 109.462 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.76 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 2.42 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 3.43 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.81 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.57 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 3.05 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.74 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 2.08 107.115 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.48 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.95 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.5 109.462 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.86 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 2.31 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' O ' ' OG ' ' A' ' 90' ' ' SER . 52.1 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 3.0 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.92 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.67 108.714 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.13 109.015 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.79 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 3.08 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 9.02 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.75 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.59 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.61 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.55 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.73 109.386 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 4.52 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.416 ' HE1' HG12 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 5.16 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.9 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 3.51 110.035 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.72 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 2.67 109.92 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.88 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' CG1' ' A' ' 71' ' ' VAL . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.71 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.38 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.98 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.68 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 3.01 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 2.19 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 2.19 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.606 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.78 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.92 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.95 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 4.14 109.563 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 2.34 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.73 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 2.41 108.147 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.86 109.46 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' GLY . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.29 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.13 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 5.18 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 4.01 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.46 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.76 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 3.1 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.93 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 6.19 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.32 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 4.58 113.137 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.94 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 5.63 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 2.11 109.263 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 5.23 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.46 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 3.74 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 2.18 107.702 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.71 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 4.06 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.606 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.73 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.694 ' ND2' ' N ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.53 109.701 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.694 ' N ' ' ND2' ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 3.08 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.96 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 2.49 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.499 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 2.1 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.406 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.66 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 3.18 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.93 109.922 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.79 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.52 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.487 ' HZ1' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 5.08 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 3.28 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 172' ' ' GLY . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.56 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.96 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.551 ' N ' ' HG ' ' A' ' 178' ' ' SER . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.19 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 4.29 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.62 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.71 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.687 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 5.13 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.56 109.686 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.487 -0.56 . . . . 3.02 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.41 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.26 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 24' ' ' GLU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 3.14 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 3.25 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.94 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.37 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.37 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.17 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' H ' HG23 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 3.52 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 4.31 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.56 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.98 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 4.19 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 4.09 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 6.1 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 3.45 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.54 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 3.04 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 4.62 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.83 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 6.06 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 5.26 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.53 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 3.02 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.719 HE22 ' NH2' ' A' ' 79' ' ' ARG . 43.5 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.51 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 3.27 109.857 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 2.25 109.456 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.35 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.17 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 3.39 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.9 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.8 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 3.46 108.258 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.54 107.188 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 4.05 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.67 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.74 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 7.19 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.99 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.8 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 4.22 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 5.03 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.84 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.77 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.9 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 2.18 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.4 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 3.11 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 2.09 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 5.03 109.72 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.76 110.699 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 2.42 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 3.43 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.583 HD22 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.81 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.57 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.583 ' CG ' HD22 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 3.05 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.719 ' NH2' HE22 ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.74 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 2.08 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.48 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.95 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.5 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.86 109.971 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 2.31 110.442 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 3.0 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.92 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.67 109.121 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.13 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.79 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 88' ' ' ALA . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 3.08 109.638 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 9.02 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.75 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.561 ' C ' ' HZ2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.59 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.61 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.561 ' HZ2' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.55 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.73 108.737 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 4.52 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 5.16 109.137 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.9 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 3.51 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.72 109.751 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 2.67 110.048 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.88 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.71 110.618 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.38 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 2.0 t-20 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.98 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.68 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 3.01 110.468 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 2.19 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 2.19 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.647 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.78 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.92 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.95 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 4.14 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 2.34 109.305 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.73 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 2.41 107.926 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.86 110.884 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.29 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.13 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 5.18 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 133' ' ' GLY . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 4.01 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.46 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.76 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 3.1 108.606 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.93 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 6.19 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.406 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.32 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 4.58 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.405 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.94 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 5.63 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 2.11 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 5.23 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.46 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 3.74 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 2.18 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.71 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 4.06 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.647 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.73 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.53 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 3.08 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.96 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 2.49 107.988 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 2.1 109.828 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.66 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 3.18 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.93 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.79 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.52 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 5.08 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 3.28 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.56 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.96 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.19 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 179' ' ' ILE . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 4.29 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.62 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.71 109.335 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.665 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 5.13 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.56 110.393 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.062 -0.718 . . . . 3.02 109.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.41 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.26 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 3.14 110.005 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 3.25 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.94 109.528 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.37 108.423 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.37 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.17 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 3.52 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 4.31 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.56 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.98 108.294 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 4.19 108.075 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 4.09 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 6.1 108.487 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 3.45 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.54 107.839 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 3.04 109.996 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 4.62 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.83 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 6.06 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 5.26 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.53 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 3.02 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.51 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 3.27 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 2.25 109.533 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.35 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.17 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 3.39 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.9 108.551 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.8 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 3.46 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.54 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 4.05 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.67 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.74 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 7.19 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.99 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.8 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 4.22 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 5.03 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.84 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.674 ' N ' ' HG1' ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.77 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.9 109.636 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 2.18 109.722 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.4 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 3.11 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 2.09 109.213 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 5.03 109.295 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.76 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 2.42 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 3.43 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.81 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.57 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 3.05 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.74 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG21 HD12 ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 2.08 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.48 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.95 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.5 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.86 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 2.31 109.494 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 3.0 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.92 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' OG1' ' A' ' 92' ' ' THR . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.67 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.13 108.945 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.79 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 3.08 108.841 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 9.02 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.75 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.59 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.61 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.55 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.73 109.533 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 4.52 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 5.16 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.9 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 3.51 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.72 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 2.67 110.383 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.88 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.71 109.789 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.38 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.98 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.68 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 3.01 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 2.19 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 2.19 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' NE ' ' OD2' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.78 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.92 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.95 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 4.14 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 2.34 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.73 109.953 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 2.41 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.86 111.314 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.29 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.13 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 5.18 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 4.01 108.935 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.46 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.76 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 3.1 108.194 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.93 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.708 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 6.19 110.49 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.584 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.32 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.412 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 4.58 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.94 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.523 ' NH1' ' CD ' ' A' ' 142' ' ' GLU . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 5.63 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 2.11 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 5.23 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.46 111.743 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 3.74 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 2.18 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.71 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 4.06 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.581 ' OD2' ' NE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.73 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.676 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.53 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 3.08 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.96 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 2.49 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.407 ' N ' HD11 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 2.1 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.66 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 3.18 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' OG ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.93 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.79 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.52 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 5.08 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 3.28 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.56 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.96 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 179' ' ' ILE . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.19 110.179 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 4.29 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.62 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.71 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.618 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 5.13 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.56 109.758 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.192 -0.67 . . . . 3.02 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.41 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.26 108.836 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 3.14 108.117 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 3.25 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.94 107.968 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.37 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.37 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.17 108.907 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 3.52 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 4.31 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.56 110.287 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.98 109.743 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 4.19 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 4.09 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 6.1 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 3.45 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.54 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 3.04 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 4.62 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 35' ' ' ILE . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HZ1' ' CB ' ' A' ' 36' ' ' LYS . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.83 109.392 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 6.06 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 5.26 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.53 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 3.02 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.51 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 3.27 109.354 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.25 109.747 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.35 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.17 109.448 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 3.39 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.59 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 88.5 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.9 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.8 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 3.46 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.54 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 4.05 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.67 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.74 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 7.19 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD2' ' H ' ' A' ' 58' ' ' PHE . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.99 113.233 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.8 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 4.22 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 5.03 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.84 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.77 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.9 109.882 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 2.18 109.695 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.59 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.4 109.016 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 3.11 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 2.09 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 5.03 109.699 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.76 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 2.42 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 3.43 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.81 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.57 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 3.05 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.74 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 2.08 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.48 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.95 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.5 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.86 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 2.31 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 3.0 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.92 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.67 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.13 108.954 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.79 108.831 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 3.08 109.477 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 9.02 108.162 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.75 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.59 108.486 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.61 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' H ' HD22 ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.55 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.73 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 4.52 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 5.16 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.9 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 3.51 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.72 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 2.67 110.049 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.88 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.71 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.38 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.98 111.571 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.68 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 3.01 110.112 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 2.19 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 2.19 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.78 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.92 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.95 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 4.14 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 2.34 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.73 109.579 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 2.41 107.857 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 128' ' ' ILE . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.86 109.188 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.29 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.13 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 5.18 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 4.01 109.614 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.46 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.76 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 3.1 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.93 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 6.19 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.553 ' O ' ' CG2' ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.32 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 4.58 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.94 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 5.63 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 2.11 109.538 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 5.23 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.46 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.687 ' CD1' ' NE ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 3.74 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.71 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 4.06 110.37 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.73 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.586 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 22.4 m120 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.53 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 3.08 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.96 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.549 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 2.49 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 2.1 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 167' ' ' GLN . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.66 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 3.18 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.93 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.79 110.246 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.52 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 5.08 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 3.28 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.56 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.96 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.19 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 4.29 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.62 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.71 108.955 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.645 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 5.13 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.56 110.009 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.873 -0.418 . . . . 3.02 109.873 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.41 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.26 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 3.14 109.028 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 ' O ' ' OG1' ' A' ' 20' ' ' THR . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 3.25 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 18' ' ' ARG . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.94 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.37 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.37 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.576 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.17 108.372 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 3.52 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 4.31 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.56 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.98 109.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 4.19 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 4.09 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 6.1 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 3.45 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.54 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 3.04 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 4.62 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.83 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 6.06 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 5.26 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.53 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 3.02 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.51 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 3.27 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.25 109.866 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.35 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.17 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 3.39 108.039 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.597 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 80.3 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.9 108.441 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.8 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 3.46 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.453 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.54 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 4.05 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.67 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.74 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 7.19 109.906 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.99 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.8 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 4.22 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 5.03 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.84 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' H ' ' CG2' ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.77 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.616 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.9 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 2.18 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.597 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.4 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 3.11 108.725 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 2.09 109.324 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 5.03 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.76 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 2.42 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 3.43 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.81 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.57 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 3.05 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.74 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 2.08 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.48 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.95 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.5 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.49 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.86 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 2.31 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 90' ' ' SER . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 3.0 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.92 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.67 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.13 109.005 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.79 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 3.08 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 9.02 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.75 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.59 108.592 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.61 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.55 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.73 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 4.52 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 5.16 109.466 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.9 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 3.51 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.731 ' HZ3' ' ND2' ' A' ' 112' ' ' ASN . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.72 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 2.67 109.422 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.88 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.71 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.38 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.731 ' ND2' ' HZ3' ' A' ' 106' ' ' LYS . 43.3 p-10 -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.98 110.772 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.68 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 3.01 109.315 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 2.19 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 2.19 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.78 109.8 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.92 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.95 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 4.14 109.236 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 2.34 109.381 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.73 110.421 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 2.41 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.86 108.975 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.29 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.13 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 5.18 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 4.01 109.434 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.46 109.768 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.76 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 3.1 110.114 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.93 111.984 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 144' ' ' THR . 30.0 m120 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 6.19 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.32 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 4.58 112.214 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.94 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 5.63 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 2.11 108.958 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 5.23 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.46 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 3.74 109.072 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 2.18 108.197 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.71 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.578 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 4.06 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.73 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.718 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.53 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 3.08 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.96 108.888 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 2.49 108.661 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 2.1 109.72 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.587 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.66 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 3.18 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.93 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.79 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.52 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 5.08 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 3.28 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.56 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.582 ' OG ' ' NE2' ' A' ' 181' ' ' GLN . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.96 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.19 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 4.29 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.582 ' NE2' ' OG ' ' A' ' 178' ' ' SER . 11.8 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.62 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.71 109.738 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.699 ' CD1' ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 5.13 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.56 110.022 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.437 -0.579 . . . . 3.02 109.437 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.41 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.26 108.8 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 3.14 108.948 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 19' ' ' LYS . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 3.25 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.94 106.841 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.37 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.37 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.578 ' CG2' ' H ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.17 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 3.52 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 4.31 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.56 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.98 110.364 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 4.19 109.538 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 4.09 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 6.1 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 3.45 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.54 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 3.04 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 4.62 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.83 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 6.06 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 5.26 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.53 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 3.02 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.51 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 3.27 109.91 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 2.25 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.35 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.17 109.903 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 3.39 108.905 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.9 108.766 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.8 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 52' ' ' TYR . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 3.46 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.414 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.54 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 4.05 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.67 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.74 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 7.19 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.99 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.8 109.547 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 4.22 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 5.03 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.84 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.77 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.9 109.604 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 2.18 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.4 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 3.11 108.55 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 70' ' ' ASN . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 2.09 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 68' ' ' VAL . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 5.03 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.76 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 2.42 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 3.43 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.81 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.57 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 3.05 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.74 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 2.08 108.178 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.48 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.95 109.152 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.5 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.86 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 2.31 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 3.0 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.92 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.67 108.031 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.13 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.79 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 3.08 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 9.02 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.75 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.59 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.681 ' H ' ' CD2' ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.61 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.55 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.73 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 4.52 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 5.16 108.743 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.9 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 3.51 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.522 ' CB ' ' HZ3' ' A' ' 106' ' ' LYS . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.72 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 2.67 110.439 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.88 108.743 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.71 110.134 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.595 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.38 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 111' ' ' ASP . 4.7 p30 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.98 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.68 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 3.01 108.924 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 2.19 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 2.19 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.78 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.92 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.95 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 4.14 108.828 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 2.34 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.73 108.95 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 2.41 108.44 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 128' ' ' ILE . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.86 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.29 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.13 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 5.18 109.04 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 4.01 109.733 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.46 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.51 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.76 108.395 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 3.1 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.93 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.451 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 6.19 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.32 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 4.58 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.94 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 5.63 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 150' ' ' ASP . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 2.11 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 149' ' ' VAL . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 5.23 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.46 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 3.74 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 2.18 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.71 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.54 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 4.06 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.73 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.724 ' H ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.53 109.503 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 163' ' ' LYS . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 3.08 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.96 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' A' ' 164' ' ' LEU . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 2.49 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 2.1 109.826 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.584 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.66 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 3.6 mm100 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 3.18 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.93 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.79 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.52 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 5.08 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 3.28 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.56 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.96 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.19 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 4.29 108.798 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.62 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.71 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 5.13 109.221 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.56 108.822 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HZ3' ' HB3' ' A' ' 11' ' ' GLU . 19.5 pttp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.251 -0.648 . . . . 3.02 109.251 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.41 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.26 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' CG2' ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 3.14 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 3.25 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.94 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.37 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.37 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.417 ' HH ' ' HA2' ' A' ' 95' ' ' GLY . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.17 111.111 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.534 ' H ' ' CG2' ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 3.52 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 4.31 109.768 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.56 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 28' ' ' GLN . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.98 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 4.19 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 4.09 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 6.1 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 3.45 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.54 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 3.04 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 4.62 110.863 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.83 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 6.06 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 5.26 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.53 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 3.02 110.208 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' CD ' ' A' ' 79' ' ' ARG . 12.6 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.51 109.468 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 3.27 109.535 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 2.25 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.35 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.17 109.347 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 3.39 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' NE2' ' CG2' ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.9 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.8 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 3.46 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.54 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 4.05 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.67 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.74 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 7.19 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.99 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.8 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 4.22 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 5.03 112.749 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.84 110.974 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.77 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.9 109.501 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 2.18 109.683 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.4 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 3.11 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 72' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 2.09 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 5.03 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.76 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 2.42 110.608 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 3.43 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.81 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.57 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 3.05 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.74 108.773 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 2.08 108.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.48 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.95 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.5 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.86 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 2.31 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 3.0 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.92 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.475 ' O ' ' OG1' ' A' ' 92' ' ' THR . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.67 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.13 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.79 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 3.08 109.475 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.476 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 9.02 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HH ' ' A' ' 21' ' ' TYR . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.75 109.584 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.59 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.61 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.55 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.73 108.889 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 4.52 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 5.16 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.9 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 3.51 109.861 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.72 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 2.67 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.88 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.488 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.71 109.847 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.38 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.98 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.68 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 3.01 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 2.19 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 2.19 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.556 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.78 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.92 108.704 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.95 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 4.14 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 2.34 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.73 109.953 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 2.41 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.86 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.619 ' O ' ' N ' ' A' ' 133' ' ' GLY . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.29 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.13 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 5.18 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 4.01 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.46 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.76 108.95 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.415 ' HA ' ' HG ' ' A' ' 184' ' ' SER . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 3.1 110.002 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.93 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.53 HD21 ' NH1' ' A' ' 148' ' ' ARG . 32.3 m120 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 6.19 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.496 ' O ' ' C ' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.32 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 4.58 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.94 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.53 ' NH1' HD21 ' A' ' 143' ' ' ASN . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 5.63 109.857 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 2.11 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 5.23 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.46 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 3.74 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 2.18 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.71 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 4.06 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.73 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.573 HD22 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.53 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.573 ' CG ' HD22 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 3.08 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.96 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 2.49 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 2.1 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.66 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 3.18 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.517 ' O ' ' OG ' ' A' ' 173' ' ' SER . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.93 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.79 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.52 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 5.08 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 3.28 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.56 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.96 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 179' ' ' ILE . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.19 110.302 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 182' ' ' ALA . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 4.29 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.62 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.71 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 5.13 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.415 ' HG ' ' HA ' ' A' ' 137' ' ' GLU . 40.0 m . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.56 109.367 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.633 -0.506 . . . . 3.02 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.41 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.26 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 3.14 108.715 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 3.25 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.94 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.37 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.37 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 22' ' ' PHE . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.17 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 3.52 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 4.31 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' CB ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.56 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' ' N ' ' A' ' 28' ' ' GLN . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.98 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 4.19 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 4.09 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 6.1 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 3.45 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.54 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 3.04 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 4.62 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.83 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 6.06 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 5.26 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.53 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 3.02 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.51 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 3.27 109.662 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 2.25 110.079 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.35 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.17 109.253 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 3.39 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.505 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.9 108.83 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.8 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 3.46 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.54 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 4.05 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.67 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.74 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 7.19 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 59' ' ' GLY . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.99 112.926 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.416 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.8 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 4.22 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 5.03 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 60' ' ' ASP . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.84 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.643 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.77 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.672 ' CE1' ' SD ' ' A' ' 131' ' ' MET . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.9 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 2.18 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.4 109.286 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' ' CD1' ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 3.11 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 2.09 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 5.03 109.204 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.76 110.917 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 2.42 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 3.43 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.572 HD22 ' CG ' ' A' ' 77' ' ' ASP . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.81 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.57 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' CG ' HD22 ' A' ' 75' ' ' ASN . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 3.05 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.74 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 2.08 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.48 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.95 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.5 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.86 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 2.31 110.278 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.503 ' O ' ' OG ' ' A' ' 90' ' ' SER . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 3.0 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.92 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.525 ' CD1' ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.67 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.13 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.79 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 3.08 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 9.02 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.75 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.59 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.563 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.61 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.55 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.73 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 4.52 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 5.16 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.9 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' ' OD1' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 3.51 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.72 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 2.67 109.856 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.88 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.71 110.06 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.38 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 36.8 t30 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.98 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.68 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 3.01 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 2.19 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' OD1' ' A' ' 119' ' ' ASN . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 2.19 108.383 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.571 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.78 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.498 ' OD1' ' OG1' ' A' ' 117' ' ' THR . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.92 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.95 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 4.14 108.921 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 2.34 108.968 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 127' ' ' ALA . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.73 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 2.41 107.937 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.86 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.29 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.13 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 5.18 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 4.01 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.46 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 131' ' ' MET . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.76 109.651 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 3.1 108.376 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.93 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 6.19 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.32 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 4.58 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.94 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 5.63 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 150' ' ' ASP . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 2.11 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 149' ' ' VAL . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 5.23 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.46 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 3.74 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 2.18 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.71 109.01 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 4.06 110.008 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.585 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.73 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.694 HD21 ' N ' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.53 109.689 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.694 ' N ' HD21 ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 3.08 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.96 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 2.1 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.66 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 3.18 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.93 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.79 110.138 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.52 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 5.08 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 3.28 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.56 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.96 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.19 109.035 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 4.29 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.62 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.71 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 5.13 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.56 109.467 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.408 -0.59 . . . . 3.02 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.41 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.26 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 3.14 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 3.25 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.94 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.37 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.696 ' HZ2' ' NE2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.37 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.595 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.17 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 3.52 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 4.31 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.56 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.98 109.423 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 4.19 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 4.09 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 6.1 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 3.45 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.54 108.429 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 3.04 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 4.62 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.83 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 6.06 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 5.26 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.53 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 3.02 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.51 109.765 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 3.27 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 2.25 109.986 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.35 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.17 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 3.39 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' OE1' ' CG2' ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.9 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.8 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 3.46 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.54 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 4.05 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.67 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.74 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 7.19 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.99 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.8 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 4.22 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 5.03 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.84 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.77 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.9 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 2.18 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.4 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 3.11 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 72' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 2.09 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 5.03 109.041 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.76 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 2.42 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 3.43 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.81 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.57 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 3.05 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.74 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 2.08 108.22 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.48 110.57 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.95 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.5 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.86 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 2.31 109.476 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.696 ' NE2' ' HZ2' ' A' ' 19' ' ' LYS . 51.2 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 3.0 110.486 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.92 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.502 ' O ' ' OG1' ' A' ' 92' ' ' THR . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.67 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 91' ' ' VAL . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.13 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' N ' ' HG ' ' A' ' 90' ' ' SER . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.79 108.453 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 3.08 108.631 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.626 ' HG ' ' N ' ' A' ' 94' ' ' ARG . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.626 ' N ' ' HG ' ' A' ' 93' ' ' SER . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 9.02 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.75 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' N ' ' HH ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.59 108.499 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.61 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.55 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.73 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 4.52 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 5.16 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.9 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 3.51 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.72 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 2.67 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.88 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.71 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.38 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.98 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.68 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 3.01 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 2.19 109.179 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 2.19 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.78 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.92 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.95 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 4.14 109.708 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 2.34 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.73 109.588 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 2.41 107.346 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.86 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.29 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.13 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 5.18 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 4.01 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' O ' ' CG2' ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.46 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 135' ' ' THR . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.76 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.541 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 3.1 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.93 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 6.19 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.32 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 4.58 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.94 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 147' ' ' LYS . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 5.63 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 2.11 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 5.23 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.46 109.693 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 3.74 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 2.18 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.71 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 4.06 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.73 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.53 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 3.08 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.96 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 2.49 108.164 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 2.1 110.14 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.66 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 3.18 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.93 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.79 109.522 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.52 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 5.08 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 3.28 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.56 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.592 ' HG ' ' N ' ' A' ' 179' ' ' ILE . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.96 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' N ' ' HG ' ' A' ' 178' ' ' SER . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.19 110.15 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 4.29 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 182' ' ' ALA . 7.1 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.62 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.71 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.675 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 5.13 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.56 109.309 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.997 -0.742 . . . . 3.02 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.41 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.26 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 3.14 109.791 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 3.25 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.94 108.514 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.37 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.37 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.17 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 3.52 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 4.31 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.56 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.98 109.413 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 4.19 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 4.09 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 6.1 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 3.45 108.554 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.54 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 3.04 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 4.62 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.83 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 6.06 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 5.26 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.53 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 3.02 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.598 ' NE2' ' NH1' ' A' ' 79' ' ' ARG . 33.3 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.51 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 3.27 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 2.25 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.35 110.087 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.17 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 3.39 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 65.0 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.9 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.8 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 52' ' ' TYR . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 3.46 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.54 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 4.05 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.67 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.74 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 7.19 110.002 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.99 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.8 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 4.22 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 5.03 112.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.84 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.77 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.551 ' H ' ' CG ' ' A' ' 131' ' ' MET . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.9 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.406 ' HB1' HE21 ' A' ' 49' ' ' GLN . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 2.18 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.4 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 3.11 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 2.09 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 5.03 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.76 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 2.42 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' VAL . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 3.43 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 1.0 OUTLIER 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.81 109.559 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.57 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 3.05 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' NH1' ' NE2' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.74 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 2.08 107.745 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.48 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.95 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.5 109.529 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.86 109.828 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 2.31 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 3.0 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.92 108.357 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 92' ' ' THR . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.67 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.13 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.79 109.159 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 3.08 109.135 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.449 ' N ' ' HG1' ' A' ' 92' ' ' THR . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 9.02 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.75 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.59 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.61 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.55 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.73 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 4.52 110.849 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 5.16 109.745 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.9 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 3.51 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HZ2' ' HB3' ' A' ' 102' ' ' ARG . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.72 108.747 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 2.67 108.833 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.88 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.502 ' N ' ' OE2' ' A' ' 120' ' ' GLU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.71 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.38 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.98 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.68 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 3.01 108.979 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 2.19 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 2.19 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.728 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.78 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.92 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.95 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 4.14 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 2.34 109.258 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.73 109.967 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 2.41 108.368 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.86 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.29 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.13 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 5.18 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 4.01 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.46 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.76 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 3.1 108.434 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.93 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 181' ' ' GLN . 81.5 m-20 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 6.19 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.32 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 4.58 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.94 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.532 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 5.63 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 2.11 108.894 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 5.23 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.46 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 3.74 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 2.18 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.71 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 4.06 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.73 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.53 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 3.08 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.96 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 2.49 108.145 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 2.1 109.44 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.66 110.027 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 3.18 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.93 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.79 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.52 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 5.08 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 3.28 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.56 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.96 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 179' ' ' ILE . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.19 109.99 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 4.29 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 143' ' ' ASN . 13.3 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.62 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 184' ' ' SER . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.71 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 5.13 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.56 107.748 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.121 -0.696 . . . . 3.02 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.41 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.26 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 3.14 108.401 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 3.25 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' LEU . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.94 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.37 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.37 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.17 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' THR . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 3.52 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 4.31 109.092 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.56 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.98 108.475 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 4.19 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 4.09 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 6.1 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 3.45 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.54 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 3.04 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 4.62 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.83 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 6.06 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 5.26 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.53 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 3.02 109.579 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.714 HE22 ' NH2' ' A' ' 79' ' ' ARG . 49.9 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.51 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 3.27 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.543 ' N ' ' CZ ' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 2.25 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.35 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.17 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 3.39 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.9 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.8 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 3.46 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.54 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 4.05 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.67 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.74 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 7.19 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.99 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.8 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 4.22 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 5.03 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.84 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.77 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.9 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 2.18 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 63' ' ' LYS . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.4 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 3.11 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 2.09 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 5.03 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.76 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 2.42 110.389 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 3.43 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.81 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.57 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 3.05 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.714 ' NH2' HE22 ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.74 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 2.08 107.875 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.48 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.95 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.5 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.86 109.327 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 2.31 109.923 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 3.0 109.767 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.534 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.92 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.472 ' O ' ' OG1' ' A' ' 92' ' ' THR . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.67 108.579 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.13 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.79 109.036 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 3.08 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.441 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 9.02 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.75 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.59 108.727 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.61 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.55 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.73 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 4.52 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.454 ' CH2' ' CD1' ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 5.16 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.9 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 3.51 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.72 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.454 ' CD1' ' CH2' ' A' ' 103' ' ' TRP . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 2.67 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.88 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.71 109.749 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.38 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.98 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.68 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 3.01 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 2.19 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.491 ' OG1' ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 2.19 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.671 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.78 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.92 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.95 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 4.14 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 2.34 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.73 109.423 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 2.41 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.86 109.986 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.29 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.13 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.536 ' O ' ' OG1' ' A' ' 135' ' ' THR . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 5.18 108.351 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 4.01 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.46 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 131' ' ' MET . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.76 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 3.1 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.93 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 6.19 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.32 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 4.58 113.754 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.94 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 5.63 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 2.11 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 5.23 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.46 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.564 ' CZ ' ' CD2' ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 3.74 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 2.18 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.71 110.559 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 4.06 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 160' ' ' ALA . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.73 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.53 109.581 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.599 ' N ' HD21 ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.705 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 3.08 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HZ3' HG21 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.96 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.564 ' CD2' ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 2.49 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 2.1 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 170' ' ' GLN . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.66 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 3.18 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.93 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.79 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.52 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 5.08 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 3.28 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.56 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.96 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 179' ' ' ILE . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.19 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 4.29 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.62 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.71 108.957 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 5.13 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.56 109.911 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.882 -0.784 . . . . 3.02 108.882 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.41 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.26 109.965 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 3.14 109.232 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 3.25 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.94 108.086 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.37 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.37 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.593 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.17 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 3.52 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 4.31 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.56 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.98 109.43 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 4.19 109.129 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.5 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 4.09 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 6.1 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 3.45 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.54 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 3.04 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 4.62 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.83 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' C ' ' H ' ' A' ' 40' ' ' SER . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 6.06 108.237 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 5.26 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 38' ' ' CYS . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.53 109.24 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 3.02 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.51 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 3.27 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 2.25 109.541 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.35 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.17 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 3.39 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.579 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 91.6 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.9 107.81 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.8 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 3.46 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.54 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 4.05 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.67 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.74 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 7.19 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.99 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.8 110.876 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 4.22 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 5.03 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.84 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.77 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.9 110.443 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 2.18 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.579 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.4 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 3.11 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 2.09 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CZ ' ' O ' ' A' ' 77' ' ' ASP . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 5.03 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.76 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 110' ' ' LEU . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 2.42 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.51 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 3.43 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CA ' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.81 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.57 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 3.05 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.74 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 2.08 106.893 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.48 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.95 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.5 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.86 110.645 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 2.31 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 3.0 110.556 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.92 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.67 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.549 ' HG ' ' HG1' ' A' ' 20' ' ' THR . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.13 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.79 108.243 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 3.08 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.598 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 9.02 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.75 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.59 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.61 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.55 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.424 ' CD2' ' HG ' ' A' ' 173' ' ' SER . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.73 109.772 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 4.52 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 5.16 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.9 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 3.51 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.72 109.738 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 109' ' ' ASP . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 2.67 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.88 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 107' ' ' LEU . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.71 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.38 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.98 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.68 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 3.01 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 2.19 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 2.19 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.78 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.92 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.95 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 4.14 109.085 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 2.34 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.73 110.998 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 2.41 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.86 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.29 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.13 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 5.18 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 4.01 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.46 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.76 108.961 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 3.1 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.93 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 6.19 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.32 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 4.58 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.94 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 5.63 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 150' ' ' ASP . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 2.11 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' VAL . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 5.23 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.46 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CE1' ' CD2' ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 3.74 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 2.18 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.71 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.46 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 4.06 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.73 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.53 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 3.08 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.96 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.479 ' CD2' ' CE1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 2.49 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 2.1 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.663 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.66 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' N ' ' CD2' ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 3.18 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.93 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.79 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.424 ' HG ' ' CD2' ' A' ' 101' ' ' LEU . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.52 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 5.08 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 3.28 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.56 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.96 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.429 ' H ' ' C ' ' A' ' 177' ' ' PRO . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.19 109.631 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 4.29 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.62 109.401 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.71 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 5.13 109.869 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.56 109.116 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.567 -0.531 . . . . 3.02 109.567 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.41 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.26 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 3.14 107.844 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 3.25 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.94 107.49 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.37 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.37 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.17 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 3.52 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 4.31 109.009 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.56 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.98 109.314 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 4.19 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 4.09 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 6.1 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 3.45 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.54 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 3.04 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 4.62 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.83 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 6.06 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 5.26 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.53 110.199 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 3.02 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.698 ' H ' ' HG ' ' A' ' 40' ' ' SER . 45.4 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.51 109.167 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 3.27 109.522 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 2.25 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.35 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.17 109.739 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 3.39 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 87.3 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.9 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.8 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 51' ' ' ILE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 3.46 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.54 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 4.05 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.663 ' NE2' ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.67 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.663 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.74 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 7.19 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.99 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.8 109.979 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 4.22 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 5.03 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.84 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.77 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.9 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 2.18 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.4 108.919 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 3.11 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 72' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 2.09 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 5.03 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.76 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 2.42 111.137 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 3.43 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.81 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.57 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 3.05 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.74 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 2.08 108.32 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.48 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.95 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.5 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.86 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 2.31 108.396 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.472 HE22 ' HZ3' ' A' ' 19' ' ' LYS . 57.1 tp60 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 3.0 109.507 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.92 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.67 107.716 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.13 108.671 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.79 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 3.08 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 9.02 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.75 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.59 108.75 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.61 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.55 108.815 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.73 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 4.52 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 5.16 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.9 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 3.51 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.72 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 2.67 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.88 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.71 110.187 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.38 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.98 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.68 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 3.01 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 2.19 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 2.19 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.78 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.92 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.95 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.447 ' SD ' ' CG2' ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 4.14 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 2.34 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.73 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.447 ' CG2' ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 2.41 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.86 109.258 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.29 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.13 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 5.18 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 135' ' ' THR . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 4.01 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.46 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 132' ' ' VAL . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.76 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 136' ' ' VAL . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 3.1 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.93 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.582 ' CD ' HD22 ' A' ' 143' ' ' ASN . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' CD ' ' A' ' 141' ' ' GLU . 31.1 m120 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 6.19 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.32 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 4.58 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.94 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 5.63 110.285 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 2.11 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 5.23 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.46 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 3.74 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 2.18 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.71 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 4.06 109.34 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.73 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.53 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 3.08 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.96 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 2.49 107.605 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 2.1 110.596 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.66 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 3.18 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.93 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.79 110.563 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.52 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 5.08 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 3.28 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.56 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.96 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.19 108.835 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 4.29 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 180' ' ' VAL . 49.7 tp60 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.62 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.71 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.637 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 5.13 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.56 110.499 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.94 0.4 . . . . 3.02 110.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.41 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.26 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 3.14 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 3.25 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.94 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.37 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.37 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.17 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 3.52 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 4.31 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.56 110.269 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.98 109.505 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 4.19 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 4.09 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 6.1 108.482 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 3.45 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.54 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 3.04 111.26 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.465 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 4.62 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.83 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 6.06 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 5.26 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.53 109.186 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 3.02 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.51 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 3.27 109.575 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 2.25 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.35 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.17 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 3.39 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.9 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.8 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 3.46 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.54 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 4.05 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 51' ' ' ILE . 32.2 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.67 109.927 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.74 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 7.19 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.99 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.8 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 4.22 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 5.03 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.84 109.488 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.77 109.234 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.9 109.349 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 2.18 109.303 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.4 108.984 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 3.11 108.877 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 2.09 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 5.03 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.76 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 2.42 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 68' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 3.43 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.81 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.57 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 3.05 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.74 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 2.08 108.337 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.48 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.95 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.5 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' CD ' ' OE1' ' A' ' 81' ' ' GLU . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.86 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 2.31 109.067 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 3.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.92 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.67 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.13 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.79 107.774 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 3.08 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.579 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 9.02 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.75 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.59 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.61 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.55 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.73 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 4.52 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 5.16 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.9 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 3.51 109.041 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.72 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 2.67 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.88 109.302 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.71 109.01 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.38 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.98 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.68 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 3.01 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 2.19 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 2.19 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.78 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.92 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.95 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 4.14 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 2.34 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.73 110.638 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 2.41 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.86 109.304 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.29 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.13 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 5.18 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 4.01 109.387 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.46 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 131' ' ' MET . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.76 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 3.1 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.93 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.54 ' ND2' ' HH ' ' A' ' 129' ' ' TYR . 17.2 t-20 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 6.19 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.511 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.32 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.413 ' O ' ' CG2' ' A' ' 149' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 4.58 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.94 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 5.63 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 145' ' ' PRO . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 2.11 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 5.23 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.46 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 3.74 109.04 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 2.18 108.088 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.71 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 4.06 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.73 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.53 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 3.08 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.96 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 2.49 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 2.1 109.601 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 167' ' ' GLN . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.66 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 3.18 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.93 110.202 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.79 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.52 109.498 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 5.08 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 3.28 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.56 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.96 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.19 109.73 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 182' ' ' ALA . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 4.29 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.62 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.71 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.677 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 5.13 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.56 109.356 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 3.02 109.429 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.41 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.26 109.021 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 3.14 109.604 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 3.25 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.623 ' HG1' ' N ' ' A' ' 18' ' ' ARG . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.94 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.623 ' N ' ' HG1' ' A' ' 17' ' ' THR . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.37 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.37 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.17 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 3.52 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 4.31 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.56 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.98 108.885 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 4.19 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 4.09 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 6.1 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 3.45 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.54 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 3.04 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 4.62 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.83 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 6.06 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 5.26 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.53 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 3.02 110.462 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.51 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 3.27 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 2.25 108.726 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.35 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.17 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 3.39 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 62' ' ' THR . 35.7 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.9 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.8 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.464 HG22 HD12 ' A' ' 51' ' ' ILE . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 3.46 108.88 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.54 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 4.05 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.67 110.842 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.74 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 7.19 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 59' ' ' GLY . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.99 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.8 109.684 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 4.22 109.646 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 5.03 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.457 ' HA ' HE21 ' A' ' 49' ' ' GLN . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.84 109.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.77 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.9 109.916 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 2.18 109.421 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.4 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 3.11 109.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 2.09 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 5.03 109.442 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.76 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 2.42 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.561 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 3.43 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.81 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.57 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 3.05 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.74 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 2.08 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.48 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.95 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.5 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.86 109.947 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 2.31 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 3.0 110.167 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.92 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.67 109.098 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.13 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.79 108.571 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 3.08 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 9.02 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.75 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.59 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.61 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.55 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.73 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 4.52 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 5.16 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.9 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 3.51 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.72 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 2.67 109.875 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.88 110.794 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.71 109.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.38 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.98 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.68 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.465 ' CE2' ' CG2' ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 3.01 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 2.19 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 2.19 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.586 ' NH1' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.78 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.92 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.95 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 4.14 109.669 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 2.34 109.425 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.73 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 2.41 109.175 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.86 107.506 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.29 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.431 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.13 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 5.18 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 4.01 108.99 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.46 108.695 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 135' ' ' THR . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.76 109.898 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 3.1 108.084 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.93 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 13.8 m120 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 6.19 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.32 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 4.58 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.94 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 5.63 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 2.11 108.792 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 5.23 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 152' ' ' ILE . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.46 110.887 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 3.74 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 2.18 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.71 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 4.06 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.658 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.73 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.674 ' C ' ' H ' ' A' ' 161' ' ' ASP . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.53 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.674 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 3.08 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.96 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.421 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 2.49 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 115' ' ' TYR . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 2.1 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 167' ' ' GLN . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.66 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 3.18 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.93 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.79 110.076 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.52 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 5.08 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 3.28 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.56 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.96 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.19 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 4.29 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.62 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.71 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 5.13 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.56 109.263 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.781 0.324 . . . . 3.02 110.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.41 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.26 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 3.14 109.168 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 3.25 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.94 107.335 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.37 108.607 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.37 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.17 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 3.52 108.012 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 4.31 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.56 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.98 109.42 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 4.19 109.711 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 4.09 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 6.1 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 3.45 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.54 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 3.04 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 4.62 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.83 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 6.06 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 5.26 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.53 109.326 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 3.02 109.212 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.643 ' H ' ' HG ' ' A' ' 40' ' ' SER . 52.2 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.51 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 3.27 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 2.25 108.585 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.35 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.17 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 3.39 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 85.8 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.9 107.81 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.8 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 3.46 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.508 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.54 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 4.05 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.67 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.74 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 7.19 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.99 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.8 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 4.22 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 5.03 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 66' ' ' THR . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.84 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.77 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.9 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 2.18 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.4 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 3.11 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 2.09 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 5.03 109.837 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.76 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 2.42 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 3.43 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.81 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.57 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 3.05 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.639 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.74 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 2.08 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.48 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.95 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.5 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.86 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 2.31 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 3.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.92 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.67 107.808 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.13 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.79 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 3.08 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 9.02 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.75 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.694 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.59 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.61 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.694 ' H ' ' HG1' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.55 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.73 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.52 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.436 ' HE1' HG12 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 5.16 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.9 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 3.51 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.72 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 2.67 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.88 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.71 109.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.38 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.98 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.68 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 3.01 109.514 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 2.19 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 2.19 108.021 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.78 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.92 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.95 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 4.14 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 2.34 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.73 109.327 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 2.41 108.058 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.86 109.374 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.29 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.13 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 5.18 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 4.01 109.856 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.46 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.76 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 3.1 109.583 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.93 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.568 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.568 ' H ' ' CG ' ' A' ' 141' ' ' GLU . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 6.19 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.32 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.433 ' N ' ' HG1' ' A' ' 144' ' ' THR . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 4.58 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.94 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 5.63 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 2.11 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 5.23 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.46 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.654 ' CD1' ' NE ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 3.74 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 2.18 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.71 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 4.06 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.73 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.53 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 3.08 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.96 109.023 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 2.49 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 2.1 108.927 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.66 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 3.18 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.93 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.79 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.52 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 5.08 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 3.28 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.56 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.96 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.19 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 4.29 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.62 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.71 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 5.13 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.56 109.945 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.605 -0.517 . . . . 3.02 109.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.41 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.26 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 3.14 109.398 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 19' ' ' LYS . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 3.25 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.94 108.117 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.37 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.37 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.48 ' OG1' ' CD2' ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.602 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.17 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 3.52 109.027 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 4.31 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.56 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 28' ' ' GLN . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.98 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 4.19 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 4.09 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 6.1 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 3.45 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.54 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 3.04 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 4.62 111.3 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.83 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 6.06 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 5.26 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.53 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 3.02 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.51 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' H ' HG21 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 3.27 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.568 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 2.25 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.35 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.17 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 3.39 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.9 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.8 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 3.46 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.54 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 4.05 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.67 109.803 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.74 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.402 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 7.19 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.99 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.8 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 4.22 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 5.03 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.84 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.737 ' HZ3' HE22 ' A' ' 130' ' ' GLN . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.77 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.9 110.833 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 2.18 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.4 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 3.11 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 2.09 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 5.03 109.538 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.76 110.444 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 2.42 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.49 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 3.43 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.81 109.576 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.57 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 3.05 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.74 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' H ' ' A' ' 43' ' ' LEU . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 2.08 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.48 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.95 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.5 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.86 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 2.31 109.957 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 3.0 110.458 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.92 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.67 108.611 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.13 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.79 107.336 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 3.08 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 9.02 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.75 110.306 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.593 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.59 109.546 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.61 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.593 ' H ' ' HG1' ' A' ' 96' ' ' THR . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.55 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.73 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.531 ' NH1' ' HZ3' ' A' ' 106' ' ' LYS . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 4.52 109.611 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 5.16 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.9 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 3.51 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HZ3' ' NH1' ' A' ' 102' ' ' ARG . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.72 109.44 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 2.67 109.992 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.88 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.71 109.25 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.38 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.98 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.68 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 3.01 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 2.19 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 2.19 108.307 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.78 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.92 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' H ' ' HG1' ' A' ' 117' ' ' THR . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.95 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 4.14 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.34 109.533 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.73 110.392 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 2.41 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 129' ' ' TYR . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.86 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.29 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.737 HE22 ' HZ3' ' A' ' 63' ' ' LYS . 32.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.13 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 5.18 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 133' ' ' GLY . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 4.01 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 133' ' ' GLY . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.46 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.76 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.593 ' H ' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 3.1 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.93 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 6.19 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.32 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 4.58 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.94 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.569 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 5.63 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 150' ' ' ASP . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 2.11 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' VAL . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 5.23 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.46 110.032 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CD1' HD22 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 3.74 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 2.18 107.633 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.71 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.564 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 4.06 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.73 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.51 HD22 ' CE ' ' A' ' 156' ' ' MET . 17.9 m120 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.53 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.61 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 3.08 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.96 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 2.49 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 2.1 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.567 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.66 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 3.18 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.93 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.79 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.52 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 5.08 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 3.28 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.56 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.96 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.409 HG21 ' HG ' ' A' ' 173' ' ' SER . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.19 109.669 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 4.29 108.885 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.62 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 184' ' ' SER . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.71 109.29 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 5.13 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 182' ' ' ALA . 5.3 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.56 109.919 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.436 -0.579 . . . . 3.02 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.41 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.26 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 3.14 109.698 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 3.25 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.556 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.94 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.413 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.37 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.508 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.37 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.17 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 3.52 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 4.31 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' OE1' ' CG2' ' A' ' 17' ' ' THR . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.56 109.513 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' TYR . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.98 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 4.19 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 4.09 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 6.1 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 3.45 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.54 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 3.04 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 4.62 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.83 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 6.06 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 5.26 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.53 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 3.02 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.566 HE21 ' C ' ' A' ' 43' ' ' LEU . 3.9 tm0? -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.51 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.566 ' C ' HE21 ' A' ' 42' ' ' GLN . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 3.27 110.089 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' NE2' ' A' ' 42' ' ' GLN . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 2.25 109.345 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.35 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.17 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 3.39 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.9 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.8 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 3.46 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.54 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 4.05 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.67 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.74 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 7.19 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.99 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.8 109.188 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 4.22 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 5.03 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.84 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.77 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.9 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 2.18 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.4 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 3.11 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 2.09 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 5.03 109.846 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.76 110.745 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 2.42 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 3.43 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.81 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.57 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.574 ' CG ' HD22 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 3.05 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.74 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 2.08 108.267 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.48 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.95 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.5 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.86 110.1 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 2.31 109.502 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' O ' ' OG ' ' A' ' 90' ' ' SER . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 3.0 109.888 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.92 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 85' ' ' PHE . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.67 108.76 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.13 109.277 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.79 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 3.08 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 9.02 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.75 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.59 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.61 109.096 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.55 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' CD1' ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.73 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 4.52 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' HZ2' ' A' ' 106' ' ' LYS . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 5.16 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.9 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 3.51 110.196 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 103' ' ' TRP . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.72 109.206 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 2.67 110.478 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.88 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.71 109.243 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.38 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.98 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.68 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 3.01 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 2.19 108.724 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.404 ' HG1' ' HG3' ' A' ' 120' ' ' GLU . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 2.19 108.86 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.697 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.78 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.92 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HG3' ' HG1' ' A' ' 117' ' ' THR . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.95 109.188 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 4.14 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 2.34 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.73 109.64 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 2.41 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.548 ' O ' ' CG1' ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.86 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.29 110.428 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.13 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 5.18 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 4.01 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 40.4 t30 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.46 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' A' ' 137' ' ' GLU . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.76 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 3.1 109.798 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.93 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.666 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.666 ' H ' ' CG ' ' A' ' 142' ' ' GLU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 6.19 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' A' ' 144' ' ' THR . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.32 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 4.58 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.94 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 5.63 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 2.11 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 5.23 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.46 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 3.74 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 2.18 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.71 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 4.06 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.73 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.53 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 3.08 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.96 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 2.49 108.158 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 2.1 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.66 110.196 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 3.18 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.496 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.93 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.416 HE22 ' HG ' ' A' ' 101' ' ' LEU . 87.3 mm-40 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.79 109.991 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.52 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 5.08 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 3.28 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.56 ' C ' ' HG ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.56 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.56 ' HG ' ' C ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.96 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.19 109.661 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 4.29 111.759 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.62 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.71 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 5.13 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.56 109.738 -179.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.536 -0.542 . . . . 3.02 109.536 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.41 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.26 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 3.14 108.16 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 3.25 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 14' ' ' GLU . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.94 107.641 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.37 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.37 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.17 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 3.52 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 4.31 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.56 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.98 109.357 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 4.19 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 4.09 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 6.1 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 3.45 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.54 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 3.04 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 4.62 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.83 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 6.06 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 5.26 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.53 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 3.02 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.51 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 3.27 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 2.25 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.35 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.17 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 3.39 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 99.1 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.9 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.8 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 3.46 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.477 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.54 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 4.05 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.67 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.74 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 7.19 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.99 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.8 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 4.22 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 5.03 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.84 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.77 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.9 109.965 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 2.18 109.754 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.591 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.4 109.535 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 3.11 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 72' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 2.09 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 5.03 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.76 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 2.42 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 3.43 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.81 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.57 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 3.05 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.74 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 2.08 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.48 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.95 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.5 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.86 109.307 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 2.31 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 3.0 110.114 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.92 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 92' ' ' THR . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.67 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.13 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.79 109.624 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 3.08 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 9.02 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.75 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.59 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.61 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.55 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.73 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 4.52 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 5.16 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.9 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 3.51 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.72 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 2.67 110.037 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.88 109.78 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.475 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.71 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.38 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 15.0 p30 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.98 109.36 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.68 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 3.01 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 2.19 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 2.19 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.484 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.78 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.92 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.95 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 4.14 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 2.34 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.73 108.562 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 2.41 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 128' ' ' ILE . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.86 109.396 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.29 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.13 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.483 ' O ' ' OG1' ' A' ' 135' ' ' THR . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 5.18 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.405 ' C ' ' HG1' ' A' ' 135' ' ' THR . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 4.01 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 133' ' ' GLY . 8.6 p30 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.46 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 131' ' ' MET . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.76 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 3.1 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.93 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 6.19 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.32 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 144' ' ' THR . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 4.58 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.477 ' OE2' ' O ' ' A' ' 144' ' ' THR . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.94 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 5.63 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 2.11 108.697 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 5.23 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 152' ' ' ILE . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.46 110.588 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 3.74 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 2.18 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.71 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 4.06 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.709 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.73 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.709 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.53 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 3.08 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.96 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.486 ' CD2' ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 2.49 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 2.1 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.66 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 3.18 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.93 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.544 ' C ' ' NE2' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.79 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.52 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 5.08 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 3.28 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 179' ' ' ILE . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.56 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.96 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.19 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 4.29 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.62 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.71 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.707 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 5.13 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.56 109.398 179.598 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.756 -0.461 . . . . 3.02 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.41 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.26 108.373 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 3.14 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 3.25 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.94 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.37 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' A' ' 87' ' ' GLN . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.37 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' HB3' ' HE ' ' A' ' 94' ' ' ARG . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.17 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 3.52 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 4.31 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.56 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.98 110.303 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 4.19 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 4.09 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 6.1 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 3.45 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.54 108.945 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 3.04 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 4.62 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.83 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 6.06 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 5.26 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.53 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 3.02 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.51 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 3.27 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 2.25 109.415 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.35 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.17 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 3.39 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.9 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.8 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' CD1' ' A' ' 55' ' ' PHE . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 3.46 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.453 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.54 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 4.05 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.67 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.74 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 7.19 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.99 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.8 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 4.22 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 5.03 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.84 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.77 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.9 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 2.18 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.4 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.11 109.9 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 2.09 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 5.03 109.461 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.76 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 2.42 110.519 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 3.43 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.81 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.57 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 3.05 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.74 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 2.08 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.48 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.95 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.5 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.86 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 2.31 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' A' ' 19' ' ' LYS . 58.4 tp60 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 3.0 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.92 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 92' ' ' THR . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.67 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 93' ' ' SER . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.13 108.437 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.79 109.466 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 3.08 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 94' ' ' ARG . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 93' ' ' SER . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 9.02 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.75 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.59 109.207 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.61 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.55 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.73 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.448 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 4.52 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 5.16 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.9 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 3.51 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.72 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 2.67 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.88 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 106' ' ' LYS . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' CD2' ' C ' ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.71 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.38 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.98 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.68 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 3.01 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 2.19 109.127 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 2.19 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.622 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.78 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.92 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.95 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 4.14 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 2.34 109.828 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.73 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 2.41 108.114 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.86 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.29 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.13 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 5.18 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 4.01 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' O ' ' CG2' ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.46 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.526 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.76 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 3.1 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.93 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' O ' ' OG1' ' A' ' 144' ' ' THR . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 6.19 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.32 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 4.58 113.207 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.94 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 5.63 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 2.11 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 5.23 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.46 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.652 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 3.74 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 2.18 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.71 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 158' ' ' LYS . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 4.06 109.4 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.73 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.53 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 3.08 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.96 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.492 ' CD1' ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 2.49 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 2.1 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.66 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 3.18 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.93 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.448 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.79 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.52 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 5.08 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 3.28 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.56 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.96 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 179' ' ' ILE . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.19 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 4.29 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.62 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.71 108.853 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.641 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 5.13 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.525 ' HG ' ' C ' ' A' ' 183' ' ' LEU . 4.4 p . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.56 109.942 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.432 -0.581 . . . . 15.72 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 5' ' ' ASN . . . 89.24 -57.02 3.95 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.674 -1.37 . . . . 11.76 109.674 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -57.74 -29.56 64.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -1.218 . . . . 12.98 109.705 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.8 p -59.4 -22.73 61.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 8.5 110.054 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -82.55 8.9 10.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.015 -1.053 . . . . 8.22 109.737 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.536 ' N ' HD21 ' A' ' 5' ' ' ASN . 29.4 t -108.76 149.78 28.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 5.49 109.7 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' SER . 54.0 mttm 56.26 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 5.37 109.911 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.68 156.9 32.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 2.74 109.146 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -60.71 147.64 83.82 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 3.02 109.448 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.41 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.26 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 3.14 108.11 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 3.25 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 18' ' ' ARG . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.94 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.37 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.37 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.17 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 3.52 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 4.31 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.56 109.771 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.98 110.097 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 4.19 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 4.09 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 6.1 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.516 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 3.45 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.54 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 3.04 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 4.62 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.83 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 6.06 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 5.26 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.53 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 3.02 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.51 109.204 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 3.27 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 2.25 109.197 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.35 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.17 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 3.39 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.9 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.8 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 3.46 108.606 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.54 107.874 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 4.05 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.67 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.74 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 7.19 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.99 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.8 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 4.22 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 5.03 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.84 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.77 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.9 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 2.18 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.4 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 3.11 109.177 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 72' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 2.09 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 5.03 109.462 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.76 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 2.42 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 3.43 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.81 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.57 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 3.05 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.74 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 2.08 107.115 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.48 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.95 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.5 109.462 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.86 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 2.31 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' O ' ' OG ' ' A' ' 90' ' ' SER . 52.1 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 3.0 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.92 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.67 108.714 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.13 109.015 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.79 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 3.08 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 9.02 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.75 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.59 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.61 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.55 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.73 109.386 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 4.52 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.416 ' HE1' HG12 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 5.16 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.9 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 3.51 110.035 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.72 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 2.67 109.92 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.88 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' CG1' ' A' ' 71' ' ' VAL . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.71 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.38 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.98 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.68 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 3.01 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 2.19 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 2.19 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.606 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.78 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.92 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.95 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 4.14 109.563 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 2.34 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.73 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 2.41 108.147 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.86 109.46 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' GLY . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.29 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.13 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 5.18 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 4.01 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.46 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.76 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 3.1 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.93 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 6.19 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.32 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 4.58 113.137 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.94 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 5.63 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 2.11 109.263 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 5.23 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.46 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 3.74 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 2.18 107.702 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.71 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 4.06 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.606 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.73 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.694 ' ND2' ' N ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.53 109.701 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.694 ' N ' ' ND2' ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 3.08 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.96 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 2.49 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.499 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 2.1 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.406 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.66 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 3.18 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.93 109.922 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.79 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.52 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.487 ' HZ1' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 5.08 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 3.28 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 172' ' ' GLY . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.56 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.96 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.551 ' N ' ' HG ' ' A' ' 178' ' ' SER . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.19 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 4.29 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.62 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.71 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.687 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 5.13 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m -63.51 161.59 14.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.56 109.686 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 185' ' ' LEU . 6.0 mp -90.21 137.17 32.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 7.56 109.032 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -96.84 132.61 42.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 10.13 109.687 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.73 -39.02 83.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.338 -0.851 . . . . 8.42 110.028 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.95 -179.89 46.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.795 -1.322 . . . . 9.13 109.795 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.1 -3.55 58.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -1.126 . . . . 11.96 109.395 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 12.92 109.389 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.655 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.292 -0.633 . . . . 15.72 109.292 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.22 48.37 1.94 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.137 -1.585 . . . . 11.76 109.137 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 57.83 34.29 24.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.558 -0.966 . . . . 12.98 109.162 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m -129.38 151.81 49.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.006 -0.739 . . . . 8.5 109.006 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 t30 58.84 53.68 5.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 8.22 109.242 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 p -57.15 163.24 2.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 5.49 109.725 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' LEU . 27.8 mtmm -84.6 167.54 16.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 5.37 109.734 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -37.28 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 2.74 109.85 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -59.51 151.28 61.5 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 3.02 109.487 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.41 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.26 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 24' ' ' GLU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 3.14 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 3.25 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.94 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.37 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.37 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.17 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' H ' HG23 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 3.52 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 4.31 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.56 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.98 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 4.19 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 4.09 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 6.1 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 3.45 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.54 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 3.04 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 4.62 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.83 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 6.06 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 5.26 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.53 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 3.02 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.719 HE22 ' NH2' ' A' ' 79' ' ' ARG . 43.5 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.51 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 3.27 109.857 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 2.25 109.456 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.35 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.17 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 3.39 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.9 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.8 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 3.46 108.258 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.54 107.188 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 4.05 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.67 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.74 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 7.19 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.99 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.8 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 4.22 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 5.03 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.84 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.77 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.9 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 2.18 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.4 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 3.11 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 2.09 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 5.03 109.72 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.76 110.699 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 2.42 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 3.43 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.583 HD22 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.81 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.57 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.583 ' CG ' HD22 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 3.05 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.719 ' NH2' HE22 ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.74 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 2.08 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.48 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.95 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.5 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.86 109.971 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 2.31 110.442 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 3.0 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.92 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.67 109.121 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.13 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.79 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 88' ' ' ALA . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 3.08 109.638 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 9.02 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.75 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.561 ' C ' ' HZ2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.59 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.61 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' HZ2' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.55 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.73 108.737 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 4.52 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 5.16 109.137 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.9 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 3.51 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.72 109.751 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 2.67 110.048 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.88 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.71 110.618 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.38 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 2.0 t-20 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.98 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.68 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 3.01 110.468 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 2.19 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 2.19 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.647 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.78 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.92 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.95 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 4.14 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 2.34 109.305 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.73 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 2.41 107.926 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.86 110.884 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.29 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.13 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 5.18 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 133' ' ' GLY . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 4.01 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.46 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.76 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 3.1 108.606 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.93 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 6.19 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.406 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.32 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 4.58 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.405 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.94 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 5.63 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 2.11 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 5.23 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.46 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 3.74 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 2.18 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.71 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 4.06 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.647 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.73 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.53 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 3.08 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.96 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 2.49 107.988 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 2.1 109.828 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.66 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 3.18 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.93 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.79 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.52 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 5.08 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 3.28 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.56 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.96 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.19 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 179' ' ' ILE . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 4.29 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.62 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.71 109.335 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.665 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 5.13 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -36.42 -69.03 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.56 110.393 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 184' ' ' SER . 61.4 tp 50.56 106.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 7.56 109.954 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 68.3 t80 54.94 59.7 3.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -0.976 . . . . 10.13 109.288 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.8 p30 -67.7 -20.44 65.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 8.42 109.949 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -78.6 176.42 54.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.781 -1.328 . . . . 9.13 109.781 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 21.8 tp -173.9 75.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -1.073 . . . . 11.96 109.203 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.944 -1.027 . . . . 12.92 109.386 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.601 -0.518 . . . . 15.72 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.62 -159.07 15.69 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.82 -1.312 . . . . 11.76 109.82 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -55.38 -36.16 66.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -1.035 . . . . 12.98 109.872 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -68.11 155.45 39.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 8.5 109.524 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.66 HD21 ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -136.18 2.43 2.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 8.22 109.389 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.66 ' N ' HD21 ' A' ' 5' ' ' ASN . 5.2 p 37.16 84.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 5.49 110.201 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.686 ' NZ ' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -58.39 -37.13 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 5.37 108.944 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -144.52 136.87 26.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.191 -1.04 . . . . 2.74 108.191 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -52.88 146.91 17.17 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.894 -1.129 . . . . 3.02 109.062 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.41 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.26 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 3.14 110.005 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 3.25 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.94 109.528 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.37 108.423 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.37 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.17 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 3.52 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 4.31 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.56 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.98 108.294 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.686 ' NE2' ' NZ ' ' A' ' 7' ' ' LYS . 40.0 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 4.19 108.075 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 4.09 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 6.1 108.487 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 3.45 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.54 107.839 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 3.04 109.996 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 4.62 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.83 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 6.06 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 5.26 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.53 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 3.02 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.51 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 3.27 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 2.25 109.533 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.35 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.17 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 3.39 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.9 108.551 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.8 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 3.46 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.54 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 4.05 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.67 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.74 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 7.19 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.99 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.8 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 4.22 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 5.03 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.84 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.674 ' N ' ' HG1' ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.77 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.9 109.636 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 2.18 109.722 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.4 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 3.11 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 2.09 109.213 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 5.03 109.295 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.76 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 2.42 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 3.43 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.81 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.57 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 3.05 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.74 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG21 HD12 ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 2.08 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.48 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.95 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.5 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.86 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 2.31 109.494 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 3.0 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.92 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' OG1' ' A' ' 92' ' ' THR . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.67 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.13 108.945 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.79 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 3.08 108.841 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 9.02 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.75 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.59 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.61 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.55 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.73 109.533 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 4.52 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 5.16 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.9 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 3.51 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.72 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 2.67 110.383 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.88 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.71 109.789 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.38 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.98 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.68 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 3.01 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 2.19 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 2.19 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' NE ' ' OD2' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.78 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.92 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.95 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 4.14 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 2.34 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.73 109.953 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 2.41 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.86 111.314 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.29 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.13 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 5.18 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 4.01 108.935 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.46 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.76 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 3.1 108.194 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.93 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.708 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 6.19 110.49 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.584 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.32 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.412 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 4.58 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.94 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.523 ' NH1' ' CD ' ' A' ' 142' ' ' GLU . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 5.63 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 2.11 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 5.23 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.46 111.743 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 3.74 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 2.18 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.71 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 4.06 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.581 ' OD2' ' NE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.73 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.676 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.53 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 3.08 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.96 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 2.49 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.407 ' N ' HD11 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 2.1 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.66 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 3.18 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' OG ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.93 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.79 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.52 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 5.08 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 3.28 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.56 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.96 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 179' ' ' ILE . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.19 110.179 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 4.29 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.62 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.71 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.618 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 5.13 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m -117.16 145.18 44.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.56 109.758 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.5 132.96 56.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.527 -0.733 . . . . 7.56 109.032 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 2.3 p90 -95.72 173.47 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 10.13 109.619 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -53.07 -37.58 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 8.42 109.817 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.13 87.09 1.83 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.676 -1.37 . . . . 9.13 109.676 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 1.0 OUTLIER -63.4 -31.4 72.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 11.96 109.082 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.009 -0.996 . . . . 12.92 109.465 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.302 -0.629 . . . . 15.72 109.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 4' ' ' SER . . . -170.82 -168.69 32.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.396 -1.482 . . . . 11.76 109.396 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? 64.5 -0.49 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.443 -1.034 . . . . 12.98 109.476 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 2' ' ' GLY . 19.6 m -123.48 146.24 48.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.277 -0.889 . . . . 8.5 109.484 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -135.75 133.7 38.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 8.22 109.628 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.5 t -111.5 143.0 43.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.853 . . . . 5.49 109.349 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -85.51 160.86 19.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 5.37 109.348 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -66.77 140.99 57.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 2.74 108.529 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 8' ' ' LEU . 11.2 mmtp -39.11 103.38 0.28 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.511 -0.743 . . . . 3.02 109.192 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.41 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.26 108.836 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 3.14 108.117 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 3.25 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.94 107.968 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.37 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.37 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.17 108.907 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 3.52 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 4.31 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.56 110.287 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.98 109.743 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 4.19 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 4.09 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 6.1 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 3.45 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.54 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 3.04 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 4.62 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 35' ' ' ILE . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' HZ1' ' CB ' ' A' ' 36' ' ' LYS . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.83 109.392 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 6.06 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 5.26 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.53 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 3.02 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.51 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 3.27 109.354 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.25 109.747 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.35 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.17 109.448 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 3.39 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 88.5 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.9 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.8 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 3.46 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.54 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 4.05 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.67 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.74 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 7.19 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD2' ' H ' ' A' ' 58' ' ' PHE . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.99 113.233 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.8 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 4.22 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 5.03 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.84 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.77 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.9 109.882 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 2.18 109.695 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.59 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.4 109.016 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 3.11 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 2.09 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 5.03 109.699 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.76 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 2.42 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 3.43 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.81 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.57 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 3.05 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.74 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 2.08 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.48 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.95 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.5 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.86 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 2.31 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 3.0 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.92 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.67 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.13 108.954 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.79 108.831 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 3.08 109.477 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 9.02 108.162 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.75 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.59 108.486 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.61 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' H ' HD22 ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.55 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.73 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 4.52 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 5.16 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.9 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 3.51 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.72 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 2.67 110.049 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.88 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.71 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.38 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.98 111.571 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.68 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 3.01 110.112 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 2.19 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 2.19 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.78 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.92 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.95 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 4.14 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 2.34 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.73 109.579 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 2.41 107.857 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 128' ' ' ILE . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.86 109.188 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.29 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.13 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 5.18 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 4.01 109.614 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.46 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.76 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 3.1 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.93 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 6.19 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.553 ' O ' ' CG2' ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.32 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 4.58 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.94 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 5.63 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 2.11 109.538 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 5.23 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.46 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.687 ' CD1' ' NE ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 3.74 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.71 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 4.06 110.37 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.73 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.586 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 22.4 m120 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.53 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.586 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 3.08 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.96 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 2.49 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 2.1 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 167' ' ' GLN . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.66 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 3.18 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.93 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.79 110.246 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.52 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 5.08 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 3.28 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.56 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.96 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.19 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 4.29 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.62 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.71 108.955 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.645 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 5.13 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.9 91.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.56 110.009 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 8.4 tt -109.7 116.3 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.561 -0.903 . . . . 7.56 108.561 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -123.86 142.62 50.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 10.13 109.927 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -124.89 2.64 8.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.513 -0.742 . . . . 8.42 109.066 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.11 137.68 13.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 9.13 109.626 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -168.92 29.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.315 -1.109 . . . . 11.96 109.297 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.008 -0.996 . . . . 12.92 109.478 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.47 -0.567 . . . . 15.72 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.06 61.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.684 -1.366 . . . . 11.76 109.684 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -59.74 -36.97 77.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -1.219 . . . . 12.98 109.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 55.8 p -70.71 168.12 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.847 . . . . 8.5 109.411 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 7' ' ' LYS . 33.3 t30 87.47 -137.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.467 -0.568 . . . . 8.22 109.467 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m 45.69 13.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 5.49 109.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 9' ' ' LYS . 7.1 ttpt -129.6 155.76 45.29 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.57 -0.9 . . . . 5.37 108.57 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -63.82 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.089 . . . . 2.74 110.598 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.612 ' H ' ' C ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER 58.54 138.47 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.025 -1.047 . . . . 3.02 109.873 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.41 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.26 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 3.14 109.028 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 ' O ' ' OG1' ' A' ' 20' ' ' THR . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 3.25 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 18' ' ' ARG . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.94 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.37 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.37 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.576 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.17 108.372 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 3.52 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 4.31 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.56 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.98 109.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 4.19 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 4.09 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 6.1 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 3.45 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.54 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 3.04 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 4.62 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.83 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 6.06 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 5.26 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.53 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 3.02 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.51 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 3.27 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 2.25 109.866 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.35 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.17 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 3.39 108.039 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 80.3 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.9 108.441 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.8 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 3.46 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.453 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.54 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 4.05 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.67 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.74 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 7.19 109.906 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.99 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.8 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 4.22 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 5.03 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.84 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' H ' ' CG2' ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.77 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.616 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.9 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 2.18 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.597 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.4 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 3.11 108.725 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 2.09 109.324 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 5.03 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.76 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 2.42 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 3.43 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.81 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.57 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 3.05 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.74 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 2.08 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.48 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.95 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.5 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.86 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 2.31 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 90' ' ' SER . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 3.0 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.92 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.67 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.13 109.005 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.79 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 3.08 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 9.02 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.75 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.59 108.592 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.61 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.55 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.73 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 4.52 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 5.16 109.466 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.9 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 3.51 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.731 ' HZ3' ' ND2' ' A' ' 112' ' ' ASN . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.72 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 2.67 109.422 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.88 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.71 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.38 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.731 ' ND2' ' HZ3' ' A' ' 106' ' ' LYS . 43.3 p-10 -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.98 110.772 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.68 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 3.01 109.315 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 2.19 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 2.19 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.78 109.8 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.92 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.95 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 4.14 109.236 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 2.34 109.381 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.73 110.421 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 2.41 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.86 108.975 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.29 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.13 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 5.18 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 4.01 109.434 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.46 109.768 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.76 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 3.1 110.114 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.93 111.984 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CB ' ' A' ' 144' ' ' THR . 30.0 m120 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 6.19 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.32 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 4.58 112.214 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.94 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 5.63 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 2.11 108.958 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 5.23 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.46 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 3.74 109.072 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 2.18 108.197 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.71 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.578 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 4.06 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.73 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.718 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.53 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 3.08 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.96 108.888 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 2.49 108.661 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 2.1 109.72 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.587 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.66 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 3.18 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.93 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.79 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.52 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 5.08 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 3.28 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.56 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.582 ' OG ' ' NE2' ' A' ' 181' ' ' GLN . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.96 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.19 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 4.29 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.582 ' NE2' ' OG ' ' A' ' 178' ' ' SER . 11.8 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.62 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.71 109.738 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.699 ' CD1' ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 5.13 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -100.96 14.57 31.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.56 110.022 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.0 mt -54.79 -35.36 63.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.047 -1.033 . . . . 7.56 110.024 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 77.3 t80 47.0 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.989 -1.07 . . . . 10.13 109.555 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 187' ' ' ASP . 53.4 p30 -92.89 9.12 36.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 8.42 109.626 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -81.04 42.2 2.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.716 -1.354 . . . . 9.13 109.716 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 3.4 mm? -60.22 -33.24 71.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -1.185 . . . . 11.96 109.465 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.97 -1.014 . . . . 12.92 109.457 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.487 -0.56 . . . . 15.72 109.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.23 165.59 24.9 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.493 . . . . 11.76 109.369 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -136.69 154.98 50.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -1.166 . . . . 12.98 109.692 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p -131.0 153.2 49.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 8.5 109.143 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -129.96 85.3 2.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 8.22 109.606 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 5' ' ' ASN . 2.7 m 39.53 21.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 5.49 109.883 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 5' ' ' ASN . 55.2 pttt -89.86 164.73 14.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 5.37 109.177 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' N ' ' CZ ' ' A' ' 31' ' ' TYR . 24.7 tp -94.72 124.2 38.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 2.74 109.023 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -82.86 145.0 49.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.998 . . . . 3.02 109.437 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.41 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.26 108.8 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 3.14 108.948 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 19' ' ' LYS . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 3.25 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.94 106.841 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.37 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.37 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.578 ' CG2' ' H ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.17 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 3.52 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 4.31 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.56 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.98 110.364 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 4.19 109.538 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 4.09 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 6.1 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 3.45 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.54 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 3.04 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 4.62 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.83 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 6.06 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 5.26 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.53 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 3.02 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.51 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 3.27 109.91 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 2.25 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.35 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.17 109.903 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 3.39 108.905 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.9 108.766 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.8 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 52' ' ' TYR . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 3.46 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.414 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.54 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 4.05 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.67 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.74 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 7.19 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.99 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.8 109.547 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 4.22 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 5.03 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.84 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.77 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.9 109.604 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 2.18 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.4 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 3.11 108.55 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 70' ' ' ASN . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 2.09 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 68' ' ' VAL . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 5.03 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.76 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 2.42 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 3.43 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.81 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.57 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 3.05 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.74 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 2.08 108.178 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.48 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.95 109.152 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.5 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.86 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 2.31 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 3.0 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.92 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.67 108.031 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.13 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.79 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 3.08 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 9.02 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.75 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.59 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.681 ' H ' ' CD2' ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.61 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.55 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.73 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 4.52 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 5.16 108.743 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.9 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 3.51 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' CB ' ' HZ3' ' A' ' 106' ' ' LYS . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.72 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 2.67 110.439 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.88 108.743 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.71 110.134 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.595 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.38 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 111' ' ' ASP . 4.7 p30 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.98 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.68 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 3.01 108.924 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 2.19 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 2.19 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.78 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.92 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.95 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 4.14 108.828 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 2.34 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.73 108.95 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 2.41 108.44 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 128' ' ' ILE . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.86 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.29 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.13 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 5.18 109.04 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 4.01 109.733 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.46 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.51 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.76 108.395 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 3.1 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.93 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.451 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 6.19 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.32 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 4.58 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.94 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 5.63 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 150' ' ' ASP . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 2.11 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 149' ' ' VAL . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 5.23 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.46 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 3.74 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 2.18 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.71 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.54 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 4.06 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.73 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.724 ' H ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.53 109.503 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 163' ' ' LYS . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 3.08 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.96 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' A' ' 164' ' ' LEU . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 2.49 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 2.1 109.826 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.584 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.66 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 3.6 mm100 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 3.18 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.93 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.79 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.52 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 5.08 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 3.28 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.56 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.96 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.19 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 4.29 108.798 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.62 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.71 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 5.13 109.221 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p -66.96 161.18 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.56 108.822 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 50.5 tp -148.06 -26.84 0.34 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.01 . . . . 7.56 110.091 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.67 115.02 25.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.963 . . . . 10.13 109.869 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.41 -35.75 81.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 8.42 108.906 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.99 12.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.179 -1.568 . . . . 9.13 109.179 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 190' ' ' VAL . 34.8 tp -55.87 -35.31 66.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -1.083 . . . . 11.96 109.497 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 189' ' ' LEU . 5.6 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.017 -0.992 . . . . 12.92 110.407 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H2 ' ' HB3' ' A' ' 4' ' ' SER . 59.6 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.337 -0.616 . . . . 15.72 109.337 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.61 -64.94 2.52 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.631 -1.387 . . . . 11.76 109.631 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -131.53 45.23 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.33 -1.1 . . . . 12.98 109.732 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 6' ' ' SER . 78.4 p -69.53 -11.82 61.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 8.5 109.632 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.4 OUTLIER -44.81 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 8.22 109.342 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' SER . 51.0 m -122.94 151.06 42.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.475 -0.766 . . . . 5.49 109.334 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -61.62 175.17 0.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 5.37 109.224 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -62.38 142.63 57.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 2.74 109.441 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HZ3' ' HB3' ' A' ' 11' ' ' GLU . 19.5 pttp -65.26 147.54 98.52 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 3.02 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.41 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.26 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' CG2' ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 3.14 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 3.25 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.94 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.37 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.37 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.534 ' CG2' ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.417 ' HH ' ' HA2' ' A' ' 95' ' ' GLY . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.17 111.111 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.534 ' H ' ' CG2' ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 3.52 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 4.31 109.768 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.56 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 28' ' ' GLN . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.98 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 4.19 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 4.09 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 6.1 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 8' ' ' LEU . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 3.45 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.54 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 3.04 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 4.62 110.863 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.83 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 6.06 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 5.26 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.53 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 3.02 110.208 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' CD ' ' A' ' 79' ' ' ARG . 12.6 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.51 109.468 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 3.27 109.535 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 2.25 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.35 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.17 109.347 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 3.39 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' NE2' ' CG2' ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.9 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.8 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 3.46 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.54 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 4.05 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.67 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.74 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 7.19 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.99 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.8 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 4.22 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 5.03 112.749 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.84 110.974 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.77 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.9 109.501 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 2.18 109.683 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.4 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 3.11 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 72' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 2.09 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 5.03 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.76 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 2.42 110.608 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 3.43 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.81 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.57 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 3.05 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.74 108.773 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 2.08 108.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.48 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.95 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.5 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.86 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 2.31 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 3.0 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.92 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.475 ' O ' ' OG1' ' A' ' 92' ' ' THR . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.67 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.13 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.79 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 3.08 109.475 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.476 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 9.02 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' HA2' ' HH ' ' A' ' 21' ' ' TYR . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.75 109.584 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.59 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.61 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.55 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.73 108.889 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 4.52 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 5.16 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.9 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 3.51 109.861 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.72 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 2.67 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.88 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.488 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.71 109.847 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.38 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.98 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.68 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 3.01 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 2.19 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 2.19 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.556 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.78 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.92 108.704 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.95 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 4.14 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 2.34 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.73 109.953 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 2.41 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.86 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.619 ' O ' ' N ' ' A' ' 133' ' ' GLY . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.29 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.13 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 5.18 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 4.01 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.46 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.76 108.95 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' HA ' ' HG ' ' A' ' 184' ' ' SER . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 3.1 110.002 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.93 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.53 HD21 ' NH1' ' A' ' 148' ' ' ARG . 32.3 m120 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 6.19 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.496 ' O ' ' C ' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.32 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 4.58 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.94 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.53 ' NH1' HD21 ' A' ' 143' ' ' ASN . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 5.63 109.857 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 2.11 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 5.23 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.46 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 3.74 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 2.18 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.71 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 4.06 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.73 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.573 HD22 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.53 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.573 ' CG ' HD22 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 3.08 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.96 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 2.49 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 2.1 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.66 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 3.18 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.517 ' O ' ' OG ' ' A' ' 173' ' ' SER . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.93 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.79 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.52 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 5.08 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 3.28 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.56 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.96 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 179' ' ' ILE . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.19 110.302 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 182' ' ' ALA . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 4.29 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.62 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.71 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 5.13 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.415 ' HG ' ' HA ' ' A' ' 137' ' ' GLU . 40.0 m -120.68 141.4 50.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.56 109.367 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.16 134.82 54.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.817 -0.809 . . . . 7.56 108.817 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -81.27 122.42 27.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.146 -0.972 . . . . 10.13 109.998 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -156.57 67.86 0.57 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.528 -0.916 . . . . 8.42 108.528 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.0 11.02 79.76 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.77 -1.732 . . . . 9.13 108.77 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 35.8 tp -58.08 -36.79 73.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.493 -1.004 . . . . 11.96 109.714 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.008 -0.996 . . . . 12.92 109.259 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.447 -0.575 . . . . 15.72 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.6 103.09 2.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.748 -1.341 . . . . 11.76 109.748 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -60.05 -30.81 69.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 12.98 109.476 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' SER . 23.5 m -54.6 -32.54 58.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 8.5 109.507 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.2 63.3 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 8.22 109.41 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' SER . 74.6 m -81.92 3.29 26.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 5.49 109.516 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 8' ' ' LEU . 24.9 mtpt 57.12 39.16 29.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.388 -0.82 . . . . 5.37 109.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 7' ' ' LYS . 37.5 tp 42.29 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.805 . . . . 2.74 109.803 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -62.94 135.95 96.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 3.02 109.633 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.41 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.26 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 3.14 108.715 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 3.25 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.94 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.37 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.37 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 22' ' ' PHE . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.17 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 3.52 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 4.31 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' CB ' ' HZ3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.56 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' ' N ' ' A' ' 28' ' ' GLN . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.98 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 4.19 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 4.09 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 6.1 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 3.45 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.54 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 3.04 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 4.62 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.83 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 6.06 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 5.26 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.53 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 3.02 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.51 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 3.27 109.662 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 2.25 110.079 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.35 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.17 109.253 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 3.39 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.505 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.9 108.83 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.8 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.456 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 3.46 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.54 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 4.05 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.67 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.74 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 7.19 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 59' ' ' GLY . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.99 112.926 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.416 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.8 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 4.22 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 5.03 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 60' ' ' ASP . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.84 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.643 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.77 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.672 ' CE1' ' SD ' ' A' ' 131' ' ' MET . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.9 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 2.18 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.4 109.286 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' ' CD1' ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 3.11 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 2.09 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 5.03 109.204 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.76 110.917 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 2.42 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 3.43 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.81 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.57 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 3.05 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.74 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 2.08 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.48 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.95 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.5 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.86 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 2.31 110.278 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.503 ' O ' ' OG ' ' A' ' 90' ' ' SER . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 3.0 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.92 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.525 ' CD1' ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.67 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.13 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.79 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 3.08 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 9.02 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.75 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.59 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.563 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.61 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.55 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.73 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 4.52 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 5.16 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.9 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' ' OD1' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 3.51 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.72 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 2.67 109.856 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.88 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.71 110.06 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.38 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 36.8 t30 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.98 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.68 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 3.01 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 2.19 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' OD1' ' A' ' 119' ' ' ASN . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 2.19 108.383 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.571 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.78 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.498 ' OD1' ' OG1' ' A' ' 117' ' ' THR . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.92 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.95 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 4.14 108.921 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 2.34 108.968 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 127' ' ' ALA . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.73 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 2.41 107.937 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.86 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.29 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.13 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 5.18 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 4.01 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.46 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 131' ' ' MET . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.76 109.651 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 3.1 108.376 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.93 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 6.19 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.32 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 4.58 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.94 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 5.63 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 150' ' ' ASP . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 2.11 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 149' ' ' VAL . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 5.23 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.46 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 3.74 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 2.18 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.71 109.01 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 4.06 110.008 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.585 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.73 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.694 HD21 ' N ' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.53 109.689 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.694 ' N ' HD21 ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 3.08 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.96 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 177.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 2.1 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.66 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 3.18 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.93 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.79 110.138 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.52 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 5.08 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 3.28 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.56 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.96 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.19 109.035 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 4.29 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.62 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.71 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 5.13 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.579 ' C ' ' H ' ' A' ' 186' ' ' TYR . 47.9 t -120.24 -61.74 1.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.56 109.467 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 186' ' ' TYR . 7.5 mp 51.38 5.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 7.56 109.847 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' A' ' 184' ' ' SER . 71.5 t80 53.3 166.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 10.13 109.604 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 186' ' ' TYR . 91.5 m-20 -55.75 -38.47 69.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.011 . . . . 8.42 109.573 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 148.45 119.54 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 9.13 109.52 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' VAL . 67.6 mt -61.38 -33.02 72.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -1.138 . . . . 11.96 109.471 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' LEU . 4.4 m . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 117.971 -1.014 . . . . 12.92 109.469 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.403 -0.591 . . . . 15.72 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.37 120.36 15.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.455 -1.458 . . . . 11.76 109.455 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ASN . 75.4 tttt -59.67 -40.23 87.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -1.148 . . . . 12.98 109.678 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' LYS . 47.1 t 40.16 -100.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.412 -0.805 . . . . 8.5 109.487 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' LYS . 83.7 m-20 -112.43 143.65 43.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.797 . . . . 8.22 109.169 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.4 m -115.44 138.48 50.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 5.49 109.479 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.565 ' HZ1' ' CD ' ' A' ' 32' ' ' LYS . 21.5 mmtp -137.92 -68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.428 -0.795 . . . . 5.37 109.272 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.579 ' CD1' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -89.17 157.55 18.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 2.74 110.065 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -66.62 151.8 95.95 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 3.02 109.408 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.41 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.26 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 3.14 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 3.25 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.94 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.429 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.37 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.696 ' HZ2' ' NE2' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.37 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.595 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.17 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 3.52 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 4.31 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.56 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.98 109.423 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 4.19 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 4.09 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 6.1 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 3.45 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.565 ' CD ' ' HZ1' ' A' ' 7' ' ' LYS . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.54 108.429 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 3.04 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 4.62 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.83 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 6.06 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 5.26 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.53 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 3.02 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.51 109.765 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 3.27 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 2.25 109.986 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.35 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.17 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 3.39 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' OE1' ' CG2' ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.9 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.8 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 3.46 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.54 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 4.05 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.67 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.74 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 7.19 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.99 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.8 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 4.22 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 5.03 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.84 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.77 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.9 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 2.18 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.4 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 3.11 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 72' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 2.09 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 5.03 109.041 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.76 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 2.42 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 3.43 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.81 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.57 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 3.05 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.74 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 2.08 108.22 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.48 110.57 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.95 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.5 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.86 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 2.31 109.476 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.696 ' NE2' ' HZ2' ' A' ' 19' ' ' LYS . 51.2 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 3.0 110.486 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.92 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.502 ' O ' ' OG1' ' A' ' 92' ' ' THR . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.67 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 91' ' ' VAL . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.13 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' N ' ' HG ' ' A' ' 90' ' ' SER . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.79 108.453 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 3.08 108.631 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.626 ' HG ' ' N ' ' A' ' 94' ' ' ARG . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.626 ' N ' ' HG ' ' A' ' 93' ' ' SER . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 9.02 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.75 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' N ' ' HH ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.59 108.499 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.61 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.55 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.73 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 4.52 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 5.16 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.9 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 3.51 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.72 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 2.67 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.88 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.71 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.38 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.98 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.68 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 3.01 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 2.19 109.179 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 2.19 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.78 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.92 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.95 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 4.14 109.708 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 2.34 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.73 109.588 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 2.41 107.346 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.86 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.29 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.13 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 5.18 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 4.01 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' O ' ' CG2' ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.46 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 135' ' ' THR . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.76 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.541 ' CD2' ' H ' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 3.1 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.93 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 6.19 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.32 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 4.58 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.94 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.417 ' N ' ' CG ' ' A' ' 147' ' ' LYS . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 5.63 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 2.11 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 5.23 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.46 109.693 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 3.74 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 2.18 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.71 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 4.06 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.73 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.53 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 3.08 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.96 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 2.49 108.164 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 2.1 110.14 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.66 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 3.18 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.93 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.79 109.522 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.52 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 5.08 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 3.28 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.56 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.592 ' HG ' ' N ' ' A' ' 179' ' ' ILE . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.96 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' N ' ' HG ' ' A' ' 178' ' ' SER . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.19 110.15 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 4.29 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 182' ' ' ALA . 7.1 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.62 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.71 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.675 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 5.13 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 185' ' ' LEU . 19.9 m -70.74 -83.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.56 109.309 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 184' ' ' SER . 8.3 tt 37.46 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.652 -0.655 . . . . 7.56 110.087 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -75.95 102.12 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.007 . . . . 10.13 108.861 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.618 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 54.1 p30 -69.82 -25.84 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 8.42 110.639 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -52.43 -32.02 37.06 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.658 -1.377 . . . . 9.13 109.658 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 38.2 tp -56.91 -36.05 69.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 11.96 109.275 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.298 -1.663 0 CA-C-O 117.957 -1.021 . . . . 12.92 109.506 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.387 -0.597 . . . . 15.72 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.43 47.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.721 -1.351 . . . . 11.76 109.721 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 tptt 61.55 45.55 8.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -1.047 . . . . 12.98 109.071 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -124.15 146.59 48.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.447 -0.783 . . . . 8.5 109.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -139.27 -172.0 3.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 8.22 109.91 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER 71.78 -81.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.505 -0.747 . . . . 5.49 109.594 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 6' ' ' SER . 68.4 mttm 36.45 -91.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.392 -0.817 . . . . 5.37 110.124 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -110.85 169.86 8.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.395 -0.815 . . . . 2.74 108.913 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.17 148.33 78.74 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 3.02 108.997 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.41 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.26 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 3.14 109.791 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 3.25 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.94 108.514 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.37 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.37 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.17 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 3.52 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 4.31 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.56 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.98 109.413 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 4.19 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 4.09 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 6.1 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 3.45 108.554 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.54 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 3.04 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 4.62 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.83 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 6.06 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 5.26 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.53 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 3.02 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.598 ' NE2' ' NH1' ' A' ' 79' ' ' ARG . 33.3 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.51 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 3.27 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 2.25 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.35 110.087 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.17 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 3.39 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 65.0 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.9 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.8 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 52' ' ' TYR . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 3.46 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.54 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 4.05 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.67 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.74 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 7.19 110.002 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.99 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.8 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 4.22 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 5.03 112.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.84 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.77 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.551 ' H ' ' CG ' ' A' ' 131' ' ' MET . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.9 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.406 ' HB1' HE21 ' A' ' 49' ' ' GLN . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 2.18 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.4 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 3.11 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 2.09 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 5.03 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.76 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 2.42 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' VAL . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 3.43 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 1.0 OUTLIER 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.81 109.559 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.57 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 3.05 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' NH1' ' NE2' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.74 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 2.08 107.745 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.48 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.95 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.5 109.529 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.86 109.828 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 2.31 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 3.0 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.92 108.357 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 92' ' ' THR . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.67 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.13 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.79 109.159 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 3.08 109.135 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.449 ' N ' ' HG1' ' A' ' 92' ' ' THR . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 9.02 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.75 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.59 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.61 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.55 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.73 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 4.52 110.849 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 5.16 109.745 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.9 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 3.51 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HZ2' ' HB3' ' A' ' 102' ' ' ARG . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.72 108.747 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 2.67 108.833 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.88 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.502 ' N ' ' OE2' ' A' ' 120' ' ' GLU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.71 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.38 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.98 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.68 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 3.01 108.979 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 2.19 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 2.19 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.728 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.78 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.92 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.95 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 4.14 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 2.34 109.258 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.73 109.967 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 2.41 108.368 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.86 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.29 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.13 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 5.18 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 4.01 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.46 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.76 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 3.1 108.434 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.93 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 181' ' ' GLN . 81.5 m-20 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 6.19 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.32 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 4.58 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.94 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.532 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 5.63 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 2.11 108.894 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 5.23 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.46 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 3.74 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 2.18 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.71 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 4.06 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.73 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.53 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 3.08 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.96 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 2.49 108.145 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 2.1 109.44 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.66 110.027 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 3.18 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.93 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.79 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.52 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 5.08 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 3.28 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.56 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.96 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 179' ' ' ILE . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.19 109.99 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 4.29 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 143' ' ' ASN . 13.3 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.62 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 184' ' ' SER . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.71 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 5.13 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m -121.85 144.06 49.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.56 107.748 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 6.2 tp -106.58 129.39 54.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 7.56 109.557 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -85.3 167.14 15.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.883 . . . . 10.13 109.082 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 40.0 p-10 -59.64 -34.73 73.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 8.42 109.644 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.583 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 163.81 153.52 7.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.648 -1.381 . . . . 9.13 109.648 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 189' ' ' LEU . 7.3 mp -63.21 -33.28 75.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.104 . . . . 11.96 109.512 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 118.017 -0.992 . . . . 12.92 109.48 -179.888 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.314 0.578 . . . . 15.72 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.75 -43.0 2.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 11.76 109.573 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -57.82 -29.26 64.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -1.185 . . . . 12.98 109.464 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -58.41 -29.78 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 8.5 109.912 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 22.5 p-10 -171.06 -59.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 8.22 110.407 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' ASN . 22.9 t 42.36 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.093 -1.004 . . . . 5.49 109.241 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -100.21 164.23 12.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.323 -0.861 . . . . 5.37 109.978 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.54 148.5 27.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 2.74 109.194 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -58.97 147.16 74.66 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 3.02 109.121 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.41 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.26 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 3.14 108.401 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 3.25 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' LEU . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.94 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.37 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.37 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.17 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 20' ' ' THR . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 3.52 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 4.31 109.092 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.56 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.98 108.475 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 4.19 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 4.09 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 6.1 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.526 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 3.45 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.54 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 3.04 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 4.62 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.83 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 6.06 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 5.26 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.53 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 3.02 109.579 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.714 HE22 ' NH2' ' A' ' 79' ' ' ARG . 49.9 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.51 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 3.27 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.543 ' N ' ' CZ ' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 2.25 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.35 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.17 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 3.39 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.9 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.8 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 3.46 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.54 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 4.05 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.67 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.74 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 7.19 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.99 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.8 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 4.22 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 5.03 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.84 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.77 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.9 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 2.18 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 63' ' ' LYS . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.4 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 3.11 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 2.09 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 5.03 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.76 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 2.42 110.389 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 3.43 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.81 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.57 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 3.05 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.714 ' NH2' HE22 ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.74 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 2.08 107.875 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.48 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.95 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.5 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.86 109.327 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 2.31 109.923 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 3.0 109.767 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.534 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.92 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 ' O ' ' OG1' ' A' ' 92' ' ' THR . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.67 108.579 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.13 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.79 109.036 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 3.08 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.441 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 9.02 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.75 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.59 108.727 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.61 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.55 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.73 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 4.52 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.454 ' CH2' ' CD1' ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 5.16 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.9 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 3.51 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.72 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.454 ' CD1' ' CH2' ' A' ' 103' ' ' TRP . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 2.67 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.88 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.71 109.749 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.38 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.98 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.68 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 3.01 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 2.19 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.491 ' OG1' ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 2.19 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.671 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.78 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.92 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.95 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 4.14 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 2.34 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.73 109.423 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 2.41 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.86 109.986 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.29 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.13 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.536 ' O ' ' OG1' ' A' ' 135' ' ' THR . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 5.18 108.351 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 4.01 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.46 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 131' ' ' MET . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.76 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 3.1 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.93 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 6.19 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.32 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 4.58 113.754 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.94 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 5.63 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 2.11 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 5.23 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.46 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.564 ' CZ ' ' CD2' ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 3.74 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 2.18 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.71 110.559 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 4.06 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 160' ' ' ALA . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.73 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.53 109.581 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.599 ' N ' HD21 ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.705 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 3.08 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HZ3' HG21 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.96 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.564 ' CD2' ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 2.49 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 2.1 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 170' ' ' GLN . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.66 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 3.18 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.93 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.79 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.52 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 5.08 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 3.28 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.56 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.96 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 179' ' ' ILE . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.19 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 4.29 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.62 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.71 108.957 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 5.13 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER 79.19 91.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.56 109.911 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 186' ' ' TYR . 6.2 mp -98.18 117.05 31.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 7.56 108.986 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 185' ' ' LEU . 51.5 p90 42.39 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.431 -0.793 . . . . 10.13 110.025 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -149.94 75.57 1.25 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 8.42 109.806 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.5 14.05 80.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.0 -1.24 . . . . 9.13 110.0 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.6 -34.9 73.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -1.217 . . . . 11.96 109.448 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.933 -1.032 . . . . 12.92 109.433 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.259 -0.645 . . . . 15.72 109.259 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.8 55.97 5.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.28 . . . . 11.76 109.901 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -71.74 117.93 13.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -1.208 . . . . 12.98 109.316 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 -17.71 65.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.803 . . . . 8.5 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -47.69 -34.94 8.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 8.22 109.908 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -141.88 152.57 43.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 5.49 109.916 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -88.74 -6.72 57.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 5.37 108.943 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 56.1 tp -103.99 136.01 44.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.997 -0.742 . . . . 2.74 108.997 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? -47.18 145.43 3.59 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.039 -1.038 . . . . 3.02 108.882 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.41 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.26 109.965 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 3.14 109.232 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 3.25 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.94 108.086 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.37 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.37 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.593 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.17 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 3.52 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 4.31 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.56 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.98 109.43 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 4.19 109.129 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.5 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 4.09 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 6.1 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 3.45 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.54 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 3.04 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 4.62 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.83 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' C ' ' H ' ' A' ' 40' ' ' SER . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 6.06 108.237 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 5.26 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 38' ' ' CYS . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.53 109.24 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 3.02 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.51 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 3.27 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 2.25 109.541 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.35 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.17 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 3.39 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.579 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 91.6 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.9 107.81 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.8 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 3.46 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.54 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 4.05 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.67 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.74 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 7.19 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.99 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.8 110.876 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 4.22 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 5.03 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.84 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.77 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.9 110.443 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 2.18 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.579 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.4 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 3.11 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 2.09 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CZ ' ' O ' ' A' ' 77' ' ' ASP . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 5.03 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.76 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 110' ' ' LEU . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 2.42 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.51 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 3.43 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CA ' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.613 ' C ' ' H ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.81 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.57 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 3.05 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.74 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 2.08 106.893 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.48 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.95 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.5 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.86 110.645 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 2.31 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 3.0 110.556 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.92 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.67 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.549 ' HG ' ' HG1' ' A' ' 20' ' ' THR . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.13 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.79 108.243 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 3.08 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.598 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 9.02 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.75 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.59 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.61 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.55 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.424 ' CD2' ' HG ' ' A' ' 173' ' ' SER . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.73 109.772 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 4.52 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 5.16 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.9 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 3.51 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.72 109.738 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 109' ' ' ASP . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 2.67 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.88 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 107' ' ' LEU . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.71 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.38 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.98 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.68 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 3.01 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 2.19 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 2.19 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.78 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.92 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.95 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 4.14 109.085 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 2.34 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.73 110.998 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 2.41 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.86 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.29 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.13 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 5.18 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 4.01 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.46 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.76 108.961 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 3.1 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.93 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 187' ' ' ASP . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 6.19 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.32 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 4.58 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.94 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 5.63 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 150' ' ' ASP . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 2.11 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 149' ' ' VAL . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 5.23 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.46 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CE1' ' CD2' ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 3.74 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 2.18 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.71 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.46 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 4.06 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.73 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.53 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 3.08 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.96 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.479 ' CD2' ' CE1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 2.49 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 2.1 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.663 ' CD1' ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.66 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' N ' ' CD2' ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 3.18 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.93 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.79 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.424 ' HG ' ' CD2' ' A' ' 101' ' ' LEU . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.52 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 5.08 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 3.28 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.56 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.96 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.429 ' H ' ' C ' ' A' ' 177' ' ' PRO . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.19 109.631 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 4.29 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.585 ' NE2' ' OD2' ' A' ' 187' ' ' ASP . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.62 109.401 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.71 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 5.13 109.869 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -68.96 154.0 42.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.56 109.116 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' LEU . 8.2 mp -66.3 -40.58 90.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.964 . . . . 7.56 109.545 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -160.03 154.91 24.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 10.13 109.522 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 7.8 p-10 -142.79 -41.1 0.32 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.192 -0.942 . . . . 8.42 109.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -97.92 10.13 64.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.839 -1.305 . . . . 9.13 109.839 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.43 ' O ' ' CD2' ' A' ' 189' ' ' LEU . 1.3 tt 52.14 11.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -1.197 . . . . 11.96 108.806 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 188' ' ' GLY . 2.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.962 -1.018 . . . . 12.92 109.486 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.288 -0.634 . . . . 15.72 109.288 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.71 0.04 62.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 11.76 109.613 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -58.93 -37.51 76.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -1.165 . . . . 12.98 109.181 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 p -83.83 175.42 9.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 8.5 109.518 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 65.99 55.05 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 8.22 109.99 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -105.87 144.23 32.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 5.49 108.977 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -147.51 -151.8 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 5.37 109.572 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.4 tp -90.57 130.84 36.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 2.74 108.887 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -58.27 148.2 64.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 3.02 109.567 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.41 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.26 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 3.14 107.844 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 3.25 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.94 107.49 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.37 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.37 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.17 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 3.52 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 4.31 109.009 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.56 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.98 109.314 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 4.19 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 4.09 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 6.1 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 3.45 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.54 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 3.04 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 4.62 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.83 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 6.06 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 5.26 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.53 110.199 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 3.02 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.698 ' H ' ' HG ' ' A' ' 40' ' ' SER . 45.4 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.51 109.167 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 3.27 109.522 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 2.25 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.35 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.17 109.739 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 3.39 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 87.3 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.9 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.8 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 51' ' ' ILE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 3.46 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.54 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 4.05 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.663 ' NE2' ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.67 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.663 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.74 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 7.19 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.99 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.8 109.979 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 4.22 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 5.03 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.84 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.77 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.9 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 2.18 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.4 108.919 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 3.11 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 72' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 2.09 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 5.03 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.76 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 2.42 111.137 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 3.43 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.81 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.57 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 3.05 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.74 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 2.08 108.32 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.48 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.95 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.5 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.63 ' CD2' ' CE2' ' A' ' 48' ' ' PHE . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.86 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 2.31 108.396 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.472 HE22 ' HZ3' ' A' ' 19' ' ' LYS . 57.1 tp60 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 3.0 109.507 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.92 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.67 107.716 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.13 108.671 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.79 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 3.08 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 9.02 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.75 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.59 108.75 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.61 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.55 108.815 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.73 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 4.52 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 5.16 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.9 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 3.51 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.72 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 2.67 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.88 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.71 110.187 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.38 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.98 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.68 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 3.01 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 2.19 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 2.19 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.78 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.92 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.95 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.447 ' SD ' ' CG2' ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 4.14 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 2.34 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.73 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.447 ' CG2' ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 2.41 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.86 109.258 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.29 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.13 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 5.18 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 135' ' ' THR . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 4.01 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.46 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 132' ' ' VAL . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.76 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 136' ' ' VAL . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 3.1 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.93 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.582 ' CD ' HD22 ' A' ' 143' ' ' ASN . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' CD ' ' A' ' 141' ' ' GLU . 31.1 m120 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 6.19 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.32 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 4.58 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.94 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 5.63 110.285 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 2.11 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 5.23 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.46 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 3.74 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 2.18 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.71 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 4.06 109.34 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.73 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.53 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 3.08 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.96 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 2.49 107.605 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 2.1 110.596 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.66 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 3.18 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.93 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.79 110.563 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.52 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 5.08 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 3.28 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.56 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.96 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.19 108.835 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 4.29 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.693 ' NE2' ' CD1' ' A' ' 186' ' ' TYR . 49.7 tp60 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.62 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.71 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.637 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 5.13 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t -139.3 24.9 2.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.56 110.499 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 8.3 mp -96.32 13.28 28.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.922 -1.111 . . . . 7.56 109.72 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.693 ' CD1' ' NE2' ' A' ' 181' ' ' GLN . 97.1 m-85 -52.75 158.56 1.31 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.009 . . . . 10.13 109.674 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -127.99 -101.5 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 8.42 109.343 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.52 97.81 2.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.484 -1.446 . . . . 9.13 109.484 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.73 -35.82 75.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -1.179 . . . . 11.96 109.407 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 117.996 -1.002 . . . . 12.92 109.507 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 15.72 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.44 -176.17 46.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.6 -1.4 . . . . 11.76 109.6 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -96.71 134.86 39.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 12.98 109.632 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -118.61 136.7 53.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 8.5 109.246 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.11 114.21 26.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.388 -0.82 . . . . 8.22 109.453 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -146.8 7.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 5.49 109.645 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' LEU . 2.6 ttmp? 53.81 82.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 5.37 108.902 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 7' ' ' LYS . 7.1 tt 56.64 107.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.377 -0.971 . . . . 2.74 108.377 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -49.24 149.74 3.5 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.262 -0.899 . . . . 3.02 110.483 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.41 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.26 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 3.14 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 3.25 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.94 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.37 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.37 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.17 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 3.52 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 4.31 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.56 110.269 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.98 109.505 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 4.19 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 4.09 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 6.1 108.482 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 3.45 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.54 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 3.04 111.26 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.465 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 4.62 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.83 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 6.06 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 5.26 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.53 109.186 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 3.02 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.51 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 3.27 109.575 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 2.25 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.35 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.17 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 3.39 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.9 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.8 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 3.46 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.54 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 4.05 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 51' ' ' ILE . 32.2 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.67 109.927 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.74 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 7.19 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.99 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.8 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 4.22 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 5.03 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.84 109.488 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.77 109.234 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.9 109.349 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 2.18 109.303 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.4 108.984 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 3.11 108.877 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 2.09 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 5.03 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.76 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 2.42 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 68' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 3.43 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.81 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.57 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 3.05 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.74 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 2.08 108.337 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.48 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.95 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.5 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.86 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 2.31 109.067 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 3.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.92 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.67 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.13 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.79 107.774 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 3.08 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.579 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 9.02 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.75 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.59 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.61 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.652 ' H ' ' HG1' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.55 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.73 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 4.52 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 5.16 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.9 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 3.51 109.041 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.72 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 2.67 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.88 109.302 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.71 109.01 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.38 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.98 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.68 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 3.01 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 2.19 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 2.19 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.78 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.92 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.95 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 4.14 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 2.34 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.73 110.638 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 2.41 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.86 109.304 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.29 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.13 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 5.18 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 4.01 109.387 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.46 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 131' ' ' MET . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.76 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 3.1 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.93 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.54 ' ND2' ' HH ' ' A' ' 129' ' ' TYR . 17.2 t-20 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 6.19 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.511 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.32 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.413 ' O ' ' CG2' ' A' ' 149' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 4.58 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.94 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 5.63 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 145' ' ' PRO . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 2.11 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 5.23 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.46 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 3.74 109.04 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 2.18 108.088 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.71 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 4.06 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.73 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.53 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 3.08 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.96 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 2.49 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 2.1 109.601 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 167' ' ' GLN . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.66 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 3.18 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.93 110.202 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.79 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.52 109.498 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 5.08 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 3.28 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.56 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.96 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.19 109.73 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 182' ' ' ALA . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 4.29 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.62 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.71 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.677 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 5.13 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p 83.12 110.96 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.56 109.356 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 3.0 mm? -79.53 -5.64 55.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 7.56 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.553 ' CB ' ' O ' ' A' ' 185' ' ' LEU . 10.7 t80 87.0 125.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.349 -0.611 . . . . 10.13 109.349 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 188' ' ' GLY . 59.8 t0 -72.03 133.14 45.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 8.42 109.313 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . -40.66 129.2 3.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.689 -1.364 . . . . 9.13 109.689 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.467 ' H ' ' CD2' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.78 -98.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 11.96 109.357 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 189' ' ' LEU . 13.3 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.947 -1.025 . . . . 12.92 109.505 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.284 -0.636 . . . . 15.72 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.93 -2.67 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.538 -1.425 . . . . 11.76 109.538 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -104.44 140.26 38.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 12.98 109.329 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 91.5 p -126.72 150.34 49.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 8.5 109.387 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' OD1' ' O ' ' A' ' 4' ' ' SER . 83.0 m-20 -158.48 -31.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 8.22 109.429 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 m -58.89 -36.16 74.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 5.49 109.795 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -173.31 -159.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 5.37 109.866 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' H ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.87 150.92 27.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 2.74 108.988 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -58.15 150.1 53.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 3.02 109.429 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.41 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.26 109.021 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 3.14 109.604 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 3.25 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.623 ' HG1' ' N ' ' A' ' 18' ' ' ARG . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.94 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.623 ' N ' ' HG1' ' A' ' 17' ' ' THR . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.37 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.37 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.17 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 3.52 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 4.31 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.56 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.98 108.885 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 4.19 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 4.09 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 6.1 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 3.45 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.54 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 3.04 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 4.62 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.83 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 6.06 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 5.26 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.53 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 3.02 110.462 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.51 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 3.27 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 2.25 108.726 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.35 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.17 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 3.39 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 62' ' ' THR . 35.7 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.9 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.8 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.464 HG22 HD12 ' A' ' 51' ' ' ILE . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 3.46 108.88 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.54 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 4.05 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.67 110.842 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.74 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 7.19 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 59' ' ' GLY . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.99 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.8 109.684 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 4.22 109.646 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 5.03 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.457 ' HA ' HE21 ' A' ' 49' ' ' GLN . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.84 109.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.77 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.9 109.916 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 2.18 109.421 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.4 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 3.11 109.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 2.09 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 5.03 109.442 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.76 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 2.42 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.561 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 3.43 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.81 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.57 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 3.05 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.74 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 2.08 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.48 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.95 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.5 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.86 109.947 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 2.31 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 3.0 110.167 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.92 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.67 109.098 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.13 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.79 108.571 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 3.08 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 9.02 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.75 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.59 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.61 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.55 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.73 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 4.52 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 5.16 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.9 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 3.51 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.72 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 2.67 109.875 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.88 110.794 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.71 109.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.38 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.98 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.68 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.465 ' CE2' ' CG2' ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 3.01 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 2.19 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 2.19 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.586 ' NH1' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.78 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.92 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.95 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 4.14 109.669 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 2.34 109.425 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.73 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 2.41 109.175 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.86 107.506 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.29 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.431 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.13 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 5.18 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 4.01 108.99 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.46 108.695 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 135' ' ' THR . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.76 109.898 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 3.1 108.084 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.93 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 13.8 m120 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 6.19 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.32 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 4.58 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.94 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 5.63 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 2.11 108.792 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 5.23 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 152' ' ' ILE . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.46 110.887 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 3.74 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 2.18 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.71 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 4.06 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.658 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.73 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.674 ' C ' ' H ' ' A' ' 161' ' ' ASP . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.53 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.674 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 3.08 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.96 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.421 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 2.49 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 115' ' ' TYR . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 2.1 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 167' ' ' GLN . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.66 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 3.18 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.93 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.79 110.076 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.52 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 5.08 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 3.28 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.56 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.96 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.19 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 4.29 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.62 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.71 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 5.13 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p -131.49 159.33 38.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.56 109.263 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.505 ' O ' ' C ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -98.61 85.8 3.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 7.56 109.629 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 26.2 p90 28.3 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.587 0.708 . . . . 10.13 111.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -78.31 114.34 17.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.011 -1.056 . . . . 8.42 108.857 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.53 168.2 38.17 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.541 -1.824 . . . . 9.13 108.541 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.99 -32.08 70.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.3 . . . . 11.96 109.372 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.043 -0.979 . . . . 12.92 109.424 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' H1 ' ' H ' ' A' ' 2' ' ' GLY . 88.4 mtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.496 -0.557 . . . . 15.72 109.496 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' H ' ' H1 ' ' A' ' 1' ' ' MET . . . 160.76 -74.76 0.2 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.609 -1.396 . . . . 11.76 109.609 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.14 117.88 30.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -1.187 . . . . 12.98 109.562 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 5' ' ' ASN . 49.6 m -131.06 145.05 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 8.5 109.323 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 4' ' ' SER . 20.5 m120 35.73 -107.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.607 -0.683 . . . . 8.22 110.039 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -118.41 145.59 45.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.392 -0.818 . . . . 5.49 109.182 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -138.79 -177.43 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.883 . . . . 5.37 109.506 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt -85.18 130.6 34.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.299 -1.0 . . . . 2.74 108.299 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -55.5 138.45 68.64 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.076 -1.015 . . . . 3.02 110.497 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.41 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.26 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 3.14 109.168 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 3.25 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.94 107.335 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.37 108.607 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.37 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.17 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 3.52 108.012 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 4.31 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.56 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.98 109.42 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 4.19 109.711 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 4.09 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 6.1 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 3.45 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.54 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 3.04 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 4.62 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.83 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 6.06 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 5.26 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 42' ' ' GLN . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.53 109.326 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 3.02 109.212 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.643 ' H ' ' HG ' ' A' ' 40' ' ' SER . 52.2 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.51 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 3.27 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 2.25 108.585 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.35 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.17 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 3.39 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 85.8 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.9 107.81 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.8 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 3.46 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.54 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 4.05 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.67 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.74 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 7.19 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.99 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.8 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 4.22 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 5.03 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 66' ' ' THR . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.84 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.77 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.9 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 2.18 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.4 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 3.11 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 2.09 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 5.03 109.837 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.76 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 2.42 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CB ' ' O ' ' A' ' 68' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 3.43 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.81 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.57 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 3.05 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.639 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.74 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 2.08 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.48 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.95 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.5 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.86 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 2.31 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 3.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.92 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.67 107.808 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.13 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG12 ' HE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.79 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 3.08 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 9.02 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.75 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.694 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.59 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.61 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.694 ' H ' ' HG1' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.55 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.73 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.52 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.436 ' HE1' HG12 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 5.16 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.9 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 3.51 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.72 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 2.67 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.88 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.71 109.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.38 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.98 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.68 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 3.01 109.514 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 2.19 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 2.19 108.021 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.78 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.92 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.95 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 4.14 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 2.34 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.73 109.327 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 2.41 108.058 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.86 109.374 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.29 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.13 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 5.18 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 4.01 109.856 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.46 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.76 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 3.1 109.583 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.93 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.568 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.568 ' H ' ' CG ' ' A' ' 141' ' ' GLU . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 6.19 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.32 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.433 ' N ' ' HG1' ' A' ' 144' ' ' THR . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 4.58 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.94 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 5.63 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 2.11 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 5.23 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.46 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.654 ' CD1' ' NE ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 3.74 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 2.18 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.71 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 4.06 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.73 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.583 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.53 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 3.08 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.96 109.023 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 2.49 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 2.1 108.927 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.66 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 3.18 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.93 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.79 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.52 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 5.08 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 3.28 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.56 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.96 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.19 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 4.29 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.62 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.71 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 5.13 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m -58.54 -27.73 64.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.56 109.945 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.2 tt 66.78 118.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 7.56 109.204 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -107.99 159.27 16.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 10.13 109.469 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.4 p30 -57.97 -32.49 67.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 8.42 110.096 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 173.99 174.64 41.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 9.13 109.613 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 3.6 mm? -65.44 -33.49 76.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -1.149 . . . . 11.96 109.358 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.299 -1.607 0 CA-C-O 117.947 -1.025 . . . . 12.92 109.559 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 15.72 109.47 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.38 179.75 50.6 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.658 -1.377 . . . . 11.76 109.658 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 5' ' ' ASN . 27.9 mttm -89.04 5.16 45.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 12.98 109.536 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' LYS . 0.8 OUTLIER 72.51 -35.67 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 8.5 109.666 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 3' ' ' LYS . 23.4 t-20 -101.67 86.04 2.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 8.22 109.455 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -176.14 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 5.49 109.181 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -97.6 161.86 13.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 5.37 109.111 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -55.81 157.72 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.089 -1.007 . . . . 2.74 109.149 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -54.62 136.71 63.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 3.02 109.605 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.41 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.26 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 3.14 109.398 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 19' ' ' LYS . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 3.25 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.94 108.117 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.37 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.37 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.48 ' OG1' ' CD2' ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.602 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.17 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 3.52 109.027 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 4.31 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.56 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 28' ' ' GLN . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.98 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 4.19 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 4.09 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 6.1 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 3.45 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.54 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 3.04 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 4.62 111.3 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.83 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 6.06 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 5.26 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.53 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 3.02 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.51 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' H ' HG21 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 3.27 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.568 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 2.25 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.35 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.17 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 3.39 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.9 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.8 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 3.46 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.54 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 4.05 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.67 109.803 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.74 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.402 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 7.19 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.99 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.8 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 4.22 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 5.03 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.84 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.737 ' HZ3' HE22 ' A' ' 130' ' ' GLN . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.77 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.9 110.833 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 2.18 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.4 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 3.11 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 2.09 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 5.03 109.538 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.76 110.444 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 2.42 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.49 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 3.43 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.81 109.576 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.57 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 3.05 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.74 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' H ' ' A' ' 43' ' ' LEU . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 2.08 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.48 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.95 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.5 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.86 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 2.31 109.957 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 3.0 110.458 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.92 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.67 108.611 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.13 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.79 107.336 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 3.08 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 9.02 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.75 110.306 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.593 ' HG1' ' H ' ' A' ' 99' ' ' GLU . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.59 109.546 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.61 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.593 ' H ' ' HG1' ' A' ' 96' ' ' THR . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.55 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.73 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.531 ' NH1' ' HZ3' ' A' ' 106' ' ' LYS . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 4.52 109.611 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 5.16 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.9 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 3.51 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HZ3' ' NH1' ' A' ' 102' ' ' ARG . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.72 109.44 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 2.67 109.992 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.88 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.71 109.25 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.38 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.98 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.68 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 3.01 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 2.19 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 2.19 108.307 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.78 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.92 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' H ' ' HG1' ' A' ' 117' ' ' THR . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.95 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 4.14 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.34 109.533 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.73 110.392 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 2.41 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 129' ' ' TYR . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.86 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.29 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.737 HE22 ' HZ3' ' A' ' 63' ' ' LYS . 32.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.13 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 5.18 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 133' ' ' GLY . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 4.01 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 133' ' ' GLY . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.46 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.76 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.593 ' H ' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 3.1 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.93 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 6.19 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.32 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 4.58 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.94 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.569 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 5.63 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 150' ' ' ASP . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 2.11 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 149' ' ' VAL . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 5.23 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.46 110.032 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CD1' HD22 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 3.74 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 2.18 107.633 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.71 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.564 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 4.06 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.73 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.51 HD22 ' CE ' ' A' ' 156' ' ' MET . 17.9 m120 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.53 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.61 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 3.08 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.96 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 2.49 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 2.1 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.567 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.66 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 3.18 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.93 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.79 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.52 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 5.08 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 3.28 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.56 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.96 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.409 HG21 ' HG ' ' A' ' 173' ' ' SER . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.19 109.669 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 4.29 108.885 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.62 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 184' ' ' SER . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.71 109.29 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.651 ' CD1' ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 5.13 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 182' ' ' ALA . 5.3 p -56.53 144.3 32.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.56 109.919 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 1.2 mm? -80.3 -48.64 12.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 7.56 109.217 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -133.46 153.61 51.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 10.13 109.483 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.7 121.36 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 8.42 109.532 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.77 10.56 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.839 -1.304 . . . . 9.13 109.839 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.38 -36.7 69.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -1.186 . . . . 11.96 109.49 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.416 ' OXT' ' CG1' ' A' ' 190' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.006 -0.997 . . . . 12.92 109.478 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.247 0.546 . . . . 15.72 109.561 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.16 -8.26 59.0 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.958 -1.257 . . . . 11.76 109.958 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -122.17 148.42 44.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.361 -1.082 . . . . 12.98 110.146 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.6 p -97.82 153.4 18.32 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.503 -0.925 . . . . 8.5 108.503 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -103.56 96.98 7.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 8.22 110.036 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -66.04 -28.28 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 5.49 108.889 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -81.03 145.65 31.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.491 -0.756 . . . . 5.37 109.093 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 134.37 36.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 2.74 108.696 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -62.54 140.4 96.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 3.02 109.436 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.41 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.26 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 3.14 109.698 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 3.25 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.556 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.94 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.413 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.37 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.508 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.37 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.17 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 3.52 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 4.31 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' OE1' ' CG2' ' A' ' 17' ' ' THR . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.56 109.513 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' TYR . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.98 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 4.19 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 4.09 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 6.1 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 3.45 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.54 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 3.04 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 4.62 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.83 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 6.06 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 5.26 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.53 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 3.02 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.566 HE21 ' C ' ' A' ' 43' ' ' LEU . 3.9 tm0? -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.51 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.566 ' C ' HE21 ' A' ' 42' ' ' GLN . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 3.27 110.089 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' NE2' ' A' ' 42' ' ' GLN . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 2.25 109.345 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.35 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.17 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 3.39 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.9 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.8 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 3.46 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.54 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 4.05 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.67 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.74 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 7.19 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.99 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.8 109.188 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 4.22 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 5.03 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.84 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.77 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.9 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 2.18 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.4 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 3.11 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 2.09 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 5.03 109.846 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.76 110.745 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 2.42 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 3.43 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.574 HD22 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.81 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.57 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' CG ' HD22 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 3.05 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.74 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 2.08 108.267 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.48 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.95 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.5 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.86 110.1 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 2.31 109.502 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' O ' ' OG ' ' A' ' 90' ' ' SER . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 3.0 109.888 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.92 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' CE1' ' A' ' 85' ' ' PHE . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.67 108.76 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.13 109.277 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.79 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 3.08 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 9.02 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.75 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.59 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.61 109.096 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.55 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' CD1' ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.73 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 4.52 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' HZ2' ' A' ' 106' ' ' LYS . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 5.16 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.9 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 3.51 110.196 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 103' ' ' TRP . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.72 109.206 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 2.67 110.478 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.88 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.71 109.243 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.38 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.98 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.68 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 3.01 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 2.19 108.724 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.404 ' HG1' ' HG3' ' A' ' 120' ' ' GLU . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 2.19 108.86 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.697 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.78 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.92 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HG3' ' HG1' ' A' ' 117' ' ' THR . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.95 109.188 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 4.14 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 2.34 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.73 109.64 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 2.41 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.548 ' O ' ' CG1' ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.86 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.29 110.428 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.13 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 5.18 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 4.01 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 40.4 t30 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.46 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' A' ' 137' ' ' GLU . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.76 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 3.1 109.798 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.93 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.577 ' OE1' ' CD2' ' A' ' 186' ' ' TYR . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.666 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.666 ' H ' ' CG ' ' A' ' 142' ' ' GLU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 6.19 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' A' ' 144' ' ' THR . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.32 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 4.58 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.94 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 5.63 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 2.11 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 5.23 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.46 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 3.74 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 2.18 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.71 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 4.06 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.73 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.53 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 3.08 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.96 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 2.49 108.158 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 2.1 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.66 110.196 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 3.18 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.496 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.93 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.416 HE22 ' HG ' ' A' ' 101' ' ' LEU . 87.3 mm-40 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.79 109.991 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.52 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 5.08 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 3.28 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.56 ' C ' ' HG ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.56 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.56 ' HG ' ' C ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.96 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.19 109.661 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 4.29 111.759 -178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.62 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.71 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 5.13 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p -88.09 6.19 37.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.56 109.738 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.4 tp -53.17 -34.26 56.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 7.56 109.644 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CD2' ' OE1' ' A' ' 141' ' ' GLU . 96.4 m-85 -99.16 145.14 27.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 10.13 109.603 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.16 14.37 2.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.417 -0.802 . . . . 8.42 109.659 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.47 16.93 38.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.441 -1.464 . . . . 9.13 109.441 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER 59.02 83.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -1.146 . . . . 11.96 109.394 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.956 -1.021 . . . . 12.92 109.469 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.398 -0.594 . . . . 15.72 109.398 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.68 41.54 15.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.46 -1.456 . . . . 11.76 109.46 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -80.93 3.76 21.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -1.139 . . . . 12.98 109.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -60.94 159.15 11.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 8.5 109.394 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -67.52 175.25 2.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 8.22 109.686 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -62.31 154.49 27.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 5.49 109.89 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 8' ' ' LEU . 34.2 ttpt -172.16 170.58 5.16 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.826 -0.805 . . . . 5.37 108.826 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' ' HG2' ' A' ' 7' ' ' LYS . 61.9 tp -61.86 130.93 48.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 2.74 109.045 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -61.43 142.38 93.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 3.02 109.536 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.41 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.26 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 3.14 108.16 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 3.25 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 14' ' ' GLU . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.94 107.641 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.37 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.37 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.17 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 3.52 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 4.31 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.56 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.98 109.357 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 4.19 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 4.09 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 6.1 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 3.45 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.54 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 3.04 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 4.62 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.83 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 6.06 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 5.26 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.53 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 3.02 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.51 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 3.27 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 2.25 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.35 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.17 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 3.39 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 99.1 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.9 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.8 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 3.46 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.54 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 4.05 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.67 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.74 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 7.19 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.99 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.8 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 4.22 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 5.03 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.84 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.77 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.9 109.965 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 2.18 109.754 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.591 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.4 109.535 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 3.11 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 72' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 2.09 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 5.03 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.76 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 2.42 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 3.43 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.81 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.57 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 3.05 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.74 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 2.08 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.48 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.95 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.5 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.86 109.307 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 2.31 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 3.0 110.114 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.92 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 92' ' ' THR . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.67 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.13 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.79 109.624 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 3.08 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.543 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 9.02 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.75 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.59 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.61 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.55 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.73 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 4.52 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 5.16 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.9 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 3.51 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.72 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 2.67 110.037 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.88 109.78 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.475 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.71 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.38 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 15.0 p30 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.98 109.36 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.68 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 3.01 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 2.19 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 2.19 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.484 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.78 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.92 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.95 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 4.14 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 2.34 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.73 108.562 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 2.41 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 128' ' ' ILE . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.86 109.396 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.29 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.13 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.483 ' O ' ' OG1' ' A' ' 135' ' ' THR . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 5.18 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.405 ' C ' ' HG1' ' A' ' 135' ' ' THR . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 4.01 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 133' ' ' GLY . 8.6 p30 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.46 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 131' ' ' MET . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.76 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 3.1 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.93 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 6.19 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.32 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 144' ' ' THR . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 4.58 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.477 ' OE2' ' O ' ' A' ' 144' ' ' THR . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.94 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 5.63 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 2.11 108.697 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 5.23 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 152' ' ' ILE . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.46 110.588 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 3.74 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 2.18 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.71 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 4.06 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.709 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.73 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.709 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.53 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 3.08 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.96 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.486 ' CD2' ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 2.49 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 2.1 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.66 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 3.18 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.93 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.544 ' C ' ' NE2' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.79 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.52 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 5.08 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 3.28 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 179' ' ' ILE . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.56 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.96 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.19 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 4.29 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.62 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.71 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.707 ' H ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 5.13 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m -64.76 153.55 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.56 109.398 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 34.9 mt -101.23 135.24 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 7.56 109.184 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -51.52 126.76 18.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 10.13 109.322 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -57.66 -38.79 75.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 8.42 109.378 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -176.68 49.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.264 -1.534 . . . . 9.13 109.264 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -92.81 0.84 57.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.182 -1.187 . . . . 11.96 109.282 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.975 -1.012 . . . . 12.92 109.452 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.293 -0.632 . . . . 15.72 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.58 -111.69 4.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.494 -1.442 . . . . 11.76 109.494 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -78.61 140.08 38.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -1.146 . . . . 12.98 109.331 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 5' ' ' ASN . 2.7 t -143.91 -99.91 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 8.5 109.299 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.532 ' N ' ' HG ' ' A' ' 4' ' ' SER . 43.9 t30 58.71 48.55 11.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 8.22 109.68 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.3 p -108.95 138.99 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.296 -0.877 . . . . 5.49 109.527 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -176.3 168.58 2.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.585 -0.697 . . . . 5.37 109.131 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 26.9 tp -99.71 123.05 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 2.74 109.067 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -78.07 149.36 76.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 3.02 109.756 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.41 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.26 108.373 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 3.14 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 3.25 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.94 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.37 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' A' ' 87' ' ' GLN . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.37 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' HB3' ' HE ' ' A' ' 94' ' ' ARG . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.17 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 3.52 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 4.31 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.56 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.98 110.303 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 4.19 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 4.09 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 6.1 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 3.45 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HZ3' ' CB ' ' A' ' 7' ' ' LYS . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.54 108.945 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 3.04 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 4.62 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.83 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 6.06 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 5.26 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.53 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 3.02 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.51 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 3.27 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 2.25 109.415 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.35 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.17 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 3.39 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.9 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.8 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' CD1' ' A' ' 55' ' ' PHE . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 3.46 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.453 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.54 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 4.05 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.67 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.74 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 7.19 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.99 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.8 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 4.22 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 5.03 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.84 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.77 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.9 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 2.18 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.4 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.11 109.9 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 2.09 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 5.03 109.461 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.76 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 2.42 110.519 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 3.43 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.81 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.57 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 3.05 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.74 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 2.08 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.48 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.95 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.5 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.86 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' OG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 2.31 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' A' ' 19' ' ' LYS . 58.4 tp60 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 3.0 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.92 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 92' ' ' THR . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.67 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 93' ' ' SER . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.13 108.437 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.79 109.466 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 89' ' ' LEU . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 3.08 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 94' ' ' ARG . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' N ' ' HG ' ' A' ' 93' ' ' SER . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 9.02 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.75 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.59 109.207 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.61 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.55 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.73 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.448 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 4.52 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 5.16 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.9 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 3.51 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.72 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 2.67 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.88 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 106' ' ' LYS . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' CD2' ' C ' ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.71 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.38 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.98 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.68 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 3.01 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 2.19 109.127 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 2.19 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.622 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.78 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.92 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.95 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 4.14 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 2.34 109.828 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.73 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 2.41 108.114 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.86 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.29 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.13 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 5.18 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 4.01 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' O ' ' CG2' ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.46 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.526 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.76 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 3.1 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.93 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' O ' ' OG1' ' A' ' 144' ' ' THR . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 6.19 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.32 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 4.58 113.207 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.94 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 5.63 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 2.11 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 5.23 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.46 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.652 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 3.74 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 2.18 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.71 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 158' ' ' LYS . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 4.06 109.4 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.73 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.53 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 3.08 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.96 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.492 ' CD1' ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 2.49 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 2.1 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.66 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 3.18 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.93 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.448 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.79 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.52 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 5.08 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 3.28 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.56 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.96 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 179' ' ' ILE . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.19 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 4.29 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.62 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.71 108.853 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.641 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 5.13 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.525 ' HG ' ' C ' ' A' ' 183' ' ' LEU . 4.4 p 40.75 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.56 109.942 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.83 -34.33 74.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 7.56 109.461 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.1 129.28 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 10.13 109.739 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.18 -36.09 76.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 8.42 109.131 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.5 -127.97 1.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 9.13 109.365 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.6 tp -159.01 84.27 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -1.197 . . . . 11.96 109.301 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.966 -1.016 . . . . 12.92 109.466 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.0 mtmp? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.448 -0.575 . . . . 2.5 109.448 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.23 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.17 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 17' ' ' THR . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 2.64 108.11 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 2.71 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 13' ' ' VAL . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.6 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.04 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.04 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.0 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.623 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 2.94 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 3.98 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.563 ' OE2' HG11 ' A' ' 13' ' ' VAL . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.1 109.771 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 86' ' ' ILE . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.44 110.097 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 3.85 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 3.75 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 5.2 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 2.74 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.06 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 2.92 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 3.92 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.37 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 5.72 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 4.71 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.05 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 2.56 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.09 109.204 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 2.82 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 1.72 109.197 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.06 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.03 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 2.65 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.8 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.4 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 2.99 108.606 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.712 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.31 107.874 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 3.63 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.23 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.18 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 136' ' ' VAL . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 6.44 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.28 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.17 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 3.59 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 4.4 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.54 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.3 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.671 ' O ' HG23 ' A' ' 68' ' ' VAL . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.12 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.79 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.04 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD2' HD23 ' A' ' 110' ' ' LEU . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 2.31 109.177 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 64' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 1.71 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 4.33 109.462 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.75 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 1.91 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 2.75 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.3 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.34 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 2.85 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.19 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 1.76 107.115 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.4 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.27 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.35 109.462 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 89' ' ' LEU . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.22 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 1.9 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 43.0 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 2.63 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.56 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.501 HD13 ' HE1' ' A' ' 85' ' ' PHE . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.17 108.714 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.01 109.015 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG11 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.2 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 2.75 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 8.35 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.29 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.18 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.22 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.12 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.31 109.386 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 3.93 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.757 ' HE1' HG11 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 4.4 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.41 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 2.69 110.035 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.23 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD13 HG22 ' A' ' 68' ' ' VAL . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 1.99 109.92 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.51 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 110' ' ' LEU . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.31 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.09 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.68 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.39 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 2.76 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 1.6 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 1.73 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.61 HH22 ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.17 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.44 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.71 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.635 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 3.66 109.563 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 1.77 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.14 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 121' ' ' MET . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 1.83 108.147 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 128' ' ' ILE . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.42 109.46 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.501 ' CE2' HG21 ' A' ' 144' ' ' THR . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.07 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.05 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 4.88 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 132' ' ' VAL . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 3.55 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.29 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.42 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' N ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 2.5 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.55 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 5.59 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.501 HG21 ' CE2' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.06 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 183' ' ' LEU . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 3.91 113.137 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.64 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 4.99 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 1.57 109.263 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 4.73 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.07 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 2.93 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 1.77 107.702 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.34 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 3.53 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CB ' HH22 ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.18 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.81 HD22 ' CG ' ' A' ' 161' ' ' ASP . 1.3 p30 -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.49 109.701 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.81 ' CG ' HD22 ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 2.83 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.45 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.865 HD11 ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 1.9 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 1.8 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.28 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 2.92 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.14 109.922 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.35 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.18 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 4.67 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.92 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 177' ' ' PRO . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.17 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.62 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 172' ' ' GLY . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 3.79 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.02 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.48 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.876 ' N ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 4.79 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.27 109.686 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.487 -0.56 . . . . 2.5 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.23 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.17 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 24' ' ' GLU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 2.64 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 2.71 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.6 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.04 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.04 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.0 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' H ' HG22 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 2.94 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 3.98 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.1 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.452 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.44 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 3.85 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 3.75 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 5.2 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 2.74 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.06 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 2.92 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 3.92 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.37 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 5.72 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 4.71 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.05 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 2.56 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 79' ' ' ARG . 21.0 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.09 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 85' ' ' PHE . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 2.82 109.857 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 1.72 109.456 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.06 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.03 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 2.65 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.8 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.4 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 2.99 108.258 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.31 107.188 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 3.63 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.23 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.18 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 6.44 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.28 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.17 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 3.59 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 4.4 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.54 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.3 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.12 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 1.79 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.04 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 2.31 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 1.71 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 4.33 109.72 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.75 110.699 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 1.91 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 2.75 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.61 HD21 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.3 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.34 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' CG ' HD21 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 2.85 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.19 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 1.76 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.4 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.27 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.35 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.22 109.971 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 1.9 110.442 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 2.63 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.56 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.17 109.121 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.01 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.2 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.638 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 8.35 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.29 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.541 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.18 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.22 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HZ3' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.12 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 180' ' ' VAL . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.31 108.737 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 3.93 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.481 ' CH2' HD13 ' A' ' 107' ' ' LEU . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 4.4 109.137 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.41 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 2.69 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 107' ' ' LEU . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.23 109.751 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 1.99 110.048 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.51 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 67' ' ' PHE . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.31 110.618 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.09 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 39.0 t30 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.68 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.39 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CE1' HG22 ' A' ' 165' ' ' THR . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 2.76 110.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 1.6 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 1.73 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.66 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.17 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.44 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.71 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 3.66 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD22 ' OE2' ' A' ' 146' ' ' GLU . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 1.77 109.305 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.14 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 121' ' ' MET . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 1.83 107.926 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 144' ' ' THR . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.42 110.884 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.07 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.05 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 4.88 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 132' ' ' VAL . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 3.55 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.29 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.42 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 2.5 108.606 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.55 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 5.59 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 128' ' ' ILE . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.06 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 3.91 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.63 ' OE2' HD22 ' A' ' 122' ' ' LEU . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.41 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.64 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 4.99 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 1.57 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.41 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 4.73 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.07 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 2.93 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 1.77 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.34 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 3.53 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.66 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.18 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 2.83 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.45 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 1.9 107.988 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 164' ' ' LEU . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 1.8 109.828 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.28 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 2.92 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.14 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.35 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.18 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 4.67 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 2.92 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.17 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.62 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.0 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 101' ' ' LEU . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 3.79 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.02 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.537 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.48 109.335 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.076 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 4.79 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.27 110.393 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.062 -0.718 . . . . 2.5 109.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.23 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.17 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 17' ' ' THR . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 2.64 110.005 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 2.71 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 13' ' ' VAL . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.6 109.528 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 18' ' ' ARG . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.04 108.423 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.04 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.0 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 2.94 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 3.98 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 17' ' ' THR . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.1 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG11 ' CG2' ' A' ' 20' ' ' THR . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.44 108.294 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 3.85 108.075 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 3.75 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 5.2 108.487 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 2.74 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.06 107.839 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 2.92 109.996 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 3.92 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.37 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 5.72 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 4.71 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.05 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 2.56 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.09 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 2.82 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 1.72 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.06 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.03 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 2.65 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.8 108.551 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.4 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 2.99 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.31 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 3.63 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.23 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.18 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 6.44 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.28 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.17 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 3.59 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 4.4 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.54 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.3 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.713 ' O ' HG23 ' A' ' 68' ' ' VAL . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.12 109.636 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 1.79 109.722 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.04 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.935 ' O ' HG22 ' A' ' 71' ' ' VAL . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 2.31 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 64' ' ' PHE . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 1.71 109.213 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 4.33 109.295 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.75 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 1.91 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 2.75 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.3 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.34 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 2.85 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.19 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 1.76 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.4 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.27 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.35 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.22 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 86' ' ' ILE . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 1.9 109.494 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 91' ' ' VAL . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 2.63 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.56 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.686 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.17 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.01 108.945 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.2 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 2.75 108.841 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 8.35 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.29 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.18 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.22 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.12 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 173' ' ' SER . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.31 109.533 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 3.93 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 4.4 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.41 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 2.69 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.23 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.729 ' HA ' HG21 ' A' ' 71' ' ' VAL . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 1.99 110.383 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.51 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 67' ' ' PHE . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.31 109.789 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.09 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.68 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.39 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 2.76 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 1.6 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 1.73 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.612 ' HE ' ' CG ' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.17 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.44 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.71 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 3.66 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 1.77 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 124' ' ' ILE . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.14 109.953 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 1.83 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 132' ' ' VAL . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.42 111.314 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.07 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.05 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 4.88 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 128' ' ' ILE . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 3.55 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.29 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.42 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.55 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.611 ' C ' HG22 ' A' ' 144' ' ' THR . 35.1 p-10 -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 5.59 110.49 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.611 HG22 ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.06 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 3.91 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.64 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HB3' HD12 ' A' ' 152' ' ' ILE . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 4.99 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 1.57 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 149' ' ' VAL . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 4.73 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 148' ' ' ARG . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.07 111.743 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 2.93 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 1.77 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.34 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 3.53 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.18 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.49 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.627 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 2.83 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.45 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 1.9 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 1.8 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.28 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 2.92 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.14 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.35 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.478 ' CB ' HD11 ' A' ' 101' ' ' LEU . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.18 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 4.67 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 2.92 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.17 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.62 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.0 110.179 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 3.79 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.02 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.48 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 4.79 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.27 109.758 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.192 -0.67 . . . . 2.5 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.23 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.17 108.836 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 2.64 108.117 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 2.71 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 17' ' ' THR . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.6 107.968 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.04 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.04 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.0 108.907 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 3.98 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.1 110.287 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 20' ' ' THR . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.44 109.743 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 3.85 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 3.75 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 5.2 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 2.74 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.06 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 2.92 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 3.92 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.37 109.392 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 5.72 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 4.71 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.05 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 2.56 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.09 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 47' ' ' GLY . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 2.82 109.354 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 1.72 109.747 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.06 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.03 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 2.65 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 26.1 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.8 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.4 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 2.99 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.512 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.31 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 3.63 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.23 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.18 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 6.44 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.28 113.233 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 135' ' ' THR . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.17 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 3.59 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 4.4 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.54 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.3 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.734 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.12 109.882 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 1.79 109.695 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.04 109.016 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 124' ' ' ILE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 2.31 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 1.71 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 4.33 109.699 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.75 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 1.91 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 2.75 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.3 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.34 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' CG ' HD21 ' A' ' 75' ' ' ASN . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 2.85 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.19 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 1.76 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.4 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.27 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.35 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.22 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 1.9 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 2.63 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.56 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.746 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.01 108.954 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' GLN . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.2 108.831 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 2.75 109.477 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 8.35 108.162 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.29 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.517 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.18 108.486 179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.22 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.12 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.31 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 3.93 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 4.4 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.41 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 2.69 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.23 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 1.99 110.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.51 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.31 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.09 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 45.6 p-10 -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.68 111.571 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.39 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.706 ' CD2' HG22 ' A' ' 165' ' ' THR . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 2.76 110.112 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 1.6 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 1.73 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.17 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.44 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.71 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 3.66 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 1.77 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 67' ' ' PHE . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.14 109.579 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 121' ' ' MET . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 1.83 107.857 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.42 109.188 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.07 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.05 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 4.88 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.449 ' HA ' ' HG1' ' A' ' 135' ' ' THR . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 3.55 109.614 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.29 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 58' ' ' PHE . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.42 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 135' ' ' THR . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 2.5 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.531 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.55 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.531 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 5.59 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.06 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 3.91 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.64 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.64 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 4.99 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 146' ' ' GLU . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 1.57 109.538 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 4.73 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.07 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 1.063 ' CZ ' HD12 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 2.93 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 1.77 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.34 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.594 ' SD ' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 3.53 110.37 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.18 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.743 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 69.7 m-20 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.49 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 2.83 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.45 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.063 HD12 ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 1.9 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.706 HG22 ' CD2' ' A' ' 115' ' ' TYR . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 1.8 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 166' ' ' LEU . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.28 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 2.92 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.644 ' OE1' ' ND2' ' A' ' 159' ' ' ASN . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.14 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.431 ' OE1' HD23 ' A' ' 166' ' ' LEU . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.35 110.246 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.18 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 4.67 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 2.92 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.17 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.62 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.0 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 3.79 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.02 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.498 ' HB3' HD23 ' A' ' 183' ' ' LEU . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.48 108.955 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 4.79 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.27 110.009 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.873 -0.418 . . . . 2.5 109.873 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.23 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.17 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 2.64 109.028 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 2.71 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' VAL . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.6 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.04 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.04 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.0 108.372 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 2.94 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 3.98 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 24' ' ' GLU . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.1 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 16' ' ' LEU . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.44 109.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 3.85 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 3.75 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 5.2 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 2.74 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.06 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 2.92 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 3.92 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.37 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 5.72 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 4.71 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.05 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 2.56 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.09 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 2.82 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 1.72 109.866 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.06 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.03 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 51' ' ' ILE . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 2.65 108.039 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.8 108.441 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.4 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 2.99 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.31 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 3.63 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.23 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.18 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 6.44 109.906 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.28 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.17 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 3.59 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 4.4 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.677 HG23 ' H ' ' A' ' 63' ' ' LYS . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.54 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.677 ' H ' HG23 ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.3 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.774 ' O ' HG23 ' A' ' 68' ' ' VAL . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.12 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 1.79 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 62' ' ' THR . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.04 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.31 108.725 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 1.71 109.324 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 4.33 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.75 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 1.91 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 2.75 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.3 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.34 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 2.85 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.19 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 1.76 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.4 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.27 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.35 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE1' HD22 ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.22 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 1.9 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 86' ' ' ILE . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 2.63 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.56 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.17 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.01 109.005 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.2 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 2.75 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 8.35 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.29 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.18 108.592 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.22 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 96' ' ' THR . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.12 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.31 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 3.93 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 4.4 109.466 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.41 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 2.69 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.597 ' NZ ' ' O ' ' A' ' 71' ' ' VAL . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.23 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 1.99 109.422 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.51 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.713 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.31 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.09 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.68 110.772 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.39 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 163' ' ' LYS . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 2.76 109.315 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.6 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 1.73 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HE1' ' A' ' 121' ' ' MET . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.17 109.8 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.44 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.71 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.675 ' O ' HG13 ' A' ' 125' ' ' VAL . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 3.66 109.236 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 122' ' ' LEU . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 1.77 109.381 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 124' ' ' ILE . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.14 110.421 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 1.83 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 132' ' ' VAL . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.42 108.975 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.07 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.05 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 4.88 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 128' ' ' ILE . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 3.55 109.434 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.48 ' C ' HG22 ' A' ' 135' ' ' THR . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.29 109.768 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.815 ' O ' HG13 ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.42 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 2.5 110.114 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.55 111.984 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 79.9 m-20 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 5.59 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.06 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.621 ' HD3' HD12 ' A' ' 183' ' ' LEU . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 3.91 112.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 149' ' ' VAL . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.64 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 4.99 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 1.57 108.958 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 4.73 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.07 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.775 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 2.93 109.072 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 1.77 108.197 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.34 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 179' ' ' ILE . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 3.53 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.18 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.743 HD21 ' HB2' ' A' ' 161' ' ' ASP . 0.4 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.49 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.743 ' HB2' HD21 ' A' ' 159' ' ' ASN . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 2.83 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 115' ' ' TYR . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.45 108.888 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.775 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 1.9 108.661 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 164' ' ' LEU . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 1.8 109.72 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.28 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 2.92 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.14 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.35 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.18 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 4.67 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 2.92 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.17 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.62 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.868 HD11 ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.0 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 3.79 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 6.7 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.02 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.521 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.48 109.738 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.0 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 4.79 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.27 110.022 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' CG ' HG23 ' A' ' 12' ' ' VAL . 15.4 ptpt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.437 -0.579 . . . . 2.5 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.23 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG23 ' CG ' ' A' ' 9' ' ' LYS . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.17 108.8 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 17' ' ' THR . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 2.64 108.948 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.678 HD22 ' OG1' ' A' ' 20' ' ' THR . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 2.71 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 24' ' ' GLU . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.6 106.841 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.04 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.04 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.678 ' OG1' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.0 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.65 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 2.94 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 3.98 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.1 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 28' ' ' GLN . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.44 110.364 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 27' ' ' VAL . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 3.85 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 3.75 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 5.2 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 2.74 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.06 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 2.92 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 3.92 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.37 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 5.72 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 4.71 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.05 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 2.56 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.09 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 47' ' ' GLY . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 2.82 109.91 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 1.72 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.06 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.03 109.903 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' HG13 ' A' ' 51' ' ' ILE . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 2.65 108.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.8 108.766 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.4 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 48' ' ' PHE . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 2.99 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.31 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 3.63 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.23 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.18 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 6.44 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.28 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG23 ' A' ' 136' ' ' VAL . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.17 109.547 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 3.59 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 4.4 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.54 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.3 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 68' ' ' VAL . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.12 109.604 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 1.79 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.04 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' VAL . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 2.31 108.55 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 1.71 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 4.33 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.75 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 106' ' ' LYS . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 1.91 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 2.75 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.3 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.34 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 2.85 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.19 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 1.76 108.178 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.4 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.27 109.152 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.35 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.22 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 1.9 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 2.63 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.56 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 85' ' ' PHE . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.17 108.031 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.01 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.2 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 2.75 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 8.35 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.29 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.18 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.22 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.12 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.31 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 3.93 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 107' ' ' LEU . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 4.4 108.743 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.41 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 2.69 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' HG21 ' A' ' 71' ' ' VAL . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.23 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 1.99 110.439 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 121' ' ' MET . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.51 108.743 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.619 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.792 HD23 ' H ' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.31 110.134 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.792 ' H ' HD23 ' A' ' 110' ' ' LEU . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.09 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.648 ' ND2' ' O ' ' A' ' 112' ' ' ASN . 2.3 p-10 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.68 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.39 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' CE2' HG22 ' A' ' 165' ' ' THR . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 2.76 108.924 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 1.6 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 1.73 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.17 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.44 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.71 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 125' ' ' VAL . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 3.66 108.828 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 1.77 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 124' ' ' ILE . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.14 108.95 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 121' ' ' MET . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 1.83 108.44 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.558 ' O ' HG22 ' A' ' 132' ' ' VAL . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.42 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.07 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.05 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.644 ' O ' HG21 ' A' ' 135' ' ' THR . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 4.88 109.04 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 128' ' ' ILE . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 3.55 109.733 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.29 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 131' ' ' MET . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.42 108.395 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 2.5 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.55 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 5.59 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.06 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 3.91 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 149' ' ' VAL . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.64 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 4.99 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 1.57 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 4.73 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.07 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 2.93 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 1.77 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.34 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.509 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 3.53 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.18 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.59 ' ND2' ' CG ' ' A' ' 161' ' ' ASP . 16.9 p-10 -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.49 109.503 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.59 ' CG ' ' ND2' ' A' ' 159' ' ' ASN . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 2.83 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.45 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 165' ' ' THR . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 1.9 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.625 ' N ' HD13 ' A' ' 164' ' ' LEU . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 1.8 109.826 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.939 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.28 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 50.6 mm-40 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 2.92 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.14 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.35 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.18 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 4.67 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 2.92 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.17 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.62 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.0 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 176' ' ' ASP . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 3.79 108.798 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.02 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.48 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 4.79 109.221 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.27 108.822 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.251 -0.648 . . . . 2.5 109.251 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.23 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.17 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 2.64 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 2.71 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.6 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.04 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.04 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.859 HG23 ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.0 111.111 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.859 ' H ' HG23 ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 2.94 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 3.98 109.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 17' ' ' THR . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.1 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 23' ' ' THR . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.44 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 3.85 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 3.75 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 5.2 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 2.74 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.06 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 2.92 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 3.92 110.863 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' HA2' ' A' ' 41' ' ' GLY . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.37 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 5.72 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 4.71 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.05 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 2.56 110.208 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.09 109.468 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 ' C ' ' A' ' 47' ' ' GLY . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 2.82 109.535 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 1.72 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.06 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.03 109.347 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 2.65 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.026 ' NE2' HG22 ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.8 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.4 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 2.99 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.31 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 3.63 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.23 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.18 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 6.44 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.28 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HB2' HG23 ' A' ' 136' ' ' VAL . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.17 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 3.59 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 4.4 112.749 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' THR . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.54 110.974 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.3 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.12 109.501 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 1.79 109.683 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 1.026 HG22 ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.04 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 2.31 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 64' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 1.71 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 4.33 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.75 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 110' ' ' LEU . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 1.91 110.608 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.065 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 2.75 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.3 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.34 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 2.85 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.19 108.773 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 1.76 108.661 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.4 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.27 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.35 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.22 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 1.9 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 2.63 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.065 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.56 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 85' ' ' PHE . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.17 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.01 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.2 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 2.75 109.475 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 8.35 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.29 109.584 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.18 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.22 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.12 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.579 HD11 HG11 ' A' ' 180' ' ' VAL . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.31 108.889 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 3.93 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 4.4 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.41 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 2.69 109.861 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.521 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.23 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 1.99 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.51 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 71' ' ' VAL . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.31 109.847 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.09 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.68 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.39 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 2.76 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 1.6 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 1.73 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.608 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.17 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.44 108.704 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.71 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 3.66 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 1.77 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ILE . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.14 109.953 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 1.83 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.42 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 144' ' ' THR . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.07 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.05 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 4.88 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 3.55 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.29 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 58' ' ' PHE . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.42 108.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 134' ' ' ASN . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 2.5 110.002 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.55 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.456 ' H ' ' HG2' ' A' ' 139' ' ' PRO . 76.9 m-20 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 5.59 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.06 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 3.91 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.64 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 4.99 109.857 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 1.57 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 4.73 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.07 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 2.93 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 1.77 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.34 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 3.53 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.18 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.59 HD21 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.49 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.59 ' CG ' HD21 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 2.83 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.45 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 1.9 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 1.8 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.28 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 2.92 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 164' ' ' LEU . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.14 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.35 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.18 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 4.67 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 2.92 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.17 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.62 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.579 HG11 HD11 ' A' ' 101' ' ' LEU . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 3.79 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.02 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.48 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 4.79 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.27 109.367 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.633 -0.506 . . . . 2.5 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.23 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.17 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 2.64 108.715 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.71 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.6 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.04 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.04 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.76 HG21 HG11 ' A' ' 27' ' ' VAL . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.0 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 2.94 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 3.98 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.1 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 20' ' ' THR . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.44 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 3.85 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 3.75 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 5.2 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 2.74 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.06 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 2.92 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 3.92 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.37 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 5.72 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 4.71 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.05 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 2.56 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.09 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.519 HD21 ' C ' ' A' ' 47' ' ' GLY . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 2.82 109.662 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 1.72 110.079 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.06 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.03 109.253 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 2.65 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.8 108.83 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.4 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 2.99 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.47 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.31 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 3.63 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.23 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.18 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 6.44 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.28 112.926 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 135' ' ' THR . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.17 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 3.59 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 4.4 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 65' ' ' ALA . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.54 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.3 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.817 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.12 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 1.79 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.04 109.286 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.906 ' CZ ' HD11 ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 2.31 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 64' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 1.71 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.805 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 4.33 109.204 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' HD11 ' A' ' 110' ' ' LEU . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.75 110.917 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 1.91 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 2.75 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.597 HD21 ' CG ' ' A' ' 77' ' ' ASP . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.3 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.34 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.597 ' CG ' HD21 ' A' ' 75' ' ' ASN . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 2.85 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.19 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 1.76 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.4 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 86' ' ' ILE . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.27 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.35 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CE1' HD11 ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.22 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' GLN . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 1.9 110.278 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' ILE . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 2.63 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.56 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.936 HD11 ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.17 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.01 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.2 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 2.75 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 8.35 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.29 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.18 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.776 ' H ' HD12 ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.22 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.12 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.31 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 3.93 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 4.4 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.41 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CZ ' ' ND2' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 2.69 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.23 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 107' ' ' LEU . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 1.99 109.856 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.51 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' OD1' ' A' ' 70' ' ' ASN . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.31 110.06 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.09 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.6 t-20 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.68 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.39 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 2.76 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 1.6 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 1.73 108.383 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.587 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.17 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.44 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.71 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 125' ' ' VAL . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 3.66 108.921 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 122' ' ' LEU . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 1.77 108.968 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.906 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.14 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 121' ' ' MET . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 1.83 107.937 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.42 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.07 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.05 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 4.88 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 3.55 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.29 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 58' ' ' PHE . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.436 ' N ' HG22 ' A' ' 135' ' ' THR . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.42 109.651 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 136' ' ' VAL . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 2.5 108.376 179.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.55 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 5.59 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.06 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 3.91 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.692 ' O ' HG22 ' A' ' 149' ' ' VAL . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.64 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 4.99 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 146' ' ' GLU . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 1.57 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 4.73 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.07 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 2.93 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 1.77 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.409 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.34 109.01 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 179' ' ' ILE . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 3.53 110.008 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' HH22 ' A' ' 118' ' ' ARG . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.18 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.749 HD22 ' CG ' ' A' ' 161' ' ' ASP . 37.6 p-10 -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.49 109.689 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.749 ' CG ' HD22 ' A' ' 159' ' ' ASN . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 2.83 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.45 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 1.9 105.773 177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 1.8 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.788 ' H ' HD12 ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.28 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 2.92 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.14 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.5 ' OE1' HD23 ' A' ' 166' ' ' LEU . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.35 110.138 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.18 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 4.67 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 2.92 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.17 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.62 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 ' SD ' ' A' ' 156' ' ' MET . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.0 109.035 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 3.79 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.02 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.494 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.48 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 4.79 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.27 109.467 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.408 -0.59 . . . . 2.5 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.23 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.17 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 2.64 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 2.71 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.6 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.462 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.04 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.04 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.0 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 2.94 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 3.98 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.1 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 20' ' ' THR . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.44 109.423 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 3.85 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 3.75 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 5.2 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 2.74 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.06 108.429 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 2.92 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 3.92 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.37 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 5.72 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 4.71 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.05 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 2.56 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' NE2' ' HG2' ' A' ' 81' ' ' GLU . 8.0 tp-100 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.09 109.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 2.82 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 1.72 109.986 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.06 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.03 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 2.65 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.8 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.4 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 2.99 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.31 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 3.63 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.23 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.18 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 6.44 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.28 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.17 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 3.59 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 4.4 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' THR . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.54 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.3 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.12 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 1.79 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 49' ' ' GLN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.04 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 2.31 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 1.71 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 4.33 109.041 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.75 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 1.91 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.663 ' N ' HG13 ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 2.75 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.648 ' ND2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.3 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.34 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 2.85 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.19 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.603 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 1.76 108.22 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.4 110.57 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.27 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.35 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.648 ' OE2' ' ND2' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.22 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 1.9 109.476 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 2.63 110.486 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.56 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.641 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.17 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.01 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.2 108.453 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 2.75 108.631 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.604 ' OG ' ' CD2' ' A' ' 21' ' ' TYR . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' CG ' ' N ' ' A' ' 95' ' ' GLY . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 8.35 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.29 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.18 108.499 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.22 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.12 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.31 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 3.93 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 4.4 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.41 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 2.69 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.23 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 1.99 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.51 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.31 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.09 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.68 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.39 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 2.76 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.491 HG21 ' HE3' ' A' ' 121' ' ' MET . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 1.6 109.179 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 1.73 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.17 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.44 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.71 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 3.66 109.708 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 1.77 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 124' ' ' ILE . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.14 109.588 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 121' ' ' MET . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 1.83 107.346 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.42 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.07 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.05 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 4.88 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 132' ' ' VAL . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 3.55 108.798 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.29 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.42 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 2.5 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.55 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 5.59 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.06 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 3.91 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.64 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' ' 152' ' ' ILE . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 4.99 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 1.57 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 4.73 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 148' ' ' ARG . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.07 109.693 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 2.93 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 1.77 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.34 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 3.53 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.18 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.49 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 2.83 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.45 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 1.9 108.164 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.721 ' N ' HD13 ' A' ' 164' ' ' LEU . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 1.8 110.14 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 1.039 ' H ' HD23 ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.28 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 2.92 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 164' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.14 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.35 109.522 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.18 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 4.67 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 2.92 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.17 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.62 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.0 110.15 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 3.79 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.71 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 57.9 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.02 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.48 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.08 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 4.79 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.27 109.309 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.23 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.17 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.875 ' O ' HG23 ' A' ' 17' ' ' THR . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 2.64 109.791 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.563 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 2.71 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.6 108.514 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.04 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.04 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.0 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 2.94 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 3.98 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.1 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 20' ' ' THR . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.44 109.413 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 3.85 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 3.75 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 5.2 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 2.74 108.554 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.06 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 2.92 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 3.92 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.37 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 5.72 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 4.71 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.05 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 2.56 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.448 ' OE1' ' NH1' ' A' ' 79' ' ' ARG . 23.8 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.09 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 2.82 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 1.72 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HA ' HE21 ' A' ' 49' ' ' GLN . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.06 110.087 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.03 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 2.65 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.554 HE21 ' HA ' ' A' ' 46' ' ' ALA . 41.1 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.8 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.4 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.477 HG21 ' CZ ' ' A' ' 85' ' ' PHE . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 2.99 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.31 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.63 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.23 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.18 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 6.44 110.002 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.28 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.17 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 3.59 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 4.4 112.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.54 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.3 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 68' ' ' VAL . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.12 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 1.79 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.04 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 2.31 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 64' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 1.71 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 4.33 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.75 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 1.91 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 2.75 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.628 ' ND2' ' OE2' ' A' ' 84' ' ' GLU . 1.4 m-20 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.3 109.559 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.34 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 2.85 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH1' ' OE1' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.19 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 1.76 107.745 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.4 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.27 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.35 109.529 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.628 ' OE2' ' ND2' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.22 109.828 -178.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.515 ' HA ' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 1.9 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 2.63 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.56 108.357 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 85' ' ' PHE . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.01 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.523 HG11 ' NE1' ' A' ' 103' ' ' TRP . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.2 109.159 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 2.75 109.135 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 8.35 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.29 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.18 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.22 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.12 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.31 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 3.93 110.849 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.523 ' NE1' HG11 ' A' ' 91' ' ' VAL . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 4.4 109.745 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.41 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 2.69 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.23 108.747 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 68' ' ' VAL . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 1.99 108.833 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.51 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 110' ' ' LEU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.31 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.09 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.68 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.39 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 165' ' ' THR . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 2.76 108.979 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 1.6 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 1.73 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.788 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.17 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.44 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.71 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 3.66 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' OD2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 1.77 109.258 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 67' ' ' PHE . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.14 109.967 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 121' ' ' MET . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 1.83 108.368 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 122' ' ' LEU . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.876 ' O ' HG22 ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.42 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.07 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.05 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 4.88 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 3.55 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.29 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.42 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.528 HD23 ' CD ' ' A' ' 142' ' ' GLU . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 2.5 108.434 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.55 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 144' ' ' THR . 21.3 m120 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 5.59 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.06 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 3.91 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.64 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.621 ' O ' HD13 ' A' ' 152' ' ' ILE . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 4.99 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' A' ' 153' ' ' PHE . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 1.57 108.894 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 4.73 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.07 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 2.93 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 1.77 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.34 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 3.53 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.18 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.49 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 2.83 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.45 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 1.9 108.145 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 115' ' ' TYR . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 1.8 109.44 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.28 110.027 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 2.92 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.14 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.35 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.18 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 4.67 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 2.92 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.17 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.62 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.0 109.99 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 3.79 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 180' ' ' VAL . 2.4 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.02 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.791 ' C ' HD12 ' A' ' 183' ' ' LEU . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.48 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 182' ' ' ALA . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 4.79 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.27 107.748 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.121 -0.696 . . . . 2.5 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.23 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.17 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' THR . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 2.64 108.401 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 2.71 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 13' ' ' VAL . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.6 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.04 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.04 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.0 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 2.94 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 3.98 109.092 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.1 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 20' ' ' THR . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.44 108.475 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 3.85 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 3.75 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 5.2 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 2.74 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.06 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 2.92 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 3.92 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.37 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 5.72 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 4.71 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.05 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 2.56 109.579 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.582 ' NE2' ' CZ ' ' A' ' 79' ' ' ARG . 19.4 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.09 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 2.82 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 1.72 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.06 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.03 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 2.65 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.8 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.4 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.31 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 3.63 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.23 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.18 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 6.44 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.28 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.17 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 3.59 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 4.4 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.54 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.3 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.12 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 1.79 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.04 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 2.31 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 1.71 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 4.33 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.75 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' LEU . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 1.91 110.389 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.965 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 2.75 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.3 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.34 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 2.85 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.19 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 1.76 107.875 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.4 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.27 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.35 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 51' ' ' ILE . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.22 109.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 1.9 109.923 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 2.63 109.767 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.965 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.56 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.17 108.579 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.01 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 87' ' ' GLN . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.2 109.036 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' ALA . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 2.75 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 8.35 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.29 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.18 108.727 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.22 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.12 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.31 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 3.93 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.473 ' CH2' HD13 ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 4.4 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.41 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 2.69 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.23 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.825 ' O ' HD23 ' A' ' 107' ' ' LEU . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 1.99 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.51 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 71' ' ' VAL . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.31 109.749 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.09 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.68 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.39 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 2.76 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 1.6 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HZ2' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 1.73 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.755 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.17 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.44 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.71 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.805 ' O ' HG23 ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 3.66 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 1.77 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 124' ' ' ILE . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.14 109.423 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 1.83 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 183' ' ' LEU . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.42 109.986 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.07 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.05 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 4.88 108.351 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 128' ' ' ILE . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 3.55 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.29 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 138' ' ' LEU . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.42 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 135' ' ' THR . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.826 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 2.5 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.55 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 5.59 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.06 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.697 ' HD3' HD22 ' A' ' 183' ' ' LEU . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 3.91 113.754 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE1' HG11 ' A' ' 125' ' ' VAL . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.64 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 4.99 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 1.57 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 4.73 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.07 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.678 ' CZ ' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 2.93 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 1.77 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.542 ' HA ' ' HZ3' ' A' ' 158' ' ' LYS . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.34 110.559 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 3.53 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.542 ' HZ3' ' HA ' ' A' ' 155' ' ' MET . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.18 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.642 ' ND2' ' OD2' ' A' ' 161' ' ' ASP . 11.7 p30 -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.49 109.581 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.642 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.651 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 2.83 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HZ2' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.45 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.678 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 1.9 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 1.8 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.28 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 2.92 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.14 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.35 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.496 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.18 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 4.67 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 2.92 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.17 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.62 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 172' ' ' GLY . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.0 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 173' ' ' SER . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 3.79 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.02 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.599 ' C ' HD23 ' A' ' 183' ' ' LEU . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.48 108.957 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 4.79 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.27 109.911 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.882 -0.784 . . . . 2.5 108.882 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.23 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.17 109.965 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 17' ' ' THR . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 2.64 109.232 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 2.71 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 13' ' ' VAL . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.6 108.086 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.04 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.04 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 16' ' ' LEU . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.0 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 2.94 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 3.98 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.1 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' GLN . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.44 109.43 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 27' ' ' VAL . 63.0 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 3.85 109.129 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 86.0 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 3.75 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 5.2 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 2.74 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.06 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 2.92 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 3.92 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.37 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 5.72 108.237 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 4.71 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.05 109.24 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 2.56 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.09 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 2.82 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 1.72 109.541 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.06 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.03 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 2.65 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.8 107.81 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.4 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 2.99 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.31 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 3.63 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.23 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.18 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 6.44 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.28 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 136' ' ' VAL . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.17 110.876 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 3.59 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.661 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 4.4 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.54 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.3 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.12 110.443 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 1.79 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 62' ' ' THR . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.04 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 2.31 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 1.71 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 4.33 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.75 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 109' ' ' ASP . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 1.91 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 2.75 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.672 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.672 ' ND2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.3 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.34 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 2.85 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.19 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 1.76 106.893 178.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.4 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.27 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.35 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CE1' HD23 ' A' ' 89' ' ' LEU . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.22 110.645 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 1.9 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 2.63 110.556 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.56 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.17 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 86' ' ' ILE . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.01 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.2 108.243 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ALA . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 2.75 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.573 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 8.35 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.29 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.18 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.22 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.12 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.31 109.772 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 3.93 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 4.4 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.41 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 2.69 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 71' ' ' VAL . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.23 109.738 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 107' ' ' LEU . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 1.99 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.51 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG21 ' A' ' 71' ' ' VAL . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.31 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.09 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.68 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.39 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 2.76 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 1.6 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.575 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.17 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.44 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.71 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.651 ' O ' HG13 ' A' ' 125' ' ' VAL . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 3.66 109.085 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 1.77 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 124' ' ' ILE . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.14 110.998 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 1.83 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.42 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.07 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.05 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 4.88 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 3.55 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.29 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.42 108.961 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.508 ' H ' HG22 ' A' ' 135' ' ' THR . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 2.5 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.55 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 5.59 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.06 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 3.91 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.546 ' O ' HG22 ' A' ' 149' ' ' VAL . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.64 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 4.99 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 146' ' ' GLU . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 1.57 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 4.73 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.07 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.74 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 2.93 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 1.77 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.34 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 3.53 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.18 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.49 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 2.83 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.45 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.74 HD21 ' CD1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 1.9 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 1.8 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 1.085 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.28 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.625 ' N ' HD22 ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 2.92 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.14 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.35 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' HG22 ' A' ' 180' ' ' VAL . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.18 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 4.67 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 2.92 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.17 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.62 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.0 109.631 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 3.79 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.02 109.401 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.48 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 4.79 109.869 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.27 109.116 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.567 -0.531 . . . . 2.5 109.567 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.23 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.17 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 2.64 107.844 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 2.71 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 13' ' ' VAL . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.6 107.49 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.04 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.04 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.735 HG23 ' H ' ' A' ' 22' ' ' PHE . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.0 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.735 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 2.94 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 3.98 109.009 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.1 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' THR . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.44 109.314 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 3.85 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 3.75 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 5.2 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 2.74 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.06 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 2.92 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 3.92 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 35' ' ' ILE . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.37 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 5.72 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 4.71 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.05 110.199 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 2.56 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.09 109.167 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 47' ' ' GLY . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 2.82 109.522 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 1.72 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.06 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.03 109.739 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 2.65 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 23.6 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.8 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.4 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 ' HE1' ' A' ' 55' ' ' PHE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 2.99 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.31 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 3.63 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.624 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.23 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.18 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 6.44 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.28 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.652 ' O ' HG22 ' A' ' 135' ' ' THR . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.17 109.979 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 3.59 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 4.4 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.54 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.3 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.12 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 1.79 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.04 108.919 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 2.31 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 64' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 1.71 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 4.33 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.75 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 110' ' ' LEU . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 1.91 111.137 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.901 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 2.75 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.3 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.34 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 2.85 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.19 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 1.76 108.32 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.4 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.27 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.35 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.681 ' CE1' HD23 ' A' ' 89' ' ' LEU . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.22 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 1.9 108.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 2.63 109.507 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.56 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.681 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.17 107.716 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.01 108.671 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.2 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 2.75 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 8.35 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.29 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.635 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.18 108.75 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.22 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.12 108.815 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.489 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.31 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 3.93 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 4.4 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.41 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.584 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 2.69 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.23 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 1.99 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.51 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.31 110.187 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.09 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.68 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.39 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 2.76 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 1.6 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 1.73 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.641 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.17 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.44 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.71 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 3.66 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 1.77 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.14 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 1.83 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 132' ' ' VAL . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.42 109.258 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.07 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.05 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 4.88 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.645 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 3.55 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 135' ' ' THR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.29 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.711 ' O ' HD23 ' A' ' 138' ' ' LEU . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.42 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 135' ' ' THR . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 2.5 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.55 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 144' ' ' THR . 81.8 m-20 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 5.59 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.06 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 3.91 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.64 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 4.99 110.285 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 1.57 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 4.73 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.07 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 2.93 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 1.77 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.34 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.57 ' CE ' HD11 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 3.53 109.34 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.18 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 161' ' ' ASP . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.49 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 2.83 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.45 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 1.9 107.605 178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.642 ' N ' HD13 ' A' ' 164' ' ' LEU . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 1.8 110.596 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD23 ' NE2' ' A' ' 170' ' ' GLN . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.28 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 2.92 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.14 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.589 ' NE2' HD23 ' A' ' 166' ' ' LEU . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.35 110.563 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.18 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 4.67 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 2.92 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.17 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.62 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 156' ' ' MET . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.0 108.835 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 3.79 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 180' ' ' VAL . 49.7 tp60 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.02 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.853 ' C ' HD13 ' A' ' 183' ' ' LEU . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.48 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.044 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 4.79 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.27 110.499 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.94 0.4 . . . . 2.5 110.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.23 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.64 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 2.71 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.6 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.04 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.04 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.0 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 20' ' ' THR . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 2.94 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 3.98 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CG ' HG21 ' A' ' 17' ' ' THR . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.1 110.269 -179.215 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 86' ' ' ILE . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.44 109.505 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 3.85 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 3.75 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 33' ' ' GLY . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 5.2 108.482 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 2.74 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.06 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 2.92 111.26 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 3.92 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.37 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 5.72 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 4.71 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' ILE . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.05 109.186 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 2.56 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.09 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 2.82 109.575 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 1.72 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.06 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.03 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 2.65 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.8 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.4 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 2.99 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.31 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 3.63 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.23 109.927 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.18 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 6.44 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.28 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.17 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 3.59 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 131' ' ' MET . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 4.4 112.325 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' THR . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.54 109.488 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 62' ' ' THR . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.3 109.234 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.751 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.12 109.349 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.79 109.303 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' THR . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.04 108.984 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.657 ' CE2' HD22 ' A' ' 110' ' ' LEU . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 2.31 108.877 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 64' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 1.71 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 4.33 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.75 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 1.91 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.614 ' N ' HG13 ' A' ' 71' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 2.75 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.3 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.34 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 2.85 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.19 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 1.76 108.337 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.4 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.27 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.35 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' CD ' ' OE1' ' A' ' 81' ' ' GLU . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.22 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 27' ' ' VAL . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 1.9 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 91' ' ' VAL . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 2.63 110.365 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.56 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.01 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLN . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.2 107.774 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 2.75 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.504 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 8.35 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.29 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.18 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.22 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.12 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.31 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 3.93 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 4.4 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 166' ' ' LEU . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 2.69 109.041 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.23 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 1.99 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 182' ' ' ALA . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.51 109.302 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 67' ' ' PHE . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.31 109.01 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.09 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.68 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.39 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 165' ' ' THR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 2.76 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 1.6 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 1.73 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.792 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.17 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.44 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.71 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 3.66 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 1.77 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 124' ' ' ILE . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.14 110.638 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 1.83 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 125' ' ' VAL . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 64' ' ' PHE . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.42 109.304 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.07 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.05 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 4.88 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 132' ' ' VAL . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 3.55 109.387 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.29 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 137' ' ' GLU . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.42 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.606 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 2.5 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.55 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 144' ' ' THR . 25.9 t30 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 5.59 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.471 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.06 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG2' HG11 ' A' ' 125' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 3.91 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.64 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 4.99 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 149' ' ' VAL . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 1.57 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 4.73 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.07 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 2.93 109.04 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 1.77 108.088 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.34 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 3.53 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.18 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.711 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.49 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 2.83 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.45 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 1.9 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 115' ' ' TYR . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 1.8 109.601 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.28 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 2.92 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.14 110.202 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.35 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.18 109.498 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 4.67 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 2.92 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.17 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.62 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 169' ' ' PHE . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.0 109.73 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 3.79 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.02 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.48 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 4.79 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.27 109.356 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.23 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 16' ' ' LEU . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.17 109.021 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 2.64 109.604 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.586 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 2.71 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 17' ' ' THR . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.6 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.475 HH12 ' HB3' ' A' ' 14' ' ' GLU . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.04 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.04 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.0 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 2.94 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 3.98 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.1 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.44 108.885 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 3.85 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 3.75 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 5.2 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 2.74 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.06 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 2.92 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 3.92 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 41' ' ' GLY . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.37 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 5.72 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 4.71 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.05 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' H ' HD13 ' A' ' 35' ' ' ILE . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 2.56 110.462 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.09 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 2.82 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 1.72 108.726 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.06 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.03 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 2.65 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 6.3 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.8 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.4 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 2.99 108.88 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.31 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 3.63 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 25.8 mm-40 -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.23 110.842 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.18 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 6.44 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.28 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 136' ' ' VAL . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.17 109.684 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 3.59 109.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 4.4 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.54 109.976 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.3 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 68' ' ' VAL . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.12 109.916 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 1.79 109.421 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.04 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 107' ' ' LEU . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 2.31 109.343 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 64' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 4.33 109.442 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.75 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 1.91 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.034 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 2.75 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.3 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.34 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 2.85 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.19 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 1.76 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.4 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.27 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.35 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.68 ' CE1' HD23 ' A' ' 89' ' ' LEU . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.22 109.947 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 1.9 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 2.63 110.167 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.034 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.68 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.17 109.098 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.01 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.2 108.571 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 2.75 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 8.35 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.29 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.18 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.22 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.12 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.31 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 3.93 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 4.4 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.41 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 2.69 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.23 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 ' CE1' ' A' ' 64' ' ' PHE . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 1.99 109.875 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.51 110.794 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 124' ' ' ILE . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.31 109.684 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.09 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.68 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.39 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.522 ' CE2' HG22 ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 2.76 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 1.6 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 1.73 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.648 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.17 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.44 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.71 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 3.66 109.669 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 122' ' ' LEU . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 1.77 109.425 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.14 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 121' ' ' MET . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 1.83 109.175 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 132' ' ' VAL . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.42 107.506 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.07 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.517 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.05 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 4.88 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 136' ' ' VAL . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 3.55 108.99 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.542 ' C ' HG22 ' A' ' 135' ' ' THR . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.29 108.695 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.542 HG22 ' C ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 132' ' ' VAL . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.42 109.898 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 2.5 108.084 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.55 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 71.3 m-20 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 5.59 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.06 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 3.91 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.64 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 4.99 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 146' ' ' GLU . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 1.57 108.792 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 4.73 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.07 110.887 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 2.93 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 1.77 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.34 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 3.53 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.18 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.657 ' H ' ' HG3' ' A' ' 158' ' ' LYS . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.49 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 2.83 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.45 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 165' ' ' THR . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 1.9 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 164' ' ' LEU . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 1.8 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.28 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 2.92 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.14 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.35 110.076 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.18 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 4.67 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 2.92 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.17 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.62 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.0 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 3.79 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.02 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' O ' ' CD ' ' A' ' 145' ' ' PRO . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.48 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 4.79 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.27 109.263 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.781 0.324 . . . . 2.5 110.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.23 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.17 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 17' ' ' THR . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 2.64 109.168 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.63 ' O ' HG22 ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 2.71 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 13' ' ' VAL . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.6 107.335 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 HH11 ' HG1' ' A' ' 17' ' ' THR . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.04 108.607 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.04 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.0 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 27' ' ' VAL . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 2.94 108.012 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 3.98 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.1 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 22' ' ' PHE . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.44 109.42 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 27' ' ' VAL . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 3.85 109.711 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 3.75 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 5.2 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 2.74 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.06 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 2.92 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 3.92 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.37 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 5.72 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 4.71 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.05 109.326 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 2.56 109.212 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' ' CZ ' ' A' ' 79' ' ' ARG . 20.9 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.09 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 2.82 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 1.72 108.585 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.06 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.03 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 2.65 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.8 107.81 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.4 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 2.99 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.31 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 3.63 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.23 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.18 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 6.44 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.28 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.17 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 3.59 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 4.4 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 66' ' ' THR . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.54 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.3 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 68' ' ' VAL . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.12 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 1.79 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' THR . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.04 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 2.31 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 64' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 1.71 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 4.33 109.837 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.75 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 1.91 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.525 ' N ' HG13 ' A' ' 71' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 2.75 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.3 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.34 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 2.85 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.489 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.19 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.4 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.27 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.35 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.22 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 1.9 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 2.63 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.56 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD23 ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.17 107.808 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.01 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.622 HG11 ' NE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.2 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 2.75 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 8.35 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.29 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.18 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.22 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.12 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.31 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 3.93 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.622 ' NE1' HG11 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 4.4 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.41 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 2.69 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.23 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 1.99 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.51 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 67' ' ' PHE . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.31 109.795 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.09 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.68 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.39 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.623 ' CE1' HG22 ' A' ' 165' ' ' THR . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 2.76 109.514 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.6 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 163' ' ' LYS . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 1.73 108.021 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.17 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.44 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.71 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 3.66 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.77 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 124' ' ' ILE . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.14 109.327 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 145' ' ' PRO . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 1.83 108.058 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 132' ' ' VAL . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.42 109.374 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.07 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.05 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 4.88 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 128' ' ' ILE . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 3.55 109.856 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.29 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.42 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 2.5 109.583 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.55 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 139' ' ' PRO . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 5.59 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.06 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.702 ' HG2' HG22 ' A' ' 125' ' ' VAL . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 3.91 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.554 ' OE1' HG11 ' A' ' 125' ' ' VAL . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.64 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.764 ' O ' HD13 ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 4.99 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 1.57 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 4.73 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.764 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.07 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.792 ' CZ ' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 2.93 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 1.77 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.34 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 3.53 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.18 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.49 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 2.83 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 117' ' ' THR . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.45 109.023 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.792 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 1.9 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 115' ' ' TYR . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 1.8 108.927 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.568 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.28 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 2.92 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.14 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.35 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.18 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 4.67 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 2.92 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.17 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.62 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.0 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 3.79 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.02 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.48 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.988 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 4.79 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.27 109.945 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.605 -0.517 . . . . 2.5 109.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.23 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.17 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 17' ' ' THR . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 2.64 109.398 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' OG1' ' A' ' 20' ' ' THR . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 2.71 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.6 108.117 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.04 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.04 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.511 ' OG1' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.0 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 2.94 109.027 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 3.98 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.1 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 HD11 ' A' ' 86' ' ' ILE . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.44 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 3.85 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 3.75 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 5.2 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HD11 ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 2.74 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.06 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 2.92 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' TYR . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 3.92 111.3 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.37 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 5.72 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 4.71 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.05 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 2.56 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.09 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 2.82 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 1.72 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.06 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.03 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 2.65 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.8 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.4 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 2.99 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.474 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.31 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 3.63 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.23 109.803 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.18 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.541 ' HA ' HG11 ' A' ' 136' ' ' VAL . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 6.44 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.28 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.17 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 3.59 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 4.4 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.54 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.3 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 107' ' ' LEU . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.12 110.833 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 1.79 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.04 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 2.31 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 1.71 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 4.33 109.538 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.53 HD22 HD11 ' A' ' 110' ' ' LEU . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.75 110.444 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 1.91 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.61 ' N ' HG13 ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 2.75 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.645 ' ND2' ' OE2' ' A' ' 84' ' ' GLU . 1.3 m-20 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.3 109.576 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.34 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 2.85 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.19 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 1.76 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.4 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.27 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.35 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HE1' HD13 ' A' ' 89' ' ' LEU . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.22 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 HG23 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 1.9 109.957 -178.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' VAL . 82.7 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 2.63 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.56 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 85' ' ' PHE . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.17 108.611 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.01 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 87' ' ' GLN . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.2 107.336 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 2.75 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 8.35 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 21' ' ' TYR . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.29 110.306 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.18 109.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.22 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.12 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.31 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 3.93 109.611 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 4.4 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.41 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 2.69 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.23 109.44 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 64' ' ' PHE . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 1.99 109.992 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.51 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 70' ' ' ASN . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.31 109.25 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.09 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.68 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.39 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 2.76 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 1.6 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 1.73 108.307 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.17 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.44 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 109' ' ' ASP . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.71 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 3.66 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 122' ' ' LEU . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 1.77 109.533 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 124' ' ' ILE . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.14 110.392 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 1.83 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.596 ' O ' HG23 ' A' ' 132' ' ' VAL . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.42 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.07 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 27.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.05 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 4.88 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' ILE . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 3.55 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.494 ' O ' HD21 ' A' ' 138' ' ' LEU . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.29 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.42 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 2.5 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.55 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 5.59 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.8 ' O ' HG23 ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.06 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 3.91 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.64 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.68 ' HG2' HD12 ' A' ' 152' ' ' ILE . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 4.99 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 1.57 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 4.73 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 148' ' ' ARG . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.07 110.032 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.785 ' CD1' HD21 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 2.93 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 1.77 107.633 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.34 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.636 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 3.53 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.18 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 156' ' ' MET . 76.1 m-20 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.49 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 2.83 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.45 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 1.9 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 1.8 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.28 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 2.92 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 168' ' ' GLU . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.14 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.35 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.18 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 4.67 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 2.92 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.17 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.62 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.0 109.669 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 180' ' ' VAL . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 3.79 108.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.02 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.48 109.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 4.79 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.27 109.919 -179.445 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.436 -0.579 . . . . 2.5 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.23 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.17 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG13 ' CD ' ' A' ' 24' ' ' GLU . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 2.64 109.698 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 2.71 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.6 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.04 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.04 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.0 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 2.94 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 3.98 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.669 ' CD ' HG13 ' A' ' 13' ' ' VAL . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.1 109.513 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.64 HG13 ' CD1' ' A' ' 86' ' ' ILE . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.44 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 3.85 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 3.75 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 5.2 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 2.74 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.06 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 2.92 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 3.92 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.37 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 5.72 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 4.71 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.05 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 2.56 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.09 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 2.82 110.089 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 1.72 109.345 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.06 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.03 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 2.65 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.8 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.4 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 2.99 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.451 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.31 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 3.63 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.23 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.18 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 6.44 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.28 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 136' ' ' VAL . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.17 109.188 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 3.59 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 4.4 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.54 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.3 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.563 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.12 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 1.79 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.04 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 110' ' ' LEU . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 2.31 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 1.71 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 4.33 109.846 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.75 110.745 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 1.91 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.985 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 2.75 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.3 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.34 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 2.85 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.19 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 1.76 108.267 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.4 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.27 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.35 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.22 110.1 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.64 ' CD1' HG13 ' A' ' 27' ' ' VAL . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 1.9 109.502 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 2.63 109.888 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.985 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.56 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.17 108.76 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.01 109.277 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 2.75 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 8.35 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.29 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.18 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 180' ' ' VAL . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.22 109.096 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.12 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.31 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 3.93 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.601 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 4.4 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.41 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' HD11 ' A' ' 116' ' ' ILE . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 2.69 110.196 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.23 109.206 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.601 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 1.99 110.478 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.51 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.31 109.243 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.09 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.68 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.39 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 2.76 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 105' ' ' PHE . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 1.6 108.724 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 1.73 108.86 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.74 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.17 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.44 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.71 109.188 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 3.66 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 1.77 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.14 109.64 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 1.83 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.42 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HG12 ' A' ' 132' ' ' VAL . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.07 110.428 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.05 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 4.88 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 3.55 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 12.5 t-20 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.29 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 136' ' ' VAL . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.42 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 135' ' ' THR . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 2.5 109.798 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.55 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.639 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.679 ' HB3' HD22 ' A' ' 183' ' ' LEU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 5.59 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.451 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.06 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 3.91 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.64 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 4.99 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 1.57 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 4.73 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.07 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 2.93 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 1.77 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.34 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 3.53 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.18 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.732 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.49 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 2.83 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.45 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 168' ' ' GLU . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 1.9 108.158 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 1.8 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 166' ' ' LEU . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.28 110.196 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 2.92 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 164' ' ' LEU . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.14 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.35 109.991 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.18 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 4.67 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 2.92 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.17 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.62 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 180' ' ' VAL . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.0 109.661 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.605 ' N ' HG22 ' A' ' 179' ' ' ILE . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 3.79 111.759 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.02 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.48 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 4.79 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.27 109.738 -179.895 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.536 -0.542 . . . . 2.5 109.536 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.23 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.17 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 2.64 108.16 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 2.71 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.6 107.641 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.04 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.04 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.598 HG21 ' CG1' ' A' ' 27' ' ' VAL . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.0 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 2.94 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 3.98 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.1 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' CG1' HG21 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.44 109.357 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 3.85 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 3.75 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 5.2 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 2.74 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.06 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 2.92 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 3.92 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.37 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 5.72 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 4.71 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.05 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 2.56 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.09 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 2.82 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.551 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 1.72 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.06 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.03 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 2.65 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 24.3 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.8 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.4 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 2.99 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.31 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 3.63 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.23 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.18 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 6.44 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.28 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.17 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 3.59 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 4.4 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.54 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.3 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.12 109.965 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 1.79 109.754 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.04 109.535 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 2.31 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 1.71 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 4.33 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.75 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 1.91 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.999 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 2.75 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.3 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.34 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 2.85 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.19 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.76 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.4 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.27 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.35 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.616 ' CE1' HD13 ' A' ' 89' ' ' LEU . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.22 109.307 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 1.9 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 2.63 110.114 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.999 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.56 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD13 ' CE1' ' A' ' 85' ' ' PHE . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.17 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.01 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.2 109.624 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 88' ' ' ALA . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 2.75 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.493 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 8.35 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.29 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.18 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.22 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.12 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.31 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 3.93 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 4.4 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.41 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 2.69 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.23 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 1.99 110.037 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.408 ' CZ ' ' HG2' ' A' ' 121' ' ' MET . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.51 109.78 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.31 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.09 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.8 OUTLIER 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.68 109.36 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.39 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 2.76 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 1.6 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 1.73 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.17 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.44 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.71 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 3.66 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 1.77 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 124' ' ' ILE . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.14 108.562 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 121' ' ' MET . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 1.83 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.42 109.396 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.07 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.05 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 131' ' ' MET . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 4.88 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 3.55 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 134' ' ' ASN . 1.7 p-10 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.29 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.42 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 2.5 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' HD22 ' A' ' 143' ' ' ASN . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.55 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.452 HD22 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 5.59 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.06 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.644 ' CG ' HD12 ' A' ' 183' ' ' LEU . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 3.91 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' O ' HG22 ' A' ' 149' ' ' VAL . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.64 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 4.99 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 1.57 108.697 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.664 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 4.73 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.07 110.588 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.806 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 2.93 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 1.77 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.34 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 3.53 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.684 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.18 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.684 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.8 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.49 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 2.83 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.45 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.806 HD21 ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 1.9 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.8 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.28 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 2.92 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.634 ' OE1' ' ND2' ' A' ' 159' ' ' ASN . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.14 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.35 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.18 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 4.67 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 2.92 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 176' ' ' ASP . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.17 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.479 ' H ' ' HG3' ' A' ' 181' ' ' GLN . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.62 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.0 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 3.79 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.02 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.48 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 4.79 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.27 109.398 179.598 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.756 -0.461 . . . . 2.5 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.23 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 12' ' ' VAL . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.17 108.373 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 2.64 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.71 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.6 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.04 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.04 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 96' ' ' THR . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.0 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 2.94 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 3.98 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.1 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 20' ' ' THR . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.44 110.303 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 3.85 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 3.75 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 5.2 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 2.74 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.06 108.945 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 2.92 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 3.92 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.37 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 5.72 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 4.71 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.05 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 2.56 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.09 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.82 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 1.72 109.415 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.06 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.03 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 2.65 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.8 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.4 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 52' ' ' TYR . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 2.99 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.31 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 3.63 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.23 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.18 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 6.44 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.28 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.17 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 3.59 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 4.4 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.54 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.3 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.12 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 1.79 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.04 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.603 ' O ' HG22 ' A' ' 71' ' ' VAL . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 2.31 109.9 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 1.71 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 4.33 109.461 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.75 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 1.91 110.519 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.994 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 2.75 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.3 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.34 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 2.85 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.19 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 1.76 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.4 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.27 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.35 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.22 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 1.9 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.494 ' OE1' ' NZ ' ' A' ' 19' ' ' LYS . 9.0 tp-100 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 2.63 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.994 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.56 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.17 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.01 108.437 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NE1' ' A' ' 103' ' ' TRP . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.2 109.466 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 88' ' ' ALA . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 2.75 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' THR . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 21' ' ' TYR . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 8.35 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.29 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 21' ' ' TYR . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.18 109.207 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.22 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.12 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.31 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.506 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 3.93 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.538 ' NE1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 4.4 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.41 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 2.69 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.23 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 1.99 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.51 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.715 ' C ' HD23 ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.31 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.09 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.68 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.39 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 2.76 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.473 HG22 ' HE3' ' A' ' 121' ' ' MET . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 1.6 109.127 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 1.73 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.694 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.17 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.44 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.71 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 3.66 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 122' ' ' LEU . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 1.77 109.828 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.14 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 121' ' ' MET . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 1.83 108.114 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.42 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.07 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.05 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 4.88 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 3.55 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.29 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.42 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 2.5 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.55 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 5.59 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.06 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 149' ' ' VAL . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 3.91 113.207 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.64 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 4.99 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.57 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 4.73 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.07 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.937 ' CE2' HD13 ' A' ' 164' ' ' LEU . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 2.93 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 1.77 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.34 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 3.53 109.4 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.18 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.724 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.49 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 2.83 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.45 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 1.9 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 1.8 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.28 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 2.92 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.14 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.506 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.35 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.18 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 4.67 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 2.92 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.17 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.62 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 172' ' ' GLY . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.0 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 3.79 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.02 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CD2' ' A' ' 183' ' ' LEU . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.48 108.853 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.928 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 4.79 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 4.4 p . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.432 -0.581 . . . . 15.48 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.45 ' O ' ' OD1' ' A' ' 5' ' ' ASN . . . 89.24 -57.02 3.95 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.674 -1.37 . . . . 11.71 109.674 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -57.74 -29.56 64.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -1.218 . . . . 12.65 109.705 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.8 p -59.4 -22.73 61.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 8.16 110.054 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 2' ' ' GLY . 32.0 p-10 -82.55 8.9 10.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.015 -1.053 . . . . 7.63 109.737 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.488 ' O ' ' O ' ' A' ' 7' ' ' LYS . 29.4 t -108.76 149.78 28.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 5.22 109.7 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' SER . 54.0 mttm 56.26 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 4.94 109.911 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.664 HD13 ' CG2' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -76.68 156.9 32.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 2.2 109.146 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.0 mtmp? -60.71 147.64 83.82 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 2.5 109.448 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.23 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.17 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 17' ' ' THR . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 2.64 108.11 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 2.71 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 13' ' ' VAL . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.6 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.04 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.04 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.0 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.623 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 2.94 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 3.98 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.563 ' OE2' HG11 ' A' ' 13' ' ' VAL . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.1 109.771 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 86' ' ' ILE . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.44 110.097 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 3.85 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 3.75 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 5.2 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 2.74 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.06 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 2.92 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 3.92 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.37 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 5.72 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 4.71 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.05 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 2.56 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.09 109.204 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 2.82 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 1.72 109.197 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.06 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.03 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 2.65 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.8 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.4 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 2.99 108.606 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.712 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.31 107.874 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 3.63 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.23 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.18 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 136' ' ' VAL . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 6.44 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.28 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.17 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 3.59 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 4.4 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.54 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.3 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.671 ' O ' HG23 ' A' ' 68' ' ' VAL . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.12 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.79 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.04 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD2' HD23 ' A' ' 110' ' ' LEU . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 2.31 109.177 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 64' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 1.71 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 4.33 109.462 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.75 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 1.91 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 2.75 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.3 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.34 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 2.85 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.19 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 1.76 107.115 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.4 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.27 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.35 109.462 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 89' ' ' LEU . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.22 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 1.9 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 43.0 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 2.63 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.56 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.501 HD13 ' HE1' ' A' ' 85' ' ' PHE . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.17 108.714 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.01 109.015 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG11 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.2 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 2.75 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 8.35 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.29 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.18 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.22 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.12 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.31 109.386 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 3.93 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.757 ' HE1' HG11 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 4.4 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.41 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 2.69 110.035 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.23 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD13 HG22 ' A' ' 68' ' ' VAL . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 1.99 109.92 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.51 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 110' ' ' LEU . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.31 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.09 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.68 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.39 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 2.76 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 1.6 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 1.73 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.61 HH22 ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.17 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.44 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.71 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.635 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 3.66 109.563 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 1.77 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.14 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 121' ' ' MET . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 1.83 108.147 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 128' ' ' ILE . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.42 109.46 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.501 ' CE2' HG21 ' A' ' 144' ' ' THR . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.07 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.05 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 4.88 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 132' ' ' VAL . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 3.55 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.29 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.42 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' N ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 2.5 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.55 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 5.59 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.501 HG21 ' CE2' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.06 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 183' ' ' LEU . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 3.91 113.137 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.64 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 4.99 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 1.57 109.263 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 4.73 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.07 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 2.93 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 1.77 107.702 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.34 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 3.53 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CB ' HH22 ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.18 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.81 HD22 ' CG ' ' A' ' 161' ' ' ASP . 1.3 p30 -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.49 109.701 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.81 ' CG ' HD22 ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 2.83 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.45 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.865 HD11 ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 1.9 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 1.8 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.28 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 2.92 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.14 109.922 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.35 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.18 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 4.67 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.92 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 177' ' ' PRO . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.17 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.62 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 172' ' ' GLY . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 3.79 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.02 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.48 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.876 ' N ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 4.79 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m -63.51 161.59 14.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.27 109.686 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 185' ' ' LEU . 6.0 mp -90.21 137.17 32.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 7.1 109.032 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -96.84 132.61 42.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 9.88 109.687 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.73 -39.02 83.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.338 -0.851 . . . . 8.42 110.028 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.95 -179.89 46.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.795 -1.322 . . . . 9.13 109.795 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.1 -3.55 58.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -1.126 . . . . 11.72 109.395 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 12.62 109.389 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.292 -0.633 . . . . 15.48 109.292 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.22 48.37 1.94 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.137 -1.585 . . . . 11.71 109.137 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 57.83 34.29 24.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.558 -0.966 . . . . 12.65 109.162 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m -129.38 151.81 49.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.006 -0.739 . . . . 8.16 109.006 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 t30 58.84 53.68 5.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 7.63 109.242 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 p -57.15 163.24 2.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 5.22 109.725 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' LEU . 27.8 mtmm -84.6 167.54 16.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 4.94 109.734 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -37.28 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 2.2 109.85 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -59.51 151.28 61.5 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 2.5 109.487 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.23 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.17 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' CG2' HD13 ' A' ' 8' ' ' LEU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 2.64 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 2.71 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.6 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.04 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.04 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.0 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' H ' HG22 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 2.94 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 3.98 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.1 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.44 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 3.85 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 3.75 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 5.2 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 2.74 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.06 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 2.92 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 3.92 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.37 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 5.72 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 4.71 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.05 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 2.56 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 79' ' ' ARG . 21.0 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.09 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 85' ' ' PHE . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 2.82 109.857 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 1.72 109.456 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.06 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.03 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 2.65 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.8 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.4 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 2.99 108.258 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.31 107.188 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 3.63 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.23 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.18 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 6.44 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.28 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.17 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 3.59 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 4.4 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.54 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.3 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.12 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 1.79 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.04 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 2.31 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 1.71 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 4.33 109.72 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.75 110.699 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 1.91 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 2.75 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.61 HD21 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.3 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.34 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' CG ' HD21 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 2.85 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.19 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 1.76 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.4 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.27 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.35 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.22 109.971 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 1.9 110.442 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 2.63 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.56 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.17 109.121 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.01 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.2 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.638 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 8.35 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.29 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.541 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.18 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.22 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HZ3' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.12 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 180' ' ' VAL . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.31 108.737 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 3.93 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.481 ' CH2' HD13 ' A' ' 107' ' ' LEU . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 4.4 109.137 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.41 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 2.69 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 107' ' ' LEU . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.23 109.751 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 1.99 110.048 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.51 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 67' ' ' PHE . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.31 110.618 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.09 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 39.0 t30 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.68 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.39 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CE1' HG22 ' A' ' 165' ' ' THR . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 2.76 110.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 1.6 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 1.73 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.66 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.17 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.44 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.71 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 3.66 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD22 ' OE2' ' A' ' 146' ' ' GLU . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 1.77 109.305 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.14 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 121' ' ' MET . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 1.83 107.926 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 144' ' ' THR . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.42 110.884 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.07 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.05 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 4.88 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 132' ' ' VAL . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 3.55 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.29 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.42 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 2.5 108.606 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.55 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 5.59 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 128' ' ' ILE . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.06 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 3.91 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.63 ' OE2' HD22 ' A' ' 122' ' ' LEU . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.41 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.64 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 4.99 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 1.57 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.41 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 4.73 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.07 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 2.93 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 1.77 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.34 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 3.53 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.66 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.18 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 2.83 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.45 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 1.9 107.988 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 164' ' ' LEU . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 1.8 109.828 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.28 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 2.92 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.14 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.35 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.18 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 4.67 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 2.92 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.17 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.62 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.0 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 101' ' ' LEU . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 3.79 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.02 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.48 109.335 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.076 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 4.79 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -36.42 -69.03 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.27 110.393 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 184' ' ' SER . 61.4 tp 50.56 106.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 7.1 109.954 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 68.3 t80 54.94 59.7 3.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -0.976 . . . . 9.88 109.288 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.8 p30 -67.7 -20.44 65.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 8.42 109.949 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -78.6 176.42 54.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.781 -1.328 . . . . 9.13 109.781 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 21.8 tp -173.9 75.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -1.073 . . . . 11.72 109.203 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.944 -1.027 . . . . 12.62 109.386 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.601 -0.518 . . . . 15.48 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.62 -159.07 15.69 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.82 -1.312 . . . . 11.71 109.82 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -55.38 -36.16 66.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -1.035 . . . . 12.65 109.872 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -68.11 155.45 39.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 8.16 109.524 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.462 ' O ' ' C ' ' A' ' 6' ' ' SER . 47.7 p-10 -136.18 2.43 2.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 7.63 109.389 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ASN . 5.2 p 37.16 84.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 5.22 110.201 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -58.39 -37.13 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 4.94 108.944 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -144.52 136.87 26.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.191 -1.04 . . . . 2.2 108.191 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -52.88 146.91 17.17 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.894 -1.129 . . . . 2.5 109.062 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.23 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.17 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 17' ' ' THR . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 2.64 110.005 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 2.71 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 13' ' ' VAL . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.6 109.528 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 18' ' ' ARG . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.04 108.423 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.04 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.0 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 2.94 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 3.98 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 17' ' ' THR . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.1 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG11 ' CG2' ' A' ' 20' ' ' THR . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.44 108.294 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 7' ' ' LYS . 16.6 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 3.85 108.075 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 3.75 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 5.2 108.487 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 2.74 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.06 107.839 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 2.92 109.996 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 3.92 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.37 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 5.72 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 4.71 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.05 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 2.56 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.09 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 2.82 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 1.72 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.06 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.03 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 2.65 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.8 108.551 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.4 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 2.99 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.31 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 3.63 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.23 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.18 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 6.44 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.28 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.17 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 3.59 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 4.4 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.54 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.3 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.713 ' O ' HG23 ' A' ' 68' ' ' VAL . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.12 109.636 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 1.79 109.722 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.04 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.935 ' O ' HG22 ' A' ' 71' ' ' VAL . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 2.31 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 64' ' ' PHE . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 1.71 109.213 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 4.33 109.295 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.75 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 1.91 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 2.75 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.3 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.34 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 2.85 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.19 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 1.76 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.4 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.27 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.35 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.22 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 86' ' ' ILE . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 1.9 109.494 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 91' ' ' VAL . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 2.63 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.56 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.686 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.17 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.01 108.945 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.2 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 2.75 108.841 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 8.35 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.29 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.18 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.22 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.12 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 173' ' ' SER . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.31 109.533 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 3.93 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 4.4 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.41 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 2.69 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.23 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.729 ' HA ' HG21 ' A' ' 71' ' ' VAL . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 1.99 110.383 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.51 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 67' ' ' PHE . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.31 109.789 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.09 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.68 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.39 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 2.76 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 1.6 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 1.73 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.612 ' HE ' ' CG ' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.17 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.44 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.71 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 3.66 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 1.77 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 124' ' ' ILE . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.14 109.953 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 1.83 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 132' ' ' VAL . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.42 111.314 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.07 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.05 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 4.88 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 128' ' ' ILE . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 3.55 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.29 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.42 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.55 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.611 ' C ' HG22 ' A' ' 144' ' ' THR . 35.1 p-10 -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 5.59 110.49 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.611 HG22 ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.06 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 3.91 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.64 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HB3' HD12 ' A' ' 152' ' ' ILE . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 4.99 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 1.57 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 149' ' ' VAL . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 4.73 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 148' ' ' ARG . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.07 111.743 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 2.93 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 1.77 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.34 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 3.53 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.18 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.49 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.627 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 2.83 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.45 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 1.9 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 1.8 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.28 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 2.92 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.14 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.35 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.478 ' CB ' HD11 ' A' ' 101' ' ' LEU . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.18 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 4.67 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 2.92 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.17 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.62 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.0 110.179 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 3.79 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.02 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.48 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 4.79 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m -117.16 145.18 44.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.27 109.758 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.5 132.96 56.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.527 -0.733 . . . . 7.1 109.032 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 2.3 p90 -95.72 173.47 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 9.88 109.619 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -53.07 -37.58 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 8.42 109.817 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.13 87.09 1.83 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.676 -1.37 . . . . 9.13 109.676 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 1.0 OUTLIER -63.4 -31.4 72.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 11.72 109.082 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.009 -0.996 . . . . 12.62 109.465 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.302 -0.629 . . . . 15.48 109.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 4' ' ' SER . . . -170.82 -168.69 32.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.396 -1.482 . . . . 11.71 109.396 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? 64.5 -0.49 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.443 -1.034 . . . . 12.65 109.476 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 2' ' ' GLY . 19.6 m -123.48 146.24 48.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.277 -0.889 . . . . 8.16 109.484 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -135.75 133.7 38.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 7.63 109.628 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.5 t -111.5 143.0 43.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.853 . . . . 5.22 109.349 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -85.51 160.86 19.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 4.94 109.348 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.77 140.99 57.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 2.2 108.529 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 8' ' ' LEU . 11.2 mmtp -39.11 103.38 0.28 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.511 -0.743 . . . . 2.5 109.192 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.23 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.17 108.836 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.661 HG21 HD13 ' A' ' 8' ' ' LEU . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 2.64 108.117 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 2.71 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 17' ' ' THR . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.6 107.968 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.04 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.04 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.0 108.907 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 3.98 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.1 110.287 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 20' ' ' THR . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.44 109.743 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 3.85 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 3.75 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 5.2 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 2.74 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.06 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 2.92 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 3.92 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.37 109.392 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 5.72 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 4.71 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.05 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 2.56 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.09 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 47' ' ' GLY . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 2.82 109.354 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 1.72 109.747 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.06 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.03 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 2.65 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 26.1 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.8 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.4 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 2.99 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.512 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.31 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 3.63 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.23 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.18 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 6.44 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.28 113.233 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 135' ' ' THR . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.17 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 3.59 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 4.4 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.54 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.3 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.734 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.12 109.882 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 1.79 109.695 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.04 109.016 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 124' ' ' ILE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 2.31 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 1.71 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 4.33 109.699 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.75 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 1.91 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 2.75 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.3 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.34 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' CG ' HD21 ' A' ' 75' ' ' ASN . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 2.85 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.19 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 1.76 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.4 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.27 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.35 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.22 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 1.9 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 2.63 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.56 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.746 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.01 108.954 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' GLN . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.2 108.831 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 2.75 109.477 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 8.35 108.162 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.29 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.517 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.18 108.486 179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.22 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.12 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.31 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 3.93 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 4.4 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.41 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 2.69 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.23 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 1.99 110.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.51 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.31 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.09 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 45.6 p-10 -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.68 111.571 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.39 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.706 ' CD2' HG22 ' A' ' 165' ' ' THR . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 2.76 110.112 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 1.6 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 1.73 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.17 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.44 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.71 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 3.66 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 1.77 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 67' ' ' PHE . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.14 109.579 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 121' ' ' MET . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 1.83 107.857 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.42 109.188 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.07 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.05 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 4.88 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.449 ' HA ' ' HG1' ' A' ' 135' ' ' THR . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 3.55 109.614 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.29 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 58' ' ' PHE . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.42 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 135' ' ' THR . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 2.5 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.531 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.55 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.531 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 5.59 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.06 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 3.91 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.64 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.64 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 4.99 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 146' ' ' GLU . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 1.57 109.538 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 4.73 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.07 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 1.063 ' CZ ' HD12 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 2.93 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 1.77 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.34 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.594 ' SD ' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 3.53 110.37 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.18 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.743 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 22.4 m120 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.49 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 2.83 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.45 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.063 HD12 ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 1.9 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.706 HG22 ' CD2' ' A' ' 115' ' ' TYR . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 1.8 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 166' ' ' LEU . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.28 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 2.92 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.14 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.431 ' OE1' HD23 ' A' ' 166' ' ' LEU . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.35 110.246 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.18 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 4.67 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 2.92 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.17 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.62 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.0 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 3.79 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.02 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.498 ' HB3' HD23 ' A' ' 183' ' ' LEU . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.48 108.955 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 4.79 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.9 91.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.27 110.009 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 8.4 tt -109.7 116.3 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.561 -0.903 . . . . 7.1 108.561 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -123.86 142.62 50.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 9.88 109.927 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -124.89 2.64 8.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.513 -0.742 . . . . 8.42 109.066 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.11 137.68 13.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 9.13 109.626 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -168.92 29.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.315 -1.109 . . . . 11.72 109.297 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.008 -0.996 . . . . 12.62 109.478 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.47 -0.567 . . . . 15.48 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.06 61.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.684 -1.366 . . . . 11.71 109.684 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -59.74 -36.97 77.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -1.219 . . . . 12.65 109.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 55.8 p -70.71 168.12 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.847 . . . . 8.16 109.411 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 7' ' ' LYS . 33.3 t30 87.47 -137.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.467 -0.568 . . . . 7.63 109.467 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m 45.69 13.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 5.22 109.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 5' ' ' ASN . 7.1 ttpt -129.6 155.76 45.29 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.57 -0.9 . . . . 4.94 108.57 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -63.82 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.089 . . . . 2.2 110.598 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER 58.54 138.47 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.025 -1.047 . . . . 2.5 109.873 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.23 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.17 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' CG2' HD13 ' A' ' 8' ' ' LEU . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 2.64 109.028 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 2.71 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' VAL . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.6 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.04 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.04 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.0 108.372 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 2.94 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 3.98 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 24' ' ' GLU . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.1 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 16' ' ' LEU . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.44 109.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 3.85 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 3.75 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 5.2 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 2.74 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.06 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 2.92 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 3.92 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.37 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 5.72 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 4.71 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.05 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 2.56 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.09 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 2.82 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 1.72 109.866 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.06 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.03 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 51' ' ' ILE . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 2.65 108.039 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.8 108.441 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.4 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 2.99 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.31 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 3.63 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.23 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.18 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 6.44 109.906 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.28 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.17 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 3.59 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 4.4 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.677 HG23 ' H ' ' A' ' 63' ' ' LYS . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.54 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.677 ' H ' HG23 ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.3 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.774 ' O ' HG23 ' A' ' 68' ' ' VAL . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.12 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 1.79 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 62' ' ' THR . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.04 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.31 108.725 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 1.71 109.324 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 4.33 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.75 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 1.91 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 2.75 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.3 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.34 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 2.85 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.19 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 1.76 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.4 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.27 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.35 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE1' HD22 ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.22 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 1.9 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 86' ' ' ILE . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 2.63 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.56 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.17 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.01 109.005 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.2 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 2.75 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 8.35 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.29 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.18 108.592 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.22 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 96' ' ' THR . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.12 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.31 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 3.93 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 4.4 109.466 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.41 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 2.69 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.597 ' NZ ' ' O ' ' A' ' 71' ' ' VAL . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.23 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 1.99 109.422 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.51 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.713 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.31 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.09 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.68 110.772 -179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.39 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 163' ' ' LYS . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 2.76 109.315 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.6 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 1.73 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HE1' ' A' ' 121' ' ' MET . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.17 109.8 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.44 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.71 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.675 ' O ' HG13 ' A' ' 125' ' ' VAL . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 3.66 109.236 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 122' ' ' LEU . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 1.77 109.381 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 124' ' ' ILE . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.14 110.421 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 1.83 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 132' ' ' VAL . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.42 108.975 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.07 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.05 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 4.88 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 128' ' ' ILE . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 3.55 109.434 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.48 ' C ' HG22 ' A' ' 135' ' ' THR . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.29 109.768 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.815 ' O ' HG13 ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.42 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 2.5 110.114 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.55 111.984 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 79.9 m-20 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 5.59 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.06 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.621 ' HD3' HD12 ' A' ' 183' ' ' LEU . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 3.91 112.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 149' ' ' VAL . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.64 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 4.99 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 1.57 108.958 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 4.73 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.07 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.775 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 2.93 109.072 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 1.77 108.197 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.34 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 179' ' ' ILE . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 3.53 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.18 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.743 HD21 ' HB2' ' A' ' 161' ' ' ASP . 0.4 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.49 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.743 ' HB2' HD21 ' A' ' 159' ' ' ASN . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 2.83 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 115' ' ' TYR . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.45 108.888 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.775 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 1.9 108.661 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 164' ' ' LEU . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 1.8 109.72 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.28 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 2.92 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.14 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.35 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.18 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 4.67 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 2.92 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.17 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.62 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.868 HD11 ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.0 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 3.79 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.535 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 6.7 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.02 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.48 109.738 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.0 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 4.79 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -100.96 14.57 31.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.27 110.022 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.0 mt -54.79 -35.36 63.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.047 -1.033 . . . . 7.1 110.024 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 77.3 t80 47.0 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.989 -1.07 . . . . 9.88 109.555 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 187' ' ' ASP . 53.4 p30 -92.89 9.12 36.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 8.42 109.626 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -81.04 42.2 2.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.716 -1.354 . . . . 9.13 109.716 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.4 mm? -60.22 -33.24 71.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -1.185 . . . . 11.72 109.465 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.97 -1.014 . . . . 12.62 109.457 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.487 -0.56 . . . . 15.48 109.487 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.23 165.59 24.9 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.493 . . . . 11.71 109.369 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -136.69 154.98 50.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -1.166 . . . . 12.65 109.692 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p -131.0 153.2 49.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 8.16 109.143 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 7' ' ' LYS . 50.9 t-20 -129.96 85.3 2.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 7.63 109.606 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 5' ' ' ASN . 2.7 m 39.53 21.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 5.22 109.883 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 5' ' ' ASN . 55.2 pttt -89.86 164.73 14.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 4.94 109.177 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD13 ' CZ ' ' A' ' 82' ' ' PHE . 24.7 tp -94.72 124.2 38.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 2.2 109.023 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' CG ' HG23 ' A' ' 12' ' ' VAL . 15.4 ptpt -82.86 145.0 49.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.998 . . . . 2.5 109.437 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.23 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.496 ' CG1' HD11 ' A' ' 8' ' ' LEU . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.17 108.8 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 17' ' ' THR . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 2.64 108.948 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.678 HD22 ' OG1' ' A' ' 20' ' ' THR . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 2.71 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 24' ' ' GLU . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.6 106.841 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.04 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.04 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.678 ' OG1' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.0 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.65 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 2.94 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 3.98 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.1 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 28' ' ' GLN . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.44 110.364 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 27' ' ' VAL . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 3.85 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 3.75 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 5.2 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 2.74 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.06 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 2.92 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 3.92 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.37 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 5.72 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 4.71 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.05 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 2.56 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.09 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 47' ' ' GLY . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 2.82 109.91 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 1.72 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.06 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.03 109.903 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' HG13 ' A' ' 51' ' ' ILE . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 2.65 108.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.8 108.766 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.4 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 48' ' ' PHE . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 2.99 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.31 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 3.63 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.23 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.18 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 6.44 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.28 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG23 ' A' ' 136' ' ' VAL . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.17 109.547 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 3.59 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 4.4 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.54 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.3 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 68' ' ' VAL . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.12 109.604 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 1.79 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.04 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' VAL . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 2.31 108.55 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 1.71 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 4.33 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.75 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 106' ' ' LYS . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 1.91 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 2.75 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.3 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.34 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 2.85 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.19 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 1.76 108.178 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.4 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.27 109.152 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.35 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.22 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 1.9 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 2.63 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.56 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 85' ' ' PHE . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.17 108.031 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.01 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.2 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 2.75 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 8.35 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.29 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.18 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.22 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.12 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.31 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 3.93 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 107' ' ' LEU . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 4.4 108.743 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.41 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 2.69 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' HG21 ' A' ' 71' ' ' VAL . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.23 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 1.99 110.439 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 121' ' ' MET . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.51 108.743 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.619 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.792 HD23 ' H ' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.31 110.134 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.792 ' H ' HD23 ' A' ' 110' ' ' LEU . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.09 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.648 ' ND2' ' O ' ' A' ' 112' ' ' ASN . 2.3 p-10 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.68 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.39 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.482 ' CE2' HG22 ' A' ' 165' ' ' THR . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 2.76 108.924 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 1.6 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 1.73 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.17 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.44 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.71 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 125' ' ' VAL . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 3.66 108.828 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 1.77 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 124' ' ' ILE . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.14 108.95 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 121' ' ' MET . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 1.83 108.44 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.558 ' O ' HG22 ' A' ' 132' ' ' VAL . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.42 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.07 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.05 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.644 ' O ' HG21 ' A' ' 135' ' ' THR . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 4.88 109.04 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 128' ' ' ILE . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 3.55 109.733 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.29 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 131' ' ' MET . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.42 108.395 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 2.5 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.55 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 5.59 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.06 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 3.91 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 149' ' ' VAL . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.64 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 4.99 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 1.57 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 4.73 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.07 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 2.93 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 1.77 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.34 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.509 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 3.53 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.18 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.794 HD22 ' H ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.49 109.503 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 163' ' ' LYS . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 2.83 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.45 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 165' ' ' THR . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 1.9 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.625 ' N ' HD13 ' A' ' 164' ' ' LEU . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 1.8 109.826 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.939 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.28 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 50.6 mm-40 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 2.92 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.14 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.35 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.18 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 4.67 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 2.92 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.17 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.62 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.0 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 176' ' ' ASP . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 3.79 108.798 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.02 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.48 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 4.79 109.221 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p -66.96 161.18 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.27 108.822 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 50.5 tp -148.06 -26.84 0.34 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.01 . . . . 7.1 110.091 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.67 115.02 25.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.963 . . . . 9.88 109.869 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.41 -35.75 81.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 8.42 108.906 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.99 12.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.179 -1.568 . . . . 9.13 109.179 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 190' ' ' VAL . 34.8 tp -55.87 -35.31 66.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -1.083 . . . . 11.72 109.497 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 189' ' ' LEU . 5.6 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.017 -0.992 . . . . 12.62 110.407 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.337 -0.616 . . . . 15.48 109.337 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.61 -64.94 2.52 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.631 -1.387 . . . . 11.71 109.631 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -131.53 45.23 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.33 -1.1 . . . . 12.65 109.732 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 6' ' ' SER . 78.4 p -69.53 -11.82 61.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 8.16 109.632 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -44.81 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 7.63 109.342 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' SER . 51.0 m -122.94 151.06 42.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.475 -0.766 . . . . 5.22 109.334 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -61.62 175.17 0.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 4.94 109.224 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -62.38 142.63 57.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 2.2 109.441 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -65.26 147.54 98.52 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 2.5 109.251 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.23 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.17 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 2.64 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 2.71 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.6 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.04 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.04 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.859 HG23 ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.0 111.111 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.859 ' H ' HG23 ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 2.94 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 3.98 109.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 17' ' ' THR . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.1 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 23' ' ' THR . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.44 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 3.85 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 3.75 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 5.2 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 8' ' ' LEU . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 2.74 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.06 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 2.92 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 3.92 110.863 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' HA2' ' A' ' 41' ' ' GLY . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.37 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 5.72 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 4.71 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.05 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 2.56 110.208 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.09 109.468 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 ' C ' ' A' ' 47' ' ' GLY . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 2.82 109.535 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 1.72 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.06 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.03 109.347 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 2.65 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.026 ' NE2' HG22 ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.8 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.4 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 2.99 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.31 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 3.63 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.23 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.18 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 6.44 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.28 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HB2' HG23 ' A' ' 136' ' ' VAL . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.17 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 3.59 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 4.4 112.749 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' THR . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.54 110.974 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.3 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.12 109.501 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 1.79 109.683 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 1.026 HG22 ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.04 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 2.31 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 64' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 1.71 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 4.33 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.75 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 110' ' ' LEU . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 1.91 110.608 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.065 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 2.75 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.3 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.34 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 2.85 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.19 108.773 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 1.76 108.661 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.4 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.27 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.35 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.22 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 1.9 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 2.63 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.065 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.56 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 85' ' ' PHE . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.17 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.01 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.2 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 2.75 109.475 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 8.35 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.29 109.584 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.18 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.22 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.12 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.579 HD11 HG11 ' A' ' 180' ' ' VAL . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.31 108.889 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 3.93 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 4.4 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.41 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 2.69 109.861 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.23 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 1.99 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.51 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 71' ' ' VAL . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.31 109.847 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.09 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.68 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.39 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 2.76 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 1.6 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 1.73 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.608 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.17 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.44 108.704 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.71 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 3.66 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 1.77 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ILE . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.14 109.953 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 1.83 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.42 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 144' ' ' THR . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.07 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.05 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 4.88 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 3.55 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.29 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 58' ' ' PHE . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.42 108.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 134' ' ' ASN . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 2.5 110.002 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.55 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.456 ' H ' ' HG2' ' A' ' 139' ' ' PRO . 76.9 m-20 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 5.59 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.06 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 3.91 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.64 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 4.99 109.857 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 1.57 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 4.73 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.07 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 2.93 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 1.77 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.34 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 3.53 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.18 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.59 HD21 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.49 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.59 ' CG ' HD21 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 2.83 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.45 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 1.9 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 1.8 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.28 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 2.92 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 164' ' ' LEU . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.14 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.35 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.18 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 4.67 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 2.92 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.17 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.62 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.579 HG11 HD11 ' A' ' 101' ' ' LEU . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 3.79 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.02 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.48 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 4.79 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.0 m -120.68 141.4 50.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.27 109.367 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.16 134.82 54.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.817 -0.809 . . . . 7.1 108.817 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -81.27 122.42 27.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.146 -0.972 . . . . 9.88 109.998 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -156.57 67.86 0.57 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.528 -0.916 . . . . 8.42 108.528 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.0 11.02 79.76 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.77 -1.732 . . . . 9.13 108.77 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 35.8 tp -58.08 -36.79 73.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.493 -1.004 . . . . 11.72 109.714 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.008 -0.996 . . . . 12.62 109.259 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.447 -0.575 . . . . 15.48 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.6 103.09 2.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.748 -1.341 . . . . 11.71 109.748 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -60.05 -30.81 69.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 12.65 109.476 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' SER . 23.5 m -54.6 -32.54 58.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 8.16 109.507 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.2 63.3 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 7.63 109.41 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' SER . 74.6 m -81.92 3.29 26.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 5.22 109.516 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 8' ' ' LEU . 24.9 mtpt 57.12 39.16 29.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.388 -0.82 . . . . 4.94 109.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 13' ' ' VAL . 37.5 tp 42.29 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.805 . . . . 2.2 109.803 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -62.94 135.95 96.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 2.5 109.633 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.23 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.17 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 8' ' ' LEU . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 2.64 108.715 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.71 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.6 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.04 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.04 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.76 HG21 HG11 ' A' ' 27' ' ' VAL . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.0 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 2.94 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 3.98 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.1 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 20' ' ' THR . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.44 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 3.85 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 3.75 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 5.2 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 2.74 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.06 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 2.92 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 3.92 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.37 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 5.72 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 4.71 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.05 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 2.56 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.09 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.519 HD21 ' C ' ' A' ' 47' ' ' GLY . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 2.82 109.662 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 1.72 110.079 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.06 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.03 109.253 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 2.65 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.8 108.83 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.4 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 2.99 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.47 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.31 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 3.63 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.23 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.18 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 6.44 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.28 112.926 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 135' ' ' THR . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.17 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 3.59 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 4.4 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 65' ' ' ALA . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.54 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.3 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.817 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.12 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 1.79 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.04 109.286 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.906 ' CZ ' HD11 ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 2.31 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 64' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 1.71 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.805 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 4.33 109.204 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' HD11 ' A' ' 110' ' ' LEU . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.75 110.917 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 1.91 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 2.75 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.3 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.34 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 2.85 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.19 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 1.76 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.4 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 86' ' ' ILE . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.27 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.35 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CE1' HD11 ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.22 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' GLN . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 1.9 110.278 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' ILE . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 2.63 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.56 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.936 HD11 ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.17 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.01 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.2 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 2.75 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 8.35 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.29 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.18 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.776 ' H ' HD12 ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.22 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.12 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.31 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 3.93 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 4.4 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.41 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CZ ' ' ND2' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 2.69 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.23 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 107' ' ' LEU . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 1.99 109.856 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.51 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' OD1' ' A' ' 70' ' ' ASN . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.31 110.06 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.09 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.6 t-20 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.68 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.39 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 2.76 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 1.6 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 1.73 108.383 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.587 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.17 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.44 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.71 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 125' ' ' VAL . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 3.66 108.921 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 122' ' ' LEU . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 1.77 108.968 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.906 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.14 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 121' ' ' MET . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 1.83 107.937 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.42 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.07 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.05 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 4.88 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 3.55 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.29 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 58' ' ' PHE . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.436 ' N ' HG22 ' A' ' 135' ' ' THR . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.42 109.651 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 136' ' ' VAL . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 2.5 108.376 179.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.55 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.69 ' OE2' HD22 ' A' ' 185' ' ' LEU . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 5.59 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.06 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 3.91 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.692 ' O ' HG22 ' A' ' 149' ' ' VAL . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.64 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 4.99 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 146' ' ' GLU . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 1.57 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 4.73 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.07 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 2.93 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 1.77 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.409 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.34 109.01 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 179' ' ' ILE . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 3.53 110.008 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' HH22 ' A' ' 118' ' ' ARG . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.18 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.749 HD22 ' CG ' ' A' ' 161' ' ' ASP . 37.6 p-10 -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.49 109.689 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.749 ' CG ' HD22 ' A' ' 159' ' ' ASN . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 2.83 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.45 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 1.9 105.773 177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 1.8 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.788 ' H ' HD12 ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.28 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 2.92 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.14 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.5 ' OE1' HD23 ' A' ' 166' ' ' LEU . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.35 110.138 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.18 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 4.67 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 2.92 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.17 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.62 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 ' SD ' ' A' ' 156' ' ' MET . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.0 109.035 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 3.79 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.02 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.494 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.48 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 4.79 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 186' ' ' TYR . 47.9 t -120.24 -61.74 1.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.27 109.467 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.69 HD22 ' OE2' ' A' ' 141' ' ' GLU . 7.5 mp 51.38 5.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 7.1 109.847 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 184' ' ' SER . 71.5 t80 53.3 166.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 9.88 109.604 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 186' ' ' TYR . 91.5 m-20 -55.75 -38.47 69.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.011 . . . . 8.42 109.573 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 148.45 119.54 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 9.13 109.52 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' VAL . 67.6 mt -61.38 -33.02 72.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -1.138 . . . . 11.72 109.471 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' LEU . 4.4 m . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 117.971 -1.014 . . . . 12.62 109.469 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.403 -0.591 . . . . 15.48 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.37 120.36 15.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.455 -1.458 . . . . 11.71 109.455 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ASN . 75.4 tttt -59.67 -40.23 87.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -1.148 . . . . 12.65 109.678 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' LYS . 47.1 t 40.16 -100.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.412 -0.805 . . . . 8.16 109.487 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' LYS . 83.7 m-20 -112.43 143.65 43.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.797 . . . . 7.63 109.169 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.4 m -115.44 138.48 50.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 5.22 109.479 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 8' ' ' LEU . 21.5 mmtp -137.92 -68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.428 -0.795 . . . . 4.94 109.272 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -89.17 157.55 18.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 2.2 110.065 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -66.62 151.8 95.95 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 2.5 109.408 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.23 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.17 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 2.64 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 2.71 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.6 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.462 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.04 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.04 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.0 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 2.94 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 3.98 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.1 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 20' ' ' THR . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.44 109.423 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 3.85 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 3.75 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 5.2 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CG ' HD12 ' A' ' 8' ' ' LEU . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 2.74 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG2' ' HZ2' ' A' ' 7' ' ' LYS . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.06 108.429 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 2.92 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 3.92 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.37 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 5.72 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 4.71 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.05 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 2.56 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' NE2' ' HG2' ' A' ' 81' ' ' GLU . 8.0 tp-100 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.09 109.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 2.82 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 1.72 109.986 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.06 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.03 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 2.65 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.8 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.4 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 2.99 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.31 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 3.63 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.23 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.18 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 6.44 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.28 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.17 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 3.59 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 4.4 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' THR . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.54 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.3 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.12 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 1.79 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 49' ' ' GLN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.04 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 2.31 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 1.71 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 4.33 109.041 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.75 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 1.91 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.663 ' N ' HG13 ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 2.75 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.3 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.34 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 2.85 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.19 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.603 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 1.76 108.22 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.4 110.57 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.27 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.35 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.22 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 1.9 109.476 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 2.63 110.486 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.56 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.641 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.17 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.01 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.2 108.453 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 2.75 108.631 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.604 ' OG ' ' CD2' ' A' ' 21' ' ' TYR . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' CG ' ' N ' ' A' ' 95' ' ' GLY . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 8.35 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.29 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.18 108.499 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.22 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.12 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.31 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 3.93 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 4.4 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.41 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 2.69 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.23 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 1.99 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.51 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.31 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.09 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.68 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.39 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 2.76 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.491 HG21 ' HE3' ' A' ' 121' ' ' MET . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 1.6 109.179 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 1.73 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.17 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.44 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.71 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 3.66 109.708 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 1.77 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 124' ' ' ILE . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.14 109.588 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 121' ' ' MET . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 1.83 107.346 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.42 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.07 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.05 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 4.88 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 132' ' ' VAL . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 3.55 108.798 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.29 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.42 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 2.5 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.55 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 5.59 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.06 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 3.91 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.64 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' ' 152' ' ' ILE . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 4.99 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 1.57 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 4.73 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 148' ' ' ARG . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.07 109.693 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 2.93 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 1.77 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.34 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 3.53 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.18 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.49 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 2.83 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.45 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 1.9 108.164 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.721 ' N ' HD13 ' A' ' 164' ' ' LEU . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 1.8 110.14 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 1.039 ' H ' HD23 ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.28 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 2.92 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 164' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.14 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.35 109.522 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.18 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 4.67 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 2.92 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.17 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.62 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.0 110.15 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 3.79 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.71 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 57.9 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.02 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.48 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.08 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 4.79 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 185' ' ' LEU . 19.9 m -70.74 -83.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.27 109.309 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 184' ' ' SER . 8.3 tt 37.46 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.652 -0.655 . . . . 7.1 110.087 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -75.95 102.12 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.007 . . . . 9.88 108.861 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.618 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 54.1 p30 -69.82 -25.84 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 8.42 110.639 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -52.43 -32.02 37.06 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.658 -1.377 . . . . 9.13 109.658 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 38.2 tp -56.91 -36.05 69.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 11.72 109.275 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.298 -1.663 0 CA-C-O 117.957 -1.021 . . . . 12.62 109.506 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.387 -0.597 . . . . 15.48 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.43 47.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.721 -1.351 . . . . 11.71 109.721 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 tptt 61.55 45.55 8.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -1.047 . . . . 12.65 109.071 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -124.15 146.59 48.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.447 -0.783 . . . . 8.16 109.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -139.27 -172.0 3.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 7.63 109.91 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER 71.78 -81.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.505 -0.747 . . . . 5.22 109.594 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 6' ' ' SER . 68.4 mttm 36.45 -91.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.392 -0.817 . . . . 4.94 110.124 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -110.85 169.86 8.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.395 -0.815 . . . . 2.2 108.913 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.17 148.33 78.74 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 2.5 108.997 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.23 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.17 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.875 ' O ' HG23 ' A' ' 17' ' ' THR . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 2.64 109.791 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.563 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 2.71 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.6 108.514 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.04 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.04 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.0 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 2.94 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 3.98 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.1 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 20' ' ' THR . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.44 109.413 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 3.85 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 3.75 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 5.2 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' CD1' HD23 ' A' ' 8' ' ' LEU . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 2.74 108.554 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.06 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 2.92 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 3.92 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.37 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 5.72 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 4.71 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.05 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 2.56 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.448 ' OE1' ' NH1' ' A' ' 79' ' ' ARG . 23.8 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.09 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 2.82 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 1.72 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HA ' HE21 ' A' ' 49' ' ' GLN . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.06 110.087 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.03 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 2.65 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.554 HE21 ' HA ' ' A' ' 46' ' ' ALA . 41.1 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.8 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.4 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.477 HG21 ' CZ ' ' A' ' 85' ' ' PHE . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 2.99 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.31 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.63 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.23 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.18 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 6.44 110.002 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.28 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.17 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 3.59 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 4.4 112.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.54 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.3 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 68' ' ' VAL . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.12 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 1.79 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.04 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 2.31 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 64' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 1.71 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 4.33 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.75 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 1.91 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 2.75 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.628 ' ND2' ' OE2' ' A' ' 84' ' ' GLU . 1.4 m-20 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.3 109.559 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.34 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 2.85 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' NH1' ' OE1' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.19 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 1.76 107.745 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.4 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.27 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.35 109.529 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.628 ' OE2' ' ND2' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.22 109.828 -178.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.515 ' HA ' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 1.9 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 2.63 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.56 108.357 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 85' ' ' PHE . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.01 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.523 HG11 ' NE1' ' A' ' 103' ' ' TRP . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.2 109.159 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 2.75 109.135 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 8.35 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.29 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.18 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.22 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.12 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.31 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 3.93 110.849 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.523 ' NE1' HG11 ' A' ' 91' ' ' VAL . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 4.4 109.745 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.41 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 2.69 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.23 108.747 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 68' ' ' VAL . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 1.99 108.833 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.51 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 110' ' ' LEU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.31 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.09 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.68 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.39 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 165' ' ' THR . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 2.76 108.979 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 1.6 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 1.73 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.788 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.17 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.44 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.71 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 3.66 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' OD2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 1.77 109.258 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 67' ' ' PHE . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.14 109.967 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 121' ' ' MET . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 1.83 108.368 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 122' ' ' LEU . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.876 ' O ' HG22 ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.42 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.07 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.05 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 4.88 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 3.55 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.29 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.42 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.528 HD23 ' CD ' ' A' ' 142' ' ' GLU . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 2.5 108.434 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.55 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 144' ' ' THR . 21.3 m120 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 5.59 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.06 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 3.91 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.64 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.621 ' O ' HD13 ' A' ' 152' ' ' ILE . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 4.99 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' A' ' 153' ' ' PHE . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 1.57 108.894 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 4.73 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.07 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 2.93 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 1.77 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.34 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 3.53 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.18 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.49 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 2.83 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.45 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 1.9 108.145 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 115' ' ' TYR . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 1.8 109.44 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.28 110.027 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 2.92 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.14 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.35 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.18 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 4.67 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 2.92 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.17 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.62 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.0 109.99 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 3.79 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 180' ' ' VAL . 2.4 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.02 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.791 ' C ' HD12 ' A' ' 183' ' ' LEU . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.48 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 182' ' ' ALA . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 4.79 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m -121.85 144.06 49.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.27 107.748 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 6.2 tp -106.58 129.39 54.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 7.1 109.557 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -85.3 167.14 15.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.883 . . . . 9.88 109.082 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 40.0 p-10 -59.64 -34.73 73.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 8.42 109.644 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.583 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 163.81 153.52 7.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.648 -1.381 . . . . 9.13 109.648 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 189' ' ' LEU . 7.3 mp -63.21 -33.28 75.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.104 . . . . 11.72 109.512 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 118.017 -0.992 . . . . 12.62 109.48 -179.888 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.314 0.578 . . . . 15.48 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.75 -43.0 2.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 11.71 109.573 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -57.82 -29.26 64.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -1.185 . . . . 12.65 109.464 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -58.41 -29.78 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 8.16 109.912 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 22.5 p-10 -171.06 -59.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 7.63 110.407 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' ASN . 22.9 t 42.36 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.093 -1.004 . . . . 5.22 109.241 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -100.21 164.23 12.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.323 -0.861 . . . . 4.94 109.978 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -83.54 148.5 27.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 2.2 109.194 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -58.97 147.16 74.66 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 2.5 109.121 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.23 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.17 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' THR . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 2.64 108.401 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 2.71 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 13' ' ' VAL . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.6 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.04 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.04 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.0 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 2.94 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 3.98 109.092 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.1 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 20' ' ' THR . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.44 108.475 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 3.85 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 3.75 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 5.2 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CG ' HD23 ' A' ' 8' ' ' LEU . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 2.74 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.06 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 2.92 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 3.92 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.37 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 5.72 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 4.71 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.05 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 2.56 109.579 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.582 ' NE2' ' CZ ' ' A' ' 79' ' ' ARG . 19.4 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.09 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 2.82 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 1.72 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.06 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.03 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 2.65 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.8 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.4 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.31 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 3.63 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.23 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.18 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 6.44 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.28 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.17 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 3.59 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 4.4 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.54 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.3 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.12 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 1.79 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.04 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 2.31 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 1.71 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 4.33 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.75 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' LEU . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 1.91 110.389 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.965 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 2.75 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.3 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.34 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 2.85 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.19 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 1.76 107.875 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.4 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.27 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.35 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 51' ' ' ILE . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.22 109.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 1.9 109.923 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 2.63 109.767 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.965 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.56 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.17 108.579 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.01 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 87' ' ' GLN . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.2 109.036 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' ALA . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 2.75 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 8.35 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.29 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.18 108.727 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.22 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.12 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.31 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 3.93 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.473 ' CH2' HD13 ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 4.4 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.41 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 2.69 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.23 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.825 ' O ' HD23 ' A' ' 107' ' ' LEU . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 1.99 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.51 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 71' ' ' VAL . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.31 109.749 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.09 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.68 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.39 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 2.76 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 1.6 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HZ2' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 1.73 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.755 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.17 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.44 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.71 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.805 ' O ' HG23 ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 3.66 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 1.77 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 124' ' ' ILE . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.14 109.423 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 1.83 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 183' ' ' LEU . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.42 109.986 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.07 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.05 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 4.88 108.351 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 128' ' ' ILE . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 3.55 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.29 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 138' ' ' LEU . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.42 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 135' ' ' THR . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.826 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 2.5 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.55 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 5.59 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.06 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.697 ' HD3' HD22 ' A' ' 183' ' ' LEU . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 3.91 113.754 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE1' HG11 ' A' ' 125' ' ' VAL . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.64 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 4.99 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 1.57 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 4.73 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.07 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.678 ' CZ ' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 2.93 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 1.77 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.542 ' HA ' ' HZ3' ' A' ' 158' ' ' LYS . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.34 110.559 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 3.53 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.542 ' HZ3' ' HA ' ' A' ' 155' ' ' MET . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.18 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.762 ' ND2' ' H ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.49 109.581 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.638 ' N ' HD22 ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.762 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.651 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 2.83 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HZ2' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.45 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.678 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 1.9 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 1.8 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.28 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 2.92 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.14 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.35 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.496 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.18 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 4.67 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 2.92 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.17 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.62 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 172' ' ' GLY . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.0 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 173' ' ' SER . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 3.79 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.02 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.599 ' C ' HD23 ' A' ' 183' ' ' LEU . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.48 108.957 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 4.79 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER 79.19 91.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.27 109.911 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 186' ' ' TYR . 6.2 mp -98.18 117.05 31.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 7.1 108.986 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 185' ' ' LEU . 51.5 p90 42.39 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.431 -0.793 . . . . 9.88 110.025 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -149.94 75.57 1.25 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 8.42 109.806 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.5 14.05 80.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.0 -1.24 . . . . 9.13 110.0 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.6 -34.9 73.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -1.217 . . . . 11.72 109.448 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.933 -1.032 . . . . 12.62 109.433 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.259 -0.645 . . . . 15.48 109.259 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.8 55.97 5.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.28 . . . . 11.71 109.901 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -71.74 117.93 13.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -1.208 . . . . 12.65 109.316 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 -17.71 65.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.803 . . . . 8.16 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -47.69 -34.94 8.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 7.63 109.908 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -141.88 152.57 43.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 5.22 109.916 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -88.74 -6.72 57.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 4.94 108.943 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 56.1 tp -103.99 136.01 44.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.997 -0.742 . . . . 2.2 108.997 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? -47.18 145.43 3.59 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.039 -1.038 . . . . 2.5 108.882 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.23 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 8' ' ' LEU . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.17 109.965 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 17' ' ' THR . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 2.64 109.232 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 2.71 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 13' ' ' VAL . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.6 108.086 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.04 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.04 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 16' ' ' LEU . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.0 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 2.94 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 3.98 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.1 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' GLN . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.44 109.43 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 27' ' ' VAL . 7.6 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 3.85 109.129 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 86.0 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 3.75 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 5.2 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 2.74 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.06 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 2.92 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 3.92 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.37 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 5.72 108.237 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 4.71 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.05 109.24 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 2.56 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.09 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 2.82 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 1.72 109.541 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.06 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.03 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 2.65 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.8 107.81 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.4 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 2.99 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.31 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 3.63 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.23 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.18 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 6.44 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.28 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 136' ' ' VAL . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.17 110.876 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 3.59 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.661 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 4.4 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.54 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.3 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.12 110.443 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 1.79 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 62' ' ' THR . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.04 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 2.31 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 1.71 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 4.33 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.75 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 109' ' ' ASP . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 1.91 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 2.75 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CA ' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.3 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.34 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 2.85 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.19 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 1.76 106.893 178.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.4 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.27 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.35 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CE1' HD23 ' A' ' 89' ' ' LEU . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.22 110.645 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 1.9 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 2.63 110.556 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.56 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.17 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 86' ' ' ILE . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.01 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.2 108.243 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ALA . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 2.75 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.573 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 8.35 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.29 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.18 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.22 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.12 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.31 109.772 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 3.93 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 4.4 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.41 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 2.69 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 71' ' ' VAL . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.23 109.738 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 107' ' ' LEU . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 1.99 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.51 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG21 ' A' ' 71' ' ' VAL . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.31 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.09 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.68 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.39 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 2.76 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 1.6 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.575 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.17 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.44 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.71 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.651 ' O ' HG13 ' A' ' 125' ' ' VAL . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 3.66 109.085 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 1.77 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 124' ' ' ILE . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.14 110.998 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 1.83 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.42 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.07 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.05 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 4.88 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 3.55 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.29 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.42 108.961 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.508 ' H ' HG22 ' A' ' 135' ' ' THR . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 2.5 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.55 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 187' ' ' ASP . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 5.59 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.06 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 3.91 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.546 ' O ' HG22 ' A' ' 149' ' ' VAL . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.64 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 4.99 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 146' ' ' GLU . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 1.57 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 4.73 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.07 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.74 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 2.93 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 1.77 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.34 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 3.53 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.18 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.49 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 2.83 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.45 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.74 HD21 ' CD1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 1.9 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 1.8 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 1.085 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.28 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.625 ' N ' HD22 ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 2.92 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.14 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.35 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' HG22 ' A' ' 180' ' ' VAL . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.18 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 4.67 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 2.92 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.17 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.62 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.0 109.631 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 3.79 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.585 ' NE2' ' OD2' ' A' ' 187' ' ' ASP . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.02 109.401 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.48 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 4.79 109.869 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -68.96 154.0 42.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.27 109.116 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 185' ' ' LEU . 8.2 mp -66.3 -40.58 90.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.964 . . . . 7.1 109.545 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -160.03 154.91 24.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 9.88 109.522 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 7.8 p-10 -142.79 -41.1 0.32 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.192 -0.942 . . . . 8.42 109.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -97.92 10.13 64.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.839 -1.305 . . . . 9.13 109.839 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 189' ' ' LEU . 1.3 tt 52.14 11.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -1.197 . . . . 11.72 108.806 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.474 ' N ' ' C ' ' A' ' 188' ' ' GLY . 2.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.962 -1.018 . . . . 12.62 109.486 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.288 -0.634 . . . . 15.48 109.288 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.71 0.04 62.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 11.71 109.613 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -58.93 -37.51 76.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -1.165 . . . . 12.65 109.181 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 p -83.83 175.42 9.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 8.16 109.518 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 65.99 55.05 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 7.63 109.99 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -105.87 144.23 32.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 5.22 108.977 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -147.51 -151.8 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 4.94 109.572 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 13' ' ' VAL . 66.4 tp -90.57 130.84 36.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 2.2 108.887 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -58.27 148.2 64.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 2.5 109.567 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.23 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.17 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.5 ' CG2' HD23 ' A' ' 8' ' ' LEU . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 2.64 107.844 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 2.71 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 13' ' ' VAL . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.6 107.49 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.04 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.04 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.735 HG23 ' H ' ' A' ' 22' ' ' PHE . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.0 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.735 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 2.94 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 3.98 109.009 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.1 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' THR . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.44 109.314 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 3.85 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 3.75 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 5.2 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 2.74 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.06 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 2.92 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 3.92 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 35' ' ' ILE . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.37 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 5.72 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 4.71 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.05 110.199 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 2.56 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.09 109.167 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 47' ' ' GLY . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 2.82 109.522 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 1.72 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.06 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.03 109.739 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 2.65 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 23.6 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.8 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.4 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 ' HE1' ' A' ' 55' ' ' PHE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 2.99 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.31 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 3.63 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.624 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.23 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.18 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 6.44 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.28 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.652 ' O ' HG22 ' A' ' 135' ' ' THR . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.17 109.979 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 3.59 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 4.4 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.54 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.3 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.12 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 1.79 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.04 108.919 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 2.31 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 64' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 1.71 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 4.33 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.75 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 110' ' ' LEU . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 1.91 111.137 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.901 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 2.75 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.3 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.34 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 2.85 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.19 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 1.76 108.32 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.4 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.27 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.35 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.681 ' CE1' HD23 ' A' ' 89' ' ' LEU . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.22 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 1.9 108.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 2.63 109.507 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.56 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.681 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.17 107.716 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.01 108.671 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.2 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 2.75 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 8.35 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.29 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.635 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.18 108.75 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.22 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 185' ' ' LEU . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.12 108.815 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.489 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.31 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 3.93 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 4.4 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.41 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.584 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 2.69 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.23 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 1.99 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.51 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.31 110.187 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.09 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.68 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.39 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 2.76 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 1.6 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 1.73 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.641 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.17 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.44 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.71 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 3.66 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 1.77 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.14 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 1.83 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 132' ' ' VAL . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.42 109.258 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.07 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.05 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 4.88 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.645 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 3.55 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 135' ' ' THR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.29 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.711 ' O ' HD23 ' A' ' 138' ' ' LEU . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.42 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 135' ' ' THR . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 2.5 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.55 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' OH ' ' A' ' 186' ' ' TYR . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 144' ' ' THR . 81.8 m-20 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 5.59 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.06 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 3.91 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.64 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 4.99 110.285 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 1.57 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 4.73 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.07 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 2.93 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 1.77 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.34 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.57 ' CE ' HD11 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 3.53 109.34 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.18 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 161' ' ' ASP . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.49 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 2.83 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.45 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 1.9 107.605 178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.642 ' N ' HD13 ' A' ' 164' ' ' LEU . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 1.8 110.596 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD23 ' NE2' ' A' ' 170' ' ' GLN . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.28 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 2.92 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.14 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.589 ' NE2' HD23 ' A' ' 166' ' ' LEU . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.35 110.563 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.18 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 4.67 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 2.92 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.17 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.62 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 156' ' ' MET . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.0 108.835 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 3.79 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.536 ' OE1' ' CD1' ' A' ' 186' ' ' TYR . 7.2 tp-100 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.02 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.853 ' C ' HD13 ' A' ' 183' ' ' LEU . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.48 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.044 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 4.79 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t -139.3 24.9 2.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.27 110.499 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.552 HD23 ' NZ ' ' A' ' 100' ' ' LYS . 8.3 mp -96.32 13.28 28.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.922 -1.111 . . . . 7.1 109.72 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.536 ' CD1' ' OE1' ' A' ' 181' ' ' GLN . 97.1 m-85 -52.75 158.56 1.31 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.009 . . . . 9.88 109.674 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -127.99 -101.5 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 8.42 109.343 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.52 97.81 2.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.484 -1.446 . . . . 9.13 109.484 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.73 -35.82 75.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -1.179 . . . . 11.72 109.407 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 117.996 -1.002 . . . . 12.62 109.507 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 15.48 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.44 -176.17 46.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.6 -1.4 . . . . 11.71 109.6 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -96.71 134.86 39.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 12.65 109.632 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -118.61 136.7 53.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 8.16 109.246 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.11 114.21 26.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.388 -0.82 . . . . 7.63 109.453 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -146.8 7.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 5.22 109.645 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' LEU . 2.6 ttmp? 53.81 82.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 4.94 108.902 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 9' ' ' LYS . 7.1 tt 56.64 107.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.377 -0.971 . . . . 2.2 108.377 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.567 ' O ' HD23 ' A' ' 8' ' ' LEU . 45.0 mtpt -49.24 149.74 3.5 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.262 -0.899 . . . . 2.5 110.483 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.23 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.64 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 2.71 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.6 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.04 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.04 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.0 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 20' ' ' THR . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 2.94 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 3.98 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CG ' HG21 ' A' ' 17' ' ' THR . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.1 110.269 -179.215 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 86' ' ' ILE . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.44 109.505 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 3.85 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 3.75 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 33' ' ' GLY . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 5.2 108.482 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 2.74 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.06 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 2.92 111.26 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 3.92 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.37 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 5.72 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 4.71 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' ILE . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.05 109.186 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 2.56 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.09 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 2.82 109.575 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 1.72 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.06 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.03 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 2.65 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.8 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.4 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 2.99 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.31 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 3.63 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.23 109.927 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.18 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 6.44 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.28 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.17 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 3.59 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 131' ' ' MET . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 4.4 112.325 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' THR . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.54 109.488 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 62' ' ' THR . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.3 109.234 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.751 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.12 109.349 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.79 109.303 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' THR . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.04 108.984 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.657 ' CE2' HD22 ' A' ' 110' ' ' LEU . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 2.31 108.877 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 64' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 1.71 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 4.33 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.75 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 1.91 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.614 ' N ' HG13 ' A' ' 71' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 2.75 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.3 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.34 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 2.85 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.19 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 1.76 108.337 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.4 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.27 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.35 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.22 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 27' ' ' VAL . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 1.9 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 91' ' ' VAL . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 2.63 110.365 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.56 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.01 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLN . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.2 107.774 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 2.75 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.504 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 8.35 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.29 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.18 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.22 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.12 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.31 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 3.93 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 4.4 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 166' ' ' LEU . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 2.69 109.041 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.23 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 1.99 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 182' ' ' ALA . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.51 109.302 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 67' ' ' PHE . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.31 109.01 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.09 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.68 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.39 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 165' ' ' THR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 2.76 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 1.6 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 1.73 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.792 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.17 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.44 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.71 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 3.66 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 1.77 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 124' ' ' ILE . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.14 110.638 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 1.83 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 125' ' ' VAL . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 64' ' ' PHE . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.42 109.304 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.07 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.05 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 4.88 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 132' ' ' VAL . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 3.55 109.387 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.29 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 137' ' ' GLU . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.42 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.606 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 2.5 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.55 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 144' ' ' THR . 25.9 t30 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 5.59 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.471 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.06 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG2' HG11 ' A' ' 125' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 3.91 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.64 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 4.99 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 149' ' ' VAL . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 1.57 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 4.73 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.07 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 2.93 109.04 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 1.77 108.088 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.34 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 3.53 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.18 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.711 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.49 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 2.83 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.45 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 1.9 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 115' ' ' TYR . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 1.8 109.601 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.28 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 2.92 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.14 110.202 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.35 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.18 109.498 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 4.67 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 2.92 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.17 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.62 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 169' ' ' PHE . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.0 109.73 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 3.79 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.02 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.48 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 4.79 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p 83.12 110.96 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.27 109.356 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 185' ' ' LEU . 3.0 mm? -79.53 -5.64 55.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 7.1 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.553 ' CB ' ' O ' ' A' ' 185' ' ' LEU . 10.7 t80 87.0 125.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.349 -0.611 . . . . 9.88 109.349 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 188' ' ' GLY . 59.8 t0 -72.03 133.14 45.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 8.42 109.313 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . -40.66 129.2 3.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.689 -1.364 . . . . 9.13 109.689 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.523 ' CD2' ' H ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.78 -98.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 11.72 109.357 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.469 HG13 ' OXT' ' A' ' 190' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.947 -1.025 . . . . 12.62 109.505 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.284 -0.636 . . . . 15.48 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.93 -2.67 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.538 -1.425 . . . . 11.71 109.538 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -104.44 140.26 38.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 12.65 109.329 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 91.5 p -126.72 150.34 49.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 8.16 109.387 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' OD1' ' O ' ' A' ' 4' ' ' SER . 83.0 m-20 -158.48 -31.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 7.63 109.429 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 m -58.89 -36.16 74.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 5.22 109.795 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -173.31 -159.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 4.94 109.866 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.87 150.92 27.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 2.2 108.988 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -58.15 150.1 53.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 2.5 109.429 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.23 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 16' ' ' LEU . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.17 109.021 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 8' ' ' LEU . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 2.64 109.604 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.586 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 2.71 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 17' ' ' THR . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.6 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.475 HH12 ' HB3' ' A' ' 14' ' ' GLU . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.04 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.04 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.0 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 2.94 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 3.98 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.1 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.44 108.885 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 3.85 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 3.75 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 5.2 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 2.74 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.06 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 2.92 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 3.92 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 41' ' ' GLY . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.37 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 5.72 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 4.71 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.05 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' H ' HD13 ' A' ' 35' ' ' ILE . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 2.56 110.462 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.09 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 2.82 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 1.72 108.726 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.06 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.03 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 2.65 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 6.3 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.8 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.4 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 2.99 108.88 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.31 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 3.63 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 25.8 mm-40 -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.23 110.842 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.18 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 6.44 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.28 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 136' ' ' VAL . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.17 109.684 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 3.59 109.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 4.4 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.54 109.976 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.3 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 68' ' ' VAL . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.12 109.916 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 1.79 109.421 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.04 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 107' ' ' LEU . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 2.31 109.343 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 64' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 4.33 109.442 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.75 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 1.91 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.034 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 2.75 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.3 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.34 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 2.85 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.19 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 1.76 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.4 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.27 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.35 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.68 ' CE1' HD23 ' A' ' 89' ' ' LEU . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.22 109.947 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 1.9 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 2.63 110.167 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.034 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.68 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.17 109.098 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.01 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.2 108.571 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 2.75 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 8.35 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.29 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.18 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.22 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.12 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.31 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 3.93 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 4.4 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.41 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 2.69 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.23 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 ' CE1' ' A' ' 64' ' ' PHE . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 1.99 109.875 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.51 110.794 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 124' ' ' ILE . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.31 109.684 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.09 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.68 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.39 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.522 ' CE2' HG22 ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 2.76 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 1.6 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 1.73 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.648 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.17 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.44 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.71 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 3.66 109.669 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 122' ' ' LEU . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 1.77 109.425 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.14 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 121' ' ' MET . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 1.83 109.175 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 132' ' ' VAL . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.42 107.506 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.07 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.517 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.05 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 4.88 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 136' ' ' VAL . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 3.55 108.99 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.542 ' C ' HG22 ' A' ' 135' ' ' THR . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.29 108.695 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.542 HG22 ' C ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 132' ' ' VAL . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.42 109.898 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 2.5 108.084 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.55 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 71.3 m-20 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 5.59 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.06 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 3.91 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.64 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 4.99 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 146' ' ' GLU . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 1.57 108.792 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 4.73 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.07 110.887 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 2.93 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 1.77 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.34 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 3.53 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.18 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.657 ' H ' ' HG3' ' A' ' 158' ' ' LYS . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.49 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 2.83 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.45 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 165' ' ' THR . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 1.9 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 164' ' ' LEU . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 1.8 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.28 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 2.92 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.14 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.35 110.076 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.18 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 4.67 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 2.92 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.17 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.62 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.0 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 3.79 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.02 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' O ' ' CD ' ' A' ' 145' ' ' PRO . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.48 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 4.79 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p -131.49 159.33 38.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.27 109.263 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.1 OUTLIER -98.61 85.8 3.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 7.1 109.629 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 26.2 p90 28.3 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.587 0.708 . . . . 9.88 111.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -78.31 114.34 17.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.011 -1.056 . . . . 8.42 108.857 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.53 168.2 38.17 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.541 -1.824 . . . . 9.13 108.541 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.99 -32.08 70.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.3 . . . . 11.72 109.372 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.043 -0.979 . . . . 12.62 109.424 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.496 -0.557 . . . . 15.48 109.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.76 -74.76 0.2 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.609 -1.396 . . . . 11.71 109.609 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.14 117.88 30.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -1.187 . . . . 12.65 109.562 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 5' ' ' ASN . 49.6 m -131.06 145.05 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 8.16 109.323 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 4' ' ' SER . 20.5 m120 35.73 -107.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.607 -0.683 . . . . 7.63 110.039 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -118.41 145.59 45.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.392 -0.818 . . . . 5.22 109.182 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -138.79 -177.43 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.883 . . . . 4.94 109.506 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 9' ' ' LYS . 5.4 tt -85.18 130.6 34.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.299 -1.0 . . . . 2.2 108.299 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' N ' HD23 ' A' ' 8' ' ' LEU . 83.0 mttt -55.5 138.45 68.64 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.076 -1.015 . . . . 2.5 110.497 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.23 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.17 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 HD22 ' A' ' 8' ' ' LEU . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 2.64 109.168 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.63 ' O ' HG22 ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 2.71 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 13' ' ' VAL . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.6 107.335 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH11 ' HG1' ' A' ' 17' ' ' THR . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.04 108.607 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.04 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.0 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 27' ' ' VAL . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 2.94 108.012 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 3.98 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.1 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 22' ' ' PHE . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.44 109.42 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 27' ' ' VAL . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 3.85 109.711 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 3.75 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 5.2 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 2.74 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.06 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 2.92 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 3.92 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.37 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 5.72 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 4.71 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.05 109.326 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 2.56 109.212 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' OE1' ' CZ ' ' A' ' 79' ' ' ARG . 20.9 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.09 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 2.82 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 1.72 108.585 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.06 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.03 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 2.65 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.8 107.81 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.4 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 2.99 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.31 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 3.63 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.23 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.18 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 6.44 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.28 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.17 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 3.59 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 4.4 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 66' ' ' THR . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.54 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.3 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 68' ' ' VAL . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.12 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 1.79 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' THR . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.04 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 2.31 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 64' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 1.71 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 4.33 109.837 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.75 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 1.91 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.525 ' N ' HG13 ' A' ' 71' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 2.75 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.3 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.34 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 2.85 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.489 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.19 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.4 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.27 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.35 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.22 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 1.9 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 2.63 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.56 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD23 ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.17 107.808 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.01 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.622 HG11 ' NE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.2 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 2.75 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 8.35 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.29 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.18 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.22 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.12 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.31 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 3.93 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.622 ' NE1' HG11 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 4.4 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.41 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 2.69 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.23 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 1.99 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.51 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 67' ' ' PHE . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.31 109.795 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.09 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.68 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.39 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.623 ' CE1' HG22 ' A' ' 165' ' ' THR . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 2.76 109.514 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.6 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 163' ' ' LYS . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 1.73 108.021 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.17 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.44 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.71 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 3.66 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.77 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 124' ' ' ILE . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.14 109.327 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 145' ' ' PRO . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 1.83 108.058 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 132' ' ' VAL . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.42 109.374 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.07 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.05 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 4.88 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 128' ' ' ILE . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 3.55 109.856 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.29 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.42 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 2.5 109.583 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.55 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 139' ' ' PRO . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 5.59 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.06 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.702 ' HG2' HG22 ' A' ' 125' ' ' VAL . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 3.91 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.554 ' OE1' HG11 ' A' ' 125' ' ' VAL . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.64 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.764 ' O ' HD13 ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 4.99 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 1.57 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 4.73 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.764 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.07 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.792 ' CZ ' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 2.93 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 1.77 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.34 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 3.53 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.18 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.49 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 2.83 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 117' ' ' THR . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.45 109.023 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.792 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 1.9 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 115' ' ' TYR . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 1.8 108.927 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.568 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.28 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 2.92 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.14 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.35 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.18 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 4.67 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 2.92 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.17 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.62 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.0 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 3.79 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.02 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.48 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.988 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 4.79 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m -58.54 -27.73 64.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.27 109.945 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 185' ' ' LEU . 5.2 tt 66.78 118.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 7.1 109.204 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -107.99 159.27 16.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 9.88 109.469 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.4 p30 -57.97 -32.49 67.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 8.42 110.096 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 173.99 174.64 41.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 9.13 109.613 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.6 mm? -65.44 -33.49 76.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -1.149 . . . . 11.72 109.358 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.299 -1.607 0 CA-C-O 117.947 -1.025 . . . . 12.62 109.559 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 15.48 109.47 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.38 179.75 50.6 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.658 -1.377 . . . . 11.71 109.658 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 5' ' ' ASN . 27.9 mttm -89.04 5.16 45.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 12.65 109.536 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' LYS . 0.8 OUTLIER 72.51 -35.67 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 8.16 109.666 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' LYS . 23.4 t-20 -101.67 86.04 2.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 7.63 109.455 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -176.14 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 5.22 109.181 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -97.6 161.86 13.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 4.94 109.111 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -55.81 157.72 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.089 -1.007 . . . . 2.2 109.149 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -54.62 136.71 63.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 2.5 109.605 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.23 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.17 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 17' ' ' THR . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 2.64 109.398 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' OG1' ' A' ' 20' ' ' THR . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 2.71 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.6 108.117 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.04 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.04 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.511 ' OG1' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.0 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 2.94 109.027 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 3.98 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.1 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 HD11 ' A' ' 86' ' ' ILE . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.44 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 3.85 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 3.75 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 5.2 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HD11 ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 2.74 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.06 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 2.92 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' TYR . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 3.92 111.3 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.37 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 5.72 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 4.71 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.05 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 2.56 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.09 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 2.82 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 1.72 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.06 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.03 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 2.65 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.8 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.4 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 2.99 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.474 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.31 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 3.63 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.8 tp60 -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.23 109.803 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.18 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.541 ' HA ' HG11 ' A' ' 136' ' ' VAL . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 6.44 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.28 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.17 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 3.59 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 4.4 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.54 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.3 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 107' ' ' LEU . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.12 110.833 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 1.79 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.04 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 2.31 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 1.71 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 4.33 109.538 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.53 HD22 HD11 ' A' ' 110' ' ' LEU . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.75 110.444 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 1.91 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.61 ' N ' HG13 ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 2.75 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.645 ' ND2' ' OE2' ' A' ' 84' ' ' GLU . 1.3 m-20 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.3 109.576 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.34 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 2.85 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.19 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 1.76 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.4 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.27 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.35 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HE1' HD13 ' A' ' 89' ' ' LEU . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.22 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 HG23 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 1.9 109.957 -178.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' VAL . 82.7 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 2.63 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.56 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 85' ' ' PHE . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.17 108.611 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.01 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 87' ' ' GLN . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.2 107.336 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 2.75 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 8.35 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 21' ' ' TYR . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.29 110.306 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.18 109.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.22 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.12 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.31 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 3.93 109.611 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 4.4 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.41 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 2.69 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.23 109.44 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 64' ' ' PHE . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 1.99 109.992 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.51 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 70' ' ' ASN . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.31 109.25 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.09 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.68 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.39 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 2.76 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 1.6 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 1.73 108.307 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.17 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.44 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 109' ' ' ASP . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.71 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 3.66 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 122' ' ' LEU . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 1.77 109.533 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 124' ' ' ILE . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.14 110.392 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 1.83 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.596 ' O ' HG23 ' A' ' 132' ' ' VAL . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.42 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.07 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 27.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.05 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 4.88 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' ILE . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 3.55 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.494 ' O ' HD21 ' A' ' 138' ' ' LEU . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.29 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.42 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 2.5 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.55 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 5.59 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.8 ' O ' HG23 ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.06 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 3.91 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.64 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.68 ' HG2' HD12 ' A' ' 152' ' ' ILE . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 4.99 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 1.57 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 4.73 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 148' ' ' ARG . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.07 110.032 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.785 ' CD1' HD21 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 2.93 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 1.77 107.633 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.34 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.636 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 3.53 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.18 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 156' ' ' MET . 76.1 m-20 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.49 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 2.83 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.45 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 1.9 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 1.8 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.28 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 2.92 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 168' ' ' GLU . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.14 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.35 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.18 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 4.67 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 2.92 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.17 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.62 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.0 109.669 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 180' ' ' VAL . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 3.79 108.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.02 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.48 109.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 4.79 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 p -56.53 144.3 32.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.27 109.919 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 1.2 mm? -80.3 -48.64 12.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 7.1 109.217 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -133.46 153.61 51.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 9.88 109.483 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.7 121.36 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 8.42 109.532 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.77 10.56 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.839 -1.304 . . . . 9.13 109.839 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.38 -36.7 69.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -1.186 . . . . 11.72 109.49 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.464 HG13 ' OXT' ' A' ' 190' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.006 -0.997 . . . . 12.62 109.478 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.247 0.546 . . . . 15.48 109.561 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.16 -8.26 59.0 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.958 -1.257 . . . . 11.71 109.958 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -122.17 148.42 44.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.361 -1.082 . . . . 12.65 110.146 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.6 p -97.82 153.4 18.32 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.503 -0.925 . . . . 8.16 108.503 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -103.56 96.98 7.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 7.63 110.036 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -66.04 -28.28 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 5.22 108.889 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -81.03 145.65 31.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.491 -0.756 . . . . 4.94 109.093 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -79.35 134.37 36.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 2.2 108.696 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -62.54 140.4 96.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 2.5 109.436 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.23 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.17 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG13 ' CD ' ' A' ' 24' ' ' GLU . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 2.64 109.698 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 2.71 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.6 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.04 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.04 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.0 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 2.94 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 3.98 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.669 ' CD ' HG13 ' A' ' 13' ' ' VAL . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.1 109.513 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.64 HG13 ' CD1' ' A' ' 86' ' ' ILE . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.44 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 3.85 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 3.75 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 5.2 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 2.74 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.06 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 2.92 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 3.92 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.37 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 5.72 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 4.71 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.05 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 2.56 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.09 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 2.82 110.089 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 1.72 109.345 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.06 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.03 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 2.65 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.8 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.4 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 2.99 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.451 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.31 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 3.63 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.23 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.18 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 6.44 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.28 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 136' ' ' VAL . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.17 109.188 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 3.59 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 4.4 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.54 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.3 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.563 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.12 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 1.79 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.04 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 110' ' ' LEU . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 2.31 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 1.71 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 4.33 109.846 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.75 110.745 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 1.91 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.985 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 2.75 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.3 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.34 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 2.85 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.19 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 1.76 108.267 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.4 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.27 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.35 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.22 110.1 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.64 ' CD1' HG13 ' A' ' 27' ' ' VAL . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 1.9 109.502 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 2.63 109.888 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.985 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.56 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.17 108.76 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.01 109.277 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 2.75 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 8.35 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.29 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.18 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 180' ' ' VAL . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.22 109.096 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.12 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.31 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 3.93 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.601 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 4.4 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.41 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' HD11 ' A' ' 116' ' ' ILE . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 2.69 110.196 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.23 109.206 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.601 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 1.99 110.478 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.51 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.31 109.243 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.09 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.68 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.39 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 2.76 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 105' ' ' PHE . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 1.6 108.724 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 1.73 108.86 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.74 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.17 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.44 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.71 109.188 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 3.66 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 1.77 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.14 109.64 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 1.83 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.42 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HG12 ' A' ' 132' ' ' VAL . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.07 110.428 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.05 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 4.88 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 3.55 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 12.5 t-20 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.29 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 136' ' ' VAL . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.42 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 135' ' ' THR . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 2.5 109.798 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.55 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.577 ' OE1' ' CD2' ' A' ' 186' ' ' TYR . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.639 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.679 ' HB3' HD22 ' A' ' 183' ' ' LEU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 5.59 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.451 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.06 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 3.91 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.64 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 4.99 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 1.57 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 4.73 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.07 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 2.93 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 1.77 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.34 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 3.53 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.18 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.732 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.49 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 2.83 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.45 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 168' ' ' GLU . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 1.9 108.158 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 1.8 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 166' ' ' LEU . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.28 110.196 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 2.92 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 164' ' ' LEU . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.14 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.35 109.991 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.18 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 4.67 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 2.92 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.17 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.62 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 180' ' ' VAL . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.0 109.661 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.605 ' N ' HG22 ' A' ' 179' ' ' ILE . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 3.79 111.759 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.02 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.48 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 4.79 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p -88.09 6.19 37.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.27 109.738 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.4 tp -53.17 -34.26 56.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 7.1 109.644 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CD2' ' OE1' ' A' ' 141' ' ' GLU . 96.4 m-85 -99.16 145.14 27.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 9.88 109.603 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.16 14.37 2.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.417 -0.802 . . . . 8.42 109.659 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.47 16.93 38.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.441 -1.464 . . . . 9.13 109.441 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER 59.02 83.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -1.146 . . . . 11.72 109.394 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.433 HG13 ' OXT' ' A' ' 190' ' ' VAL . 5.2 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.956 -1.021 . . . . 12.62 109.469 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.398 -0.594 . . . . 15.48 109.398 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.68 41.54 15.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.46 -1.456 . . . . 11.71 109.46 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -80.93 3.76 21.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -1.139 . . . . 12.65 109.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -60.94 159.15 11.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 8.16 109.394 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -67.52 175.25 2.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 7.63 109.686 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -62.31 154.49 27.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 5.22 109.89 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 8' ' ' LEU . 34.2 ttpt -172.16 170.58 5.16 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.826 -0.805 . . . . 4.94 108.826 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.457 HD23 ' CG2' ' A' ' 13' ' ' VAL . 61.9 tp -61.86 130.93 48.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 2.2 109.045 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -61.43 142.38 93.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 2.5 109.536 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.23 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.17 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' CG2' HD23 ' A' ' 8' ' ' LEU . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 2.64 108.16 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 2.71 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.6 107.641 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.04 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.04 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.598 HG21 ' CG1' ' A' ' 27' ' ' VAL . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.0 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 2.94 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 3.98 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.1 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' CG1' HG21 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.44 109.357 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 3.85 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 3.75 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 5.2 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 2.74 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.06 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 2.92 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 3.92 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.37 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 5.72 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 4.71 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.05 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 2.56 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.09 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 2.82 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.551 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 1.72 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.06 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.03 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 2.65 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HG2' ' HB1' ' A' ' 65' ' ' ALA . 24.3 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.8 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.4 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 2.99 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.31 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 3.63 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.23 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.18 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 6.44 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.28 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.17 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 3.59 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 4.4 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.54 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.3 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.12 109.965 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 1.79 109.754 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.04 109.535 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 2.31 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 1.71 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 4.33 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.75 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 1.91 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.999 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 2.75 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.3 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.34 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 2.85 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.19 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.76 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.4 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.27 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.35 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.616 ' CE1' HD13 ' A' ' 89' ' ' LEU . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.22 109.307 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 1.9 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 2.63 110.114 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.999 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.56 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD13 ' CE1' ' A' ' 85' ' ' PHE . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.17 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.01 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.2 109.624 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 88' ' ' ALA . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 2.75 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.493 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 8.35 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.29 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.18 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.22 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.12 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.31 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 3.93 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 4.4 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.41 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 2.69 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.23 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 1.99 110.037 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.408 ' CZ ' ' HG2' ' A' ' 121' ' ' MET . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.51 109.78 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.31 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.09 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.8 OUTLIER 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.68 109.36 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.39 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 2.76 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 1.6 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 1.73 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.17 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.44 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.71 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 3.66 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 1.77 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 124' ' ' ILE . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.14 108.562 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 121' ' ' MET . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 1.83 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.42 109.396 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.07 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.05 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 131' ' ' MET . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 4.88 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 3.55 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 134' ' ' ASN . 1.7 p-10 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.29 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.42 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 2.5 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' HD22 ' A' ' 143' ' ' ASN . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.55 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.452 HD22 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 5.59 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.06 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.644 ' CG ' HD12 ' A' ' 183' ' ' LEU . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 3.91 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' O ' HG22 ' A' ' 149' ' ' VAL . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.64 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 4.99 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 1.57 108.697 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.664 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 4.73 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.07 110.588 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.806 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 2.93 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 1.77 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.34 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 3.53 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.684 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.18 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.684 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.49 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 2.83 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.45 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.806 HD21 ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 1.9 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.8 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.28 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 2.92 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.14 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.35 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.18 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 4.67 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 2.92 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 176' ' ' ASP . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.17 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.479 ' H ' ' HG3' ' A' ' 181' ' ' GLN . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.62 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.0 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 3.79 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.02 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.48 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 4.79 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m -64.76 153.55 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.27 109.398 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 34.9 mt -101.23 135.24 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 7.1 109.184 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -51.52 126.76 18.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 9.88 109.322 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -57.66 -38.79 75.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 8.42 109.378 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -176.68 49.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.264 -1.534 . . . . 9.13 109.264 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -92.81 0.84 57.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.182 -1.187 . . . . 11.72 109.282 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.975 -1.012 . . . . 12.62 109.452 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.293 -0.632 . . . . 15.48 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.58 -111.69 4.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.494 -1.442 . . . . 11.71 109.494 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -78.61 140.08 38.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -1.146 . . . . 12.65 109.331 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 5' ' ' ASN . 2.7 t -143.91 -99.91 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 8.16 109.299 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.5 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.9 t30 58.71 48.55 11.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 7.63 109.68 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.3 p -108.95 138.99 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.296 -0.877 . . . . 5.22 109.527 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -176.3 168.58 2.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.585 -0.697 . . . . 4.94 109.131 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 13' ' ' VAL . 26.9 tp -99.71 123.05 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 2.2 109.067 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -78.07 149.36 76.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 2.5 109.756 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.23 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 8' ' ' LEU . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.17 108.373 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 8' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 2.64 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.71 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.6 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.04 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 16' ' ' LEU . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.04 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 96' ' ' THR . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.0 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 2.94 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 3.98 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.1 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 20' ' ' THR . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.44 110.303 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 3.85 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 3.75 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 5.2 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 2.74 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.608 ' HZ3' ' HA ' ' A' ' 7' ' ' LYS . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.06 108.945 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 2.92 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 3.92 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.37 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 5.72 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 4.71 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.05 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 2.56 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.09 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.82 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 1.72 109.415 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.06 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.03 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 2.65 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.8 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.4 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 52' ' ' TYR . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 2.99 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.31 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 3.63 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.23 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.18 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 6.44 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.28 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.17 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 3.59 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 4.4 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.54 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.3 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.12 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 1.79 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.04 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.603 ' O ' HG22 ' A' ' 71' ' ' VAL . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 2.31 109.9 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 1.71 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 4.33 109.461 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.75 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 1.91 110.519 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.994 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 2.75 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.3 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.34 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 2.85 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.19 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 1.76 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.4 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.27 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.35 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.22 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 1.9 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.494 ' OE1' ' NZ ' ' A' ' 19' ' ' LYS . 9.0 tp-100 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 2.63 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.994 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.56 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.17 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.01 108.437 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NE1' ' A' ' 103' ' ' TRP . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.2 109.466 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 88' ' ' ALA . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 2.75 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' THR . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 21' ' ' TYR . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 8.35 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.29 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 21' ' ' TYR . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.18 109.207 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.22 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.12 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.31 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.506 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 3.93 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.538 ' NE1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 4.4 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.41 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 2.69 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.23 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 1.99 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.51 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.715 ' C ' HD23 ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.31 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.09 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.68 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.39 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 2.76 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.473 HG22 ' HE3' ' A' ' 121' ' ' MET . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 1.6 109.127 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 1.73 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.694 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.17 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.44 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.71 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 3.66 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 122' ' ' LEU . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 1.77 109.828 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.14 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 121' ' ' MET . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 1.83 108.114 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.42 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.07 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.05 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 4.88 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 3.55 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.29 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.42 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 2.5 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.55 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 5.59 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.06 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 149' ' ' VAL . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 3.91 113.207 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.64 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 4.99 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.57 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 4.73 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.07 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.937 ' CE2' HD13 ' A' ' 164' ' ' LEU . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 2.93 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 1.77 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.34 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 3.53 109.4 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.18 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.724 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.49 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 2.83 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.45 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 1.9 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 1.8 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.28 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 2.92 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.14 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.506 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.35 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.18 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 4.67 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 2.92 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.17 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.62 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 172' ' ' GLY . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.0 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 3.79 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.02 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CD2' ' A' ' 183' ' ' LEU . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.48 108.853 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.928 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 4.79 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 4.4 p 40.75 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.27 109.942 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.83 -34.33 74.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 7.1 109.461 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.1 129.28 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 9.88 109.739 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.18 -36.09 76.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 8.42 109.131 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.5 -127.97 1.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 9.13 109.365 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.6 tp -159.01 84.27 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -1.197 . . . . 11.72 109.301 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 190' ' ' VAL . 6.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.966 -1.016 . . . . 12.62 109.466 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.0 mtmp? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.448 -0.575 . . . . 2.5 109.448 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.23 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.17 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 17' ' ' THR . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 2.64 108.11 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 2.71 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 13' ' ' VAL . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.6 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.04 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.04 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.0 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.623 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 2.94 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 3.98 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.563 ' OE2' HG11 ' A' ' 13' ' ' VAL . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.1 109.771 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 86' ' ' ILE . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.44 110.097 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 3.85 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 3.75 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 5.2 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 2.74 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.06 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 2.92 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 3.92 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.37 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 5.72 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 4.71 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.05 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 2.56 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.453 HE21 ' HB2' ' A' ' 79' ' ' ARG . 63.6 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.09 109.204 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 2.82 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 1.72 109.197 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.06 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.03 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 2.65 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.8 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.4 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 2.99 108.606 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.712 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.31 107.874 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 3.63 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.23 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.18 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 136' ' ' VAL . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 6.44 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.28 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.17 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 3.59 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 4.4 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.54 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.3 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.671 ' O ' HG23 ' A' ' 68' ' ' VAL . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.12 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.79 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.04 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD2' HD23 ' A' ' 110' ' ' LEU . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 2.31 109.177 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 64' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 1.71 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 4.33 109.462 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.75 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 1.91 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 2.75 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.3 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.34 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 2.85 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.19 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 1.76 107.115 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.4 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.27 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' HE21 ' A' ' 87' ' ' GLN . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.35 109.462 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 89' ' ' LEU . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.22 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 1.9 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 52.1 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 2.63 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.56 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.501 HD13 ' HE1' ' A' ' 85' ' ' PHE . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.17 108.714 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.01 109.015 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG11 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.2 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 2.75 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 8.35 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.29 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.18 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.22 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.12 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.31 109.386 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 3.93 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.757 ' HE1' HG11 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 4.4 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.41 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 2.69 110.035 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.23 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD13 HG22 ' A' ' 68' ' ' VAL . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 1.99 109.92 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.51 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 110' ' ' LEU . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.31 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.09 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.68 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.39 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 2.76 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 1.6 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 1.73 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.61 HH22 ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.17 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.44 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.71 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.635 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 3.66 109.563 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 1.77 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.14 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 121' ' ' MET . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 1.83 108.147 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 128' ' ' ILE . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.42 109.46 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.501 ' CE2' HG21 ' A' ' 144' ' ' THR . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.07 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.05 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 4.88 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 132' ' ' VAL . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 3.55 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.29 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.42 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' N ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 2.5 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.55 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 5.59 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.501 HG21 ' CE2' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.06 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 183' ' ' LEU . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 3.91 113.137 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.64 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 4.99 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 1.57 109.263 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 4.73 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.07 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 2.93 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 1.77 107.702 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.34 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 3.53 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CB ' HH22 ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.18 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.717 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.49 109.701 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.694 ' N ' ' ND2' ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 2.83 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.45 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.865 HD11 ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 1.9 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 1.8 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.28 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 2.92 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.14 109.922 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.35 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.18 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 4.67 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.92 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 177' ' ' PRO . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.17 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.62 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 172' ' ' GLY . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 3.79 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.02 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.48 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.876 ' N ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 4.79 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.27 109.686 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.487 -0.56 . . . . 2.5 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.23 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.17 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.468 ' CG1' ' OE1' ' A' ' 24' ' ' GLU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 2.64 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 2.71 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.6 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.04 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.04 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.0 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' H ' HG22 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 2.94 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 3.98 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.1 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.452 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.44 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 3.85 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 3.75 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 5.2 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 2.74 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.06 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 2.92 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 3.92 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.37 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 5.72 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 4.71 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.05 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 2.56 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.739 HE22 ' NH2' ' A' ' 79' ' ' ARG . 43.5 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.09 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 85' ' ' PHE . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 2.82 109.857 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 1.72 109.456 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.06 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.03 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 2.65 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.8 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.4 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 2.99 108.258 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.31 107.188 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 3.63 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.23 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.18 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 6.44 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.28 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.17 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 3.59 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 4.4 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.54 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.3 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.12 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 1.79 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.04 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 2.31 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 1.71 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 4.33 109.72 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 70' ' ' ASN . 0.5 OUTLIER -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.75 110.699 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 1.91 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 2.75 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.61 HD21 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.3 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.34 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' CG ' HD21 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 2.85 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.739 ' NH2' HE22 ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.19 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 1.76 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.4 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.27 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.35 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.22 109.971 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 1.9 110.442 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 2.63 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.56 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.17 109.121 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.01 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.2 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.638 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 8.35 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.29 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.541 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.18 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.22 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HZ3' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.12 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 180' ' ' VAL . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.31 108.737 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 3.93 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.481 ' CH2' HD13 ' A' ' 107' ' ' LEU . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 4.4 109.137 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.41 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 2.69 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 107' ' ' LEU . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.23 109.751 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 1.99 110.048 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.51 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 67' ' ' PHE . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.31 110.618 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.09 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 2.0 t-20 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.68 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.39 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CE1' HG22 ' A' ' 165' ' ' THR . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 2.76 110.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 1.6 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 1.73 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.66 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.17 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.44 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.71 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 3.66 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD22 ' OE2' ' A' ' 146' ' ' GLU . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 1.77 109.305 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.14 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 121' ' ' MET . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 1.83 107.926 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 144' ' ' THR . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.42 110.884 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.07 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.05 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 4.88 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 132' ' ' VAL . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 3.55 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.29 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.42 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 2.5 108.606 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.55 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 5.59 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 128' ' ' ILE . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.06 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 3.91 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.63 ' OE2' HD22 ' A' ' 122' ' ' LEU . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.41 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.64 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 4.99 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 1.57 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.41 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 4.73 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.07 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 2.93 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 1.77 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.34 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 3.53 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.66 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.18 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 2.83 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.45 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 1.9 107.988 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 164' ' ' LEU . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 1.8 109.828 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.28 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 2.92 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.14 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.35 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.18 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 4.67 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 2.92 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.17 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.62 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.0 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 101' ' ' LEU . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 3.79 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.02 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.537 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.48 109.335 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.076 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 4.79 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.27 110.393 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.062 -0.718 . . . . 2.5 109.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.23 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.17 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 17' ' ' THR . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 2.64 110.005 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 2.71 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 13' ' ' VAL . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.6 109.528 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 18' ' ' ARG . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.04 108.423 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.04 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.0 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 2.94 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 3.98 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 17' ' ' THR . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.1 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG11 ' CG2' ' A' ' 20' ' ' THR . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.44 108.294 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 3.85 108.075 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 3.75 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 5.2 108.487 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 2.74 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.06 107.839 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 2.92 109.996 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 3.92 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.37 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 5.72 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 4.71 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.05 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 2.56 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.09 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 2.82 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 1.72 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.06 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.03 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 2.65 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.8 108.551 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.4 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 2.99 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.31 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 3.63 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.23 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.18 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 6.44 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.28 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.17 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 3.59 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 4.4 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.54 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.3 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.713 ' O ' HG23 ' A' ' 68' ' ' VAL . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.12 109.636 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 1.79 109.722 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.04 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.935 ' O ' HG22 ' A' ' 71' ' ' VAL . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 2.31 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 64' ' ' PHE . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 1.71 109.213 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 4.33 109.295 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.75 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 1.91 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 2.75 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.3 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.34 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 2.85 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.19 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 1.76 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.4 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.27 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.35 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.22 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 86' ' ' ILE . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 1.9 109.494 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 91' ' ' VAL . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 2.63 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.56 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.686 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.17 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.01 108.945 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.2 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 2.75 108.841 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 8.35 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.29 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.18 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.22 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.12 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 173' ' ' SER . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.31 109.533 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 3.93 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 4.4 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.41 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 2.69 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.23 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.729 ' HA ' HG21 ' A' ' 71' ' ' VAL . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 1.99 110.383 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.51 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 67' ' ' PHE . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.31 109.789 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.09 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.68 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.39 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 2.76 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 1.6 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 1.73 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.612 ' HE ' ' CG ' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.17 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.44 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.71 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 3.66 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 1.77 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 124' ' ' ILE . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.14 109.953 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 1.83 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 132' ' ' VAL . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.42 111.314 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.07 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.05 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 4.88 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 128' ' ' ILE . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 3.55 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.29 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.42 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.55 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.739 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 5.59 110.49 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.611 HG22 ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.06 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 3.91 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.64 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HB3' HD12 ' A' ' 152' ' ' ILE . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 4.99 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 1.57 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 149' ' ' VAL . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 4.73 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 148' ' ' ARG . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.07 111.743 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 2.93 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 1.77 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.34 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 3.53 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.18 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.49 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.627 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 2.83 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.45 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 1.9 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 1.8 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.28 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 2.92 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.14 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.35 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.478 ' CB ' HD11 ' A' ' 101' ' ' LEU . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.18 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 4.67 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 2.92 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.17 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.62 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.0 110.179 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 3.79 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.02 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.48 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 4.79 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.27 109.758 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.192 -0.67 . . . . 2.5 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.23 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.17 108.836 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 2.64 108.117 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 2.71 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 17' ' ' THR . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.6 107.968 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.04 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.04 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.0 108.907 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 3.98 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.1 110.287 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 20' ' ' THR . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.44 109.743 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 3.85 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 3.75 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 5.2 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 2.74 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.06 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 2.92 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 3.92 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.37 109.392 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 5.72 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 4.71 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.05 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 2.56 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.09 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 47' ' ' GLY . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 2.82 109.354 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 1.72 109.747 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.06 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.03 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 2.65 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.59 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 88.5 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.8 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.4 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 2.99 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.512 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.31 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 3.63 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.23 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.18 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 6.44 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.28 113.233 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 135' ' ' THR . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.17 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 3.59 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 4.4 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.54 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.3 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.734 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.12 109.882 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 1.79 109.695 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.59 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.04 109.016 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 124' ' ' ILE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 2.31 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 1.71 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 4.33 109.699 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.75 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 1.91 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 2.75 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.3 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.34 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' CG ' HD21 ' A' ' 75' ' ' ASN . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 2.85 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.19 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 1.76 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.4 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.27 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.35 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.22 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 1.9 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 2.63 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.56 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.746 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.01 108.954 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' GLN . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.2 108.831 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 2.75 109.477 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 8.35 108.162 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.29 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.517 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.18 108.486 179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.22 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.12 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.31 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 3.93 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 4.4 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.41 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 2.69 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.23 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 1.99 110.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.51 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.31 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.09 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.68 111.571 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.39 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.706 ' CD2' HG22 ' A' ' 165' ' ' THR . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 2.76 110.112 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 1.6 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 1.73 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.17 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.44 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.71 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 3.66 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 1.77 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 67' ' ' PHE . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.14 109.579 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 121' ' ' MET . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 1.83 107.857 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.42 109.188 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.07 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.05 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 4.88 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.449 ' HA ' ' HG1' ' A' ' 135' ' ' THR . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 3.55 109.614 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.29 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 58' ' ' PHE . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.42 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 135' ' ' THR . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 2.5 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.531 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.55 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.531 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 5.59 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.06 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 3.91 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.64 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.64 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 4.99 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 146' ' ' GLU . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 1.57 109.538 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 4.73 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.07 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 1.063 ' CZ ' HD12 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 2.93 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 1.77 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.34 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.594 ' SD ' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 3.53 110.37 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.18 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.743 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 22.4 m120 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.49 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 2.83 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.45 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.063 HD12 ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 1.9 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.706 HG22 ' CD2' ' A' ' 115' ' ' TYR . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 1.8 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 166' ' ' LEU . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.28 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 2.92 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.14 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.431 ' OE1' HD23 ' A' ' 166' ' ' LEU . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.35 110.246 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.18 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 4.67 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 2.92 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.17 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.62 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.0 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 3.79 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.02 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.498 ' HB3' HD23 ' A' ' 183' ' ' LEU . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.48 108.955 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 4.79 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.27 110.009 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.873 -0.418 . . . . 2.5 109.873 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.23 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.17 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 2.64 109.028 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 2.71 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' VAL . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.6 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.04 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.04 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.0 108.372 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 2.94 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 3.98 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 24' ' ' GLU . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.1 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 16' ' ' LEU . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.44 109.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 3.85 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 3.75 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 5.2 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 2.74 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.06 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 2.92 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 3.92 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.37 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 5.72 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 4.71 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.05 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 2.56 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.09 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 2.82 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 1.72 109.866 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.06 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.03 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 51' ' ' ILE . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 2.65 108.039 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.597 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 80.3 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.8 108.441 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.4 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 2.99 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.31 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 3.63 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.23 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.18 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 6.44 109.906 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.28 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.17 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 3.59 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 4.4 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.677 HG23 ' H ' ' A' ' 63' ' ' LYS . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.54 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.677 ' H ' HG23 ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.3 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.774 ' O ' HG23 ' A' ' 68' ' ' VAL . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.12 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 1.79 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.597 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.04 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.31 108.725 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 1.71 109.324 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 4.33 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.75 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 1.91 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 2.75 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.3 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.34 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 2.85 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.19 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 1.76 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.4 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.27 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.35 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE1' HD22 ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.22 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 1.9 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 86' ' ' ILE . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 2.63 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.56 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.17 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.01 109.005 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.2 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 2.75 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 8.35 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.29 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.18 108.592 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.22 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 96' ' ' THR . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.12 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.31 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 3.93 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 4.4 109.466 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.41 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 2.69 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 106' ' ' LYS . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.23 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 1.99 109.422 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.51 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.713 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.31 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.09 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.531 ' ND2' ' NZ ' ' A' ' 106' ' ' LYS . 43.3 p-10 -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.68 110.772 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.39 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 163' ' ' LYS . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 2.76 109.315 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.6 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 1.73 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HE1' ' A' ' 121' ' ' MET . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.17 109.8 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.44 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.71 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.675 ' O ' HG13 ' A' ' 125' ' ' VAL . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 3.66 109.236 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 122' ' ' LEU . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 1.77 109.381 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 124' ' ' ILE . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.14 110.421 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 1.83 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 132' ' ' VAL . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.42 108.975 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.07 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.05 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 4.88 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 128' ' ' ILE . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 3.55 109.434 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.48 ' C ' HG22 ' A' ' 135' ' ' THR . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.29 109.768 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.815 ' O ' HG13 ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.42 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 2.5 110.114 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.55 111.984 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 30.0 m120 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 5.59 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.06 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.621 ' HD3' HD12 ' A' ' 183' ' ' LEU . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 3.91 112.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 149' ' ' VAL . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.64 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 4.99 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 1.57 108.958 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 4.73 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.07 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.775 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 2.93 109.072 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 1.77 108.197 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.34 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 179' ' ' ILE . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 3.53 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.18 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.812 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.49 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 2.83 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 115' ' ' TYR . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.45 108.888 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.775 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 1.9 108.661 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 164' ' ' LEU . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 1.8 109.72 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.28 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 2.92 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.14 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.35 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.18 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 4.67 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 2.92 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.17 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.582 ' OG ' ' NE2' ' A' ' 181' ' ' GLN . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.62 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.868 HD11 ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.0 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 3.79 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.582 ' NE2' ' OG ' ' A' ' 178' ' ' SER . 11.8 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.02 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.521 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.48 109.738 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.0 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 4.79 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.27 110.022 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' CG ' HG23 ' A' ' 12' ' ' VAL . 15.4 ptpt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.437 -0.579 . . . . 2.5 109.437 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.23 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG23 ' CG ' ' A' ' 9' ' ' LYS . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.17 108.8 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 17' ' ' THR . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 2.64 108.948 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.678 HD22 ' OG1' ' A' ' 20' ' ' THR . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 2.71 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 24' ' ' GLU . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.6 106.841 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.04 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.04 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.678 ' OG1' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.0 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.65 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 2.94 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 3.98 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.1 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 28' ' ' GLN . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.44 110.364 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 27' ' ' VAL . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 3.85 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 3.75 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 5.2 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 2.74 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.06 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 2.92 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 3.92 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.37 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 5.72 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 4.71 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.05 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 2.56 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.09 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 47' ' ' GLY . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 2.82 109.91 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 1.72 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.06 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.03 109.903 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' HG13 ' A' ' 51' ' ' ILE . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 2.65 108.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' NE2' HG22 ' A' ' 62' ' ' THR . 48.5 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.8 108.766 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.4 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 48' ' ' PHE . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 2.99 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.31 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 3.63 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.23 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.18 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 6.44 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.28 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG23 ' A' ' 136' ' ' VAL . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.17 109.547 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 3.59 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 4.4 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.54 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.3 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 68' ' ' VAL . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.12 109.604 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 1.79 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.04 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' VAL . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 2.31 108.55 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 1.71 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 4.33 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.75 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG23 HD22 ' A' ' 112' ' ' ASN . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 1.91 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 2.75 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.3 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.34 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 2.85 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.19 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 1.76 108.178 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.4 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.27 109.152 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.35 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.22 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 1.9 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 2.63 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.56 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 85' ' ' PHE . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.17 108.031 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.01 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.2 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 2.75 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 8.35 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.29 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.18 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.22 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.12 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.31 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 3.93 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 107' ' ' LEU . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 4.4 108.743 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.41 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 2.69 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' HG21 ' A' ' 71' ' ' VAL . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.23 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 1.99 110.439 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 121' ' ' MET . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.51 108.743 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.619 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.792 HD23 ' H ' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.31 110.134 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.792 ' H ' HD23 ' A' ' 110' ' ' LEU . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.09 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.619 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 4.7 p30 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.68 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.39 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' CE2' HG22 ' A' ' 165' ' ' THR . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 2.76 108.924 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 1.6 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 1.73 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.17 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.44 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.71 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 125' ' ' VAL . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 3.66 108.828 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 1.77 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 124' ' ' ILE . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.14 108.95 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 121' ' ' MET . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 1.83 108.44 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.558 ' O ' HG22 ' A' ' 132' ' ' VAL . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.42 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.07 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.05 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.644 ' O ' HG21 ' A' ' 135' ' ' THR . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 4.88 109.04 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 128' ' ' ILE . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 3.55 109.733 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.29 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 131' ' ' MET . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.42 108.395 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 2.5 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.55 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 5.59 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.06 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 3.91 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 149' ' ' VAL . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.64 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 4.99 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 1.57 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 4.73 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.07 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 2.93 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 1.77 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.34 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.509 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 3.53 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.18 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.794 HD22 ' H ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.49 109.503 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 163' ' ' LYS . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 2.83 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.45 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 165' ' ' THR . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 1.9 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.625 ' N ' HD13 ' A' ' 164' ' ' LEU . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 1.8 109.826 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.939 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.28 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 3.6 mm100 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 2.92 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.14 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.35 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.18 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 4.67 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 2.92 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.17 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.62 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.0 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 176' ' ' ASP . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 3.79 108.798 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.02 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.48 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 4.79 109.221 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.27 108.822 179.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.251 -0.648 . . . . 2.5 109.251 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.23 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.17 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 2.64 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 2.71 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.6 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.04 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.04 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.859 HG23 ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.0 111.111 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.859 ' H ' HG23 ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 2.94 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 3.98 109.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 17' ' ' THR . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.1 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 23' ' ' THR . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.44 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 3.85 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 3.75 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 5.2 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 2.74 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.06 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 2.92 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 3.92 110.863 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' HA2' ' A' ' 41' ' ' GLY . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.37 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 5.72 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 4.71 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.05 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 2.56 110.208 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' CD ' ' A' ' 79' ' ' ARG . 12.6 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.09 109.468 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 ' C ' ' A' ' 47' ' ' GLY . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 2.82 109.535 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 1.72 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.06 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.03 109.347 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 2.65 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.026 ' NE2' HG22 ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.8 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.4 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 2.99 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.31 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 3.63 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.23 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.18 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 6.44 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.28 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HB2' HG23 ' A' ' 136' ' ' VAL . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.17 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 3.59 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 4.4 112.749 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' THR . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.54 110.974 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.3 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.12 109.501 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 1.79 109.683 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 1.026 HG22 ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.04 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 2.31 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 64' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 1.71 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 4.33 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.75 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 110' ' ' LEU . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 1.91 110.608 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.065 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 2.75 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.3 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.34 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 2.85 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.19 108.773 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 1.76 108.661 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.4 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.27 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.35 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.22 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 1.9 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 2.63 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.065 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.56 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 85' ' ' PHE . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.17 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.01 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.2 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 2.75 109.475 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 8.35 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.29 109.584 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.18 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.22 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.12 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.579 HD11 HG11 ' A' ' 180' ' ' VAL . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.31 108.889 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 3.93 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 4.4 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.41 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 2.69 109.861 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.521 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.23 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 1.99 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.51 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 71' ' ' VAL . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.31 109.847 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.09 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.68 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.39 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 2.76 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 1.6 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 1.73 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.608 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.17 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.44 108.704 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.71 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 3.66 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 1.77 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ILE . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.14 109.953 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 1.83 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.42 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 144' ' ' THR . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.07 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.05 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 4.88 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 3.55 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.29 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 58' ' ' PHE . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.42 108.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 134' ' ' ASN . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 2.5 110.002 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.55 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.557 HD22 ' NH1' ' A' ' 148' ' ' ARG . 32.3 m120 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 5.59 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.06 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 3.91 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.64 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.557 ' NH1' HD22 ' A' ' 143' ' ' ASN . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 4.99 109.857 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 1.57 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 4.73 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.07 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 2.93 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 1.77 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.34 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 3.53 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.18 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.59 HD21 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.49 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.59 ' CG ' HD21 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 2.83 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.45 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 1.9 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 1.8 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.28 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 2.92 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 164' ' ' LEU . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.14 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.35 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.18 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 4.67 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 2.92 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.17 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.62 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.579 HG11 HD11 ' A' ' 101' ' ' LEU . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 3.79 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.02 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.48 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 4.79 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.27 109.367 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.633 -0.506 . . . . 2.5 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.23 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.17 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 2.64 108.715 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.71 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.6 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.04 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.04 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.76 HG21 HG11 ' A' ' 27' ' ' VAL . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.0 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 2.94 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 3.98 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.1 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 20' ' ' THR . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.44 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 3.85 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 3.75 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 5.2 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 2.74 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.06 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 2.92 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 3.92 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.37 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 5.72 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 4.71 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.05 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 2.56 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.09 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.519 HD21 ' C ' ' A' ' 47' ' ' GLY . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 2.82 109.662 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 1.72 110.079 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.06 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.03 109.253 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 2.65 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.8 108.83 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.4 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 2.99 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.47 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.31 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 3.63 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.23 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.18 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 6.44 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.28 112.926 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 135' ' ' THR . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.17 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 3.59 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 4.4 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 65' ' ' ALA . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.54 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.3 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.817 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.12 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 1.79 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.04 109.286 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.906 ' CZ ' HD11 ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 2.31 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 64' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 1.71 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.805 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 4.33 109.204 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' HD11 ' A' ' 110' ' ' LEU . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.75 110.917 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 1.91 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 2.75 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.597 HD21 ' CG ' ' A' ' 77' ' ' ASP . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.3 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.34 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.597 ' CG ' HD21 ' A' ' 75' ' ' ASN . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 2.85 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.19 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 1.76 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.4 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 86' ' ' ILE . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.27 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.35 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CE1' HD11 ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.22 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' GLN . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 1.9 110.278 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' ILE . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 2.63 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.56 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.936 HD11 ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.17 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.01 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.2 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 2.75 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 8.35 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.29 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.18 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.776 ' H ' HD12 ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.22 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.12 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.31 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 3.93 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 4.4 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.41 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' ' OD1' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 2.69 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.23 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 107' ' ' LEU . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 1.99 109.856 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.51 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' OD1' ' A' ' 70' ' ' ASN . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.31 110.06 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.09 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 36.8 t30 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.68 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.39 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 2.76 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 1.6 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 1.73 108.383 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.587 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.17 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.44 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.71 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 125' ' ' VAL . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 3.66 108.921 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 122' ' ' LEU . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 1.77 108.968 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.906 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.14 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 121' ' ' MET . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 1.83 107.937 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.42 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.07 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.05 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 4.88 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 3.55 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.29 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 58' ' ' PHE . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.436 ' N ' HG22 ' A' ' 135' ' ' THR . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.42 109.651 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 136' ' ' VAL . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 2.5 108.376 179.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.55 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 5.59 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.06 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 3.91 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.692 ' O ' HG22 ' A' ' 149' ' ' VAL . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.64 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 4.99 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 146' ' ' GLU . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 1.57 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 4.73 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.07 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 2.93 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 1.77 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.409 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.34 109.01 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 179' ' ' ILE . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 3.53 110.008 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' HH22 ' A' ' 118' ' ' ARG . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.18 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.731 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.49 109.689 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 2.83 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.45 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 1.9 105.773 177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 1.8 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.788 ' H ' HD12 ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.28 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 2.92 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.14 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.5 ' OE1' HD23 ' A' ' 166' ' ' LEU . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.35 110.138 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.18 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 4.67 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 2.92 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.17 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.62 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 ' SD ' ' A' ' 156' ' ' MET . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.0 109.035 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 3.79 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.02 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.494 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.48 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 4.79 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.27 109.467 179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.408 -0.59 . . . . 2.5 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.23 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.17 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 2.64 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 2.71 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.6 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.462 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.04 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HZ1' ' HG3' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.04 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.0 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 2.94 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 3.98 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.1 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 20' ' ' THR . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.44 109.423 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 3.85 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 3.75 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 5.2 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 2.74 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.06 108.429 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 2.92 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 3.92 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.37 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 5.72 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 4.71 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.05 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 2.56 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.404 HE22 ' CG ' ' A' ' 81' ' ' GLU . 52.4 tp60 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.09 109.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 2.82 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 1.72 109.986 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.06 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.03 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 2.65 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.8 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.4 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 2.99 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.31 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 3.63 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.23 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.18 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 6.44 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.28 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.17 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 3.59 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 4.4 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' THR . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.54 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.3 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.12 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 1.79 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 49' ' ' GLN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.04 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 2.31 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 1.71 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 4.33 109.041 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.75 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 1.91 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.663 ' N ' HG13 ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 2.75 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.3 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.34 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 2.85 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.19 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.603 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 1.76 108.22 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' CG ' HE22 ' A' ' 42' ' ' GLN . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.4 110.57 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.27 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.35 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.22 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 1.9 109.476 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.572 ' HG3' ' HZ1' ' A' ' 19' ' ' LYS . 51.2 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 2.63 110.486 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.56 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.641 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.17 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.01 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.2 108.453 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 2.75 108.631 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.604 ' OG ' ' CD2' ' A' ' 21' ' ' TYR . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' CG ' ' N ' ' A' ' 95' ' ' GLY . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 8.35 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.29 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.18 108.499 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.22 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.12 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.31 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 3.93 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 4.4 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.41 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 2.69 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.23 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 1.99 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.51 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.31 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.09 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.68 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.39 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 2.76 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.491 HG21 ' HE3' ' A' ' 121' ' ' MET . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 1.6 109.179 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 1.73 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.17 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.44 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.71 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 3.66 109.708 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 1.77 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 124' ' ' ILE . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.14 109.588 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 121' ' ' MET . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 1.83 107.346 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.42 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.07 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.05 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 4.88 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 132' ' ' VAL . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 3.55 108.798 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.29 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.42 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 2.5 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.55 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 5.59 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.06 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 3.91 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.64 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' ' 152' ' ' ILE . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 4.99 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 1.57 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 4.73 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 148' ' ' ARG . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.07 109.693 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 2.93 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 1.77 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.34 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 3.53 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.18 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.49 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 2.83 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.45 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 1.9 108.164 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.721 ' N ' HD13 ' A' ' 164' ' ' LEU . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 1.8 110.14 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 1.039 ' H ' HD23 ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.28 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 2.92 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 164' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.14 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.35 109.522 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.18 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 4.67 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 2.92 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.17 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.62 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.0 110.15 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 3.79 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.71 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 7.1 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.02 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.48 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.08 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 4.79 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.27 109.309 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.997 -0.742 . . . . 2.5 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.23 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.17 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.875 ' O ' HG23 ' A' ' 17' ' ' THR . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 2.64 109.791 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.563 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 2.71 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.6 108.514 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.04 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.04 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.0 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 2.94 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 3.98 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.1 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 20' ' ' THR . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.44 109.413 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 3.85 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 3.75 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 5.2 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 2.74 108.554 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.06 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 2.92 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 3.92 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.37 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 5.72 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 4.71 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.05 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 2.56 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.598 ' NE2' ' NH1' ' A' ' 79' ' ' ARG . 33.3 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.09 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 2.82 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 1.72 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.06 110.087 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.03 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 2.65 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 65.0 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.8 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.4 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.477 HG21 ' CZ ' ' A' ' 85' ' ' PHE . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 2.99 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.31 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.63 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.23 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.18 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 6.44 110.002 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.28 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.17 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 3.59 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 4.4 112.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.54 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.3 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 68' ' ' VAL . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.12 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 1.79 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.04 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 2.31 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 64' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 1.71 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 4.33 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.75 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 1.91 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 2.75 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 1.0 OUTLIER 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.3 109.559 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.34 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 2.85 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' NH1' ' NE2' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.19 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 1.76 107.745 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.4 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.27 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.35 109.529 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.22 109.828 -178.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.515 ' HA ' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 1.9 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 2.63 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.56 108.357 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 85' ' ' PHE . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.01 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.523 HG11 ' NE1' ' A' ' 103' ' ' TRP . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.2 109.159 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 2.75 109.135 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 8.35 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.29 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.18 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.22 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.12 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.31 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 3.93 110.849 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.523 ' NE1' HG11 ' A' ' 91' ' ' VAL . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 4.4 109.745 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.41 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 2.69 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.23 108.747 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 68' ' ' VAL . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 1.99 108.833 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.51 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 110' ' ' LEU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.31 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.09 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.68 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.39 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 165' ' ' THR . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 2.76 108.979 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 1.6 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 1.73 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.788 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.17 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.44 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.71 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 3.66 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' OD2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 1.77 109.258 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 67' ' ' PHE . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.14 109.967 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 121' ' ' MET . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 1.83 108.368 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 122' ' ' LEU . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.876 ' O ' HG22 ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.42 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.07 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.05 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 4.88 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 3.55 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.29 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.42 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.528 HD23 ' CD ' ' A' ' 142' ' ' GLU . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 2.5 108.434 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.55 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 181' ' ' GLN . 81.5 m-20 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 5.59 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.06 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 3.91 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.64 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.621 ' O ' HD13 ' A' ' 152' ' ' ILE . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 4.99 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' A' ' 153' ' ' PHE . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 1.57 108.894 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 4.73 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.07 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 2.93 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 1.77 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.34 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 3.53 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.18 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.49 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 2.83 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.45 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 1.9 108.145 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 115' ' ' TYR . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 1.8 109.44 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.28 110.027 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 2.92 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.14 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.35 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.18 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 4.67 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 2.92 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.17 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.62 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.0 109.99 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 3.79 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 143' ' ' ASN . 13.3 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.02 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.791 ' C ' HD12 ' A' ' 183' ' ' LEU . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.48 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 182' ' ' ALA . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 4.79 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.27 107.748 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.121 -0.696 . . . . 2.5 109.121 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.23 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.17 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' THR . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 2.64 108.401 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 2.71 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 13' ' ' VAL . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.6 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.04 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.04 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.0 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 2.94 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 3.98 109.092 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.1 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 20' ' ' THR . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.44 108.475 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 3.85 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 3.75 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 5.2 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 2.74 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.06 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 2.92 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 3.92 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.37 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 5.72 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 4.71 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.05 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 2.56 109.579 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.743 HE22 ' NH2' ' A' ' 79' ' ' ARG . 49.9 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.09 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 2.82 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 1.72 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.06 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.03 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 2.65 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.8 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.4 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.31 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 3.63 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.23 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.18 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 6.44 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.28 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.17 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 3.59 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 4.4 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.54 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.3 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.12 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 1.79 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.04 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 2.31 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 1.71 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 4.33 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.75 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' LEU . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 1.91 110.389 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.965 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 2.75 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.3 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.34 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 2.85 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.743 ' NH2' HE22 ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.19 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 1.76 107.875 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.4 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.27 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.35 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 51' ' ' ILE . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.22 109.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 1.9 109.923 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 2.63 109.767 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.965 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.56 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.17 108.579 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.01 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 87' ' ' GLN . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.2 109.036 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' ALA . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 2.75 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 8.35 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.29 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.18 108.727 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.22 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.12 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.31 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 3.93 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.473 ' CH2' HD13 ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 4.4 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.41 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 2.69 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.23 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.825 ' O ' HD23 ' A' ' 107' ' ' LEU . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 1.99 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.51 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 71' ' ' VAL . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.31 109.749 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.09 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.68 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.39 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 2.76 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 1.6 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HZ2' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 1.73 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.755 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.17 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.44 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.71 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.805 ' O ' HG23 ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 3.66 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 1.77 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 124' ' ' ILE . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.14 109.423 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 1.83 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 183' ' ' LEU . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.42 109.986 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.07 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.05 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 4.88 108.351 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 128' ' ' ILE . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 3.55 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.29 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 138' ' ' LEU . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.42 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 135' ' ' THR . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.826 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 2.5 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.55 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 5.59 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.06 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.697 ' HD3' HD22 ' A' ' 183' ' ' LEU . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 3.91 113.754 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE1' HG11 ' A' ' 125' ' ' VAL . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.64 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 4.99 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 1.57 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 4.73 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.07 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.678 ' CZ ' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 2.93 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 1.77 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.542 ' HA ' ' HZ3' ' A' ' 158' ' ' LYS . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.34 110.559 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 3.53 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.542 ' HZ3' ' HA ' ' A' ' 155' ' ' MET . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.18 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.762 ' ND2' ' H ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.49 109.581 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.638 ' N ' HD22 ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.762 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.651 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 2.83 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HZ2' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.45 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.678 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 1.9 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 1.8 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.28 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 2.92 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.14 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.35 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.496 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.18 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 4.67 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 2.92 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.17 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.62 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 172' ' ' GLY . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.0 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 173' ' ' SER . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 3.79 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.02 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.599 ' C ' HD23 ' A' ' 183' ' ' LEU . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.48 108.957 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 4.79 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.27 109.911 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.882 -0.784 . . . . 2.5 108.882 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.23 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.17 109.965 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 17' ' ' THR . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 2.64 109.232 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 2.71 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 13' ' ' VAL . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.6 108.086 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.04 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.04 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 16' ' ' LEU . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.0 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 2.94 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 3.98 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.1 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' GLN . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.44 109.43 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 27' ' ' VAL . 63.0 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 3.85 109.129 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.5 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 3.75 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 5.2 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 2.74 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.06 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 2.92 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 3.92 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.37 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 5.72 108.237 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 4.71 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.05 109.24 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 2.56 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.09 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 2.82 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 1.72 109.541 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.06 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.03 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 2.65 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.579 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 91.6 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.8 107.81 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.4 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 2.99 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.31 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 3.63 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.23 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.18 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 6.44 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.28 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 136' ' ' VAL . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.17 110.876 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 3.59 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.661 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 4.4 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.54 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.3 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.12 110.443 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 1.79 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.579 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.04 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 2.31 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 1.71 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 4.33 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.75 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 109' ' ' ASP . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 1.91 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 2.75 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CA ' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.3 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.34 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 2.85 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.19 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 1.76 106.893 178.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.4 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.27 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.35 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CE1' HD23 ' A' ' 89' ' ' LEU . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.22 110.645 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 1.9 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 2.63 110.556 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.56 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.17 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 86' ' ' ILE . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.01 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.2 108.243 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ALA . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 2.75 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.573 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 8.35 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.29 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.18 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.22 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.12 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.31 109.772 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 3.93 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 4.4 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.41 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 2.69 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 71' ' ' VAL . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.23 109.738 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 107' ' ' LEU . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 1.99 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.51 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG21 ' A' ' 71' ' ' VAL . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.31 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.09 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.68 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.39 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 2.76 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 1.6 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.575 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.17 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.44 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.71 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.651 ' O ' HG13 ' A' ' 125' ' ' VAL . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 3.66 109.085 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 1.77 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 124' ' ' ILE . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.14 110.998 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 1.83 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.42 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.07 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.05 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 4.88 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 3.55 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.29 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.42 108.961 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.508 ' H ' HG22 ' A' ' 135' ' ' THR . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 2.5 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.55 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 5.59 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.06 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 3.91 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.546 ' O ' HG22 ' A' ' 149' ' ' VAL . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.64 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 4.99 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 146' ' ' GLU . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 1.57 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 4.73 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.07 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.74 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 2.93 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 1.77 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.34 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 3.53 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.18 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.49 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 2.83 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.45 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.74 HD21 ' CD1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 1.9 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 1.8 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 1.085 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.28 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.625 ' N ' HD22 ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 2.92 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.14 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.35 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' HG22 ' A' ' 180' ' ' VAL . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.18 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 4.67 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 2.92 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.17 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.62 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.0 109.631 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 3.79 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.02 109.401 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.48 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 4.79 109.869 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.27 109.116 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.567 -0.531 . . . . 2.5 109.567 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.23 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.17 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 2.64 107.844 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 2.71 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 13' ' ' VAL . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.6 107.49 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.04 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.04 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.735 HG23 ' H ' ' A' ' 22' ' ' PHE . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.0 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.735 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 2.94 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 3.98 109.009 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.1 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' THR . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.44 109.314 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 3.85 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 3.75 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 5.2 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 2.74 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.06 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 2.92 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 3.92 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 35' ' ' ILE . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.37 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 5.72 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 4.71 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.05 110.199 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 2.56 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.09 109.167 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 47' ' ' GLY . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 2.82 109.522 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 1.72 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.06 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.03 109.739 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 2.65 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 87.3 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.8 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.4 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 ' HE1' ' A' ' 55' ' ' PHE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 2.99 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.31 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 3.63 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.663 ' NE2' ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.23 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.663 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.18 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 6.44 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.28 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.652 ' O ' HG22 ' A' ' 135' ' ' THR . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.17 109.979 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 3.59 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 4.4 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.54 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.3 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.12 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 1.79 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.04 108.919 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 2.31 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 64' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 1.71 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 4.33 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.75 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 110' ' ' LEU . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 1.91 111.137 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.901 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 2.75 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.3 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.34 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 2.85 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.19 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 1.76 108.32 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.4 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.27 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.35 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.681 ' CE1' HD23 ' A' ' 89' ' ' LEU . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.22 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 1.9 108.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 2.63 109.507 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.56 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.681 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.17 107.716 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.01 108.671 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.2 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 2.75 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 8.35 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.29 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.635 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.18 108.75 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.22 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.12 108.815 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.489 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.31 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 3.93 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 4.4 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.41 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.584 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 2.69 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.23 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 1.99 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.51 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.31 110.187 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.09 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.68 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.39 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 2.76 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 1.6 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 1.73 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.641 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.17 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.44 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.71 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 3.66 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 1.77 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.14 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 1.83 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 132' ' ' VAL . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.42 109.258 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.07 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.05 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 4.88 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.645 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 3.55 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 135' ' ' THR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.29 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.711 ' O ' HD23 ' A' ' 138' ' ' LEU . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.42 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 135' ' ' THR . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 2.5 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.55 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.621 ' CD ' HD21 ' A' ' 143' ' ' ASN . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.621 HD21 ' CD ' ' A' ' 141' ' ' GLU . 31.1 m120 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 5.59 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.06 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 3.91 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.64 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 4.99 110.285 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 1.57 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 4.73 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.07 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 2.93 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 1.77 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.34 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.57 ' CE ' HD11 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 3.53 109.34 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.18 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 161' ' ' ASP . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.49 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 2.83 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.45 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 1.9 107.605 178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.642 ' N ' HD13 ' A' ' 164' ' ' LEU . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 1.8 110.596 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD23 ' NE2' ' A' ' 170' ' ' GLN . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.28 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 2.92 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.14 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.589 ' NE2' HD23 ' A' ' 166' ' ' LEU . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.35 110.563 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.18 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 4.67 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 2.92 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.17 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.62 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 156' ' ' MET . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.0 108.835 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 3.79 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 180' ' ' VAL . 49.7 tp60 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.02 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.853 ' C ' HD13 ' A' ' 183' ' ' LEU . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.48 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.044 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 4.79 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t . . . . . 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.27 110.499 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.94 0.4 . . . . 2.5 110.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.23 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.64 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 2.71 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.6 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.04 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.04 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.0 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 20' ' ' THR . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 2.94 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 3.98 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CG ' HG21 ' A' ' 17' ' ' THR . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.1 110.269 -179.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 86' ' ' ILE . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.44 109.505 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 3.85 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 3.75 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 33' ' ' GLY . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 5.2 108.482 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 2.74 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.06 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 2.92 111.26 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 3.92 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.37 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 5.72 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 4.71 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' ILE . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.05 109.186 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 2.56 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.09 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 2.82 109.575 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 1.72 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.06 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.03 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 2.65 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.8 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.4 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HA ' HE21 ' A' ' 54' ' ' GLN . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 2.99 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.31 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 3.63 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.471 HE21 ' HA ' ' A' ' 51' ' ' ILE . 32.2 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.23 109.927 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.18 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 6.44 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.28 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.17 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 3.59 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 131' ' ' MET . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 4.4 112.325 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' THR . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.54 109.488 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 62' ' ' THR . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.3 109.234 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.751 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.12 109.349 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.79 109.303 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' THR . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.04 108.984 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.657 ' CE2' HD22 ' A' ' 110' ' ' LEU . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 2.31 108.877 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 64' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 1.71 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 4.33 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.75 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 1.91 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.614 ' N ' HG13 ' A' ' 71' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 2.75 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.3 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.34 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 2.85 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.19 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 1.76 108.337 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.4 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.27 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.35 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' CD ' ' OE1' ' A' ' 81' ' ' GLU . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.22 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 27' ' ' VAL . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 1.9 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 91' ' ' VAL . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 2.63 110.365 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.56 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.01 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLN . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.2 107.774 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 2.75 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.504 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 8.35 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.29 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.18 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.22 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.12 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.31 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 3.93 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 4.4 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 166' ' ' LEU . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 2.69 109.041 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.23 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 1.99 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 182' ' ' ALA . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.51 109.302 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 67' ' ' PHE . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.31 109.01 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.09 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.68 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.39 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 165' ' ' THR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 2.76 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 1.6 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 1.73 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.792 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.17 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.44 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.71 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 3.66 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 1.77 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 124' ' ' ILE . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.14 110.638 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 1.83 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 125' ' ' VAL . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 64' ' ' PHE . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.42 109.304 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.07 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.05 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 4.88 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 132' ' ' VAL . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 3.55 109.387 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.29 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 137' ' ' GLU . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.42 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.606 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 2.5 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.55 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 144' ' ' THR . 17.2 t-20 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 5.59 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.471 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.06 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG2' HG11 ' A' ' 125' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 3.91 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.64 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 4.99 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 149' ' ' VAL . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 1.57 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 4.73 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.07 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 2.93 109.04 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 1.77 108.088 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.34 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 3.53 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.18 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.711 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.49 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 2.83 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.45 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 1.9 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 115' ' ' TYR . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 1.8 109.601 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.28 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 2.92 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.14 110.202 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.35 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.18 109.498 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 4.67 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 2.92 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.17 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.62 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 169' ' ' PHE . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.0 109.73 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 3.79 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.02 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.48 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 4.79 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.27 109.356 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 2.5 109.429 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.23 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 16' ' ' LEU . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.17 109.021 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 2.64 109.604 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.586 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 2.71 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 17' ' ' THR . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.6 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.475 HH12 ' HB3' ' A' ' 14' ' ' GLU . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.04 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.04 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.0 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 2.94 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 3.98 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.1 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.44 108.885 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 3.85 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 3.75 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 5.2 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 2.74 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.06 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 2.92 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 3.92 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 41' ' ' GLY . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.37 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 5.72 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 4.71 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.05 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' H ' HD13 ' A' ' 35' ' ' ILE . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 2.56 110.462 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.09 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 2.82 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 1.72 108.726 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.06 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.03 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 2.65 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 62' ' ' THR . 35.7 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.8 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.4 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 2.99 108.88 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.31 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 3.63 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.23 110.842 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.18 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 6.44 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.28 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 136' ' ' VAL . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.17 109.684 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 3.59 109.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 4.4 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.499 ' HA ' HE21 ' A' ' 49' ' ' GLN . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.54 109.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.3 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 68' ' ' VAL . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.12 109.916 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 1.79 109.421 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.04 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 107' ' ' LEU . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 2.31 109.343 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 64' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 4.33 109.442 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.75 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 1.91 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.034 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 2.75 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.3 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.34 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 2.85 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.19 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 1.76 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.4 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.27 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.35 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.68 ' CE1' HD23 ' A' ' 89' ' ' LEU . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.22 109.947 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 1.9 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 2.63 110.167 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.034 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.68 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.17 109.098 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.01 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.2 108.571 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 2.75 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 8.35 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.29 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.18 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.22 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.12 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.31 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 3.93 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 4.4 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.41 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 2.69 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.23 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 ' CE1' ' A' ' 64' ' ' PHE . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 1.99 109.875 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.51 110.794 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 124' ' ' ILE . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.31 109.684 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.09 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.68 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.39 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.522 ' CE2' HG22 ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 2.76 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 1.6 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 1.73 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.648 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.17 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.44 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.71 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 3.66 109.669 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 122' ' ' LEU . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 1.77 109.425 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.14 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 121' ' ' MET . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 1.83 109.175 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 132' ' ' VAL . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.42 107.506 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.07 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.517 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.05 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 4.88 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 136' ' ' VAL . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 3.55 108.99 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.542 ' C ' HG22 ' A' ' 135' ' ' THR . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.29 108.695 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.542 HG22 ' C ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 132' ' ' VAL . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.42 109.898 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 2.5 108.084 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.55 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 13.8 m120 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 5.59 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.06 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 3.91 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.64 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 4.99 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 146' ' ' GLU . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 1.57 108.792 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 4.73 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.07 110.887 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 2.93 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 1.77 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.34 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 3.53 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.18 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.657 ' H ' ' HG3' ' A' ' 158' ' ' LYS . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.49 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 2.83 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.45 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 165' ' ' THR . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 1.9 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 164' ' ' LEU . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 1.8 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.28 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 2.92 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.14 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.35 110.076 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.18 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 4.67 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 2.92 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.17 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.62 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.0 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 3.79 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.02 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.562 ' O ' ' CD ' ' A' ' 145' ' ' PRO . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.48 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 4.79 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.27 109.263 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 120.781 0.324 . . . . 2.5 110.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.23 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.17 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 17' ' ' THR . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 2.64 109.168 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.63 ' O ' HG22 ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 2.71 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 13' ' ' VAL . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.6 107.335 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 HH11 ' HG1' ' A' ' 17' ' ' THR . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.04 108.607 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.04 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.0 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 27' ' ' VAL . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 2.94 108.012 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 3.98 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.1 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 22' ' ' PHE . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.44 109.42 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 27' ' ' VAL . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 3.85 109.711 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 3.75 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 5.2 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 2.74 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.06 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 2.92 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 3.92 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.37 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 5.72 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 4.71 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.05 109.326 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 2.56 109.212 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' NE2' ' CZ ' ' A' ' 79' ' ' ARG . 52.2 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.09 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 2.82 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 1.72 108.585 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.06 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.03 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 2.65 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 85.8 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.8 107.81 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.4 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 2.99 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.31 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 3.63 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.23 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.18 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 6.44 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.28 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.17 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 3.59 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 4.4 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 49' ' ' GLN . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.54 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.3 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 68' ' ' VAL . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.12 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 1.79 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.04 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 2.31 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 64' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 1.71 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 4.33 109.837 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.75 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 1.91 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.525 ' N ' HG13 ' A' ' 71' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 2.75 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.3 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.34 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 2.85 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.639 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.19 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.4 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.27 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.35 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.22 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 1.9 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 2.63 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.56 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD23 ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.17 107.808 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.01 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.622 HG11 ' NE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.2 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 2.75 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 8.35 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.29 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.18 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.22 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.12 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.31 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 3.93 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.622 ' NE1' HG11 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 4.4 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.41 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 2.69 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.23 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 1.99 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.51 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 67' ' ' PHE . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.31 109.795 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.09 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.68 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.39 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.623 ' CE1' HG22 ' A' ' 165' ' ' THR . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 2.76 109.514 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.6 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 163' ' ' LYS . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 1.73 108.021 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.17 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.44 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.71 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 3.66 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.77 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 124' ' ' ILE . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.14 109.327 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 145' ' ' PRO . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 1.83 108.058 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 132' ' ' VAL . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.42 109.374 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.07 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.05 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 4.88 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 128' ' ' ILE . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 3.55 109.856 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.29 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.42 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 2.5 109.583 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.55 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 139' ' ' PRO . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 5.59 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.06 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.702 ' HG2' HG22 ' A' ' 125' ' ' VAL . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 3.91 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.554 ' OE1' HG11 ' A' ' 125' ' ' VAL . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.64 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.764 ' O ' HD13 ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 4.99 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 1.57 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 4.73 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.764 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.07 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.792 ' CZ ' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 2.93 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 1.77 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.34 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 3.53 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.18 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.49 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 2.83 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 117' ' ' THR . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.45 109.023 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.792 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 1.9 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 115' ' ' TYR . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 1.8 108.927 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.568 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.28 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 2.92 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.14 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.35 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.18 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 4.67 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 2.92 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.17 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.62 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.0 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 3.79 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.02 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.48 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.988 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 4.79 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.27 109.945 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.605 -0.517 . . . . 2.5 109.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.23 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.17 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 17' ' ' THR . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 2.64 109.398 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' OG1' ' A' ' 20' ' ' THR . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 2.71 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.6 108.117 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.04 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.04 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.511 ' OG1' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.0 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 2.94 109.027 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 3.98 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.1 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 HD11 ' A' ' 86' ' ' ILE . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.44 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 3.85 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 3.75 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 5.2 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HD11 ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 2.74 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.06 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 2.92 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' TYR . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 3.92 111.3 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.37 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 5.72 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 4.71 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.05 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 2.56 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.09 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 2.82 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 1.72 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.06 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.03 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 2.65 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.8 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.4 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 2.99 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.474 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.31 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 3.63 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 54' ' ' GLN . 0.8 OUTLIER -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.23 109.803 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.18 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.541 ' HA ' HG11 ' A' ' 136' ' ' VAL . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 6.44 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.28 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.17 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 3.59 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 4.4 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.54 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.3 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 107' ' ' LEU . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.12 110.833 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 1.79 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.04 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 2.31 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 1.71 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 4.33 109.538 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.53 HD22 HD11 ' A' ' 110' ' ' LEU . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.75 110.444 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 1.91 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.61 ' N ' HG13 ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 2.75 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.489 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.3 109.576 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.34 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 2.85 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.19 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 1.76 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.4 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.27 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.35 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HE1' HD13 ' A' ' 89' ' ' LEU . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.22 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 HG23 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 1.9 109.957 -178.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.3 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 2.63 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.56 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 85' ' ' PHE . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.17 108.611 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.01 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 87' ' ' GLN . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.2 107.336 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 2.75 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 8.35 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 21' ' ' TYR . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.29 110.306 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.18 109.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.22 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.12 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.31 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 3.93 109.611 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 4.4 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.41 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 2.69 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.23 109.44 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 64' ' ' PHE . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 1.99 109.992 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.51 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 70' ' ' ASN . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.31 109.25 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.09 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.68 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.39 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 2.76 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 1.6 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 1.73 108.307 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.17 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.44 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 109' ' ' ASP . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.71 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 3.66 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 122' ' ' LEU . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 1.77 109.533 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 124' ' ' ILE . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.14 110.392 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 1.83 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.596 ' O ' HG23 ' A' ' 132' ' ' VAL . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.42 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.07 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 32.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.05 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 4.88 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' ILE . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 3.55 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.494 ' O ' HD21 ' A' ' 138' ' ' LEU . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.29 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.42 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 2.5 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.55 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 5.59 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.8 ' O ' HG23 ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.06 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 3.91 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.64 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.68 ' HG2' HD12 ' A' ' 152' ' ' ILE . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 4.99 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 1.57 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 4.73 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 148' ' ' ARG . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.07 110.032 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.785 ' CD1' HD21 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 2.93 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 1.77 107.633 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.34 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.564 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 3.53 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.18 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.544 HD21 ' CE ' ' A' ' 156' ' ' MET . 17.9 m120 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.49 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 2.83 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.45 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 1.9 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 1.8 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.28 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 2.92 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 168' ' ' GLU . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.14 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.35 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.18 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 4.67 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 2.92 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.17 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.62 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.0 109.669 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 180' ' ' VAL . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 3.79 108.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.02 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.48 109.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 4.79 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.27 109.919 -179.445 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.436 -0.579 . . . . 2.5 109.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.23 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.17 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.669 HG13 ' CD ' ' A' ' 24' ' ' GLU . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 2.64 109.698 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 2.71 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.6 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.04 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.04 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.0 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 2.94 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 3.98 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.669 ' CD ' HG13 ' A' ' 13' ' ' VAL . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.1 109.513 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.64 HG13 ' CD1' ' A' ' 86' ' ' ILE . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.44 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 3.85 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 3.75 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 5.2 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 2.74 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.06 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 2.92 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 3.92 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.37 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 5.72 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 4.71 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.05 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 2.56 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.581 HE21 ' C ' ' A' ' 43' ' ' LEU . 3.9 tm0? -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.09 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.581 ' C ' HE21 ' A' ' 42' ' ' GLN . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 2.82 110.089 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' NE2' ' A' ' 42' ' ' GLN . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 1.72 109.345 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.06 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.03 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 2.65 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.8 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.4 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 2.99 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.451 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.31 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 3.63 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.23 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.18 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 6.44 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.28 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 136' ' ' VAL . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.17 109.188 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 3.59 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 4.4 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.54 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.3 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.563 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.12 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 1.79 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.04 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 110' ' ' LEU . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 2.31 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 1.71 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 4.33 109.846 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.75 110.745 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 1.91 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.985 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 2.75 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.3 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.34 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 2.85 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.19 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 1.76 108.267 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.4 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.27 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.35 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.22 110.1 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.64 ' CD1' HG13 ' A' ' 27' ' ' VAL . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 1.9 109.502 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 2.63 109.888 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.985 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.56 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.17 108.76 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.01 109.277 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 2.75 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 8.35 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.29 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.18 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 180' ' ' VAL . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.22 109.096 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.12 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.31 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 3.93 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.601 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 4.4 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.41 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' HD11 ' A' ' 116' ' ' ILE . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 2.69 110.196 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.23 109.206 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.601 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 1.99 110.478 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.51 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.31 109.243 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.09 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.68 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.39 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 2.76 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 105' ' ' PHE . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 1.6 108.724 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 1.73 108.86 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.74 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.17 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.44 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.71 109.188 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 3.66 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 1.77 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.14 109.64 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 1.83 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.42 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HG12 ' A' ' 132' ' ' VAL . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.07 110.428 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.05 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 4.88 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 3.55 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 40.4 t30 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.29 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 136' ' ' VAL . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.42 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 135' ' ' THR . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 2.5 109.798 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.55 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.639 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.679 ' HB3' HD22 ' A' ' 183' ' ' LEU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 5.59 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.451 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.06 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 3.91 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.64 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 4.99 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 1.57 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 4.73 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.07 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 2.93 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 1.77 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.34 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 3.53 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.18 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.732 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.49 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 2.83 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.45 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 168' ' ' GLU . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 1.9 108.158 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 1.8 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 166' ' ' LEU . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.28 110.196 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 2.92 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 164' ' ' LEU . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.14 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.436 HE22 ' HG ' ' A' ' 101' ' ' LEU . 87.3 mm-40 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.35 109.991 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.18 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 4.67 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 2.92 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.17 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.62 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 180' ' ' VAL . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.0 109.661 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.605 ' N ' HG22 ' A' ' 179' ' ' ILE . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 3.79 111.759 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.02 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.48 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 4.79 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.27 109.738 -179.895 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.536 -0.542 . . . . 2.5 109.536 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.23 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.17 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 2.64 108.16 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 2.71 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.6 107.641 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.04 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.04 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.598 HG21 ' CG1' ' A' ' 27' ' ' VAL . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.0 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 2.94 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 3.98 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.1 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' CG1' HG21 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.44 109.357 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 3.85 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 3.75 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 5.2 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 2.74 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.06 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 2.92 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 3.92 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.37 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 5.72 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 4.71 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.05 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 2.56 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.09 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 2.82 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.551 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 1.72 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.06 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.03 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 2.65 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.591 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 99.1 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.8 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.4 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 2.99 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.31 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 3.63 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.23 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.18 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 6.44 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.28 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.17 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 3.59 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 4.4 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.54 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.3 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.12 109.965 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 1.79 109.754 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.591 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.04 109.535 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 2.31 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 1.71 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 4.33 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.75 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 1.91 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.999 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 2.75 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.3 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.34 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 2.85 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.19 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.76 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.4 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.27 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.35 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.616 ' CE1' HD13 ' A' ' 89' ' ' LEU . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.22 109.307 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 1.9 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 2.63 110.114 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.999 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.56 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD13 ' CE1' ' A' ' 85' ' ' PHE . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.17 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.01 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.2 109.624 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 88' ' ' ALA . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 2.75 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.493 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 8.35 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.29 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.18 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.22 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.12 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.31 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 3.93 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 4.4 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.41 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 2.69 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.23 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 1.99 110.037 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.408 ' CZ ' ' HG2' ' A' ' 121' ' ' MET . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.51 109.78 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.31 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.09 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 15.0 p30 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.68 109.36 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.39 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 2.76 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 1.6 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 1.73 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.17 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.44 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.71 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 3.66 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 1.77 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 124' ' ' ILE . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.14 108.562 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 121' ' ' MET . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 1.83 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.42 109.396 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.07 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.05 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 131' ' ' MET . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 4.88 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 3.55 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 133' ' ' GLY . 8.6 p30 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.29 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.42 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 2.5 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' HD22 ' A' ' 143' ' ' ASN . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.55 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.452 HD22 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 5.59 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.06 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.644 ' CG ' HD12 ' A' ' 183' ' ' LEU . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 3.91 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' O ' HG22 ' A' ' 149' ' ' VAL . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.64 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 4.99 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 1.57 108.697 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.664 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 4.73 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.07 110.588 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.806 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 2.93 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 1.77 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.34 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 3.53 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.684 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.18 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.684 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.49 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 2.83 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.45 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.806 HD21 ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 1.9 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.8 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.28 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 2.92 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.14 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.544 ' C ' ' NE2' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.35 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.18 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 4.67 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 2.92 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 176' ' ' ASP . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.17 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.479 ' H ' ' HG3' ' A' ' 181' ' ' GLN . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.62 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.0 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 3.79 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.02 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.48 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 4.79 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.27 109.398 179.598 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.756 -0.461 . . . . 2.5 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.23 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' H ' HG13 ' A' ' 12' ' ' VAL . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.17 108.373 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 2.64 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.71 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.6 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.04 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.689 ' NZ ' HE22 ' A' ' 87' ' ' GLN . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.04 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 96' ' ' THR . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.0 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 2.94 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 3.98 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.1 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 20' ' ' THR . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.44 110.303 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 3.85 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 3.75 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 5.2 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 2.74 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.06 108.945 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 2.92 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 3.92 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.37 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 5.72 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 4.71 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.05 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 2.56 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.09 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.82 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 1.72 109.415 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.06 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.03 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 2.65 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.8 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.4 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 52' ' ' TYR . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 2.99 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.31 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 3.63 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.23 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.18 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 6.44 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.28 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.17 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 3.59 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 4.4 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.54 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.3 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.12 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 1.79 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.04 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.603 ' O ' HG22 ' A' ' 71' ' ' VAL . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 2.31 109.9 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 1.71 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 4.33 109.461 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.75 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 1.91 110.519 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.994 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 2.75 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.3 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.34 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 2.85 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.19 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 1.76 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.4 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.27 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.35 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.22 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 1.9 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.689 HE22 ' NZ ' ' A' ' 19' ' ' LYS . 58.4 tp60 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 2.63 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.994 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.56 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.17 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.01 108.437 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NE1' ' A' ' 103' ' ' TRP . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.2 109.466 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 88' ' ' ALA . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 2.75 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' THR . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 21' ' ' TYR . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 8.35 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.29 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 21' ' ' TYR . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.18 109.207 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.22 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.12 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.31 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.506 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 3.93 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.538 ' NE1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 4.4 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.41 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 2.69 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.23 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 1.99 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.51 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.715 ' C ' HD23 ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.31 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.09 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.68 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.39 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 2.76 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.473 HG22 ' HE3' ' A' ' 121' ' ' MET . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 1.6 109.127 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 1.73 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.694 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.17 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.44 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.71 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 3.66 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 122' ' ' LEU . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 1.77 109.828 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.14 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 121' ' ' MET . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 1.83 108.114 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.42 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.07 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.05 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 4.88 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 3.55 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.29 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.42 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 2.5 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.55 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 5.59 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.06 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 149' ' ' VAL . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 3.91 113.207 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.64 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 4.99 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.57 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 4.73 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.07 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.937 ' CE2' HD13 ' A' ' 164' ' ' LEU . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 2.93 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 1.77 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.34 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 3.53 109.4 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.18 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.724 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.49 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 2.83 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.45 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 1.9 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 1.8 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.28 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 2.92 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.14 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.506 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.35 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.18 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 4.67 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 2.92 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.17 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.62 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 172' ' ' GLY . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.0 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 3.79 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.02 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CD2' ' A' ' 183' ' ' LEU . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.48 108.853 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.928 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 4.79 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 4.4 p . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.432 -0.581 . . . . 15.48 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.608 ' O ' ' ND2' ' A' ' 5' ' ' ASN . . . 89.24 -57.02 3.95 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.674 -1.37 . . . . 11.71 109.674 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -57.74 -29.56 64.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -1.218 . . . . 12.65 109.705 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.8 p -59.4 -22.73 61.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 8.16 110.054 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -82.55 8.9 10.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.015 -1.053 . . . . 7.63 109.737 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.569 ' N ' HD22 ' A' ' 5' ' ' ASN . 29.4 t -108.76 149.78 28.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 5.22 109.7 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' SER . 54.0 mttm 56.26 156.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 4.94 109.911 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.664 HD13 ' CG2' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -76.68 156.9 32.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 2.2 109.146 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.0 mtmp? -60.71 147.64 83.82 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 2.5 109.448 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.67 -32.29 15.03 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.585 2.19 . . . . 3.23 112.916 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.08 -44.81 94.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.054 -1.029 . . . . 3.91 109.929 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -29.37 36.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 C-N-CA 119.005 -1.078 . . . . 2.17 109.381 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.807 ' O ' HG23 ' A' ' 17' ' ' THR . 72.0 t -65.24 -43.17 95.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.617 -1.233 . . . . 2.64 108.11 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.601 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.59 -48.66 78.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.056 -0.72 . . . . 4.15 109.056 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 84.5 tt0 -68.22 -33.09 73.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.998 -1.064 . . . . 3.01 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' O ' ' OG1' ' A' ' 20' ' ' THR . 62.7 tp -68.83 -41.14 78.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.261 -0.899 . . . . 2.71 108.735 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 13' ' ' VAL . 80.6 p -64.59 -31.24 72.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.877 -0.729 . . . . 3.6 109.245 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.601 ' NE ' ' OE2' ' A' ' 14' ' ' GLU . 93.5 mtt-85 -50.14 -33.66 19.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.489 -1.3 . . . . 5.04 107.489 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.5 ptmm? -134.17 112.17 10.89 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.123 -1.066 . . . . 5.04 108.123 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.8 m -168.2 -27.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.899 -1.126 . . . . 2.89 110.66 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 65.15 -9.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.277 -1.009 . . . . 6.0 108.277 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.623 ' H ' ' C ' ' A' ' 20' ' ' THR . 1.6 m-85 -117.76 164.74 14.54 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.518 -1.29 . . . . 2.94 107.518 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.4 p -85.33 164.21 18.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.801 -1.187 . . . . 3.98 110.079 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.563 ' OE2' HG11 ' A' ' 13' ' ' VAL . 84.7 tt0 -62.1 -38.13 87.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.718 -0.614 . . . . 4.23 110.226 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 12.2 mptt -60.6 -40.8 93.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.952 . . . . 5.1 109.771 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 98.3 mt-10 -64.64 -39.47 93.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.029 -1.044 . . . . 3.8 110.184 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 86' ' ' ILE . 74.2 t -68.91 -46.65 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.069 -1.019 . . . . 2.44 110.097 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.71 -41.48 98.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.025 -1.047 . . . . 3.85 109.858 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.08 -39.14 93.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.958 -1.089 . . . . 3.75 109.147 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.566 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -68.66 -46.35 69.34 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 5.2 108.56 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 35' ' ' ILE . 53.3 t80 -59.96 -56.86 16.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.727 . . . . 2.74 109.378 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 17.7 tttm -63.78 -29.51 70.71 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 5.06 108.89 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.3 -70.19 1.05 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.738 -0.744 . . . . 2.92 111.314 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 36.5 p90 -76.82 -23.43 52.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.776 -1.426 . . . . 3.92 111.398 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.3 mm -55.79 -42.62 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.691 -1.256 . . . . 3.57 109.757 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 32' ' ' LYS . 32.0 mtmm -59.48 -45.92 90.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.843 -1.161 . . . . 6.37 109.469 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 7.82 108.697 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.65 84.57 50.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 5.72 108.793 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -48.36 -30.83 16.13 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.381 2.054 . . . . 4.71 112.122 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -60.28 -35.96 76.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 5.05 109.02 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.37 -0.28 74.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.408 -1.477 . . . . 2.56 109.408 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.453 HE21 ' HB2' ' A' ' 79' ' ' ARG . 63.6 tt0 -103.68 119.5 39.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 3.09 109.204 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.85 139.8 33.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 2.82 109.687 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.573 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 75.8 m-20 -74.34 175.34 7.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.451 -0.781 . . . . 2.91 109.121 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -59.05 -39.44 82.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.256 -0.902 . . . . 1.72 109.197 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.49 96.21 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 2.06 109.248 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.7 94.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.334 -1.506 . . . . 2.03 109.334 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' CE2' ' A' ' 72' ' ' PHE . 51.5 t80 -61.64 -37.29 83.44 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.204 -1.174 . . . . 2.65 108.531 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 56.3 mt-30 -65.43 -36.59 84.39 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.911 -1.118 . . . . 2.8 108.928 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -63.81 -51.58 64.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 3.4 110.566 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.4 pp -63.09 -39.3 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.799 -1.188 . . . . 2.99 108.606 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.712 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 t80 -62.57 -37.83 87.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.874 -1.158 . . . . 5.31 107.874 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.99 -40.57 89.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.531 -0.914 . . . . 3.63 108.531 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -60.2 -42.0 94.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.367 -0.833 . . . . 4.23 108.939 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.2 m-85 -71.81 -31.78 66.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.126 -1.064 . . . . 4.18 108.126 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 136' ' ' VAL . 51.7 m-85 -132.01 71.2 80.34 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.445 -0.784 . . . . 6.44 109.85 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.31 -21.69 19.71 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.967 2.445 . . . . 4.28 113.287 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 92.5 m-85 -77.48 8.64 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.849 -1.157 . . . . 4.17 109.832 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.77 -175.95 47.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.087 -1.605 . . . . 3.59 109.087 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -155.49 -64.46 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.241 . . . . 5.63 109.899 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -55.34 -22.06 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.282 1.988 . . . . 4.4 112.169 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 57.34 -3.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 3.54 109.801 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' PRO . 45.7 mtpt -58.13 -37.06 73.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 3.3 109.196 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.671 ' O ' HG23 ' A' ' 68' ' ' VAL . 51.3 p90 -68.08 -34.58 76.69 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.407 -0.808 . . . . 2.12 109.374 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -54.4 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.284 -0.885 . . . . 1.79 109.716 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OE1' ' A' ' 49' ' ' GLN . 36.8 m -62.26 -38.13 88.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 2.04 109.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD2' HD23 ' A' ' 110' ' ' LEU . 3.5 m-30 -57.31 -47.99 80.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.843 . . . . 2.31 109.177 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 64' ' ' PHE . 58.9 t -58.68 -52.68 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.002 -1.11 . . . . 1.71 108.002 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -52.87 -40.26 63.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.781 . . . . 4.33 109.462 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -58.94 -42.92 90.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 2.75 110.648 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 110' ' ' LEU . 34.6 m -108.71 3.11 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.034 . . . . 1.91 110.694 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' VAL . 82.7 t80 -100.24 -4.48 29.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 2.75 109.842 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.8 t0 -88.8 115.77 26.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 2.3 109.195 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' OE2' ' CH2' ' A' ' 103' ' ' TRP . 76.0 mm-40 -65.54 -38.04 88.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.146 -0.971 . . . . 5.3 110.526 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 14.3 m120 -89.83 -3.76 57.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.948 -1.095 . . . . 3.3 109.784 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 75' ' ' ASN . 41.8 mtpt 45.94 33.16 1.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.094 -1.004 . . . . 5.34 108.792 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 73' ' ' ASP . 24.8 p-10 -88.59 2.98 52.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 3.11 109.836 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.75 7.23 81.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.97 -1.252 . . . . 2.85 109.97 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 79.8 mtp180 -145.5 145.1 30.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.238 . . . . 4.19 109.651 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -93.29 133.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.115 -1.439 . . . . 1.76 107.115 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -95.96 161.12 14.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.996 -1.065 . . . . 2.4 111.249 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -56.14 -50.51 70.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.652 -0.655 . . . . 3.27 109.677 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.407 ' HB2' HE21 ' A' ' 87' ' ' GLN . 85.1 p -61.5 -38.17 86.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.015 -1.053 . . . . 2.35 109.462 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -71.16 -41.13 70.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 2.09 110.327 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 89' ' ' LEU . 1.5 t80 -68.6 -53.92 19.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 2.22 110.61 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -63.31 -47.03 93.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.888 -1.132 . . . . 1.9 109.739 -178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.427 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 52.1 mt-30 -68.03 -47.25 68.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.584 -1.323 . . . . 2.63 110.403 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -65.08 -39.88 93.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 1.56 109.292 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.501 HD13 ' HE1' ' A' ' 85' ' ' PHE . 18.4 tp -59.8 -41.68 91.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.336 -0.853 . . . . 2.17 108.714 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -63.0 -39.81 95.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 2.01 109.015 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG11 ' HE1' ' A' ' 103' ' ' TRP . 71.1 t -64.06 -37.41 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 107.919 -1.141 . . . . 2.2 107.919 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -37.2 83.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.307 -0.627 . . . . 2.75 109.307 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 m -56.72 -48.01 78.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.958 -1.089 . . . . 3.47 109.362 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 172.21 71.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.032 -0.729 . . . . 8.35 109.032 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.1 -169.65 34.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.536 -1.426 . . . . 3.29 109.536 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -62.74 149.89 42.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.207 -1.173 . . . . 3.18 108.979 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.48 -36.41 44.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.276 -0.89 . . . . 4.22 108.987 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.28 -39.93 78.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 3.59 109.896 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.33 -48.46 61.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.047 -1.033 . . . . 3.04 109.728 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -60.75 -41.61 95.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 3.12 109.249 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 tp -62.31 -40.14 95.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 2.31 109.386 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -61.69 -43.89 97.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 3.93 109.444 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.757 ' HE1' HG11 ' A' ' 91' ' ' VAL . 89.0 m95 -61.8 -35.07 77.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.169 -0.957 . . . . 4.4 108.835 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.41 79.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.855 . . . . 1.41 109.831 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 37.5 m-85 -61.69 -43.34 99.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.017 -1.052 . . . . 2.69 110.035 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -57.23 -45.85 83.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.033 -1.042 . . . . 3.23 109.375 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD13 HG22 ' A' ' 68' ' ' VAL . 47.8 tp -72.07 -39.45 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.198 -0.939 . . . . 1.99 109.92 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -56.59 -30.99 63.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.423 -0.798 . . . . 2.51 110.437 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.45 ' OD1' ' OE1' ' A' ' 120' ' ' GLU . 53.8 t0 -119.75 120.22 35.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -0.931 . . . . 1.8 108.675 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 110' ' ' LEU . 1.2 tm? -60.7 -51.68 68.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.496 -0.752 . . . . 3.31 110.228 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 112' ' ' ASN . 19.9 p-10 -95.29 2.0 54.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.926 -1.109 . . . . 2.09 110.458 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 111' ' ' ASP . 4.4 p30 11.73 57.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.483 0.658 . . . . 3.68 111.722 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' ASP . 30.5 p-10 -82.56 14.8 2.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 2.51 109.239 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 -13.23 55.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.069 -1.612 . . . . 2.39 109.069 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 165' ' ' THR . 3.6 m-85 -126.41 137.37 53.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.988 . . . . 2.76 109.257 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -115.77 139.99 39.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.013 -0.736 . . . . 1.6 109.013 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 p -117.73 159.51 22.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.839 -1.171 . . . . 1.73 107.839 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.61 HH22 ' CB ' ' A' ' 157' ' ' ASP . 16.4 mmt-85 -62.55 -39.79 94.75 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.131 . . . . 3.17 110.134 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.21 -40.12 73.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.856 -1.153 . . . . 2.44 108.924 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 97.3 mt-10 -68.97 -40.03 79.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.224 -0.923 . . . . 1.71 109.081 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.635 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.7 ttp -63.4 -44.53 94.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 3.66 109.563 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.73 -40.74 84.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 1.77 109.343 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.0 -46.76 89.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 2.01 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 34.6 mm -68.19 -40.52 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 1.14 109.846 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 121' ' ' MET . 54.3 t -57.71 -48.37 83.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.933 -1.105 . . . . 1.83 108.147 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -61.32 -36.1 79.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.389 -0.82 . . . . 2.16 109.213 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.25 68.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 1.78 109.803 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 128' ' ' ILE . 13.0 pt -73.57 -27.84 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.965 -1.084 . . . . 2.42 109.46 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.501 ' CE2' HG21 ' A' ' 144' ' ' THR . 3.1 t80 -65.6 -47.91 74.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 5.07 108.614 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.06 -43.42 98.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 3.05 108.82 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.615 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 62.6 ttp -64.46 -39.46 93.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.489 -0.93 . . . . 4.88 108.489 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 132' ' ' VAL . 75.1 t -86.78 -0.16 6.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.273 -0.64 . . . . 3.55 109.273 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.28 -157.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.997 -1.641 . . . . 3.52 108.997 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 28.4 m120 43.06 -124.12 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -1.152 . . . . 4.29 109.264 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 136' ' ' VAL . 11.4 p -147.19 25.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.082 -1.011 . . . . 3.68 110.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 137' ' ' GLU . 9.5 p -44.28 -43.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.776 -1.203 . . . . 5.42 109.72 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.572 ' N ' HG13 ' A' ' 136' ' ' VAL . 1.5 mm-40 164.83 48.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.379 -0.971 . . . . 5.6 108.379 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' N ' HD23 ' A' ' 138' ' ' LEU . 1.5 pt? -68.91 147.14 97.79 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.842 -1.161 . . . . 2.5 109.751 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 140' ' ' GLU . 55.6 Cg_endo -69.92 134.81 28.53 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.602 2.201 . . . . 3.55 112.487 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 139' ' ' PRO . 14.3 tt0 35.56 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.802 -0.561 . . . . 5.65 109.551 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 140' ' ' GLU . 97.3 mt-10 -66.9 -38.08 85.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.038 . . . . 6.82 109.768 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -175.51 65.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.425 -0.797 . . . . 6.56 109.322 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 144' ' ' THR . 51.0 t30 -66.08 -28.07 68.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 5.59 109.858 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.501 HG21 ' CE2' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -41.1 111.09 0.78 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 3.06 109.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 183' ' ' LEU . 72.1 Cg_endo -80.0 86.35 1.68 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.255 1.97 . . . . 3.91 113.137 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -92.46 -75.31 0.49 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.766 -0.828 . . . . 3.87 108.766 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -58.64 -31.84 68.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.022 -1.049 . . . . 3.64 108.426 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -56.36 -45.67 80.38 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 4.99 109.951 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.0 m -71.71 -34.99 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.871 -1.143 . . . . 1.57 109.263 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 91.7 m-20 -54.09 -49.55 68.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.556 -1.34 . . . . 2.71 109.25 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -79.35 -50.02 11.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.181 -0.95 . . . . 4.73 110.205 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.64 -53.95 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 2.07 110.833 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -69.32 -40.23 77.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.248 . . . . 2.93 109.803 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.56 -36.64 56.19 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.549 -1.261 . . . . 1.77 107.702 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.7 ttp -70.26 -38.47 75.12 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.4 0.619 . . . . 2.34 109.905 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.9 ttt -73.61 -31.07 63.36 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.971 -1.081 . . . . 3.53 111.369 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CB ' HH22 ' A' ' 118' ' ' ARG . 57.4 t0 -86.19 6.35 29.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.828 -1.17 . . . . 2.4 111.422 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 160' ' ' ALA . 54.9 mtmt -59.26 -27.09 65.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.819 -1.175 . . . . 4.18 109.996 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.717 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -39.14 -23.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.731 -0.605 . . . . 2.49 109.701 -179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 90.79 16.67 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.02 -0.425 . . . . 3.15 110.58 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.694 ' N ' ' ND2' ' A' ' 159' ' ' ASN . 81.5 m-20 -55.52 -35.36 65.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.842 -1.161 . . . . 3.4 108.973 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.49 -14.04 59.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.936 -1.666 . . . . 2.83 108.936 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -152.58 -179.94 8.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -1.045 . . . . 2.45 109.496 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.865 HD11 ' CD1' ' A' ' 153' ' ' PHE . 7.1 tp -109.7 124.65 51.58 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.943 -1.503 . . . . 1.9 106.943 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 115' ' ' TYR . 39.6 m -122.11 152.19 40.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.075 -1.016 . . . . 1.8 110.599 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.1 mp -52.8 -26.89 15.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.691 -0.631 . . . . 2.28 110.639 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -53.73 -48.71 69.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.287 -1.508 . . . . 2.92 108.73 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.28 -37.56 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 1.85 109.614 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -64.35 -58.38 6.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.453 -0.779 . . . . 2.14 109.922 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -63.66 -44.66 93.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.363 -0.836 . . . . 2.35 110.559 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -66.76 -42.67 85.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.76 -1.213 . . . . 2.92 109.376 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -68.82 -37.93 84.63 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 1.77 109.101 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.9 p -61.57 -35.31 77.44 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.444 -1.033 . . . . 2.18 109.611 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -94.14 -9.89 35.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 4.67 109.58 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.39 -52.09 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.92 109.552 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 177' ' ' PRO . 14.3 m-20 -118.45 90.02 37.93 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.504 -0.747 . . . . 2.61 109.253 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 80.3 Cg_exo -45.19 -179.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.503 2.136 . . . . 2.17 112.418 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.2 p 82.33 -30.88 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.594 -0.691 . . . . 2.62 109.381 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 172' ' ' GLY . 93.5 mt -61.43 -37.72 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 2.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 182' ' ' ALA . 16.1 m -114.79 9.09 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 3.79 110.89 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.484 ' OE1' ' O ' ' A' ' 178' ' ' SER . 8.8 pt20 -46.64 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.664 -1.272 . . . . 6.02 109.033 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -64.96 146.62 54.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.007 -1.058 . . . . 4.48 109.48 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.876 ' N ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.7 -1.13 17.78 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.708 -0.849 . . . . 4.79 108.708 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m -63.51 161.59 14.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 5.27 109.686 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 185' ' ' LEU . 6.0 mp -90.21 137.17 32.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 7.1 109.032 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -96.84 132.61 42.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 9.88 109.687 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.73 -39.02 83.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.338 -0.851 . . . . 8.42 110.028 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.95 -179.89 46.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.795 -1.322 . . . . 9.13 109.795 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.1 -3.55 58.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -1.126 . . . . 11.72 109.395 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 12.62 109.389 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.292 -0.633 . . . . 15.48 109.292 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.22 48.37 1.94 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.137 -1.585 . . . . 11.71 109.137 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 57.83 34.29 24.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.558 -0.966 . . . . 12.65 109.162 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m -129.38 151.81 49.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.006 -0.739 . . . . 8.16 109.006 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 t30 58.84 53.68 5.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 7.63 109.242 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 p -57.15 163.24 2.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 5.22 109.725 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' LEU . 27.8 mtmm -84.6 167.54 16.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.452 -0.78 . . . . 4.94 109.734 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -37.28 158.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 2.2 109.85 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -59.51 151.28 61.5 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 2.5 109.487 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.0 -28.85 12.56 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.443 2.096 . . . . 3.23 112.277 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.84 -45.3 93.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 3.91 109.764 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 m -67.72 -36.29 75.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.961 -1.087 . . . . 2.17 108.339 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' CG2' HD13 ' A' ' 8' ' ' LEU . 54.8 t -54.2 -45.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.264 -1.013 . . . . 2.64 108.264 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.37 -37.73 88.4 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.826 -1.176 . . . . 4.15 107.826 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.68 -34.94 78.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.538 -0.726 . . . . 3.01 109.288 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.6 -54.13 15.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 2.71 109.061 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -53.39 -37.39 62.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.004 -1.48 . . . . 3.6 107.004 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttt-85 -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.145 -0.687 . . . . 5.04 109.145 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 20' ' ' THR . 28.0 ttpt -144.09 120.14 10.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -0.977 . . . . 5.04 109.969 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER 160.48 -20.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 2.89 108.814 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.449 ' OH ' ' C ' ' A' ' 95' ' ' GLY . 18.7 m-85 72.73 -6.71 1.58 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.668 -0.645 . . . . 6.0 110.34 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' H ' HG22 ' A' ' 20' ' ' THR . 53.1 m-85 -119.42 148.1 43.62 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.525 -0.917 . . . . 2.94 108.525 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 26' ' ' GLU . 61.4 p -73.43 156.63 38.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.894 -1.129 . . . . 3.98 108.579 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' OE1' ' CG1' ' A' ' 13' ' ' VAL . 23.3 pt-20 -55.89 -18.3 8.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.298 -0.876 . . . . 4.23 110.212 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -62.26 -49.36 75.99 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.558 -1.339 . . . . 5.1 109.03 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' OE1' ' OG1' ' A' ' 23' ' ' THR . 51.3 mp0 -73.09 -40.29 65.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 3.8 111.079 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.2 -39.69 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.409 -1.432 . . . . 2.44 108.642 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.04 -40.33 87.15 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.15 -0.969 . . . . 3.85 109.122 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.21 -47.1 74.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 3.75 109.709 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 89.0 m95 -67.58 -40.82 84.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 5.2 108.911 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 84.7 t80 -57.05 -53.56 56.69 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.726 -0.842 . . . . 2.74 108.726 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.225 -0.922 . . . . 5.06 108.981 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.87 -64.25 4.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.889 -0.884 . . . . 2.92 110.889 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 45.7 p90 -81.78 -31.9 31.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.776 -1.426 . . . . 3.92 110.878 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.1 mm -57.65 -43.99 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.815 -1.178 . . . . 3.57 109.529 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.61 -50.77 72.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 6.37 109.485 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.22 -38.79 92.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 7.82 108.811 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 m -132.09 85.44 50.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.51 -0.744 . . . . 5.72 109.025 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 40' ' ' SER . 76.2 Cg_exo -46.57 154.62 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.381 2.054 . . . . 4.71 112.002 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.7 p 78.22 -28.78 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.399 -0.813 . . . . 5.05 108.841 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' PRO . . . 81.45 20.05 65.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 2.56 109.562 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.739 HE22 ' NH2' ' A' ' 79' ' ' ARG . 43.5 tt0 -91.93 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -1.125 . . . . 3.09 109.415 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 85' ' ' PHE . 72.8 mt -113.47 144.3 43.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 2.82 109.857 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -67.14 169.62 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.426 -0.796 . . . . 2.91 109.14 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . . . -63.11 -38.23 90.37 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.389 -0.819 . . . . 1.72 109.456 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.8 93.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 2.06 109.701 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.85 -44.84 96.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 2.03 109.349 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -61.52 -39.42 90.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -1.095 . . . . 2.65 108.745 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -65.56 -35.8 81.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.002 -1.062 . . . . 2.8 108.69 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -61.85 -53.54 54.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.807 . . . . 3.4 110.25 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 52' ' ' TYR . 2.3 pp -63.21 -33.0 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.621 -1.299 . . . . 2.99 108.258 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -61.63 -38.77 88.87 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.188 -1.412 . . . . 5.31 107.188 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.16 -40.4 89.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.392 -0.966 . . . . 3.63 108.392 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -54.65 -42.03 70.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.701 -0.8 . . . . 4.23 108.881 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.1 m-85 -79.91 -37.66 34.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 4.18 108.896 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 55' ' ' PHE . 20.4 m-85 -126.7 79.41 71.83 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.398 -0.814 . . . . 6.44 109.209 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.28 -36.12 58.65 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.96 2.44 . . . . 4.28 112.647 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.58 12.06 37.51 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.036 . . . . 4.17 108.727 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -78.15 22.28 3.11 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.343 -1.103 . . . . 3.59 110.343 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 62' ' ' THR . 13.7 m-20 44.03 63.37 8.4 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.922 -1.34 . . . . 5.63 109.103 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' O ' ' OG1' ' A' ' 62' ' ' THR . 72.5 Cg_exo -45.52 81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.017 2.478 . . . . 4.4 112.794 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 66' ' ' THR . 51.1 m -167.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 3.54 110.128 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 46.6 mtpt -61.32 -51.5 68.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 3.3 110.689 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CD1' ' SD ' ' A' ' 131' ' ' MET . 40.6 t80 -72.4 -45.28 60.45 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.645 -1.284 . . . . 2.12 109.729 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.07 82.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.26 -0.9 . . . . 1.79 110.242 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 62' ' ' THR . 9.2 t -67.26 -31.98 72.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 2.04 108.831 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.7 m-30 -59.42 -44.09 92.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 2.31 108.666 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.5 t -64.9 -51.7 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.933 -1.105 . . . . 1.71 108.405 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -55.78 -37.59 68.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.058 -1.027 . . . . 4.33 109.72 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 70' ' ' ASN . 0.5 OUTLIER -63.38 -53.42 52.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.002 -1.061 . . . . 2.75 110.699 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 72' ' ' PHE . 25.4 m -84.72 -41.13 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.934 -1.104 . . . . 1.91 110.09 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 49.6 t80 -53.48 -35.73 60.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.687 . . . . 2.75 109.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 57.3 t0 -67.17 106.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.975 -1.078 . . . . 2.3 108.623 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.54 -36.9 85.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 5.3 110.829 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.61 HD21 ' CG ' ' A' ' 77' ' ' ASP . 37.5 p-10 -91.5 -3.77 56.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.882 -1.136 . . . . 3.3 110.086 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 47.17 40.08 9.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -0.971 . . . . 5.34 109.717 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' CG ' HD21 ' A' ' 75' ' ' ASN . 34.4 p-10 -87.45 2.8 49.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.022 . . . . 3.11 109.648 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.4 1.32 90.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.347 -1.501 . . . . 2.85 109.347 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.739 ' NH2' HE22 ' A' ' 42' ' ' GLN . 48.6 mtm180 -139.58 149.04 43.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -1.071 . . . . 4.19 108.91 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 131.45 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.026 . . . . 1.76 108.463 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 82' ' ' PHE . 95.6 mt-10 -98.18 163.78 12.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 2.4 109.239 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.504 ' CG ' ' N ' ' A' ' 83' ' ' SER . 2.6 p90 -46.28 -39.84 10.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 3.27 108.877 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 16.2 t -59.18 -52.06 67.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.405 -0.81 . . . . 2.35 109.877 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 73' ' ' ASP . 97.4 mt-10 -68.49 -41.87 79.44 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.653 -1.279 . . . . 2.09 109.87 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.5 t80 -62.31 -55.19 30.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.862 -1.149 . . . . 2.22 109.971 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.8 tt -62.07 -31.33 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 1.9 110.442 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -66.24 -40.8 90.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.652 -1.28 . . . . 2.63 109.786 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.91 -37.58 86.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.298 -1.371 . . . . 1.56 107.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 35.6 mt -61.64 -36.65 81.39 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.745 0.783 . . . . 2.17 109.121 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.2 m -66.81 -49.68 65.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 2.01 109.266 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.62 -36.42 77.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.875 -1.157 . . . . 2.2 107.875 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.9 m -55.99 -45.27 79.04 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.638 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -65.83 -46.65 77.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 3.47 109.636 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -154.61 -69.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 8.35 109.225 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.449 ' C ' ' OH ' ' A' ' 21' ' ' TYR . . . 90.87 164.08 39.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.368 -1.493 . . . . 3.29 109.368 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.541 ' C ' ' HZ3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -99.02 154.07 18.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 3.18 109.017 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.3 tp -52.86 -38.6 61.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.176 -0.953 . . . . 4.22 108.748 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -72.4 -42.26 65.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.275 -0.891 . . . . 3.59 109.796 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.61 -43.38 80.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 3.04 109.705 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HZ3' ' C ' ' A' ' 96' ' ' THR . 32.9 mtmm -62.91 -39.04 93.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 3.12 109.141 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 180' ' ' VAL . 27.6 tp -60.64 -46.27 90.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 2.31 108.737 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.33 -38.66 85.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 3.93 108.863 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.481 ' CH2' HD13 ' A' ' 107' ' ' LEU . 58.8 t90 -59.54 -46.9 87.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.453 -0.78 . . . . 4.4 109.137 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.5 -41.17 76.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.289 -0.882 . . . . 1.41 109.086 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.97 -50.04 75.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.499 -0.751 . . . . 2.69 110.823 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 107' ' ' LEU . 1.5 ptpm? -64.44 -41.13 96.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.853 -1.154 . . . . 3.23 109.751 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 6.0 tt -69.46 -34.21 74.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.937 -1.102 . . . . 1.99 110.048 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -24.24 63.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.029 -1.044 . . . . 2.51 109.235 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 36.5 t0 -134.39 105.36 6.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 1.8 109.615 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 67' ' ' PHE . 60.7 tp -61.77 -44.5 96.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.571 . . . . 3.31 110.618 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 113' ' ' ASP . 20.5 p-10 -91.59 24.17 3.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.038 -1.039 . . . . 2.09 108.871 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 111' ' ' ASP . 2.0 t-20 -34.99 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.505 0.669 . . . . 3.68 110.789 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 111' ' ' ASP . 33.7 p-10 -99.23 20.26 13.87 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.048 -1.094 . . . . 2.51 108.048 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.58 -4.98 40.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.728 -1.749 . . . . 2.39 108.728 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CE1' HG22 ' A' ' 165' ' ' THR . 1.9 m-85 -137.98 140.76 40.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -1.098 . . . . 2.76 110.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -117.61 134.55 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.225 -1.028 . . . . 1.6 108.225 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -118.86 160.17 22.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.243 -1.021 . . . . 1.73 108.243 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.66 HH21 ' CB ' ' A' ' 157' ' ' ASP . 13.0 mmt85 -60.16 -39.63 87.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.998 -1.064 . . . . 3.17 109.531 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -57.49 -44.63 85.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 2.44 109.055 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 97.4 mt-10 -65.55 -38.15 88.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.083 -1.08 . . . . 1.71 108.083 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.669 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 62.2 ttp -62.63 -40.67 97.73 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.115 -0.698 . . . . 3.66 109.115 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD22 ' OE2' ' A' ' 146' ' ' GLU . 89.2 mt -64.78 -38.03 89.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 1.77 109.305 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.77 -47.81 84.64 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.01 109.225 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.7 mm -72.78 -43.04 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 1.14 110.004 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 121' ' ' MET . 48.5 t -56.29 -44.82 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.834 -1.166 . . . . 1.83 107.926 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.48 -38.77 88.48 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.178 -1.045 . . . . 2.16 108.178 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.83 -41.39 87.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.565 -0.709 . . . . 1.78 110.185 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 144' ' ' THR . 98.3 mt -62.93 -57.8 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.029 -1.044 . . . . 2.42 110.884 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -67.31 -43.18 82.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.607 -1.308 . . . . 5.07 109.318 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.436 ' N ' ' CG ' ' A' ' 129' ' ' TYR . 63.5 tt0 -60.12 -41.14 92.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.94 -1.1 . . . . 3.05 108.293 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.67 ' SD ' ' CD1' ' A' ' 64' ' ' PHE . 19.4 ttt -60.86 -46.31 91.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.424 -0.954 . . . . 4.88 108.424 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 132' ' ' VAL . 11.6 t -92.37 10.35 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 3.55 109.144 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -44.5 -30.63 2.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.544 -1.822 . . . . 3.52 108.544 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -76.16 -116.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.408 -1.054 . . . . 4.29 108.435 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' VAL . 22.5 p -147.73 25.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 3.68 110.422 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 46.2 t -45.59 -48.19 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.742 -1.224 . . . . 5.42 109.098 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 136' ' ' VAL . 1.6 mm-40 165.37 71.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.437 -0.949 . . . . 5.6 108.437 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -73.71 148.67 87.7 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 2.5 108.606 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 140' ' ' GLU . 42.0 Cg_endo -72.06 129.74 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.72 1.614 . . . . 3.55 111.903 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 139' ' ' PRO . 60.1 mp0 32.08 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.34 0.59 . . . . 5.65 110.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -92.76 -2.47 55.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 6.82 109.327 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 183' ' ' LEU . 21.1 pt-20 -65.64 -44.49 86.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 6.56 109.515 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' N ' ' CG ' ' A' ' 142' ' ' GLU . 17.5 t-20 54.82 46.96 23.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.036 -1.04 . . . . 5.59 109.99 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 128' ' ' ILE . 0.2 OUTLIER 50.68 70.51 1.97 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 3.06 109.798 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.32 95.13 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.769 2.313 . . . . 3.91 111.875 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.63 ' OE2' HD22 ' A' ' 122' ' ' LEU . 84.4 tt0 -44.45 -36.55 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.496 -0.753 . . . . 3.87 110.361 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.41 ' HB3' HH12 ' A' ' 151' ' ' ARG . 42.3 mtmt -64.63 -44.3 90.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.734 -1.229 . . . . 3.64 110.252 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' O ' ' CG1' ' A' ' 152' ' ' ILE . 81.1 mmt-85 -65.18 -45.46 84.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 4.99 111.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 m -66.23 -33.32 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.67 -1.269 . . . . 1.57 109.403 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.31 -59.78 4.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.095 -1.003 . . . . 2.71 109.691 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.41 HH12 ' HB3' ' A' ' 147' ' ' LYS . 67.9 mtt85 -64.71 -42.48 95.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.002 -1.061 . . . . 4.73 109.5 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 148' ' ' ARG . 5.8 mm -58.36 -42.34 83.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.391 -0.818 . . . . 2.07 109.851 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.669 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.7 m-85 -65.44 -39.42 92.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.799 -1.188 . . . . 2.93 109.317 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.64 63.55 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.151 -1.42 . . . . 1.77 107.318 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.2 ttp -66.76 -33.39 75.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.82 -0.807 . . . . 2.34 108.82 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.4 mmt -80.17 -29.67 38.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 3.53 110.004 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.66 ' CB ' HH21 ' A' ' 118' ' ' ARG . 49.8 t0 -98.96 16.07 23.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.231 -0.918 . . . . 2.4 111.416 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 160' ' ' ALA . 40.2 mtmt -49.85 -24.47 2.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.669 -1.269 . . . . 4.18 109.56 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 17.9 m120 -39.26 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.41 -1.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.967 -0.753 . . . . 3.15 108.967 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -57.47 -37.91 73.67 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.481 -0.762 . . . . 3.4 108.962 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.37 -4.62 73.78 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.796 -1.722 . . . . 2.83 108.796 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -134.71 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -1.005 . . . . 2.45 110.85 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -109.9 126.43 53.86 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.115 . . . . 1.9 107.988 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 164' ' ' LEU . 19.2 p -124.74 166.25 16.52 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 1.8 109.828 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -59.83 -32.12 70.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 2.28 109.579 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.6 tt0 -46.42 -39.35 10.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.821 -1.175 . . . . 2.92 108.792 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.31 -42.28 59.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 1.85 110.286 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' OG ' ' A' ' 173' ' ' SER . 44.6 m-85 -68.38 -45.08 73.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.974 -1.079 . . . . 2.14 110.219 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 171' ' ' GLU . 17.6 pt20 -68.28 -46.34 70.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 2.35 110.564 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 170' ' ' GLN . 98.9 mt-10 -65.85 -36.01 82.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.028 -1.045 . . . . 2.92 110.506 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.21 -44.06 6.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.768 -1.206 . . . . 1.77 110.15 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 83.5 p -59.51 -36.31 75.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.266 -1.138 . . . . 2.18 110.112 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -89.99 1.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.206 -0.934 . . . . 4.67 109.301 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.45 -84.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.502 -0.749 . . . . 2.92 109.341 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.0 134.46 28.7 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 2.61 108.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 61.4 Cg_endo -74.64 -170.9 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.182 1.921 . . . . 2.17 112.408 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.59 -40.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.688 -0.632 . . . . 2.62 110.116 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 180' ' ' VAL . 3.1 tp -61.27 -36.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 2.0 109.536 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.485 HG22 HD13 ' A' ' 101' ' ' LEU . 94.6 t -68.15 -38.83 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 3.79 109.415 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -89.04 79.81 7.15 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.284 -0.885 . . . . 6.02 108.729 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.537 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -59.49 -26.07 64.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.412 -0.805 . . . . 4.48 109.335 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.076 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -88.26 -72.35 0.54 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 4.79 109.704 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -36.42 -69.03 0.12 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.618 -0.677 . . . . 5.27 110.393 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 184' ' ' SER . 61.4 tp 50.56 106.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 7.1 109.954 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 68.3 t80 54.94 59.7 3.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -0.976 . . . . 9.88 109.288 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.8 p30 -67.7 -20.44 65.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 8.42 109.949 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -78.6 176.42 54.41 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.781 -1.328 . . . . 9.13 109.781 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 21.8 tp -173.9 75.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -1.073 . . . . 11.72 109.203 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.944 -1.027 . . . . 12.62 109.386 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.601 -0.518 . . . . 15.48 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.62 -159.07 15.69 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.82 -1.312 . . . . 11.71 109.82 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -55.38 -36.16 66.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -1.035 . . . . 12.65 109.872 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -68.11 155.45 39.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 8.16 109.524 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.692 HD22 ' N ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -136.18 2.43 2.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 7.63 109.389 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.692 ' N ' HD22 ' A' ' 5' ' ' ASN . 5.2 p 37.16 84.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 5.22 110.201 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.686 ' NZ ' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -58.39 -37.13 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 4.94 108.944 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.694 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -144.52 136.87 26.42 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.191 -1.04 . . . . 2.2 108.191 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -52.88 146.91 17.17 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.894 -1.129 . . . . 2.5 109.062 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.5 -31.08 61.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.54 2.16 . . . . 3.23 112.86 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.27 -47.33 86.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 3.91 109.864 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.3 t -65.96 -44.72 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.127 -0.983 . . . . 2.17 109.72 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 17' ' ' THR . 53.8 t -55.04 -46.53 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 2.64 110.005 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.47 -49.96 75.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.013 -1.054 . . . . 4.15 109.247 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.05 -28.97 70.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.13 -0.981 . . . . 3.01 108.7 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.5 OUTLIER -66.69 -43.28 84.85 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.481 -0.933 . . . . 2.71 108.481 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 13' ' ' VAL . 11.2 p -64.61 -32.77 74.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 3.6 109.528 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 18' ' ' ARG . 27.6 mtt85 -50.64 -35.2 29.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.857 -1.152 . . . . 5.04 108.423 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' LEU . 30.5 ttpt -140.68 123.59 16.38 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.459 -0.941 . . . . 5.04 108.459 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -171.07 -24.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.776 -1.202 . . . . 2.89 111.216 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 60.64 2.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.259 -1.386 . . . . 6.0 107.259 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' THR . 27.8 m-85 -140.03 171.42 14.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.243 -1.021 . . . . 2.94 108.243 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.3 p -85.57 168.01 14.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.724 -1.235 . . . . 3.98 109.409 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 17' ' ' THR . 13.6 pt-20 -65.1 -28.37 69.4 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.248 -0.907 . . . . 4.23 109.98 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -66.88 -42.49 85.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 5.1 110.608 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.14 -42.35 96.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 3.8 110.295 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG11 ' CG2' ' A' ' 20' ' ' THR . 15.7 m -68.06 -30.87 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 2.44 108.294 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.686 ' NE2' ' NZ ' ' A' ' 7' ' ' LYS . 40.0 tt0 -62.3 -42.65 99.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.075 -1.083 . . . . 3.85 108.075 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.64 -44.05 91.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.406 -0.809 . . . . 3.75 108.946 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -64.83 -37.81 88.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.487 -0.931 . . . . 5.2 108.487 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 90.6 t80 -53.89 -45.93 71.24 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.788 -1.19 . . . . 2.74 107.788 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -82.61 -9.37 59.42 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.839 -1.171 . . . . 5.06 107.839 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -65.93 -44.95 90.79 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.996 -1.242 . . . . 2.92 109.996 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' O ' ' OD2' ' A' ' 37' ' ' ASP . 6.2 p90 -106.1 -26.29 11.68 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.182 -1.187 . . . . 3.92 111.211 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 4.6 mm -57.23 -37.92 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 3.57 109.805 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.55 -41.32 89.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.036 -1.04 . . . . 6.37 109.737 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.3 p30 -64.4 -33.68 76.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.905 -1.122 . . . . 7.82 108.476 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 89.7 m -153.73 133.05 7.18 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.569 -0.9 . . . . 5.72 108.569 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.38 -11.61 30.32 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.072 1.848 . . . . 4.71 112.261 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -102.5 139.85 37.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 5.05 109.447 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.82 11.08 69.99 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.735 -1.346 . . . . 2.56 109.735 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -83.97 115.5 22.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -1.216 . . . . 3.09 109.598 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.84 134.25 54.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.527 -0.733 . . . . 2.82 109.688 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' OD1' ' CD ' ' A' ' 79' ' ' ARG . 81.0 m-20 -79.44 176.59 9.55 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.864 -0.791 . . . . 2.91 108.864 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.39 -30.71 69.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.253 -0.905 . . . . 1.72 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.88 93.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 2.06 110.028 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.8 -53.48 44.93 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.294 -1.523 . . . . 2.03 109.294 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -44.29 95.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.244 -1.151 . . . . 2.65 107.901 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 41.9 tt0 -56.14 -38.27 70.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.551 -0.907 . . . . 2.8 108.551 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -60.97 -42.46 98.34 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.383 -0.823 . . . . 3.4 109.021 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.2 mt -57.12 -55.2 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 2.99 109.41 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -55.88 -40.67 73.29 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.438 -0.905 . . . . 5.31 110.497 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -62.87 -35.61 80.56 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.572 -1.33 . . . . 3.63 109.762 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.26 -43.86 89.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.894 . . . . 4.23 112.588 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 24.4 m-85 -101.11 -33.7 10.02 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.541 -1.349 . . . . 4.18 111.199 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -125.1 77.8 66.99 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.963 -1.085 . . . . 6.44 109.262 179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.37 -21.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.791 2.327 . . . . 4.28 112.499 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.0 1.34 52.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 4.17 110.305 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.13 -124.54 2.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.391 -1.484 . . . . 3.59 109.391 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 p30 -122.27 54.21 5.29 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.426 -1.043 . . . . 5.63 108.779 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 18.0 Cg_endo -59.2 -5.88 3.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 123.086 2.524 . . . . 4.4 112.83 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -101.2 -82.1 0.47 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.929 -1.107 . . . . 3.54 111.021 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 62' ' ' THR . 18.1 mtmm -60.55 -46.44 90.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.24 -0.912 . . . . 3.3 111.771 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.713 ' O ' HG23 ' A' ' 68' ' ' VAL . 37.1 t80 -61.66 -46.07 91.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.849 -1.157 . . . . 2.12 109.636 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -57.84 -48.64 79.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 1.79 109.722 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.59 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 72.5 p -60.75 -39.47 88.87 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.964 . . . . 2.04 108.399 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.935 ' O ' HG22 ' A' ' 71' ' ' VAL . 8.4 m-30 -62.66 -36.65 83.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.797 -0.816 . . . . 2.31 108.797 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 64' ' ' PHE . 48.9 t -65.05 -68.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 1.71 109.213 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -47.93 -29.17 3.13 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.878 -1.139 . . . . 4.33 109.295 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 66' ' ' THR . 90.9 m-20 -75.51 -61.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.051 -1.031 . . . . 2.75 110.58 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 67' ' ' PHE . 34.8 m -72.74 -35.92 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.096 -1.003 . . . . 1.91 111.212 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 11.5 t80 -75.18 1.03 14.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.005 -1.059 . . . . 2.75 109.709 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -67.92 92.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.006 -1.059 . . . . 2.3 108.829 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.46 -36.56 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 5.3 110.284 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.0 m120 -89.98 6.37 42.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 3.3 109.815 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 75' ' ' ASN . 17.2 ptpt 40.39 21.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 5.34 109.469 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASN . 54.3 p-10 -92.63 2.53 56.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 3.11 110.262 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.08 15.01 80.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.568 -1.413 . . . . 2.85 109.568 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' CD ' ' OD1' ' A' ' 44' ' ' ASP . 81.9 mmt-85 -142.96 130.91 21.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -1.179 . . . . 4.19 109.075 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 80' ' ' ILE . 15.3 mm -89.73 128.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.064 -1.087 . . . . 1.76 108.064 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -90.24 161.55 15.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.284 -0.885 . . . . 2.4 111.006 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -53.67 -57.33 11.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.584 -0.697 . . . . 3.27 109.322 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 90.6 p -56.74 -36.65 70.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.08 -1.012 . . . . 2.35 108.804 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.23 -39.38 86.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 2.09 109.3 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 88.2 t80 -76.15 -51.08 12.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 2.22 110.952 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 86' ' ' ILE . 11.1 tp -57.84 -32.36 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.805 -1.185 . . . . 1.9 109.494 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 91' ' ' VAL . 93.6 mt-30 -75.01 -57.79 3.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 2.63 110.484 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.33 -41.79 96.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.781 -1.2 . . . . 1.56 109.319 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.686 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -57.79 -44.32 86.2 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.874 -1.158 . . . . 2.17 107.874 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.6 -33.56 75.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.988 -1.07 . . . . 2.01 108.945 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 95' ' ' GLY . 89.0 t -63.26 -36.47 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.196 -1.038 . . . . 2.2 108.196 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 p -67.91 -30.64 70.02 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.259 -0.901 . . . . 2.75 108.841 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -54.96 -55.83 26.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.965 . . . . 3.47 109.552 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLY . 82.4 mtt180 -152.84 32.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 8.35 108.945 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . -41.38 153.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.92 -1.272 . . . . 3.29 109.92 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -84.54 163.24 19.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.419 -1.047 . . . . 3.18 108.999 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.6 mt -54.16 -37.89 64.93 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.172 -0.955 . . . . 4.22 109.399 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.85 -45.42 89.56 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.177 -0.952 . . . . 3.59 109.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.56 -40.36 92.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.948 . . . . 3.04 109.129 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.6 -39.46 93.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.4 -0.813 . . . . 3.12 109.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 173' ' ' SER . 9.0 tt -62.28 -43.24 99.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 2.31 109.533 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -63.57 -46.04 87.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 3.93 109.473 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -39.44 92.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 4.4 108.887 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.32 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.497 -0.752 . . . . 1.41 110.094 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 166' ' ' LEU . 74.7 t80 -66.98 -54.65 19.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 2.69 110.871 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -56.52 -40.34 74.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.994 -1.066 . . . . 3.23 108.984 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.729 ' HA ' HG21 ' A' ' 71' ' ' VAL . 7.3 tt -73.54 -28.21 61.75 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.506 -0.746 . . . . 1.99 110.383 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.667 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.7 OUTLIER -51.63 -41.03 61.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.944 -1.098 . . . . 2.51 110.139 -178.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' OD2' ' OD1' ' A' ' 111' ' ' ASP . 57.8 t0 -109.8 121.42 45.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 1.8 109.984 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 67' ' ' PHE . 34.7 tp -58.62 -42.63 88.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 3.31 109.789 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.624 ' O ' ' N ' ' A' ' 113' ' ' ASP . 53.5 p30 -98.23 23.88 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 2.09 108.996 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 111' ' ' ASP . 17.3 t-20 -29.13 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.75 0.786 . . . . 3.68 110.779 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.2 p30 -99.59 17.73 19.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 2.51 108.783 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 -16.05 52.39 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.413 -1.875 . . . . 2.39 108.413 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.16 132.43 48.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.576 -0.955 . . . . 2.76 109.687 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.6 135.51 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.308 -0.997 . . . . 1.6 108.308 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.9 p -115.03 157.29 23.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.584 -0.895 . . . . 1.73 108.584 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.612 ' HE ' ' CG ' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -58.22 -40.39 81.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.059 -1.025 . . . . 3.17 110.182 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -56.0 -41.36 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.879 -1.138 . . . . 2.44 108.908 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 97.4 mt-10 -69.51 -36.22 76.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.303 -0.873 . . . . 1.71 108.66 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.667 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 75.3 mmm -62.74 -40.24 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 3.66 109.072 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.44 -41.99 62.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 1.77 109.849 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -60.44 -44.3 95.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 2.01 109.916 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 124' ' ' ILE . 10.7 mm -73.7 -50.91 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 1.14 109.953 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -44.95 81.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.899 -1.126 . . . . 1.83 108.304 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -60.84 -41.65 96.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.706 -0.85 . . . . 2.16 108.706 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 1.78 109.996 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 132' ' ' VAL . 89.6 mt -59.65 -59.09 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 2.42 111.314 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -70.55 -28.82 65.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.652 -1.28 . . . . 5.07 110.656 -178.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -55.34 -48.32 74.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.679 -1.263 . . . . 3.05 109.557 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 95.2 mmm -96.38 -37.98 10.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 4.88 109.809 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 128' ' ' ILE . 4.9 t -82.33 -0.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.05 -1.031 . . . . 3.55 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -53.42 -39.36 59.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.79 -1.724 . . . . 3.52 108.79 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.57 87.39 2.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.344 -0.984 . . . . 4.29 108.344 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 136' ' ' VAL . 63.0 m -121.7 147.67 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 3.68 109.623 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -45.46 -44.42 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.387 -0.82 . . . . 5.42 108.85 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -139.76 124.01 17.92 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.619 -0.676 . . . . 5.6 109.528 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -142.75 159.67 56.2 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 143' ' ' ASN . 34.1 Cg_exo -58.24 104.25 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.305 1.337 . . . . 3.55 112.359 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -68.07 -38.19 82.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 5.65 109.409 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.52 -30.88 71.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 6.82 109.51 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.9 tt0 -161.79 64.71 0.25 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.624 -0.88 . . . . 6.56 108.624 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.739 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -46.81 -8.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.617 . . . . 5.59 110.49 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.611 HG22 ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 168.86 143.36 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 3.06 108.89 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 149' ' ' VAL . 60.5 Cg_endo -86.73 80.75 1.54 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.224 1.949 . . . . 3.91 111.91 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 146' ' ' GLU . 3.3 tm-20 -94.22 -77.19 0.46 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.927 -1.108 . . . . 3.87 110.167 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -61.99 -35.66 79.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.981 -1.074 . . . . 3.64 109.87 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HB3' HD12 ' A' ' 152' ' ' ILE . 84.3 mtp180 -58.56 -73.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.265 -0.897 . . . . 4.99 109.839 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 145' ' ' PRO . 14.6 p -46.96 -37.58 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 1.57 109.829 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 149' ' ' VAL . 90.7 m-20 -53.43 -69.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.51 -1.369 . . . . 2.71 109.452 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -70.27 -46.02 65.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.042 -1.037 . . . . 4.73 110.935 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 148' ' ' ARG . 55.8 mt -59.36 -63.11 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.163 -0.961 . . . . 2.07 111.743 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -37.28 83.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.97 -1.081 . . . . 2.93 110.846 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 150' ' ' ASP . . . -55.17 -35.63 64.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.023 -1.471 . . . . 1.77 107.547 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 50.4 ttp -69.89 -48.25 59.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.348 0.594 . . . . 2.34 109.615 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.5 ' O ' ' OE1' ' A' ' 168' ' ' GLU . 18.9 ttt -71.45 -30.28 65.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 3.53 110.356 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 23.5 t0 -69.5 6.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.292 -0.88 . . . . 2.4 111.33 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' N ' ' A' ' 160' ' ' ALA . 32.8 mttm -71.54 -79.22 0.07 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.684 -1.26 . . . . 4.18 109.378 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 161' ' ' ASP . 24.3 m120 41.02 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.49 109.858 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 55.29 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 3.15 110.643 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.627 ' H ' ' C ' ' A' ' 159' ' ' ASN . 48.7 p-10 -67.2 -36.87 82.65 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.892 -1.13 . . . . 3.4 110.13 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 98.15 -19.64 53.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.37 -1.092 . . . . 2.83 110.37 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.483 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 68.2 mttt -130.29 177.31 7.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.023 -1.281 . . . . 2.45 110.177 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 165' ' ' THR . 0.2 OUTLIER -108.91 121.85 45.97 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.302 -0.999 . . . . 1.9 108.302 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.547 ' N ' HD13 ' A' ' 164' ' ' LEU . 20.3 p -122.93 176.41 6.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.158 -0.964 . . . . 1.8 110.56 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -56.02 -38.68 70.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.351 -0.843 . . . . 2.28 110.696 -179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 166' ' ' LEU . 61.7 tt0 -44.81 -42.87 8.22 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.762 -1.211 . . . . 2.92 109.794 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.5 ' OE1' ' O ' ' A' ' 156' ' ' MET . 41.3 mt-10 -73.93 -43.42 58.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 1.85 111.121 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' SER . 25.1 m-85 -71.8 -50.3 31.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.792 -1.193 . . . . 2.14 110.535 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.41 -48.88 73.71 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.061 -1.024 . . . . 2.35 110.616 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 94.0 mt-10 -74.94 -43.89 51.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.581 -1.324 . . . . 2.92 109.574 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -63.61 -47.58 85.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.623 -1.391 . . . . 1.77 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.478 ' CB ' HD11 ' A' ' 101' ' ' LEU . 97.4 p -62.73 -36.11 81.95 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.234 -1.157 . . . . 2.18 109.365 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.26 -4.79 58.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 4.67 109.08 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -123.98 -82.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.549 -0.72 . . . . 2.92 109.434 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-20 -70.76 125.71 92.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 2.61 109.555 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 178' ' ' SER . 73.4 Cg_endo -78.25 179.9 6.06 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.303 2.002 . . . . 2.17 112.354 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.81 -36.89 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 2.62 110.147 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.55 -48.0 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 2.0 110.179 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 182' ' ' ALA . 17.5 m -75.42 -24.75 17.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.03 -1.044 . . . . 3.79 109.474 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.485 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 54.2 tt0 -73.06 47.6 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 6.02 108.671 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -58.04 -35.81 71.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.818 . . . . 4.48 109.318 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -173.99 25.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 4.79 109.927 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.2 m -117.16 145.18 44.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.265 -0.897 . . . . 5.27 109.758 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.5 132.96 56.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.527 -0.733 . . . . 7.1 109.032 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 2.3 p90 -95.72 173.47 7.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 9.88 109.619 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -53.07 -37.58 61.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 8.42 109.817 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 109.13 87.09 1.83 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.676 -1.37 . . . . 9.13 109.676 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 1.0 OUTLIER -63.4 -31.4 72.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 11.72 109.082 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.009 -0.996 . . . . 12.62 109.465 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.302 -0.629 . . . . 15.48 109.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 4' ' ' SER . . . -170.82 -168.69 32.93 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.396 -1.482 . . . . 11.71 109.396 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? 64.5 -0.49 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.443 -1.034 . . . . 12.65 109.476 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 2' ' ' GLY . 19.6 m -123.48 146.24 48.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.277 -0.889 . . . . 8.16 109.484 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -135.75 133.7 38.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 7.63 109.628 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.5 t -111.5 143.0 43.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.853 . . . . 5.22 109.349 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -85.51 160.86 19.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 4.94 109.348 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.77 140.99 57.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 2.2 108.529 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 8' ' ' LEU . 11.2 mmtp -39.11 103.38 0.28 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.511 -0.743 . . . . 2.5 109.192 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -48.77 -25.24 7.97 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.205 1.937 . . . . 3.23 112.662 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.74 -45.8 88.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 3.91 109.479 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.449 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -71.48 -34.59 53.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.07 -1.019 . . . . 2.17 108.836 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.661 HG21 HD13 ' A' ' 8' ' ' LEU . 91.5 t -60.15 -43.98 94.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.117 -1.068 . . . . 2.64 108.117 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.93 -39.56 92.46 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.452 -1.314 . . . . 4.15 107.452 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.64 -35.71 78.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.746 -0.835 . . . . 3.01 108.746 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' OG1' ' A' ' 20' ' ' THR . 52.5 mt -62.93 -45.97 89.96 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.097 . . . . 2.71 108.448 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 17' ' ' THR . 16.1 p -55.81 -38.13 69.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.656 -1.277 . . . . 3.6 107.968 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -60.6 -35.82 77.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.83 -1.174 . . . . 5.04 107.83 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.6 ttpt -145.35 109.94 5.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 5.04 109.121 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 16' ' ' LEU . 54.7 m -171.82 -26.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.382 -0.824 . . . . 2.89 109.436 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 9.5 m-85 71.13 -3.55 2.02 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.196 -0.94 . . . . 6.0 108.907 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 20' ' ' THR . 51.2 m-85 -125.5 161.15 27.76 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -76.74 162.02 28.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.017 -1.052 . . . . 3.98 109.904 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLU . 13.0 tm-20 -63.73 -38.61 91.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.643 -0.66 . . . . 4.23 110.518 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -65.34 -40.45 93.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.084 -1.01 . . . . 5.1 110.287 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -63.96 -40.68 96.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.006 -1.059 . . . . 3.8 110.45 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 20' ' ' THR . 10.3 m -70.01 -41.68 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.914 -1.116 . . . . 2.44 109.743 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -58.9 -42.61 89.97 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.037 -1.04 . . . . 3.85 108.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.5 -41.51 96.4 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.89 . . . . 3.75 109.254 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 39.4 m95 -63.79 -42.48 97.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 5.2 109.025 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 17.8 t80 -56.3 -45.1 80.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.701 -0.625 . . . . 2.74 109.612 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -88.68 -2.58 58.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.801 -1.187 . . . . 5.06 108.47 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.65 -60.52 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.949 -1.26 . . . . 2.92 109.949 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 30' ' ' TRP . 17.1 p90 -80.07 -34.05 38.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.985 -1.303 . . . . 3.92 110.305 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mm -59.64 -30.77 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.995 -1.066 . . . . 3.57 109.493 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -55.04 -39.27 68.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 6.37 109.392 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 57.8 t0 -57.92 -38.74 76.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 7.82 108.911 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 13.3 m -160.47 138.8 7.43 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.437 -0.79 . . . . 5.72 108.992 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.91 77.06 3.87 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.2 1.934 . . . . 4.71 112.188 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -157.14 -59.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.012 -1.055 . . . . 5.05 109.965 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.05 58.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.525 . . . . 2.56 109.289 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HH11 ' A' ' 79' ' ' ARG . 62.5 tt0 -94.68 121.84 36.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -1.05 . . . . 3.09 109.606 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 47' ' ' GLY . 23.0 tp -113.97 128.01 56.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.4 -0.813 . . . . 2.82 109.354 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -78.58 177.21 8.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -0.903 . . . . 2.91 109.269 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -60.87 -39.44 89.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 1.72 109.747 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.6 93.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 2.06 109.726 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -61.46 -47.07 92.8 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.448 -1.461 . . . . 2.03 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.56 -47.75 84.1 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.033 -1.274 . . . . 2.65 108.544 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 88.5 mt-30 -59.67 -33.27 71.34 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.296 -1.001 . . . . 2.8 108.296 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -60.81 -43.59 97.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.52 -0.738 . . . . 3.4 109.811 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.586 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.8 pt -68.44 -35.97 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.741 -1.225 . . . . 2.99 109.411 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.512 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 t80 -69.09 -45.04 71.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 5.31 108.489 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.84 -39.67 92.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.947 . . . . 3.63 109.334 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.2 -42.72 91.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 4.23 109.64 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.0 m-85 -77.61 -32.76 53.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 4.18 109.098 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 60' ' ' ASP . 9.9 m-85 -131.6 71.9 80.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 6.44 109.842 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -93.87 -22.7 0.28 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 123.491 2.794 . . . . 4.28 113.233 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HG23 ' A' ' 135' ' ' THR . 98.0 m-85 -58.46 -30.99 67.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.046 -1.034 . . . . 4.17 110.621 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 131' ' ' MET . . . -158.72 103.96 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.529 -1.32 . . . . 3.59 110.297 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 16.6 p-10 -178.47 86.92 0.22 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.418 -1.049 . . . . 5.63 109.305 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 62' ' ' THR . 52.8 Cg_exo -49.09 -62.59 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.313 2.009 . . . . 4.4 112.216 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.546 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 1.1 m 160.75 -18.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.533 -0.729 . . . . 3.54 109.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -57.9 -48.4 79.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 3.3 110.071 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.734 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 63.2 t80 -69.05 -41.92 76.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 2.12 109.882 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -58.53 -50.47 73.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 1.79 109.695 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.59 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.7 m -63.08 -38.05 89.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 2.04 109.016 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 124' ' ' ILE . 1.4 t80 -56.29 -48.01 77.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.433 -0.792 . . . . 2.31 109.466 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 35.7 t -60.81 -57.0 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.009 -1.108 . . . . 1.71 108.009 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -53.46 -31.36 45.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.0 . . . . 4.33 109.699 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.34 -48.86 76.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.048 -1.033 . . . . 2.75 110.976 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.87 -35.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.773 -1.204 . . . . 1.91 109.847 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 82.6 t80 -48.86 -33.9 11.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.765 -0.584 . . . . 2.75 110.206 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.21 118.53 11.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.955 -1.091 . . . . 2.3 108.74 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.08 -38.67 91.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.788 . . . . 5.3 111.119 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 40.3 p-10 -97.06 -2.76 42.65 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.879 -1.138 . . . . 3.3 110.42 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 50.77 40.17 23.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 5.34 109.71 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' CG ' HD21 ' A' ' 75' ' ' ASN . 55.5 p30 -83.2 5.1 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.11 109.633 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.65 19.26 68.7 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.186 -1.166 . . . . 2.85 110.186 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.583 ' NH1' ' OE2' ' A' ' 81' ' ' GLU . 37.5 ptt85 -168.87 145.56 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.161 -1.199 . . . . 4.19 109.508 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -94.52 127.23 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.556 -1.276 . . . . 1.76 107.556 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.583 ' OE2' ' NH1' ' A' ' 79' ' ' ARG . 96.0 mt-10 -100.21 179.12 4.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.958 -1.089 . . . . 2.4 111.372 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.569 ' CZ ' ' CD1' ' A' ' 31' ' ' TYR . 4.9 t80 -58.9 -50.35 74.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.756 -0.59 . . . . 3.27 110.613 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.8 t -58.09 -47.74 82.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.067 -1.02 . . . . 2.35 109.468 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 93.2 mt-10 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.293 -0.879 . . . . 2.09 110.083 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 52.4 t80 -68.22 -56.65 7.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.875 -1.14 . . . . 2.22 110.597 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -63.21 -43.39 98.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.949 -1.094 . . . . 1.9 109.837 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 32.1 tt0 -71.42 -52.63 17.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 2.63 110.568 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.22 -40.97 90.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 1.56 109.792 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.746 HD13 ' C ' ' A' ' 89' ' ' LEU . 3.0 tm? -58.37 -45.07 88.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -59.25 -37.99 78.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.295 -0.878 . . . . 2.01 108.954 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' GLN . 75.5 t -61.6 -38.18 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 2.2 108.831 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.7 p -67.1 -31.05 71.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.36 -0.837 . . . . 2.75 109.477 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -53.36 -44.82 68.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.929 -1.107 . . . . 3.47 108.437 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 37.5 mmt180 -145.68 -64.75 0.32 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.162 -1.051 . . . . 8.35 108.162 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 166.52 40.56 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.863 -1.295 . . . . 3.29 109.863 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.517 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -98.57 156.74 16.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -1.082 . . . . 3.18 108.486 179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.8 pt? -54.44 -38.17 66.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.864 -1.148 . . . . 4.22 109.332 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 88.6 m-20 -74.7 -48.46 25.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 3.59 109.914 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -64.62 -42.83 95.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.116 -0.99 . . . . 3.04 109.405 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -62.86 -40.46 97.54 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.308 -0.87 . . . . 3.12 108.745 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.23 -43.96 88.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.827 . . . . 2.31 108.958 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 3.93 108.857 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -59.31 -44.8 92.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.804 . . . . 4.4 109.27 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.6 -43.02 77.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.41 109.922 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 -49.0 79.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 2.69 109.752 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -61.45 -43.41 98.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 3.23 109.823 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 8.6 tp -67.37 -38.57 84.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 1.99 110.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CE1' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -65.96 -31.19 71.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.818 -1.177 . . . . 2.51 111.071 -178.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.2 t0 -125.11 114.59 19.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.162 -0.961 . . . . 1.8 110.642 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.2 tp -80.06 -47.58 14.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 3.31 109.864 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.3 p30 -100.31 43.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 2.09 109.727 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -54.9 67.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.766 -0.584 . . . . 3.68 111.571 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 111' ' ' ASP . 26.9 p-10 -67.08 -32.91 74.4 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.98 -1.075 . . . . 2.51 108.446 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.425 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -162.86 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.363 -1.495 . . . . 2.39 109.363 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.706 ' CD2' HG22 ' A' ' 165' ' ' THR . 12.9 m-85 -126.11 -179.23 4.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.371 -1.076 . . . . 2.76 110.112 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.63 137.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.865 -1.161 . . . . 1.6 107.865 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 161.75 16.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.98 -1.118 . . . . 1.73 107.98 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.687 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 21.9 mmt-85 -60.95 -41.84 97.07 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.952 -1.092 . . . . 3.17 109.373 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -60.72 -42.14 96.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 2.44 109.319 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' CD ' ' OD1' ' A' ' 111' ' ' ASP . 99.7 mt-10 -66.86 -39.72 87.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 1.71 109.53 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.645 ' CE ' ' CE1' ' A' ' 108' ' ' TYR . 2.4 tpt -63.96 -42.54 97.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 3.66 109.285 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.83 -39.4 90.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 1.77 109.278 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -58.95 -48.68 80.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 2.01 109.468 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 67' ' ' PHE . 27.0 mm -69.79 -39.37 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 1.14 109.579 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 121' ' ' MET . 51.1 t -57.23 -45.13 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 1.83 107.857 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.56 -40.38 91.43 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.619 -0.882 . . . . 2.16 108.619 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.89 -50.26 74.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 1.78 109.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 93.4 mt -64.95 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.42 109.188 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.9 t80 -59.4 -45.6 91.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.918 -0.771 . . . . 5.07 108.918 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -62.23 -37.98 87.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 3.05 108.638 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . 23.9 ttt -59.25 -35.78 74.3 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.348 -0.845 . . . . 4.88 108.774 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.449 ' HA ' ' HG1' ' A' ' 135' ' ' THR . 16.8 m -116.49 18.45 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.51 -0.744 . . . . 3.55 109.614 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -82.81 -70.42 1.35 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.545 -1.422 . . . . 3.52 109.545 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.94 2.38 12.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.236 -1.155 . . . . 4.29 108.825 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 58' ' ' PHE . 29.1 m -72.87 132.16 43.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.374 -0.829 . . . . 3.68 109.378 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.15 -34.04 67.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.306 -0.872 . . . . 5.42 109.537 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 135' ' ' THR . 57.4 mp0 -96.88 96.64 8.68 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.536 -0.728 . . . . 5.6 110.619 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.91 168.09 16.92 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.641 -1.244 . . . . 2.5 107.641 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.531 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 91.2 Cg_endo -89.7 105.83 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.627 1.551 . . . . 3.55 112.893 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.25 -32.15 73.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -0.851 . . . . 5.65 109.155 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.619 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 56.6 mp0 -60.65 -26.15 66.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 6.82 109.482 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 26.7 tt0 102.34 42.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 108.822 -0.807 . . . . 6.56 108.822 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.531 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 4.5 m-20 -77.92 20.09 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.611 -0.885 . . . . 5.59 108.611 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 144' ' ' THR . 7.1 t -134.52 60.3 41.82 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.657 . . . . 3.06 109.468 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.84 93.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.957 2.438 . . . . 3.91 113.537 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.64 ' O ' HG22 ' A' ' 149' ' ' VAL . 85.7 tt0 -99.27 -75.45 0.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 3.87 109.506 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -56.76 -33.84 66.99 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.95 -1.094 . . . . 3.64 108.88 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' CD ' ' OE2' ' A' ' 142' ' ' GLU . 95.7 mtt-85 -58.53 -43.54 89.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.5 -0.75 . . . . 4.99 110.266 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 146' ' ' GLU . 30.6 m -72.16 -30.26 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.768 -1.207 . . . . 1.57 109.538 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -63.28 -63.31 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.221 -0.924 . . . . 2.71 110.046 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.5 -43.89 89.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.965 -1.084 . . . . 4.73 108.839 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.75 -32.3 46.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.662 -0.866 . . . . 2.07 108.662 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 1.063 ' CZ ' HD12 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -63.47 -46.57 85.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.551 -0.907 . . . . 2.93 108.551 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.15 -41.1 62.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.216 -1.031 . . . . 1.77 108.216 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.7 ttp -77.55 -37.59 50.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.436 -0.79 . . . . 2.34 110.058 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.594 ' SD ' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.151 -0.968 . . . . 3.53 110.37 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 4.9 t0 -94.88 16.3 16.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 2.4 110.731 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 157' ' ' ASP . 10.4 ptpt -34.71 -46.3 0.29 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.775 0.797 . . . . 4.18 110.655 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.743 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 22.4 m120 -39.44 -29.21 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.841 -0.537 . . . . 2.49 109.982 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 85.04 1.44 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.669 -0.645 . . . . 3.15 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.7 p30 -61.64 -30.58 70.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.163 -0.961 . . . . 3.4 109.421 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.1 -0.07 62.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.062 -1.215 . . . . 2.83 110.062 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 75.6 mttt -135.7 150.2 49.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.117 -1.225 . . . . 2.45 110.5 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.063 HD12 ' CZ ' ' A' ' 153' ' ' PHE . 1.3 mt -87.53 97.87 11.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 1.9 108.693 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.706 HG22 ' CD2' ' A' ' 115' ' ' TYR . 6.9 p -94.98 154.29 17.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.873 . . . . 1.8 110.478 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 166' ' ' LEU . 7.7 mp -54.55 -30.15 53.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.553 -0.717 . . . . 2.28 109.827 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 166' ' ' LEU . 91.6 mt-30 -36.24 -77.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 2.92 110.525 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 2.4 pm0 -69.3 -27.24 65.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.961 . . . . 1.85 110.309 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -64.94 0.77 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 2.14 109.749 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.431 ' OE1' HD23 ' A' ' 166' ' ' LEU . 27.0 mt-30 -64.45 -40.71 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 2.35 110.246 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -65.13 -38.96 92.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 2.92 110.131 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 176' ' ' ASP . . . -81.02 -38.04 16.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.64 -1.384 . . . . 1.77 109.64 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 86.3 p -59.65 -37.59 79.13 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.381 -1.07 . . . . 2.18 109.638 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -87.59 -2.72 58.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 4.67 108.722 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.64 -83.14 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 2.92 109.724 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 172' ' ' GLY . 11.7 t70 -71.47 133.8 84.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 2.61 109.713 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -78.16 -169.95 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.277 1.985 . . . . 2.17 112.191 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.9 p 79.18 -40.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.473 -0.767 . . . . 2.62 109.956 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.87 -51.41 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 2.0 109.339 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.28 -39.06 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 3.79 109.554 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -73.03 54.43 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.392 -0.817 . . . . 6.02 109.757 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.498 ' HB3' HD23 ' A' ' 183' ' ' LEU . . . -57.51 -28.95 63.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 4.48 108.955 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.94 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -145.82 -35.93 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.389 -0.82 . . . . 4.79 109.553 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.9 91.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 5.27 110.009 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 8.4 tt -109.7 116.3 31.45 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.561 -0.903 . . . . 7.1 108.561 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -123.86 142.62 50.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.396 -0.815 . . . . 9.88 109.927 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -124.89 2.64 8.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.513 -0.742 . . . . 8.42 109.066 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.11 137.68 13.52 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 9.13 109.626 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.471 HD12 ' C ' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -168.92 29.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.315 -1.109 . . . . 11.72 109.297 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.008 -0.996 . . . . 12.62 109.478 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.47 -0.567 . . . . 15.48 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 -10.06 61.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.684 -1.366 . . . . 11.71 109.684 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -59.74 -36.97 77.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -1.219 . . . . 12.65 109.121 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 55.8 p -70.71 168.12 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.847 . . . . 8.16 109.411 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 7' ' ' LYS . 33.3 t30 87.47 -137.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.467 -0.568 . . . . 7.63 109.467 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m 45.69 13.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 5.22 109.097 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 5' ' ' ASN . 7.1 ttpt -129.6 155.76 45.29 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.57 -0.9 . . . . 4.94 108.57 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -63.82 22.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.089 . . . . 2.2 110.598 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER 58.54 138.47 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.025 -1.047 . . . . 2.5 109.873 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.45 -29.18 4.94 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.351 2.034 . . . . 3.23 113.414 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.01 -46.89 85.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.914 -1.116 . . . . 3.91 110.298 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.4 -30.23 49.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.015 -1.053 . . . . 2.17 108.379 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' CG2' HD13 ' A' ' 8' ' ' LEU . 77.5 t -65.35 -47.8 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.353 -0.842 . . . . 2.64 109.028 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.94 -45.34 74.83 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.934 -1.136 . . . . 4.15 107.934 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.01 -32.85 74.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.592 -0.892 . . . . 3.01 108.592 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.9 tt -68.02 -39.68 83.08 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.805 -0.813 . . . . 2.71 108.805 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' VAL . 60.8 p -70.58 -26.86 63.71 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.537 -0.727 . . . . 3.6 110.145 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 17' ' ' THR . 81.8 mtt180 -48.89 -32.94 9.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.319 -1.363 . . . . 5.04 107.319 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' O ' ' OG1' ' A' ' 20' ' ' THR . 31.5 ttpt -137.56 115.41 11.45 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.974 -1.121 . . . . 5.04 107.974 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -168.28 -24.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.882 -1.136 . . . . 2.89 110.825 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 94' ' ' ARG . 21.1 m-85 64.3 -2.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.372 -0.973 . . . . 6.0 108.372 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' THR . 55.2 m-85 -128.19 164.12 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.765 -0.828 . . . . 2.94 108.765 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -75.0 168.09 20.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.95 -1.094 . . . . 3.98 109.339 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 24' ' ' GLU . 6.6 mt-10 -66.08 -37.31 85.48 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.855 -0.738 . . . . 4.23 110.184 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.12 -38.0 84.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 5.1 110.76 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.65 -40.64 92.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.124 . . . . 3.8 110.187 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 16' ' ' LEU . 65.0 t -72.69 -45.24 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.982 -1.074 . . . . 2.44 109.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -63.32 -43.1 98.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.986 -1.071 . . . . 3.85 109.827 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.2 -43.05 92.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.032 . . . . 3.75 109.193 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.561 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -64.67 -38.45 91.03 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.294 -0.878 . . . . 5.2 108.71 179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 65.0 t80 -57.43 -56.72 18.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.81 . . . . 2.74 109.244 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -66.02 -27.85 68.42 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 5.06 108.966 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -67.21 2.34 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 120.48 -0.867 . . . . 2.92 110.953 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 44.4 p90 -78.28 -29.9 48.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.812 -1.405 . . . . 3.92 111.074 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.0 mm -59.35 -47.55 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.743 -1.223 . . . . 3.57 109.948 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.76 -53.2 60.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 6.37 109.533 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.83 -39.29 93.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 7.82 109.506 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -132.22 81.67 60.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 5.72 109.39 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -52.61 -28.63 37.74 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.645 2.23 . . . . 4.71 112.306 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.7 t -59.84 -43.64 94.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 5.05 109.472 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.18 14.45 63.89 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.725 -1.35 . . . . 2.56 109.725 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -107.26 120.82 43.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.199 -1.177 . . . . 3.09 109.693 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -107.84 145.16 34.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 2.82 109.612 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.594 ' OD1' ' NH1' ' A' ' 79' ' ' ARG . 57.9 m-20 -87.37 174.62 8.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.487 -0.758 . . . . 2.91 109.284 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -61.36 -41.64 97.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 1.72 109.866 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.55 76.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.149 -0.969 . . . . 2.06 109.74 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.12 -41.69 70.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.339 -1.504 . . . . 2.03 109.339 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 51' ' ' ILE . 68.7 t80 -57.83 -43.31 85.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.96 -1.318 . . . . 2.65 108.039 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 80.3 mt-30 -60.23 -34.58 73.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.109 -0.994 . . . . 2.8 108.441 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -60.63 -43.52 97.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 3.4 109.724 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.5 pt -65.97 -35.63 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 118.132 -1.427 . . . . 2.99 108.874 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -68.24 -37.63 81.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 5.31 108.652 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.33 -41.68 98.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 3.63 109.463 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.57 -41.06 96.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 4.23 110.01 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.1 m-85 -79.85 -37.26 35.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.983 -1.073 . . . . 4.18 109.308 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 6.6 m-85 -130.13 75.28 79.56 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 6.44 109.906 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.98 -9.59 14.2 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.041 2.494 . . . . 4.28 112.52 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -91.26 6.9 43.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 4.17 110.118 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 60' ' ' ASP . . . -132.62 121.57 2.98 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.684 -1.367 . . . . 3.59 109.684 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 59' ' ' GLY . 20.9 t0 -41.26 103.61 0.31 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.489 -1.006 . . . . 5.63 109.225 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.15 67.95 4.06 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.309 2.006 . . . . 4.4 112.873 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.677 HG23 ' H ' ' A' ' 63' ' ' LYS . 2.7 t -136.86 -58.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 3.54 109.516 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.677 ' H ' HG23 ' A' ' 62' ' ' THR . 57.7 mttt -65.88 -62.17 1.65 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.703 -1.248 . . . . 3.3 108.303 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.774 ' O ' HG23 ' A' ' 68' ' ' VAL . 53.2 t80 -65.28 -42.24 93.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.087 -0.709 . . . . 2.12 109.087 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.48 -52.89 61.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 1.79 110.063 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.597 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 24.3 m -63.59 -44.23 94.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 2.04 109.36 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 71' ' ' VAL . 3.5 m-30 -57.9 -44.0 86.5 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 2.31 108.725 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.2 t -62.9 -44.81 99.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.488 -0.758 . . . . 1.71 109.324 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CD2' ' N ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -54.56 -68.76 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.902 -1.124 . . . . 4.33 109.473 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.687 ' N ' ' CD2' ' A' ' 69' ' ' PHE . 36.8 t30 -58.29 -39.8 80.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.913 . . . . 2.75 111.626 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' O ' ' NZ ' ' A' ' 106' ' ' LYS . 94.8 t -76.38 -57.58 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.855 -1.153 . . . . 1.91 111.738 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.9 1.07 3.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 2.75 110.826 -178.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.586 ' OD2' ' N ' ' A' ' 76' ' ' LYS . 22.2 t70 -70.47 144.89 51.28 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.856 -1.153 . . . . 2.3 109.028 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.43 -36.5 73.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 5.3 110.441 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 42.8 p30 -145.58 31.51 1.08 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.728 -1.232 . . . . 3.3 110.904 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 54.4 pttt 31.81 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.498 -0.751 . . . . 5.34 111.773 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 75' ' ' ASN . 81.2 m-20 -58.68 -17.06 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.792 -1.192 . . . . 3.11 108.604 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.29 -12.4 33.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.812 -1.715 . . . . 2.85 108.812 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NH1' ' OD1' ' A' ' 44' ' ' ASP . 92.6 mtt-85 -142.28 144.6 33.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -1.015 . . . . 4.19 108.743 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.79 126.76 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.83 -1.174 . . . . 1.76 107.83 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -99.96 170.81 8.25 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.103 -0.998 . . . . 2.4 111.224 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -52.49 -56.01 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.785 -0.572 . . . . 3.27 110.292 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 t -54.56 -43.29 71.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.034 . . . . 2.35 109.328 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 96.1 mt-10 -70.26 -34.12 72.42 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -0.891 . . . . 2.09 109.416 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE1' HD22 ' A' ' 89' ' ' LEU . 3.2 t80 -68.97 -59.14 3.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 2.22 109.969 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 87' ' ' GLN . 9.0 tp -60.98 -43.36 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.805 -1.184 . . . . 1.9 110.273 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 86' ' ' ILE . 63.9 tt0 -73.74 -55.93 5.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 2.63 110.954 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 84' ' ' GLU . . . -61.7 -40.14 93.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 1.56 109.363 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 85' ' ' PHE . 13.6 tp -61.71 -40.27 94.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 2.17 108.506 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.4 p -60.2 -39.13 85.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.298 -0.876 . . . . 2.01 109.005 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -37.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.965 -1.124 . . . . 2.2 107.965 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -34.06 76.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.815 -0.553 . . . . 2.75 109.509 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 10.8 m -54.2 -42.58 69.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.116 . . . . 3.47 108.658 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 93' ' ' SER . 64.9 mtp85 -159.86 -56.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.266 -1.013 . . . . 8.35 108.266 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.79 170.21 46.8 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.855 -1.298 . . . . 3.29 109.855 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -97.27 163.01 13.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -1.045 . . . . 3.18 108.592 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.37 -40.0 70.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.001 -1.062 . . . . 4.22 109.09 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -72.27 -49.3 35.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 3.59 109.675 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' H ' ' A' ' 96' ' ' THR . 77.9 mm-40 -63.47 -35.74 81.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 3.04 109.352 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -59.89 -44.23 94.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.203 -0.936 . . . . 3.12 108.805 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.79 -41.15 97.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.165 -0.959 . . . . 2.31 108.469 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -61.25 -38.59 87.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.53 -0.915 . . . . 3.93 108.53 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 34.5 t90 -59.91 -51.18 70.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 4.4 109.466 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.27 -36.81 74.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 1.41 109.937 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -62.0 -58.19 8.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 2.69 110.28 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 106' ' ' LYS . 8.8 mtpm? -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 3.23 108.537 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 36.6 tp -61.34 -37.6 83.88 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.56 -0.713 . . . . 1.99 109.422 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -14.84 54.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.336 -0.852 . . . . 2.51 109.812 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 54.8 t0 -127.98 115.52 18.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.8 109.623 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.713 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.1 pt? -62.21 -36.71 82.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.506 -0.746 . . . . 3.31 109.365 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 113' ' ' ASP . 54.1 p30 -112.39 40.17 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.712 . . . . 2.09 109.151 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.531 ' ND2' ' NZ ' ' A' ' 106' ' ' LYS . 43.3 p-10 -34.22 86.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.75 0.786 . . . . 3.68 110.772 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 111' ' ' ASP . 50.7 p30 -101.39 16.38 25.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 2.51 109.067 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.21 -14.58 58.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.821 -1.712 . . . . 2.39 108.821 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 163' ' ' LYS . 6.7 m-85 -130.71 139.41 50.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.559 -0.965 . . . . 2.76 109.315 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.8 mt -116.63 143.71 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.6 109.282 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 p -121.98 159.27 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.983 -1.118 . . . . 1.73 107.983 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HE1' ' A' ' 121' ' ' MET . 31.9 mmm-85 -61.55 -38.41 87.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.035 -1.04 . . . . 3.17 109.8 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.23 -42.06 98.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 2.44 109.553 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.04 -38.83 92.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 1.71 108.738 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.675 ' O ' HG13 ' A' ' 125' ' ' VAL . 63.9 ttp -62.66 -47.26 84.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.47 -0.769 . . . . 3.66 109.236 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 122' ' ' LEU . 87.8 mt -58.48 -39.23 79.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 1.77 109.381 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -60.21 -41.5 93.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.115 -0.991 . . . . 2.01 108.655 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 124' ' ' ILE . 34.8 mm -68.35 -53.18 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.373 -0.829 . . . . 1.14 110.421 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -57.13 -41.13 77.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.024 -1.473 . . . . 1.83 107.024 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 21.8 t70 -59.37 -38.22 79.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.672 -1.232 . . . . 2.16 107.672 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.89 91.89 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.373 -0.973 . . . . 1.78 108.373 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 132' ' ' VAL . 60.1 mt -65.35 -40.55 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.384 -0.822 . . . . 2.42 108.975 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER -57.94 -52.25 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.141 -0.974 . . . . 5.07 108.907 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -64.71 -43.05 94.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 3.05 109.671 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.616 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 15.9 ttp -61.75 -34.45 75.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 4.88 109.46 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 128' ' ' ILE . 3.1 p -104.97 6.16 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 3.55 109.434 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -54.97 -31.47 55.63 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.177 -1.169 . . . . 3.52 110.177 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.48 ' C ' HG22 ' A' ' 135' ' ' THR . 19.6 m120 -78.31 -75.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.023 -1.28 . . . . 4.29 109.768 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -163.45 -70.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.036 -1.04 . . . . 3.68 110.121 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.815 ' O ' HG13 ' A' ' 136' ' ' VAL . 2.5 p 27.46 52.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.642 0.734 . . . . 5.42 110.476 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.95 82.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 5.6 108.752 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -89.35 150.15 44.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 2.5 110.114 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 58.5 Cg_exo -46.48 154.98 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.273 1.982 . . . . 3.55 111.984 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -72.49 -117.75 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.268 -0.895 . . . . 5.65 109.596 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.7 -26.01 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 6.82 110.375 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.08 -51.65 69.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.972 -1.08 . . . . 6.56 109.202 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 30.0 m120 54.09 41.81 31.86 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.412 -0.805 . . . . 5.59 108.836 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 75.6 135.73 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 109.14 -0.689 . . . . 3.06 109.14 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.621 ' HD3' HD12 ' A' ' 183' ' ' LEU . 83.5 Cg_endo -78.25 83.86 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.214 1.943 . . . . 3.91 112.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 149' ' ' VAL . 84.6 tt0 -97.29 -75.72 0.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.306 -0.871 . . . . 3.87 109.665 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -62.35 -32.05 72.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.91 -1.119 . . . . 3.64 109.126 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 148' ' ' ARG . 1.5 mpt_? -56.53 -48.08 78.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -0.841 . . . . 4.99 109.792 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.6 m -70.64 -34.66 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.912 -1.118 . . . . 1.57 108.958 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 54.8 t0 -50.64 -51.4 49.37 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.52 -1.363 . . . . 2.71 108.699 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.472 ' CG ' ' N ' ' A' ' 152' ' ' ILE . 9.8 ptm180 -83.57 -49.01 9.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 4.73 110.345 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.472 ' N ' ' CG ' ' A' ' 151' ' ' ARG . 81.5 mt -58.01 -53.45 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 2.07 110.319 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.775 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -67.0 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.899 -1.125 . . . . 2.93 109.072 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.81 -40.47 66.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 120.76 -1.213 . . . . 1.77 108.197 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.4 ttp -67.82 -42.78 80.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.496 -0.753 . . . . 2.34 109.455 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 179' ' ' ILE . 86.6 mtp -62.74 -35.41 79.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 3.53 109.509 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.39 15.46 1.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.67 -0.863 . . . . 2.4 108.67 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.641 ' O ' ' N ' ' A' ' 160' ' ' ALA . 15.0 ptmt -52.28 -42.85 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.907 0.86 . . . . 4.18 109.798 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.812 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -38.3 -19.49 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.689 -0.687 . . . . 2.49 110.15 -179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.25 20.91 0.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 3.15 108.784 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -54.16 -37.42 64.41 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.219 -0.66 . . . . 3.4 109.219 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.74 48.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.914 -1.674 . . . . 2.83 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 115' ' ' TYR . 7.4 ttmm -139.9 158.34 44.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.531 -0.982 . . . . 2.45 108.888 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.775 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -95.49 127.88 41.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 1.9 108.661 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 164' ' ' LEU . 3.4 p -119.01 168.85 10.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.388 -0.82 . . . . 1.8 109.72 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.907 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -72.51 -29.91 64.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.009 . . . . 2.28 109.73 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 166' ' ' LEU . 99.8 mm-40 -46.47 -39.1 10.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.91 -1.119 . . . . 2.92 108.501 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.25 -34.76 73.22 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.393 -0.817 . . . . 1.85 109.193 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' O ' ' OG ' ' A' ' 173' ' ' SER . 9.1 m-85 -71.8 -45.28 62.08 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 2.14 109.13 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.42 -61.5 2.49 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 2.35 110.095 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 96.9 mt-10 -70.24 -37.62 75.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.997 -1.064 . . . . 2.92 110.242 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.91 -54.82 8.85 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.047 -1.073 . . . . 1.77 110.526 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 9.1 m -57.08 -38.48 73.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.198 -1.178 . . . . 2.18 109.712 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -83.18 -1.44 53.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 4.67 109.224 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -118.92 -83.23 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.959 -0.756 . . . . 2.92 108.959 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -79.04 129.5 72.81 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 2.61 109.248 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 178' ' ' SER . 74.0 Cg_endo -77.06 -169.98 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.326 2.017 . . . . 2.17 112.286 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.582 ' OG ' ' NE2' ' A' ' 181' ' ' GLN . 0.6 OUTLIER 80.11 -39.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.483 -0.76 . . . . 2.62 110.076 179.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.868 HD11 ' SD ' ' A' ' 156' ' ' MET . 6.6 mm -56.23 -44.67 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 2.0 110.883 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.3 m -97.62 -10.86 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.903 -1.123 . . . . 3.79 111.356 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.582 ' NE2' ' OG ' ' A' ' 178' ' ' SER . 11.8 pt20 -47.3 112.77 0.58 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.673 -1.267 . . . . 6.02 108.137 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' C ' HD13 ' A' ' 183' ' ' LEU . . . -77.49 165.36 24.45 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.898 -1.126 . . . . 4.48 109.738 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.0 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -96.22 -8.94 31.64 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.847 -0.797 . . . . 4.79 108.847 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -100.96 14.57 31.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.837 . . . . 5.27 110.022 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.0 mt -54.79 -35.36 63.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.047 -1.033 . . . . 7.1 110.024 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 77.3 t80 47.0 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.989 -1.07 . . . . 9.88 109.555 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 187' ' ' ASP . 53.4 p30 -92.89 9.12 36.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 8.42 109.626 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -81.04 42.2 2.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.716 -1.354 . . . . 9.13 109.716 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.4 mm? -60.22 -33.24 71.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -1.185 . . . . 11.72 109.465 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.97 -1.014 . . . . 12.62 109.457 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.487 -0.56 . . . . 15.48 109.487 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.23 165.59 24.9 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.493 . . . . 11.71 109.369 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -136.69 154.98 50.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -1.166 . . . . 12.65 109.692 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p -131.0 153.2 49.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 8.16 109.143 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -129.96 85.3 2.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 7.63 109.606 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 5' ' ' ASN . 2.7 m 39.53 21.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 5.22 109.883 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 5' ' ' ASN . 55.2 pttt -89.86 164.73 14.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 4.94 109.177 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD13 ' CZ ' ' A' ' 82' ' ' PHE . 24.7 tp -94.72 124.2 38.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 2.2 109.023 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' CG ' HG23 ' A' ' 12' ' ' VAL . 15.4 ptpt -82.86 145.0 49.03 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.998 . . . . 2.5 109.437 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -48.71 -31.04 18.14 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.924 1.749 . . . . 3.23 112.597 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.7 -42.42 99.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.028 . . . . 3.91 109.777 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.496 ' CG1' HD11 ' A' ' 8' ' ' LEU . 88.9 t -67.58 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.11 -0.994 . . . . 2.17 108.8 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 17' ' ' THR . 43.0 t -57.36 -46.16 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.346 -0.846 . . . . 2.64 108.948 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -40.57 96.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 4.15 108.855 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.84 -36.32 83.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.854 . . . . 3.01 109.193 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.678 HD22 ' OG1' ' A' ' 20' ' ' THR . 33.9 mt -65.37 -42.23 92.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.931 -1.108 . . . . 2.71 108.935 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 24' ' ' GLU . 15.7 p -59.08 -36.07 74.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.841 -1.54 . . . . 3.6 106.841 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -30.44 71.47 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.881 -1.155 . . . . 5.04 107.881 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' TYR . 28.7 ttpt -135.57 -129.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.5 -0.926 . . . . 5.04 108.5 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.678 ' OG1' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER 61.1 -31.9 0.07 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -0.771 . . . . 2.89 111.154 178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 19' ' ' LYS . 27.1 m-85 71.81 3.79 4.8 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.495 -0.753 . . . . 6.0 111.452 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.65 ' H ' ' CG2' ' A' ' 20' ' ' THR . 92.1 m-85 -129.18 165.34 21.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 2.94 108.829 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -71.23 168.02 18.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.065 -1.022 . . . . 3.98 110.244 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.4 mp0 -62.16 -35.99 80.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.616 -0.677 . . . . 4.23 110.314 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 6.6 mptt -63.11 -43.51 98.25 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.331 -0.856 . . . . 5.1 111.415 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -40.57 90.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.8 110.723 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 28' ' ' GLN . 17.0 m -71.48 -42.41 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.1 . . . . 2.44 110.364 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 27' ' ' VAL . 97.0 mt-30 -62.91 -43.13 99.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.811 -1.181 . . . . 3.85 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.09 -41.54 97.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 3.75 109.699 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -71.07 -45.64 63.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 5.2 109.189 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.682 ' CG ' ' N ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -50.28 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.431 -0.951 . . . . 2.74 108.431 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' N ' ' CG ' ' A' ' 31' ' ' TYR . 27.9 ttmt -62.12 -20.87 64.52 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.391 -0.966 . . . . 5.06 108.391 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.37 -72.49 0.46 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 111.09 -0.804 . . . . 2.92 111.09 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -34.75 77.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.771 -1.429 . . . . 3.92 110.211 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.8 mt -64.63 -25.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.732 -1.23 . . . . 3.57 108.983 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -48.06 -41.17 25.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 6.37 109.088 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.66 -37.97 86.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -0.975 . . . . 7.82 108.928 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' ILE . 1.4 p -162.33 152.63 14.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.427 -0.796 . . . . 5.72 109.187 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.65 -21.82 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.496 2.13 . . . . 4.71 111.956 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.6 p -65.02 156.43 31.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.955 . . . . 5.05 108.586 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.69 41.89 1.41 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 2.56 109.603 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -118.29 141.32 48.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -1.03 . . . . 3.09 108.96 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 47' ' ' GLY . 37.7 tp -113.34 133.15 55.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 2.82 109.91 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.15 173.31 2.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 2.91 109.24 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.96 -40.73 98.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.35 -0.844 . . . . 1.72 109.739 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.46 98.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 2.06 110.038 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -55.5 -50.13 61.61 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.903 -1.279 . . . . 2.03 109.903 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' HG13 ' A' ' 51' ' ' ILE . 65.0 t80 -60.17 -40.28 89.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -1.228 . . . . 2.65 108.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' NE2' HG22 ' A' ' 62' ' ' THR . 48.5 mt-30 -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.571 -1.331 . . . . 2.8 108.766 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -64.84 -43.33 93.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.25 -0.906 . . . . 3.4 111.344 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 48' ' ' PHE . 1.5 pp -68.66 -36.71 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.569 -1.332 . . . . 2.99 109.724 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' N ' HG13 ' A' ' 51' ' ' ILE . 53.5 t80 -61.46 -45.05 95.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.745 -1.222 . . . . 5.31 107.755 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -66.21 -34.08 77.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.132 -0.692 . . . . 3.63 109.132 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -56.06 -46.01 79.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 4.23 109.826 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -81.59 -37.37 27.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 4.18 108.723 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' ' OE2' ' A' ' 137' ' ' GLU . 64.7 m-85 -125.69 81.63 64.89 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.622 -0.674 . . . . 6.44 109.418 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.06 -24.78 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.968 2.445 . . . . 4.28 112.246 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' HG23 ' A' ' 136' ' ' VAL . 80.9 m-85 -86.29 7.12 26.64 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.153 -0.967 . . . . 4.17 109.547 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.61 168.68 0.13 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.497 -1.441 . . . . 3.59 109.497 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -57.17 169.9 0.64 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -1.158 . . . . 5.63 109.066 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' O ' ' OG1' ' A' ' 62' ' ' THR . 52.5 Cg_exo -48.19 -59.17 1.35 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.378 2.052 . . . . 4.4 112.446 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 2.2 m -170.36 -28.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 3.54 110.26 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -45.28 80.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.988 -1.07 . . . . 3.3 110.346 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' O ' HG23 ' A' ' 68' ' ' VAL . 78.8 t80 -64.61 -42.01 95.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.974 -1.079 . . . . 2.12 109.604 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.49 86.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 1.79 109.715 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.444 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 69.0 p -65.91 -35.61 81.1 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.263 -0.898 . . . . 2.04 109.011 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' O ' HG12 ' A' ' 71' ' ' VAL . 3.6 m-30 -58.88 -41.81 87.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.55 -0.907 . . . . 2.31 108.55 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.3 t -65.14 -67.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.321 -0.992 . . . . 1.71 108.321 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.4 t80 -41.99 -25.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.417 -0.802 . . . . 4.33 109.428 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' VAL . 80.6 m-20 -81.02 -68.79 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.128 -0.983 . . . . 2.75 109.681 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG23 HD22 ' A' ' 112' ' ' ASN . 12.3 p -68.09 -43.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.097 -1.002 . . . . 1.91 110.553 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . 18.0 t80 -55.57 -38.29 69.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.952 -1.093 . . . . 2.75 109.944 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -64.91 98.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.871 -1.143 . . . . 2.3 108.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.89 -41.6 97.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 5.3 110.015 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -65.64 -27.42 68.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 3.3 109.673 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 58.82 35.75 24.41 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.715 -0.846 . . . . 5.34 108.715 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 40.5 p30 -92.27 4.13 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.734 . . . . 3.11 109.817 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.74 -0.74 89.25 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.78 -1.328 . . . . 2.85 109.78 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 66.8 mtt85 -141.57 147.71 38.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.152 . . . . 4.19 109.096 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -95.4 126.61 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 1.76 108.178 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.46 162.07 15.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 2.4 110.508 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -49.71 -37.32 28.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.545 -0.722 . . . . 3.27 109.152 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.7 t -59.26 -52.31 66.21 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.206 -0.934 . . . . 2.35 110.261 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.5 -38.63 77.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 2.09 110.451 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 85' ' ' PHE . 1.6 t80 -69.06 -59.39 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 2.22 111.315 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.92 -42.23 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.767 -1.208 . . . . 1.9 110.524 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -67.16 -54.79 17.98 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.742 -1.223 . . . . 2.63 111.287 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.65 95.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 1.56 109.686 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CE1' ' A' ' 85' ' ' PHE . 12.6 tp -57.68 -39.51 77.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.031 -1.099 . . . . 2.17 108.031 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -60.71 -42.23 96.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.334 -0.853 . . . . 2.01 108.713 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -37.5 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.775 -1.195 . . . . 2.2 107.775 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -31.12 70.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.378 -0.601 . . . . 2.75 109.378 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -53.71 -54.01 44.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.97 -1.081 . . . . 3.47 109.487 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 177.77 60.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.522 -0.736 . . . . 8.35 109.216 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.71 -175.76 50.56 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 3.29 109.616 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.9 m -73.93 151.88 40.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -1.129 . . . . 3.18 109.035 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 97' ' ' LEU . 2.2 mm? -55.56 -30.49 60.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.217 -0.927 . . . . 4.22 108.778 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.02 -42.85 91.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 3.59 109.22 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -65.61 -41.34 92.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 3.04 108.917 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -62.37 -40.26 95.85 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.63 -0.878 . . . . 3.12 108.63 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.2 tp -58.75 -43.84 90.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.721 -0.844 . . . . 2.31 108.721 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -59.31 -40.75 87.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.155 -1.054 . . . . 3.93 108.155 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CZ3' HD13 ' A' ' 107' ' ' LEU . 23.5 t90 -59.8 -44.32 94.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.743 -0.836 . . . . 4.4 108.743 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.05 85.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 1.41 109.507 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.28 -51.13 70.2 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.413 -0.804 . . . . 2.69 110.572 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' HG21 ' A' ' 71' ' ' VAL . 9.9 mtmp? -60.25 -43.73 95.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 3.23 109.53 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 7.5 tt -69.7 -33.32 72.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.314 -0.866 . . . . 1.99 110.439 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 121' ' ' MET . 0.1 OUTLIER -54.06 -24.57 17.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.95 -1.094 . . . . 2.51 108.743 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.619 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 54.5 t0 -118.52 126.04 51.16 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.792 HD23 ' H ' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -60.7 -35.29 75.92 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.344 -0.848 . . . . 3.31 110.134 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.792 ' H ' HD23 ' A' ' 110' ' ' LEU . 42.5 p30 -113.07 -19.71 11.77 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.22 -0.925 . . . . 2.09 110.256 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.619 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 4.7 p30 41.72 51.14 4.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.117 -0.989 . . . . 3.68 109.965 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.506 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 26.1 m-20 -70.57 10.44 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 2.51 108.88 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.38 -17.91 52.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.246 -1.941 . . . . 2.39 108.246 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.482 ' CE2' HG22 ' A' ' 165' ' ' THR . 12.3 m-85 -123.14 131.34 53.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.717 -0.872 . . . . 2.76 108.924 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.7 mt -112.86 138.97 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 1.6 109.084 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 p -116.81 159.15 22.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.226 -1.028 . . . . 1.73 108.226 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' NH2' ' OD2' ' A' ' 157' ' ' ASP . 29.7 mmt-85 -60.61 -37.56 81.83 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.078 -1.014 . . . . 3.17 109.395 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.73 -44.53 95.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 2.44 109.476 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.77 -42.09 91.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.71 108.722 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 125' ' ' VAL . 63.9 ttp -63.55 -42.34 98.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.828 -0.804 . . . . 3.66 108.828 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.5 -37.58 87.86 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.961 -0.755 . . . . 1.77 108.961 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.2 -46.65 89.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.101 -1.0 . . . . 2.01 108.743 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 124' ' ' ILE . 35.1 mm -67.38 -32.49 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 1.14 108.95 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 121' ' ' MET . 44.0 t -59.05 -47.15 90.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.11 -0.993 . . . . 1.83 108.44 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -63.72 -38.25 90.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.527 -0.733 . . . . 2.16 109.227 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.87 67.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 1.78 109.648 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.558 ' O ' HG22 ' A' ' 132' ' ' VAL . 43.8 pt -67.92 -34.19 65.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.982 -1.074 . . . . 2.42 108.898 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -53.11 -44.95 68.04 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.503 -1.295 . . . . 5.07 107.503 179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -64.58 -37.73 88.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.57 -1.27 . . . . 3.05 107.57 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.644 ' O ' HG21 ' A' ' 135' ' ' THR . 15.7 ttp -62.25 -34.24 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.04 -0.726 . . . . 4.88 109.04 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 128' ' ' ILE . 29.2 m -104.06 0.02 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 3.55 109.733 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -93.4 125.92 8.4 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.335 -1.506 . . . . 3.52 109.335 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 t30 56.95 40.04 29.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -1.231 . . . . 4.29 108.899 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 131' ' ' MET . 43.4 p -131.01 176.5 8.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.537 -0.727 . . . . 3.68 109.635 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.2 t -113.08 -0.01 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.395 -0.965 . . . . 5.42 108.395 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.581 ' OE2' ' CD1' ' A' ' 56' ' ' PHE . 67.2 tt0 -106.73 52.19 0.72 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 5.6 109.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 135' ' ' THR . 0.7 OUTLIER -126.44 155.06 74.94 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.106 -0.996 . . . . 2.5 109.376 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 142' ' ' GLU . 32.1 Cg_exo -53.38 142.63 57.32 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.2 1.267 . . . . 3.55 111.251 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.86 -42.67 84.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.876 -1.14 . . . . 5.65 108.357 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.42 -28.28 61.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.25 -1.018 . . . . 6.82 108.25 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 76.3 tt0 61.68 57.36 2.26 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.544 -0.91 . . . . 6.56 108.544 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 144' ' ' THR . 20.1 t-20 -51.23 -41.36 60.27 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.57 -0.852 . . . . 5.59 108.941 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.505 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.8 OUTLIER 32.8 62.65 1.42 Allowed Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.758 -0.589 . . . . 3.06 110.028 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' CG ' ' O ' ' A' ' 182' ' ' ALA . 65.5 Cg_endo -76.39 92.17 1.09 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.564 2.176 . . . . 3.91 113.1 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 149' ' ' VAL . 35.6 tt0 -96.27 -74.84 0.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 3.87 108.899 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.46 -30.37 64.98 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.007 -1.058 . . . . 3.64 108.392 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -46.72 89.55 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 4.99 110.218 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 146' ' ' GLU . 18.1 m -67.53 -36.72 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.729 -1.232 . . . . 1.57 109.591 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.31 -52.01 67.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.898 -1.126 . . . . 2.71 109.777 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -71.17 -45.47 63.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 4.73 109.546 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.73 -46.48 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 2.07 110.448 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -66.43 -40.29 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.662 -1.274 . . . . 2.93 109.388 -179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.11 -32.59 35.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.27 -1.372 . . . . 1.77 107.386 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' CG ' ' A' ' 158' ' ' LYS . 56.0 ttp -77.2 -55.1 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.731 -0.605 . . . . 2.34 109.504 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.509 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.4 mmm -56.12 -31.5 63.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 3.53 109.814 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 63.4 t0 -66.23 16.41 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.543 -0.723 . . . . 2.4 110.595 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 156' ' ' MET . 6.0 mtmp? -42.72 -33.89 0.81 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.86 -1.15 . . . . 4.18 110.366 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.794 HD22 ' H ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -47.56 -29.64 3.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.145 -0.972 . . . . 2.49 109.503 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 62.3 22.94 13.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 3.15 109.539 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 163' ' ' LYS . 25.8 p-10 -63.97 -22.56 66.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 3.4 109.192 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.87 -18.68 46.1 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.935 -1.666 . . . . 2.83 108.935 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.491 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 61.7 mttt -138.99 177.56 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.433 -1.039 . . . . 2.45 109.282 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 165' ' ' THR . 0.8 OUTLIER -110.27 120.13 41.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.837 -1.171 . . . . 1.9 107.837 178.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.625 ' N ' HD13 ' A' ' 164' ' ' LEU . 34.4 p -110.83 167.39 10.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.157 -0.965 . . . . 1.8 109.826 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.939 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -67.58 -30.99 70.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 2.28 110.131 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 166' ' ' LEU . 3.6 mm100 -46.18 -37.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.852 -1.155 . . . . 2.92 108.466 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.67 -39.38 70.34 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.452 -0.78 . . . . 1.85 109.236 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 173' ' ' SER . 19.9 m-85 -69.02 -44.64 72.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.124 -0.985 . . . . 2.14 109.733 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.63 -53.12 45.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.127 -0.983 . . . . 2.35 110.633 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.77 -38.79 86.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 2.92 109.33 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.74 -21.57 57.55 Favored Glycine 0 C--O 1.198 -2.114 0 N-CA-C 109.195 -1.562 . . . . 1.77 109.195 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 169' ' ' PHE . 11.0 t -62.23 -38.22 88.4 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.92 -1.341 . . . . 2.18 107.992 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -59.31 -54.96 40.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.227 -0.989 . . . . 4.67 109.045 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.405 ' C ' ' OD1' ' A' ' 176' ' ' ASP . . . -76.7 -20.77 56.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.576 -1.268 . . . . 2.92 107.576 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 172' ' ' GLY . 4.4 p-10 41.17 56.1 8.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 CA-C-N 114.888 -1.051 . . . . 2.61 112.361 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 179' ' ' ILE . 73.6 Cg_endo -81.77 109.57 2.02 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.402 1.402 . . . . 2.17 109.786 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.5 t 48.23 10.97 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.757 -1.214 . . . . 2.62 110.024 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 177' ' ' PRO . 24.1 mm -89.9 -73.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.627 -1.296 . . . . 2.0 110.129 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 176' ' ' ASP . 1.9 m -64.63 -19.4 25.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.143 -0.973 . . . . 3.79 108.798 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -86.36 44.42 1.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.354 -0.98 . . . . 6.02 108.354 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 145' ' ' PRO . . . -47.05 -35.22 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.833 . . . . 4.48 109.817 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -127.97 -28.05 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 4.79 109.221 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.6 p -66.96 161.18 24.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 5.27 108.822 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 50.5 tp -148.06 -26.84 0.34 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.01 . . . . 7.1 110.091 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.67 115.02 25.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.963 . . . . 9.88 109.869 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.41 -35.75 81.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 8.42 108.906 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.99 12.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.179 -1.568 . . . . 9.13 109.179 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 190' ' ' VAL . 34.8 tp -55.87 -35.31 66.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.359 -1.083 . . . . 11.72 109.497 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 189' ' ' LEU . 5.6 p . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.017 -0.992 . . . . 12.62 110.407 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.337 -0.616 . . . . 15.48 109.337 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.61 -64.94 2.52 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.631 -1.387 . . . . 11.71 109.631 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -131.53 45.23 2.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.33 -1.1 . . . . 12.65 109.732 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 6' ' ' SER . 78.4 p -69.53 -11.82 61.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 8.16 109.632 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.534 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.4 OUTLIER -44.81 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 7.63 109.342 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 4' ' ' SER . 51.0 m -122.94 151.06 42.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.475 -0.766 . . . . 5.22 109.334 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -61.62 175.17 0.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 4.94 109.224 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -62.38 142.63 57.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 2.2 109.441 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -65.26 147.54 98.52 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 2.5 109.251 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.05 -32.09 12.66 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 3.23 112.363 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -58.31 -38.6 77.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 3.91 109.474 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -70.58 -41.92 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.208 -0.932 . . . . 2.17 108.989 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 17' ' ' THR . 27.7 t -56.21 -40.67 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.848 -1.158 . . . . 2.64 109.495 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.81 -57.8 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.782 -1.199 . . . . 4.15 110.991 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.91 -33.65 75.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.091 -1.005 . . . . 3.01 110.867 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 19' ' ' LYS . 35.7 tp -70.12 -55.2 10.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.965 -1.084 . . . . 2.71 109.268 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 13' ' ' VAL . 71.6 p -58.82 -32.41 69.35 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.391 -0.966 . . . . 3.6 108.391 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -29.69 63.02 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.849 -1.537 . . . . 5.04 106.849 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' LEU . 2.3 ttpm? -145.11 110.33 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.868 -0.79 . . . . 5.04 108.868 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.859 HG23 ' H ' ' A' ' 22' ' ' PHE . 1.3 t -174.33 -29.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.195 -0.94 . . . . 2.89 109.428 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 78.56 10.78 1.78 Allowed 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.302 0.573 . . . . 6.0 111.111 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.859 ' H ' HG23 ' A' ' 20' ' ' THR . 82.9 m-85 -134.13 161.78 33.93 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.459 -0.941 . . . . 2.94 108.459 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 77.4 p -73.02 166.48 23.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.839 -1.163 . . . . 3.98 109.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' HG21 ' A' ' 17' ' ' THR . 27.3 mt-10 -62.98 -38.42 91.08 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.564 -0.71 . . . . 4.23 109.639 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -64.65 -37.86 89.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.019 -1.05 . . . . 5.1 109.501 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -68.39 -40.68 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 3.8 111.189 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 23' ' ' THR . 1.4 m -71.47 -41.48 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.59 -1.319 . . . . 2.44 109.665 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.4 mt-30 -63.36 -42.3 98.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.073 -1.017 . . . . 3.85 109.22 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -68.16 -37.92 81.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 3.75 109.823 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -65.7 -47.54 75.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.122 -0.986 . . . . 5.2 109.118 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 8' ' ' LEU . 53.7 t80 -58.43 -56.7 18.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.77 . . . . 2.74 109.518 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -63.44 -26.63 68.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.455 -0.943 . . . . 5.06 108.455 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.86 -66.69 2.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 111.12 -0.792 . . . . 2.92 111.12 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 39.2 p90 -75.67 -30.83 59.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.654 -1.498 . . . . 3.92 110.863 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' HA2' ' A' ' 41' ' ' GLY . 4.9 mm -57.85 -43.88 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.835 -1.166 . . . . 3.57 109.471 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.62 -47.69 84.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 6.37 109.186 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -64.57 -39.44 93.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 7.82 108.735 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.8 83.88 51.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 5.72 108.864 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.17 -20.74 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.242 . . . . 4.71 112.452 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -56.24 -38.3 70.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.072 -1.018 . . . . 5.05 108.845 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 73.52 23.06 77.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.208 -1.157 . . . . 2.56 110.208 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' NE2' ' CD ' ' A' ' 79' ' ' ARG . 12.6 pt20 -139.82 151.08 45.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.274 . . . . 3.09 109.468 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 ' C ' ' A' ' 47' ' ' GLY . 35.7 tp -116.12 135.06 54.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.465 -0.772 . . . . 2.82 109.535 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -56.71 168.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.91 109.119 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.64 95.24 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.405 -0.809 . . . . 1.72 109.701 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.08 96.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 2.06 109.649 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -59.72 -43.12 98.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.347 -1.501 . . . . 2.03 109.347 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.59 -40.11 96.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -1.142 . . . . 2.65 109.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.026 ' NE2' HG22 ' A' ' 66' ' ' THR . 85.7 mt-30 -64.31 -36.34 83.78 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.92 -1.112 . . . . 2.8 109.092 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -66.14 -54.18 28.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 3.4 110.711 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.16 -36.98 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.894 -1.129 . . . . 2.99 109.1 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -63.73 -38.1 89.86 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.795 -1.187 . . . . 5.31 107.795 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -61.48 -42.05 98.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.747 -0.834 . . . . 3.63 108.747 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -59.14 -42.03 89.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 4.23 109.112 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 4.4 m-30 -69.31 -37.59 77.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 4.18 108.845 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 55.3 m-85 -132.09 71.63 79.78 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 6.44 110.329 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -97.36 33.46 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.715 2.943 . . . . 4.28 113.476 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' HB2' HG23 ' A' ' 136' ' ' VAL . 95.5 m-85 -99.21 8.42 44.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.54 -1.35 . . . . 4.17 111.024 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.97 37.79 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.016 -1.564 . . . . 3.59 110.725 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 131' ' ' MET . 0.6 OUTLIER -59.46 112.49 5.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.595 -0.944 . . . . 5.63 109.352 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 22.6 Cg_endo -93.1 41.52 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.838 2.359 . . . . 4.4 112.749 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 66' ' ' THR . 20.6 m -97.17 -80.99 0.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 3.54 110.974 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 62.2 mttm -59.3 -45.66 90.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 3.3 111.002 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 43.5 t80 -63.28 -43.96 96.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 2.12 109.501 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -66.3 -50.64 62.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.156 -0.965 . . . . 1.79 109.683 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 1.026 HG22 ' NE2' ' A' ' 49' ' ' GLN . 69.2 p -64.65 -32.59 74.33 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.348 -0.845 . . . . 2.04 109.431 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.1 m-30 -62.73 -48.23 80.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.346 -0.846 . . . . 2.31 109.197 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 64' ' ' PHE . 21.7 t -59.31 -50.99 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.734 -1.209 . . . . 1.71 107.734 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -53.01 -46.32 68.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 4.33 109.423 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.596 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 86.2 m-20 -65.3 -43.2 91.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 2.75 110.58 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 110' ' ' LEU . 24.4 t -86.83 -58.01 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.998 -1.064 . . . . 1.91 110.608 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.065 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 84.3 t80 -51.53 -37.28 48.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 2.75 110.685 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.34 104.97 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.776 -1.202 . . . . 2.3 108.397 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 97.1 mt-10 -66.66 -43.03 85.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 5.3 110.505 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -65.26 -31.09 72.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.078 -1.014 . . . . 3.3 109.67 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm 56.73 35.52 26.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.401 -0.963 . . . . 5.34 108.401 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.83 4.95 53.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 3.11 109.892 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.1 -7.85 76.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.346 -1.502 . . . . 2.85 109.346 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 77.8 mtt85 -131.61 147.31 52.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -1.008 . . . . 4.19 108.773 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 80' ' ' ILE . 1.7 tp -83.99 141.86 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.956 -1.09 . . . . 1.76 108.661 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.15 152.86 17.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 2.4 110.44 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -46.35 -48.0 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.5 -0.75 . . . . 3.27 109.136 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -58.1 -42.98 86.83 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.056 -1.027 . . . . 2.35 108.648 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 99.0 mt-10 -67.99 -41.4 82.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.21 -0.931 . . . . 2.09 109.556 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.655 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -67.12 -56.57 9.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.077 . . . . 2.22 110.538 -179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -29.76 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.873 -1.142 . . . . 1.9 109.605 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -74.25 -57.91 3.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.936 -1.102 . . . . 2.63 110.925 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.065 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.52 -42.25 87.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.587 -1.321 . . . . 1.56 107.921 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.655 HD22 ' CE1' ' A' ' 85' ' ' PHE . 16.9 tp -57.71 -41.14 81.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.648 -0.871 . . . . 2.17 108.648 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 t -61.66 -39.14 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.335 -0.853 . . . . 2.01 108.981 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.68 -38.3 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 2.2 108.975 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.9 p -64.61 -35.25 80.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.313 -0.867 . . . . 2.75 109.475 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 t -57.49 -51.68 68.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 3.47 109.531 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -141.72 -67.0 0.4 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 8.35 109.257 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 123.78 0.81 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 3.29 109.584 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.576 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.39 165.33 11.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.246 . . . . 3.18 109.116 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 66.6 mt -52.29 -36.91 54.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.951 . . . . 4.22 109.321 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.3 -51.23 68.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 3.59 109.682 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 96' ' ' THR . 21.1 mp0 -65.96 -39.69 90.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 3.04 109.585 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -61.23 -41.18 96.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 3.12 109.33 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.579 HD11 HG11 ' A' ' 180' ' ' VAL . 8.4 tt -64.83 -43.46 93.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 2.31 108.889 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HG3' ' HZ2' ' A' ' 106' ' ' LYS . 34.4 tpt85 -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 3.93 108.952 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.42 -46.1 91.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.787 . . . . 4.4 109.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.99 99.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 1.41 110.358 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 69.0 t80 -60.93 -51.46 69.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 2.69 109.861 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' HZ2' ' HG3' ' A' ' 102' ' ' ARG . 31.2 mtmm -65.02 -39.78 93.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 3.23 110.279 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -66.33 -36.68 83.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 1.99 110.188 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.666 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 13.6 m-85 -60.15 -17.09 38.15 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.742 -1.224 . . . . 2.51 111.104 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 66.7 t0 -136.06 126.64 27.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.804 -1.185 . . . . 1.8 110.246 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 71' ' ' VAL . 45.3 tp -69.6 -53.47 18.65 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.72 -0.612 . . . . 3.31 109.847 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.6 p30 -76.71 -36.01 57.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 2.09 110.618 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.637 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 p-10 38.46 36.88 0.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.4 -0.813 . . . . 3.68 109.565 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 44.1 p-10 -64.6 -35.26 80.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.879 . . . . 2.51 110.072 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.581 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -138.1 -75.06 0.06 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 2.39 109.417 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -128.19 -167.26 1.74 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.389 -1.065 . . . . 2.76 109.089 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.478 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 2.2 mt -109.21 146.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.559 -0.713 . . . . 1.6 109.147 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 p -124.96 156.22 38.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.214 -1.032 . . . . 1.73 108.214 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.608 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.04 -39.6 90.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.882 -1.136 . . . . 3.17 109.772 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.8 -44.35 90.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.027 -1.046 . . . . 2.44 108.704 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE1' ' CG ' ' A' ' 109' ' ' ASP . 98.2 mt-10 -68.44 -37.8 80.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.496 -0.927 . . . . 1.71 108.496 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.666 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 6.5 tpp -61.8 -41.24 97.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.807 -0.812 . . . . 3.66 108.807 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.9 -39.18 87.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 1.77 109.477 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.85 -40.93 90.24 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.139 -0.976 . . . . 2.01 108.748 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ILE . 24.7 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 1.14 109.953 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 53.2 t -59.24 -47.22 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.711 -1.243 . . . . 1.83 108.175 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.491 ' OD1' ' OE2' ' A' ' 146' ' ' GLU . 95.5 m-20 -64.02 -37.13 86.32 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.309 -0.869 . . . . 2.16 109.298 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.561 ' O ' ' SD ' ' A' ' 131' ' ' MET . . . -70.5 -64.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 1.78 110.95 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 132' ' ' VAL . 5.5 pt -64.11 -35.03 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 2.42 110.965 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 144' ' ' THR . 48.9 t80 -69.6 -49.58 52.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.746 -1.221 . . . . 5.07 110.228 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.64 -47.73 71.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.612 -1.305 . . . . 3.05 109.483 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.586 ' O ' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -72.5 -32.43 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 4.88 109.96 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.6 t -129.86 41.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.893 . . . . 3.55 110.608 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -72.24 27.19 0.69 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.406 -1.478 . . . . 3.52 109.406 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 132' ' ' VAL . 33.7 m120 -97.26 -152.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.334 -1.098 . . . . 4.29 109.866 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 p -64.77 -33.79 76.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.045 . . . . 3.68 110.827 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 58' ' ' PHE . 44.4 t -55.99 134.99 19.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 120.646 -1.284 . . . . 5.42 108.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 54.47 38.11 29.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 5.6 109.244 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 134' ' ' ASN . 1.6 tp -109.2 99.44 36.12 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 2.5 110.002 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HG2' ' H ' ' A' ' 143' ' ' ASN . 37.9 Cg_endo -75.32 138.97 22.96 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.982 1.788 . . . . 3.55 111.953 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.29 -42.4 93.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.191 -0.943 . . . . 5.65 109.833 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 78.5 mm-40 -66.02 -32.21 73.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 6.82 109.292 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.557 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 43.0 tt0 91.09 66.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.441 -0.577 . . . . 6.56 109.441 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.557 HD22 ' NH1' ' A' ' 148' ' ' ARG . 32.3 m120 -76.01 -24.26 55.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.334 -0.854 . . . . 5.59 109.426 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -33.45 -54.58 0.71 Allowed Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 3.06 112.272 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.496 ' C ' ' O ' ' A' ' 144' ' ' THR . 72.2 Cg_exo -23.26 95.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 122.894 2.396 . . . . 3.91 112.861 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 126' ' ' ASP . 97.6 mt-10 -55.92 -32.85 64.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.754 -0.591 . . . . 3.87 110.031 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -59.34 -38.58 80.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 3.64 109.836 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.557 ' NH1' HD22 ' A' ' 143' ' ' ASN . 78.9 ttt180 -57.93 -51.06 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 4.99 109.857 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.93 -32.17 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 1.57 108.842 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 57.6 t0 -51.4 -53.84 32.68 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.408 -1.433 . . . . 2.71 108.444 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -82.54 -48.74 10.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.193 -0.942 . . . . 4.73 110.506 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -52.37 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.079 -1.013 . . . . 2.07 110.525 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.88 -41.22 78.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.835 -1.166 . . . . 2.93 109.427 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.41 -39.04 66.92 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.581 -1.324 . . . . 1.77 107.446 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.2 ttp -64.32 -29.44 70.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.007 -0.738 . . . . 2.34 109.007 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 tpt -96.21 -4.3 42.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 3.53 110.055 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 61.2 t0 -103.93 16.03 27.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.096 -1.002 . . . . 2.4 110.69 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' ALA . 12.7 pttt -64.69 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.841 -1.162 . . . . 4.18 110.247 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.59 HD21 ' CG ' ' A' ' 161' ' ' ASP . 20.5 p-10 29.26 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.476 0.655 . . . . 2.49 110.709 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 33.35 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.711 -0.618 . . . . 3.15 111.542 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.59 ' CG ' HD21 ' A' ' 159' ' ' ASN . 0.5 OUTLIER -119.7 -43.56 2.57 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.001 -1.062 . . . . 3.4 109.324 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.52 ' O ' ' NH2' ' A' ' 118' ' ' ARG . . . 96.71 -21.36 46.28 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.078 -1.209 . . . . 2.83 110.078 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.504 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 12.6 mtmm -114.71 171.71 7.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.331 -1.1 . . . . 2.45 109.494 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -95.81 113.81 25.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 1.9 108.989 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -110.5 166.81 10.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 1.8 109.2 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 169' ' ' PHE . 7.4 mp -58.4 -41.46 84.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.039 -1.038 . . . . 2.28 110.23 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.498 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 95.5 mt-30 -37.71 -46.32 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 2.92 109.888 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -69.56 -38.36 77.38 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.332 -0.855 . . . . 1.85 109.941 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 164' ' ' LEU . 49.2 m-85 -72.46 -46.54 54.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.687 -1.258 . . . . 2.14 110.621 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.496 ' OE1' ' OE2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -63.47 -63.52 1.16 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.575 -1.328 . . . . 2.35 109.782 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 167' ' ' GLN . 39.8 mp0 -68.82 -39.53 79.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.902 -1.123 . . . . 2.92 111.126 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -67.91 -48.3 55.39 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.569 -1.3 . . . . 1.77 110.285 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 22.1 m -58.49 -49.54 77.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.031 -1.276 . . . . 2.18 109.401 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 4.67 108.994 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.89 -42.56 80.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.558 -0.714 . . . . 2.92 109.991 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.98 150.87 26.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 2.61 109.622 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.6 Cg_endo -76.18 -172.05 1.25 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.627 2.218 . . . . 2.17 112.394 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.4 p 80.4 -40.04 0.18 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 2.62 110.169 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.03 -44.54 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 2.0 110.302 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.579 HG11 HD11 ' A' ' 101' ' ' LEU . 3.6 m -107.64 -12.34 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.164 -0.96 . . . . 3.79 110.583 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -73.66 15.95 0.24 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.957 -1.089 . . . . 6.02 108.284 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 180' ' ' VAL . . . 53.9 -170.32 0.05 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.921 -0.77 . . . . 4.48 108.921 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.8 OUTLIER -91.2 31.49 1.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.236 -0.915 . . . . 4.79 108.578 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.0 m -120.68 141.4 50.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.771 . . . . 5.27 109.367 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.16 134.82 54.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.817 -0.809 . . . . 7.1 108.817 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -81.27 122.42 27.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.146 -0.972 . . . . 9.88 109.998 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -156.57 67.86 0.57 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.528 -0.916 . . . . 8.42 108.528 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.0 11.02 79.76 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.77 -1.732 . . . . 9.13 108.77 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 35.8 tp -58.08 -36.79 73.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.493 -1.004 . . . . 11.72 109.714 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.008 -0.996 . . . . 12.62 109.259 -179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.447 -0.575 . . . . 15.48 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.6 103.09 2.87 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.748 -1.341 . . . . 11.71 109.748 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -60.05 -30.81 69.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 12.65 109.476 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' SER . 23.5 m -54.6 -32.54 58.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 8.16 109.507 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.2 63.3 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 7.63 109.41 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 4' ' ' SER . 74.6 m -81.92 3.29 26.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 5.22 109.516 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 8' ' ' LEU . 24.9 mtpt 57.12 39.16 29.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.388 -0.82 . . . . 4.94 109.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 13' ' ' VAL . 37.5 tp 42.29 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.805 . . . . 2.2 109.803 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -62.94 135.95 96.36 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 2.5 109.633 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -49.49 -31.65 24.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.981 1.787 . . . . 3.23 112.807 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.92 -42.32 97.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.927 -1.108 . . . . 3.91 109.611 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.34 -38.13 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 2.17 108.619 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 8' ' ' LEU . 40.8 t -57.85 -44.65 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.715 -0.846 . . . . 2.64 108.715 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.51 -39.5 88.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.278 -1.008 . . . . 4.15 108.278 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.48 -34.18 77.62 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.861 -0.792 . . . . 3.01 108.861 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 20' ' ' THR . 12.3 mt -66.57 -58.82 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 2.71 109.786 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' LEU . 5.1 p -50.88 -40.18 55.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.875 -1.528 . . . . 3.6 106.875 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -61.53 -36.67 81.22 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.201 -1.037 . . . . 5.04 108.201 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.8 ttpt -146.16 107.79 4.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.853 -0.795 . . . . 5.04 108.853 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.76 HG21 HG11 ' A' ' 27' ' ' VAL . 97.2 m -170.67 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 2.89 109.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 20' ' ' THR . 6.1 m-85 71.49 -13.44 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 6.0 108.373 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD2' ' OE1' ' A' ' 26' ' ' GLU . 1.8 m-85 -114.88 158.38 22.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.868 -1.16 . . . . 2.94 107.868 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -76.07 162.13 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.882 -1.136 . . . . 3.98 109.748 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.99 -32.51 74.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.468 -0.77 . . . . 4.23 109.523 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HZ2' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -61.17 -40.62 94.59 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.578 -1.326 . . . . 5.1 109.476 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.592 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -69.68 -43.14 73.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 3.8 111.215 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.76 HG11 HG21 ' A' ' 20' ' ' THR . 2.4 m -69.78 -41.02 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.635 -1.29 . . . . 2.44 109.452 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 96.8 mt-30 -61.39 -41.06 96.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.068 -1.02 . . . . 3.85 109.244 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.31 -40.83 94.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 3.75 109.355 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.433 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 38.6 m95 -67.36 -42.89 82.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 5.2 109.449 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 45.7 t80 -56.41 -47.55 78.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 2.74 109.267 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -84.5 -6.21 59.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 5.06 108.511 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.47 -55.02 7.96 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.725 -1.35 . . . . 2.92 109.725 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 9.4 p90 -87.3 -30.91 20.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.984 -1.304 . . . . 3.92 110.796 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 7.5 mm -59.91 -43.59 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.661 -1.275 . . . . 3.57 110.366 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -62.32 -41.42 98.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.972 -1.08 . . . . 6.37 111.111 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.649 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 26.3 p30 -66.2 -27.55 68.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.816 -1.178 . . . . 7.82 109.669 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -159.01 90.23 2.04 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.219 -0.926 . . . . 5.72 109.177 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 76.8 Cg_exo -47.02 114.39 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.93 1.754 . . . . 4.71 111.596 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 39' ' ' PRO . 2.8 m 174.01 -102.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 5.05 108.967 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.36 -11.42 4.08 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.814 -1.315 . . . . 2.56 109.814 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -97.36 120.66 38.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -1.208 . . . . 3.09 109.227 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.519 HD21 ' C ' ' A' ' 47' ' ' GLY . 24.8 tp -103.63 128.76 50.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 2.82 109.662 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -70.17 175.81 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 2.91 109.402 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.805 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -62.05 -39.96 94.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.461 -0.775 . . . . 1.72 110.079 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -44.99 96.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 2.06 109.718 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' C ' HD21 ' A' ' 43' ' ' LEU . . . -57.35 -41.87 93.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.253 -1.539 . . . . 2.03 109.253 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -58.82 -44.89 90.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.02 -1.282 . . . . 2.65 108.28 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.74 -34.98 73.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.081 -1.012 . . . . 2.8 108.83 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -60.81 -44.22 97.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 3.4 109.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 52' ' ' TYR . 4.9 pt -63.82 -35.12 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.095 -1.442 . . . . 2.99 108.646 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.47 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.2 m-85 -67.19 -39.29 86.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.966 -1.084 . . . . 5.31 108.285 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -59.32 -36.86 76.42 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.737 -1.227 . . . . 3.63 108.44 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.5 -37.1 86.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 4.23 109.911 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -93.68 -12.23 29.78 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 4.18 109.583 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -139.63 70.67 37.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 6.44 109.269 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -68.83 -6.67 18.6 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.407 2.738 . . . . 4.28 112.926 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 135' ' ' THR . 6.9 m-85 -56.96 -8.19 0.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.108 -0.995 . . . . 4.17 109.667 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' O ' ' CE ' ' A' ' 131' ' ' MET . . . 63.13 -129.52 40.87 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.316 -1.114 . . . . 3.59 110.316 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER 72.46 151.43 0.14 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.448 -1.031 . . . . 5.63 109.1 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' LYS . 66.8 Cg_exo -33.62 95.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.288 1.992 . . . . 4.4 111.606 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 65' ' ' ALA . 6.8 t -59.29 22.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.775 -0.578 . . . . 3.54 110.964 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' PRO . 84.3 tttt -56.69 -38.26 72.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.789 -1.194 . . . . 3.3 108.88 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.817 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 p90 -62.82 -37.41 86.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 2.12 108.808 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -62.29 -48.02 81.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.39 -0.819 . . . . 1.79 109.087 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -65.94 -41.74 90.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.86 . . . . 2.04 109.286 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.906 ' CZ ' HD11 ' A' ' 124' ' ' ILE . 36.6 t80 -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.399 -0.813 . . . . 2.31 109.147 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 64' ' ' PHE . 35.1 t -59.49 -52.43 61.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.231 -1.026 . . . . 1.71 108.231 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.805 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -53.57 -35.22 60.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.799 -1.188 . . . . 4.33 109.204 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' HD11 ' A' ' 110' ' ' LEU . 19.6 t-20 -61.42 -48.94 78.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 2.75 110.917 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' PHE . 3.1 p -94.16 -39.18 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.812 -1.18 . . . . 1.91 109.986 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 65.4 t80 -46.76 -32.56 3.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.815 -0.553 . . . . 2.75 109.86 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 60.1 t0 -71.11 113.49 8.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.022 -1.049 . . . . 2.3 108.804 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.41 -38.15 84.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.313 -0.867 . . . . 5.3 111.185 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 75' ' ' ASN . 38.8 p-10 -90.06 -3.68 57.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.857 -1.152 . . . . 3.3 110.543 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt 52.24 39.99 28.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.083 -1.011 . . . . 5.34 109.786 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 79' ' ' ARG . 58.3 p-10 -87.73 2.15 51.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.903 -1.123 . . . . 3.11 109.794 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.79 1.27 90.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.819 -1.312 . . . . 2.85 109.819 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.487 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 96.6 mtt180 -148.08 137.72 22.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -1.085 . . . . 4.19 108.835 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.33 125.71 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.523 -1.288 . . . . 1.76 107.523 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.71 153.21 21.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 2.4 110.819 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 86' ' ' ILE . 3.1 t80 -49.18 -46.15 45.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.616 -0.677 . . . . 3.27 109.653 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.5 m -60.13 -41.99 93.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.045 -1.034 . . . . 2.35 108.899 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 96.5 mt-10 -72.3 -36.71 69.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.336 -0.852 . . . . 2.09 109.614 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CE1' HD11 ' A' ' 89' ' ' LEU . 23.2 t80 -66.03 -53.99 31.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 2.22 110.537 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 87' ' ' GLN . 8.9 tp -67.57 -44.09 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 1.9 110.278 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 86' ' ' ILE . 14.8 mm100 -68.31 -47.09 68.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.869 -1.144 . . . . 2.63 110.163 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.02 -35.79 81.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.804 -1.185 . . . . 1.56 108.719 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.936 HD11 ' CE1' ' A' ' 85' ' ' PHE . 14.0 mt -58.27 -42.96 87.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.027 -1.046 . . . . 2.17 108.188 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 97.9 p -61.43 -39.66 91.58 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 2.01 108.618 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.48 -38.83 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.291 -1.374 . . . . 2.2 107.291 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -39.51 89.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.011 -0.736 . . . . 2.75 109.011 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 20.3 m -59.07 -42.67 90.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 3.47 108.954 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.0 mtp85 -158.7 -70.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.465 -0.939 . . . . 8.35 108.465 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.22 -173.09 55.24 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.7 -1.36 . . . . 3.29 109.7 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -99.09 158.93 15.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.346 -1.091 . . . . 3.18 108.504 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.776 ' H ' HD12 ' A' ' 97' ' ' LEU . 6.7 mp -53.35 -38.82 63.65 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.014 -1.054 . . . . 4.22 108.694 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.25 -41.19 81.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 3.59 109.691 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.25 -40.88 98.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 3.04 109.701 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -61.9 -41.5 97.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.127 -0.983 . . . . 3.12 108.989 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.34 -41.16 93.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.302 -0.874 . . . . 2.31 108.655 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -64.09 -38.63 91.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.224 -0.923 . . . . 3.93 109.002 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -58.83 -52.11 67.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 4.4 109.46 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.63 74.73 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 1.41 109.786 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' ' OD1' ' A' ' 112' ' ' ASN . 75.3 t80 -60.17 -49.88 75.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 2.69 110.329 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 109' ' ' ASP . 61.8 mttm -60.29 -41.47 93.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.092 -1.005 . . . . 3.23 109.889 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 107' ' ' LEU . 1.4 tt -72.1 -34.95 69.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.959 -1.088 . . . . 1.99 109.856 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -27.53 63.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 2.51 110.006 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 112' ' ' ASN . 15.9 t70 -141.94 153.27 44.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 1.8 109.699 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD11 ' OD1' ' A' ' 70' ' ' ASN . 55.7 tp -86.56 -79.96 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 3.31 110.06 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.617 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 43.5 p30 -69.72 -37.1 76.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 2.09 110.68 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.617 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 36.8 t30 65.73 -51.06 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.509 -0.745 . . . . 3.68 110.243 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.0 OUTLIER 50.09 28.04 2.82 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.185 -0.947 . . . . 2.51 108.966 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 166' ' ' LEU . . . 90.6 7.38 66.9 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.307 -1.117 . . . . 2.39 110.307 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.508 ' O ' ' O ' ' A' ' 112' ' ' ASN . 47.8 p90 -172.03 169.55 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.888 -1.36 . . . . 2.76 110.443 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.34 152.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.505 -0.747 . . . . 1.6 109.918 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.9 p -127.21 159.23 34.93 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.383 -0.969 . . . . 1.73 108.383 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.587 HH22 ' CG ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -64.6 -33.15 75.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.996 -1.065 . . . . 3.17 110.581 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 2.9 p-10 -68.19 -46.19 71.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.558 -1.339 . . . . 2.44 109.118 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 81.0 mt-10 -70.64 -42.53 70.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 1.71 108.893 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 125' ' ' VAL . 54.3 ttp -65.34 -49.32 69.85 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.921 -0.77 . . . . 3.66 108.921 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 122' ' ' LEU . 44.1 tp -61.77 -39.79 92.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.968 -0.752 . . . . 1.77 108.968 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.83 -36.79 80.01 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.011 -1.056 . . . . 2.01 108.439 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.906 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 5.2 mm -64.1 -56.24 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.299 -0.876 . . . . 1.14 109.955 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 121' ' ' MET . 0.8 OUTLIER -51.13 -40.15 21.37 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 O-C-N 120.508 -1.37 . . . . 1.83 107.937 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -58.0 -38.02 75.37 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.578 -1.326 . . . . 2.16 107.601 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 124' ' ' ILE . . . -72.1 -58.7 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.548 -0.72 . . . . 1.78 109.46 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 99.1 mt -57.22 -50.04 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 2.42 109.602 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 133' ' ' GLY . 2.3 t80 -55.35 -41.81 73.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 5.07 108.427 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -53.34 -46.18 69.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.185 -0.947 . . . . 3.05 108.823 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.672 ' SD ' ' CE1' ' A' ' 64' ' ' PHE . 18.2 tpt -74.48 -50.13 19.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 4.88 108.858 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 132' ' ' VAL . 55.0 t -69.76 -0.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.949 -0.76 . . . . 3.55 108.949 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -77.58 134.03 14.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.645 -1.782 . . . . 3.52 108.645 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 t30 53.11 40.82 31.84 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.022 -1.281 . . . . 4.29 107.882 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 58' ' ' PHE . 23.5 m -105.55 157.4 17.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.59 -0.694 . . . . 3.68 109.655 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.436 ' N ' HG22 ' A' ' 135' ' ' THR . 7.0 t -94.98 143.44 11.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.258 -0.901 . . . . 5.42 109.651 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 136' ' ' VAL . 96.6 mt-10 58.74 52.14 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 5.6 110.351 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -101.55 160.8 25.49 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.376 -0.972 . . . . 2.5 108.376 179.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.3 Cg_exo -49.19 99.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.5 1.467 . . . . 3.55 112.456 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.5 -33.62 60.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 5.65 109.577 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.69 ' OE2' HD22 ' A' ' 185' ' ' LEU . 21.8 pt-20 -63.41 -32.23 73.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.41 -0.806 . . . . 6.82 110.473 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 15.6 pt-20 -134.58 -37.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 6.56 110.174 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.532 ' O ' ' OG1' ' A' ' 144' ' ' THR . 35.8 t-20 60.97 70.73 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.032 -1.043 . . . . 5.59 109.424 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 53.4 105.44 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.796 . . . . 3.06 109.536 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.25 87.7 1.49 Allowed 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.353 2.036 . . . . 3.91 112.662 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.692 ' O ' HG22 ' A' ' 149' ' ' VAL . 46.8 mt-10 -86.69 -76.05 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.414 -0.804 . . . . 3.87 110.189 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -56.44 -33.87 66.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.879 -1.138 . . . . 3.64 109.05 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -57.4 -43.46 83.74 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 4.99 109.964 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 146' ' ' GLU . 27.1 m -71.73 -33.9 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.82 -1.175 . . . . 1.57 109.513 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -57.3 -53.8 54.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.671 -1.268 . . . . 2.71 109.367 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -72.47 -46.19 56.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 4.73 110.382 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.77 -55.63 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.88 . . . . 2.07 111.216 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -65.54 -35.09 79.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.491 -1.381 . . . . 2.93 109.844 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.81 -38.08 66.9 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.201 -1.4 . . . . 1.77 107.416 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.409 ' HG3' ' NZ ' ' A' ' 158' ' ' LYS . 51.9 ttp -66.15 -41.42 90.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.01 -0.737 . . . . 2.34 109.01 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 179' ' ' ILE . 85.7 mtp -74.48 -28.44 61.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 3.53 110.008 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' HH22 ' A' ' 118' ' ' ARG . 13.4 t70 -90.05 16.0 9.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.4 111.365 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.629 ' O ' ' N ' ' A' ' 160' ' ' ALA . 27.2 mttt -55.58 -25.88 40.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.773 -1.204 . . . . 4.18 109.772 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.731 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -42.58 -15.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.69 -0.631 . . . . 2.49 109.689 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.58 -4.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.657 -0.652 . . . . 3.15 110.442 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 58.4 p-10 -64.17 -31.78 73.11 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.949 -1.095 . . . . 3.4 109.531 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.637 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 76.01 6.42 82.53 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.124 -1.591 . . . . 2.83 109.124 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 65.9 mttt -137.48 143.09 41.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.999 . . . . 2.45 109.264 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -84.7 132.9 34.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.773 -1.936 . . . . 1.9 105.773 177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -121.9 160.42 24.8 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.578 -0.849 . . . . 1.8 110.27 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.788 ' H ' HD12 ' A' ' 166' ' ' LEU . 6.8 mp -51.27 -36.22 41.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.737 -0.602 . . . . 2.28 109.582 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 166' ' ' LEU . 57.5 tp60 -44.21 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.809 -1.182 . . . . 2.92 109.769 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -74.45 -31.23 62.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 1.85 110.795 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -66.21 -56.43 11.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 2.14 110.396 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.5 ' OE1' HD23 ' A' ' 166' ' ' LEU . 26.4 mt-30 -68.5 -43.08 77.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.672 -1.267 . . . . 2.35 110.138 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -66.68 -40.76 88.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 2.92 109.284 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.11 -41.19 54.73 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 1.77 109.297 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 1.2 t -55.06 -49.38 71.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -1.183 . . . . 2.18 109.113 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -63.59 -33.36 75.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 4.67 109.28 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.36 -79.47 0.58 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.634 -0.666 . . . . 2.92 109.915 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.605 ' N ' ' O ' ' A' ' 172' ' ' GLY . 34.5 t70 -52.91 117.45 11.23 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.61 109.467 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 178' ' ' SER . 65.8 Cg_endo -78.6 -170.91 1.08 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.103 1.869 . . . . 2.17 112.37 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 79.61 -40.15 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.51 -0.744 . . . . 2.62 109.691 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.517 HD11 ' SD ' ' A' ' 156' ' ' MET . 98.7 mt -63.8 -55.52 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.999 -1.063 . . . . 2.0 109.035 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 182' ' ' ALA . 73.2 t -81.29 -33.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 3.79 109.267 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -74.09 32.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 6.02 109.644 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.494 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.3 -35.19 62.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 4.48 109.252 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -173.26 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 4.79 109.684 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 186' ' ' TYR . 47.9 t -120.24 -61.74 1.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.329 -0.857 . . . . 5.27 109.467 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.69 HD22 ' OE2' ' A' ' 141' ' ' GLU . 7.5 mp 51.38 5.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 7.1 109.847 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 184' ' ' SER . 71.5 t80 53.3 166.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 9.88 109.604 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 186' ' ' TYR . 91.5 m-20 -55.75 -38.47 69.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.083 -1.011 . . . . 8.42 109.573 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 148.45 119.54 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 9.13 109.52 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' VAL . 67.6 mt -61.38 -33.02 72.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -1.138 . . . . 11.72 109.471 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' LEU . 4.4 m . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 117.971 -1.014 . . . . 12.62 109.469 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.403 -0.591 . . . . 15.48 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.37 120.36 15.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.455 -1.458 . . . . 11.71 109.455 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ASN . 75.4 tttt -59.67 -40.23 87.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -1.148 . . . . 12.65 109.678 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 3' ' ' LYS . 47.1 t 40.16 -100.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.412 -0.805 . . . . 8.16 109.487 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' LYS . 83.7 m-20 -112.43 143.65 43.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.797 . . . . 7.63 109.169 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.4 m -115.44 138.48 50.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 5.22 109.479 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 8' ' ' LEU . 21.5 mmtp -137.92 -68.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.428 -0.795 . . . . 4.94 109.272 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -89.17 157.55 18.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 2.2 110.065 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -66.62 151.8 95.95 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 2.5 109.408 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.78 -39.52 2.43 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.091 1.861 . . . . 3.23 112.9 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.07 -45.33 77.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.11 -0.994 . . . . 3.91 110.697 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.05 -31.71 55.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.841 -1.162 . . . . 2.17 108.734 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -50.31 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.101 -0.999 . . . . 2.64 108.575 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.87 -44.1 66.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 4.15 108.448 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' HH11 ' A' ' 18' ' ' ARG . 97.4 mt-10 -67.61 -30.76 70.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.32 -0.993 . . . . 3.01 108.32 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.557 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -67.82 -45.46 74.65 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 2.71 108.563 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' ARG . 44.3 p -62.27 -33.48 74.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 3.6 109.261 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.462 HH11 ' HA ' ' A' ' 15' ' ' GLU . 73.4 mtt85 -49.83 -29.9 8.82 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.505 -1.294 . . . . 5.04 107.505 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.572 ' HZ1' ' HG3' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -141.0 111.3 6.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.57 -0.9 . . . . 5.04 108.57 179.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 22' ' ' PHE . 4.0 m -166.01 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.938 -1.102 . . . . 2.89 110.637 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.604 ' CD2' ' OG ' ' A' ' 93' ' ' SER . 33.0 m-85 62.47 0.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.682 -1.229 . . . . 6.0 107.682 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 61.8 m-85 -132.6 164.43 26.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.602 -0.888 . . . . 2.94 108.602 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.5 p -77.76 171.83 14.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 3.98 109.671 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.5 mt-10 -66.07 -36.03 82.1 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.523 -0.736 . . . . 4.23 110.085 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 31.0 mmtp -60.36 -38.46 83.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.88 -1.137 . . . . 5.1 109.659 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.73 -40.02 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 3.8 110.864 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 20' ' ' THR . 1.0 OUTLIER -74.07 -32.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.807 -1.183 . . . . 2.44 109.423 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -66.29 -47.89 72.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.088 -1.007 . . . . 3.85 109.297 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.481 ' OE1' ' O ' ' A' ' 25' ' ' LYS . 5.2 mp0 -65.81 -43.03 89.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.012 . . . . 3.75 109.259 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -64.19 -39.01 93.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 5.2 108.626 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' CG ' HD12 ' A' ' 8' ' ' LEU . 60.9 t80 -53.41 -52.47 59.25 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.531 -1.285 . . . . 2.74 107.531 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG2' ' HZ2' ' A' ' 7' ' ' LYS . 47.0 mtmt -66.7 -30.98 71.36 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.429 -0.952 . . . . 5.06 108.429 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.55 -66.9 1.72 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.899 -0.881 . . . . 2.92 110.899 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 31' ' ' TYR . 2.8 p90 -79.95 -33.88 39.23 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.799 -1.413 . . . . 3.92 110.876 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 6.0 mm -60.37 -28.58 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.875 -1.141 . . . . 3.57 109.688 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -54.33 -41.73 69.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.058 -1.026 . . . . 6.37 109.557 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.64 -37.62 76.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 7.82 108.75 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 29.9 p -157.34 124.03 2.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.694 -0.854 . . . . 5.72 108.694 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.24 -30.07 7.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.695 1.597 . . . . 4.71 111.969 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.0 m -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 5.05 109.325 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.81 23.23 22.19 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.289 -1.524 . . . . 2.56 109.289 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.404 HE22 ' CG ' ' A' ' 81' ' ' GLU . 52.4 tp60 -96.93 120.64 37.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -1.098 . . . . 3.09 109.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.12 129.42 55.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.359 -0.838 . . . . 2.82 109.468 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -66.73 171.21 5.44 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.262 -0.899 . . . . 2.91 109.368 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -63.41 -38.0 89.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.43 -0.794 . . . . 1.72 109.986 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.4 95.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 2.06 110.061 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.05 95.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.067 -1.613 . . . . 2.03 109.067 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.73 -47.05 88.03 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.264 -1.139 . . . . 2.65 108.657 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.699 ' OE1' HG22 ' A' ' 66' ' ' THR . 27.9 mt-30 -60.79 -34.25 74.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.185 -0.947 . . . . 2.8 108.48 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -59.18 -44.08 92.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -0.762 . . . . 3.4 109.659 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 8.0 pt -70.06 -33.47 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.748 -1.181 . . . . 2.99 109.471 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -66.69 -47.14 73.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 5.31 108.941 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -62.51 -37.89 87.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 3.63 109.217 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.94 -40.58 76.67 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 4.23 109.256 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 4.2 m-85 -83.68 -41.16 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 4.18 109.552 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 2.6 m-85 -125.55 68.53 60.57 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 6.44 109.939 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.11 -28.14 5.07 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.71 2.273 . . . . 4.28 112.987 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -63.08 -27.19 69.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 4.17 110.483 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.76 178.9 53.81 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.853 -1.299 . . . . 3.59 109.853 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 6.4 t70 -56.95 120.89 41.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -1.171 . . . . 5.63 108.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' O ' ' OG1' ' A' ' 62' ' ' THR . 89.2 Cg_endo -80.5 33.56 0.52 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.227 1.952 . . . . 4.4 113.374 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 66' ' ' THR . 57.7 m -166.89 -49.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.617 -1.302 . . . . 3.54 111.279 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 45.1 mtpt -59.1 -55.89 29.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.962 -1.086 . . . . 3.3 111.364 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -76.23 -34.87 59.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.773 -1.204 . . . . 2.12 110.069 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.683 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -64.19 -44.94 90.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.972 -1.08 . . . . 1.79 109.086 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 49' ' ' GLN . 75.1 p -67.35 -38.04 84.2 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.302 -0.874 . . . . 2.04 109.275 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 3.4 m-85 -62.01 -42.15 98.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.946 . . . . 2.31 109.206 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 64' ' ' PHE . 77.5 t -61.83 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 1.71 108.7 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 3.4 t80 -56.81 -38.6 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.052 -1.03 . . . . 4.33 109.041 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 66' ' ' THR . 91.0 m-20 -60.79 -35.63 76.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.964 -1.085 . . . . 2.75 110.492 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.9 p -104.48 -53.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.006 -1.059 . . . . 1.91 110.833 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.663 ' N ' HG13 ' A' ' 71' ' ' VAL . 6.0 t80 -53.59 -42.75 67.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 2.75 109.855 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -83.1 120.95 26.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.13 . . . . 2.3 108.05 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' C ' ' N ' ' A' ' 76' ' ' LYS . 33.3 tt0 -118.6 -137.42 0.35 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.289 -0.882 . . . . 5.3 109.957 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 49.07 17.92 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.485 -0.931 . . . . 3.3 108.485 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' N ' ' C ' ' A' ' 74' ' ' GLU . 12.9 mtmt 43.48 18.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.874 -0.788 . . . . 5.34 108.874 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 75' ' ' ASN . 57.6 t0 -61.06 -38.6 86.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.552 -0.717 . . . . 3.11 109.828 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.45 83.3 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.788 -1.725 . . . . 2.85 108.788 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -143.04 139.3 30.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.292 -1.003 . . . . 4.19 108.292 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.603 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -78.57 131.12 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.208 . . . . 1.76 108.22 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' CG ' HE22 ' A' ' 42' ' ' GLN . 96.6 mt-10 -95.54 164.73 12.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.91 . . . . 2.4 110.57 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.86 -52.52 60.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 3.27 109.741 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -54.04 -46.87 72.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.071 -1.018 . . . . 2.35 109.376 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.1 mt-10 -66.48 -36.96 84.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.326 -0.859 . . . . 2.09 109.825 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.641 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -69.68 -59.33 3.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 2.22 109.807 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.2 tp -58.5 -26.29 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 1.9 109.476 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.572 ' HG3' ' HZ1' ' A' ' 19' ' ' LYS . 51.2 tt0 -71.76 -67.39 0.53 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.04 -1.038 . . . . 2.63 110.486 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.09 -36.23 72.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.644 -1.285 . . . . 1.56 108.448 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.641 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.6 tp -57.57 -40.18 78.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.374 -1.343 . . . . 2.17 107.374 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 p -62.35 -34.58 76.94 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.141 -1.059 . . . . 2.01 108.141 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 -36.18 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.453 -0.943 . . . . 2.2 108.453 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.1 p -62.47 -32.87 73.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 2.75 108.631 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.604 ' OG ' ' CD2' ' A' ' 21' ' ' TYR . 78.9 p -52.69 -37.72 59.4 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.277 -0.969 . . . . 3.47 108.528 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' CG ' ' N ' ' A' ' 95' ' ' GLY . 7.5 ptm180 -175.97 -44.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.507 -0.923 . . . . 8.35 108.507 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 94' ' ' ARG . . . 76.94 142.8 1.49 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.134 -1.186 . . . . 3.29 110.134 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.97 163.13 15.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -1.069 . . . . 3.18 108.499 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.5 mt -50.39 -42.3 53.36 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.97 -1.082 . . . . 4.22 108.974 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -66.87 -40.81 87.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 3.59 109.413 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -64.39 -37.65 88.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 3.04 109.658 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 94' ' ' ARG . 62.4 mttm -60.87 -40.9 94.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.965 . . . . 3.12 109.422 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 76.4 mt -67.42 -42.68 82.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 2.31 109.849 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -68.75 -43.69 75.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.92 -1.113 . . . . 3.93 109.677 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -66.63 -49.23 66.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 4.4 109.729 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.91 -45.87 63.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 1.41 110.499 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CB ' ' O ' ' A' ' 101' ' ' LEU . 69.2 t80 -61.5 -48.72 79.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 2.69 109.999 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ASP . 53.8 mtpt -59.91 -43.33 94.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.115 -0.991 . . . . 3.23 109.321 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.12 -38.31 82.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 1.99 109.753 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 2.51 108.753 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 16.6 t0 -107.55 137.79 44.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 1.8 109.277 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 110' ' ' LEU . 2.4 tm? -63.57 -42.4 98.32 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.117 -0.989 . . . . 3.31 108.935 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.0 p30 -114.17 -18.18 11.7 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.032 -1.042 . . . . 2.09 110.071 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 44.08 57.34 4.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 3.68 109.002 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -77.61 14.3 1.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.181 -0.949 . . . . 2.51 108.966 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.13 -8.67 49.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.479 -1.448 . . . . 2.39 109.479 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.71 134.23 38.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -1.114 . . . . 2.76 110.446 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.491 HG21 ' HE3' ' A' ' 121' ' ' MET . 76.8 mt -122.91 131.52 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.179 -0.674 . . . . 1.6 109.179 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 p -114.06 164.4 13.88 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.935 -1.135 . . . . 1.73 107.935 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.62 ' NH2' ' CB ' ' A' ' 157' ' ' ASP . 3.3 mpt_? -57.92 -39.25 77.5 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.909 -1.119 . . . . 3.17 109.497 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -56.7 -40.78 76.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.021 -1.05 . . . . 2.44 108.996 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.92 -39.22 79.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 1.71 108.957 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mtt -65.97 -40.12 90.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 3.66 109.708 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.61 -38.63 84.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.079 -1.013 . . . . 1.77 109.389 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -64.38 -47.02 80.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 2.01 109.287 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 124' ' ' ILE . 19.4 mm -71.53 -44.08 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 1.14 109.588 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 121' ' ' MET . 79.2 t -59.03 -41.79 84.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.346 -1.353 . . . . 1.83 107.346 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.84 -37.86 83.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.896 -1.15 . . . . 2.16 107.896 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -49.84 69.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 1.78 108.893 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.98 -35.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.268 -1.012 . . . . 2.42 108.268 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -59.57 -46.52 88.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.464 -0.939 . . . . 5.07 108.464 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -60.51 -39.98 89.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.167 -1.049 . . . . 3.05 108.167 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.559 ' SD ' ' CD2' ' A' ' 64' ' ' PHE . 14.6 ttp -62.93 -40.49 97.78 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.073 -1.084 . . . . 4.88 108.073 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 132' ' ' VAL . 41.9 t -88.66 -0.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.798 -0.815 . . . . 3.55 108.798 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -59.0 -36.57 88.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 3.52 109.503 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 135' ' ' THR . 19.0 t-20 -81.91 -75.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -1.171 . . . . 4.29 109.167 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 137' ' ' GLU . 37.2 p -158.56 -76.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 3.68 109.948 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.3 m 42.48 16.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.055 -1.028 . . . . 5.42 109.409 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 135' ' ' THR . 1.8 tm-20 68.64 89.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 5.6 109.783 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.55 145.06 81.69 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.178 -0.951 . . . . 2.5 108.79 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 143' ' ' ASN . 50.7 Cg_endo -73.02 112.03 3.42 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.994 1.796 . . . . 3.55 111.938 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.28 -38.36 87.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 5.65 109.607 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -67.4 -36.41 81.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.877 . . . . 6.82 109.891 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -101.7 -58.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.224 -0.922 . . . . 6.56 109.185 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 139' ' ' PRO . 25.3 t30 64.82 41.6 4.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.548 -0.72 . . . . 5.59 110.671 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 143' ' ' ASN . 1.2 t 30.96 65.58 0.93 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.701 -0.624 . . . . 3.06 111.125 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.62 94.87 0.44 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.192 2.595 . . . . 3.91 112.305 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.83 -37.16 83.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 3.87 110.778 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 148' ' ' ARG . 54.0 pttt -68.95 -41.84 77.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.7 -1.25 . . . . 3.64 110.189 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' HD12 ' A' ' 152' ' ' ILE . 57.2 ttt85 -62.62 -44.31 96.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 4.99 110.696 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.52 -35.75 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.822 -1.174 . . . . 1.57 109.526 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.3 -49.99 75.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 2.71 109.382 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -69.52 -45.6 68.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 4.73 109.55 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 148' ' ' ARG . 6.9 mt -59.28 -38.9 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 2.07 109.693 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 157' ' ' ASP . 1.5 m-85 -68.07 -39.21 83.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.74 -1.225 . . . . 2.93 109.471 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.93 -37.86 64.28 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.084 -1.447 . . . . 1.77 107.226 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.1 ttp -67.49 -33.09 74.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.979 -0.749 . . . . 2.34 108.979 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.7 mtp -84.77 -22.55 29.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 3.53 109.805 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CB ' ' NH2' ' A' ' 118' ' ' ARG . 22.4 t70 -94.52 16.18 16.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 2.4 111.574 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' ALA . 98.4 mttt -50.14 -25.41 3.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.74 -1.225 . . . . 4.18 109.59 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.1 m120 -40.72 -28.1 0.07 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.668 -0.645 . . . . 2.49 109.46 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.36 -3.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 3.15 109.792 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.4 p30 -61.5 -31.09 71.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.18 -0.95 . . . . 3.4 109.331 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 96.93 -20.19 51.78 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.427 -1.469 . . . . 2.83 109.427 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.6 mptt -120.02 -177.59 3.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -1.048 . . . . 2.45 109.793 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -122.36 129.93 52.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.164 -1.05 . . . . 1.9 108.164 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.721 ' N ' HD13 ' A' ' 164' ' ' LEU . 25.4 p -118.57 161.11 20.58 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 1.8 110.14 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 1.039 ' H ' HD23 ' A' ' 166' ' ' LEU . 1.1 pt? -56.34 -36.32 68.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 2.28 111.073 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 166' ' ' LEU . 51.5 tt0 -42.95 -39.98 2.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 2.92 109.134 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.7 -37.07 65.29 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.408 -0.808 . . . . 1.85 109.911 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.422 ' CE2' HD12 ' A' ' 164' ' ' LEU . 36.4 m-85 -72.2 -44.41 63.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.912 -1.118 . . . . 2.14 110.431 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -51.22 60.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.742 -1.224 . . . . 2.35 109.522 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.53 -41.26 80.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 2.92 109.954 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.68 -45.24 66.95 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.707 -1.357 . . . . 1.77 109.707 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -59.2 -37.55 77.71 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 2.18 109.923 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -89.85 3.51 52.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 4.67 109.496 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.43 -83.19 0.65 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.441 -0.787 . . . . 2.92 109.81 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.87 144.98 37.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 2.61 110.07 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 178' ' ' SER . 90.7 Cg_endo -78.98 179.56 6.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.667 2.245 . . . . 2.17 112.242 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.7 p 77.65 -39.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 2.62 109.837 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.58 -36.75 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 2.0 110.15 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 180' ' ' VAL . 2.3 p -114.13 -3.49 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -0.883 . . . . 3.79 109.815 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.71 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 7.1 tt0 -56.95 -31.22 64.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.095 -1.003 . . . . 6.02 108.809 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 181' ' ' GLN . . . 80.95 178.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 4.48 108.878 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.08 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -93.39 -50.09 5.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.27 -0.894 . . . . 4.79 109.665 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 185' ' ' LEU . 19.9 m -70.74 -83.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 5.27 109.309 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 184' ' ' SER . 8.3 tt 37.46 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.652 -0.655 . . . . 7.1 110.087 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -75.95 102.12 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.007 . . . . 9.88 108.861 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.618 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 54.1 p30 -69.82 -25.84 63.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 8.42 110.639 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -52.43 -32.02 37.06 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.658 -1.377 . . . . 9.13 109.658 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 38.2 tp -56.91 -36.05 69.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 11.72 109.275 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.298 -1.663 0 CA-C-O 117.957 -1.021 . . . . 12.62 109.506 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.387 -0.597 . . . . 15.48 109.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.43 47.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.721 -1.351 . . . . 11.71 109.721 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.2 tptt 61.55 45.55 8.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -1.047 . . . . 12.65 109.071 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -124.15 146.59 48.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.447 -0.783 . . . . 8.16 109.141 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -139.27 -172.0 3.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 7.63 109.91 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER 71.78 -81.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.505 -0.747 . . . . 5.22 109.594 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 6' ' ' SER . 68.4 mttm 36.45 -91.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.392 -0.817 . . . . 4.94 110.124 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -110.85 169.86 8.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.395 -0.815 . . . . 2.2 108.913 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -60.17 148.33 78.74 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 2.5 108.997 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.52 -32.53 59.08 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 3.23 112.556 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.59 91.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.991 . . . . 3.91 109.759 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.81 -43.93 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 2.17 109.707 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.875 ' O ' HG23 ' A' ' 17' ' ' THR . 45.7 t -60.73 -41.99 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.935 . . . . 2.64 109.791 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.34 -50.18 72.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 4.15 109.913 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.3 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.01 . . . . 3.01 108.982 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.563 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.2 mm? -63.79 -38.21 90.25 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 2.71 109.042 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 13' ' ' VAL . 7.5 p -68.97 -34.01 74.63 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.061 -1.024 . . . . 3.6 108.514 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.25 -34.38 68.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 5.04 108.943 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' THR . 21.6 pttm -136.17 -150.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 5.04 109.46 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.3 m 88.07 -18.0 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.434 . . . . 2.89 110.399 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 59.88 1.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.467 -0.938 . . . . 6.0 108.467 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 20' ' ' THR . 65.5 m-85 -128.73 161.46 29.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.226 -0.657 . . . . 2.94 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.0 p -76.23 166.44 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.007 . . . . 3.98 109.167 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -73.93 -17.63 61.0 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.034 0.921 . . . . 4.23 108.787 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -61.27 -43.39 98.95 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.941 -1.1 . . . . 5.1 109.283 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.14 -38.62 63.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 3.8 110.907 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 20' ' ' THR . 2.1 m -69.81 -37.65 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.639 -1.288 . . . . 2.44 109.413 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.82 -45.5 78.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.945 -1.097 . . . . 3.85 108.747 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -66.09 -43.27 87.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 3.75 109.174 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -65.41 -39.96 92.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 5.2 109.103 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' CD1' HD23 ' A' ' 8' ' ' LEU . 90.5 t80 -55.56 -47.15 76.84 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.554 -0.906 . . . . 2.74 108.554 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -82.48 -7.42 59.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.808 -1.182 . . . . 5.06 107.808 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.39 -60.96 5.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.192 -1.163 . . . . 2.92 110.192 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.54 -39.88 51.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.846 -1.385 . . . . 3.92 110.087 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.8 mm -54.06 -43.74 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.872 -1.143 . . . . 3.57 109.56 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.95 -50.29 74.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.022 -1.049 . . . . 6.37 109.653 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -65.49 -40.03 92.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 7.82 109.49 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.8 t -134.88 83.91 39.43 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 5.72 109.253 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -47.9 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.679 2.253 . . . . 4.71 112.481 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 38' ' ' CYS . 4.8 p -175.12 101.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 5.05 109.268 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.85 60.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.743 -1.343 . . . . 2.56 109.743 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.598 ' NE2' ' NH1' ' A' ' 79' ' ' ARG . 33.3 tt0 -84.92 119.1 24.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 3.09 109.448 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.37 145.07 40.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.459 -0.775 . . . . 2.82 109.98 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.15 -170.95 3.32 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.882 -0.785 . . . . 2.91 108.882 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.631 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.87 -41.57 96.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 1.72 110.113 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.48 92.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 2.06 110.087 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.01 97.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.558 -1.417 . . . . 2.03 109.558 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.65 -45.57 93.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.859 -1.377 . . . . 2.65 108.379 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 65.0 mt-30 -60.04 -33.08 71.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.043 . . . . 2.8 108.298 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -60.96 -45.26 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 3.4 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.477 HG21 ' CZ ' ' A' ' 85' ' ' PHE . 6.3 pt -64.44 -33.87 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 118.411 -1.315 . . . . 2.99 108.868 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -64.81 -39.86 94.27 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.064 -1.022 . . . . 5.31 108.418 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -62.31 -39.8 94.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.63 109.132 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 4.23 109.79 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 5.6 m-85 -89.49 -24.4 21.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 4.18 109.785 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 28.3 m-85 -136.72 69.56 59.13 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 6.44 110.002 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -88.12 -1.25 7.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.167 2.578 . . . . 4.28 112.487 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.85 6.69 27.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 4.17 109.99 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.68 -158.5 7.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.401 . . . . 3.59 109.596 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' MET . 13.5 t0 -124.56 81.33 60.17 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.379 -1.071 . . . . 5.63 109.541 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 15.7 Cg_exo -64.93 70.29 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.861 2.374 . . . . 4.4 112.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.0 m -102.47 -79.32 0.53 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 3.54 109.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.36 -46.59 85.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 3.3 110.246 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 68' ' ' VAL . 29.7 t80 -63.52 -45.8 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 2.12 109.523 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -61.85 -49.13 77.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.422 -0.799 . . . . 1.79 109.535 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 35.3 m -64.42 -38.56 91.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 2.04 109.016 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -56.59 -49.41 74.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 2.31 109.06 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 64' ' ' PHE . 23.1 t -58.12 -52.05 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.011 -1.055 . . . . 1.71 108.168 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -57.55 -32.41 67.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.05 . . . . 4.33 109.249 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -59.19 -46.04 89.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 2.75 110.016 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.3 p -100.06 -44.0 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.982 -1.074 . . . . 1.91 109.494 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 54.0 t80 -49.12 -35.25 15.94 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.125 -0.695 . . . . 2.75 109.125 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 79' ' ' ARG . 59.5 t0 -74.34 127.0 31.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 2.3 109.213 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.5 mt-10 -99.18 167.32 10.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.877 . . . . 5.3 110.0 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 1.0 OUTLIER 76.04 -7.22 1.85 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 3.3 109.559 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 53.53 33.89 17.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 5.34 109.247 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -86.82 -4.26 59.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -0.954 . . . . 3.11 109.544 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.41 78.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.438 -0.887 . . . . 2.85 110.987 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' NH1' ' NE2' ' A' ' 42' ' ' GLN . 37.3 ptt180 -157.41 154.61 29.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.362 . . . . 4.19 109.721 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -101.36 132.31 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.745 -1.206 . . . . 1.76 107.745 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.96 157.67 15.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 2.4 109.913 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -49.5 -42.58 43.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.456 -0.778 . . . . 3.27 109.081 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.3 p -60.56 -46.87 88.61 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.154 -0.966 . . . . 2.35 109.529 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 95.9 mt-10 -72.41 -34.81 68.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 2.09 109.837 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.694 ' CE1' HD11 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -58.24 -63.25 1.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.906 -1.121 . . . . 2.22 109.828 -178.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.515 ' HA ' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -67.43 -41.94 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 1.9 111.164 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 86' ' ' ILE . 94.9 mt-30 -66.35 -45.96 78.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.646 -1.284 . . . . 2.63 110.353 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.78 -35.0 79.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.675 -1.266 . . . . 1.56 108.357 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.694 HD11 ' CE1' ' A' ' 85' ' ' PHE . 22.8 mt -59.22 -41.71 89.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.592 -1.262 . . . . 2.17 107.592 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.3 t -57.73 -39.61 77.67 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.166 -1.05 . . . . 2.01 108.166 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.523 HG11 ' NE1' ' A' ' 103' ' ' TRP . 93.0 t -63.4 -37.27 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.792 -0.763 . . . . 2.2 109.159 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -62.34 -35.86 80.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.043 -1.035 . . . . 2.75 109.135 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t -55.44 -40.83 72.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.105 -1.072 . . . . 3.47 108.105 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 176.38 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.774 -0.825 . . . . 8.35 108.774 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.24 -147.04 7.9 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 3.29 109.521 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 155.49 17.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.274 -1.133 . . . . 3.18 108.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -56.73 -38.22 72.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.079 -1.013 . . . . 4.22 109.013 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -70.86 -43.38 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 3.59 110.103 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.957 . . . . 3.04 110.132 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -59.39 -42.97 92.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.103 -0.998 . . . . 3.12 109.458 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.55 ' O ' ' CG ' ' A' ' 105' ' ' PHE . 78.6 mt -67.07 -38.86 86.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 2.31 110.163 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.13 -45.34 85.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 3.93 110.849 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.523 ' NE1' HG11 ' A' ' 91' ' ' VAL . 74.5 m95 -67.39 -43.96 80.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.82 -1.175 . . . . 4.4 109.745 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.57 -38.61 80.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 1.41 109.352 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 101' ' ' LEU . 7.4 m-30 -69.69 -52.06 28.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 2.69 109.584 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -60.14 -39.39 86.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 3.23 108.747 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 68' ' ' VAL . 26.9 tp -62.36 -36.55 82.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 1.99 108.833 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.66 2.19 20.31 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.265 -0.897 . . . . 2.51 110.046 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -150.07 111.08 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.177 -1.577 . . . . 1.8 111.902 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 110' ' ' LEU . 3.2 tm? -95.63 -34.79 11.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 3.31 112.856 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 52.1 p30 -94.64 16.68 14.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.206 -1.559 . . . . 2.09 114.729 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -154.33 -58.96 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 119.741 -1.849 . . . . 3.68 110.364 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.686 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.2 OUTLIER 66.44 53.68 0.96 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.648 1.213 . . . . 2.51 108.281 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 172.19 -31.98 0.12 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 106.22 -2.752 . . . . 2.39 106.22 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 165' ' ' THR . 2.9 m-85 -136.9 140.92 42.66 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.979 -0.749 . . . . 2.76 108.979 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.2 mt -123.76 134.77 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.904 -0.776 . . . . 1.6 108.904 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -114.49 153.72 29.48 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.136 -1.431 . . . . 1.73 107.136 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.788 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -56.88 -35.58 69.1 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.692 -1.255 . . . . 3.17 109.48 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.01 -42.73 99.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.061 -1.024 . . . . 2.44 109.174 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 110' ' ' LEU . 84.0 tt0 -65.69 -37.9 87.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.71 108.509 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.683 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 66.6 mtt -59.6 -37.78 79.48 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.163 -1.051 . . . . 3.66 108.163 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' OD2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -66.82 -43.99 82.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.258 -0.645 . . . . 1.77 109.258 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.13 -45.64 93.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 2.01 109.891 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 67' ' ' PHE . 26.4 mm -69.96 -40.54 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 1.14 109.967 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 121' ' ' MET . 75.7 t -62.63 -44.98 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.736 -1.228 . . . . 1.83 108.368 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 122' ' ' LEU . 89.4 m-20 -62.91 -37.31 86.46 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.532 -0.914 . . . . 2.16 108.532 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.04 -47.46 80.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 1.78 109.275 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.876 ' O ' HG22 ' A' ' 132' ' ' VAL . 84.1 mt -68.57 -41.78 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 2.42 110.218 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -62.75 -54.97 31.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.84 . . . . 5.07 110.637 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -64.61 -41.33 96.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.135 . . . . 3.05 109.759 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.682 ' N ' ' SD ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -65.85 -35.19 79.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 4.88 110.011 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 128' ' ' ILE . 10.8 m -97.47 -0.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.062 . . . . 3.55 109.071 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 132' ' ' VAL . . . 42.76 -155.22 0.14 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.484 -1.446 . . . . 3.52 109.484 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 135' ' ' THR . 36.6 t30 -56.31 -35.59 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -1.107 . . . . 4.29 109.457 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER 57.01 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 3.68 109.242 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.83 -36.93 51.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.015 -1.053 . . . . 5.42 108.829 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -96.87 129.16 44.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.601 -0.687 . . . . 5.6 109.497 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.528 HD23 ' CD ' ' A' ' 142' ' ' GLU . 3.5 mp -116.97 152.86 49.21 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.434 -0.95 . . . . 2.5 108.434 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.539 ' O ' ' C ' ' A' ' 140' ' ' GLU . 41.6 Cg_endo -71.5 130.55 17.4 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.142 1.895 . . . . 3.55 113.022 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 139' ' ' PRO . 96.0 mt-10 21.19 -126.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.522 0.677 . . . . 5.65 111.566 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.622 ' O ' ' CB ' ' A' ' 142' ' ' GLU . 35.1 tt0 -58.52 -26.3 63.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.552 -0.718 . . . . 6.82 109.858 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.622 ' CB ' ' O ' ' A' ' 141' ' ' GLU . 72.6 tt0 107.6 75.83 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 108.751 -0.833 . . . . 6.56 108.751 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 181' ' ' GLN . 81.5 m-20 -82.8 -16.19 48.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.303 -0.873 . . . . 5.59 110.317 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -37.61 -56.43 1.76 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.331 -0.856 . . . . 3.06 110.781 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 144' ' ' THR . 93.8 Cg_exo -37.7 100.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.422 2.081 . . . . 3.91 112.449 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -49.65 -35.99 23.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 3.87 110.76 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -57.82 -45.61 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.846 -1.159 . . . . 3.64 109.587 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.621 ' O ' HD13 ' A' ' 152' ' ' ILE . 68.3 mtp85 -61.91 -41.25 97.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -0.941 . . . . 4.99 109.487 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.662 HG12 ' CD2' ' A' ' 153' ' ' PHE . 2.3 t -63.25 -41.77 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 1.57 108.894 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.848 . . . . 2.71 110.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.2 -48.05 66.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 4.73 109.161 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.95 -38.59 67.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.417 -0.802 . . . . 2.07 109.049 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.683 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 0.6 OUTLIER -67.12 -41.04 86.83 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.838 -1.145 . . . . 2.93 109.689 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -51.05 -37.32 44.75 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.35 -1.34 . . . . 1.77 107.607 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.09 -38.56 72.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.663 -0.648 . . . . 2.34 109.704 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmt -78.1 -34.11 50.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 3.53 111.229 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 159' ' ' ASN . 39.0 t0 -91.14 15.21 12.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 2.4 111.157 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' ALA . 38.7 mmtt -48.94 -21.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.766 -1.209 . . . . 4.18 108.028 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -37.87 -28.25 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.99 -0.55 . . . . 2.49 109.539 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.23 -7.94 0.75 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.605 . . . . 3.15 110.425 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.512 ' OD2' ' OD1' ' A' ' 159' ' ' ASN . 84.0 m-20 -58.47 -36.94 74.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.993 -1.067 . . . . 3.4 108.972 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.83 -21.06 46.65 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.767 -1.733 . . . . 2.83 108.767 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -127.72 170.67 12.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -1.021 . . . . 2.45 109.585 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -99.22 127.0 45.14 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.145 -1.057 . . . . 1.9 108.145 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 115' ' ' TYR . 16.4 p -127.35 167.63 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.691 -0.631 . . . . 1.8 109.44 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 166' ' ' LEU . 9.9 mp -57.98 -24.88 59.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.9 . . . . 2.28 110.027 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -55.99 -49.92 72.28 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.58 -1.325 . . . . 2.92 109.613 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 33.8 mp0 -76.33 -41.12 49.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.025 . . . . 1.85 110.24 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.4 OUTLIER -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.14 109.856 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -65.56 -46.42 79.54 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.017 -1.052 . . . . 2.35 110.361 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.52 -38.42 80.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.116 -0.99 . . . . 2.92 110.65 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.37 -46.65 6.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.118 -1.193 . . . . 1.77 110.118 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 93.5 p -58.56 -35.27 72.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.308 -1.113 . . . . 2.18 109.796 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -5.58 58.86 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 4.67 108.83 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.04 -79.52 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 2.92 109.578 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.04 148.02 34.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 2.61 109.627 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 178' ' ' SER . 71.8 Cg_endo -77.95 -170.01 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.567 2.178 . . . . 2.17 112.166 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 77.28 -37.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.458 -0.776 . . . . 2.62 110.066 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.48 -41.26 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 2.0 109.99 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.4 t -86.28 2.06 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 3.79 109.773 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 143' ' ' ASN . 13.3 pt20 -44.16 132.07 5.79 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.233 -0.917 . . . . 6.02 109.091 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.791 ' C ' HD12 ' A' ' 183' ' ' LEU . . . -98.07 24.39 7.12 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.474 -0.935 . . . . 4.48 108.474 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 182' ' ' ALA . 0.7 OUTLIER 44.47 15.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.678 -0.86 . . . . 4.79 108.678 -179.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 182' ' ' ALA . 49.4 m -121.85 144.06 49.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.748 -1.204 . . . . 5.27 107.748 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 6.2 tp -106.58 129.39 54.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 7.1 109.557 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -85.3 167.14 15.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.883 . . . . 9.88 109.082 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 40.0 p-10 -59.64 -34.73 73.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 8.42 109.644 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.583 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 163.81 153.52 7.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.648 -1.381 . . . . 9.13 109.648 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 189' ' ' LEU . 7.3 mp -63.21 -33.28 75.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -1.104 . . . . 11.72 109.512 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 118.017 -0.992 . . . . 12.62 109.48 -179.888 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.314 0.578 . . . . 15.48 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.75 -43.0 2.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 11.71 109.573 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -57.82 -29.26 64.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -1.185 . . . . 12.65 109.464 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -58.41 -29.78 66.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 8.16 109.912 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 22.5 p-10 -171.06 -59.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 7.63 110.407 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 5' ' ' ASN . 22.9 t 42.36 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.093 -1.004 . . . . 5.22 109.241 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -100.21 164.23 12.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.323 -0.861 . . . . 4.94 109.978 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -83.54 148.5 27.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 2.2 109.194 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -58.97 147.16 74.66 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 2.5 109.121 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.48 -19.61 60.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.587 2.191 . . . . 3.23 112.937 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.99 -46.7 88.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.959 -1.088 . . . . 3.91 110.054 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.27 -34.64 54.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.873 -1.142 . . . . 2.17 109.002 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' THR . 51.7 t -56.39 -45.63 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.041 -1.037 . . . . 2.64 108.401 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.28 -37.89 89.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.976 -1.12 . . . . 4.15 107.976 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -61.45 -34.2 75.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.59 -0.694 . . . . 3.01 109.313 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 19' ' ' LYS . 81.3 mt -72.54 -55.78 6.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.902 -1.124 . . . . 2.71 109.358 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 13' ' ' VAL . 2.0 p -50.25 -34.94 24.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.688 -1.597 . . . . 3.6 106.688 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -63.98 -31.76 73.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.3 -1.0 . . . . 5.04 108.3 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 16' ' ' LEU . 48.8 pttt -165.97 116.47 1.02 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 5.04 109.819 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -174.42 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.325 -0.859 . . . . 2.89 110.06 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 71.71 -5.21 1.71 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.451 -0.781 . . . . 6.0 108.946 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 47.8 m-85 -128.5 159.31 35.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 2.94 109.286 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.9 p -74.23 160.81 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -0.977 . . . . 3.98 109.092 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.74 -29.31 70.58 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.223 -0.923 . . . . 4.23 109.884 -179.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -45.72 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.597 -1.314 . . . . 5.1 109.314 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.42 -41.19 80.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 3.8 110.879 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG11 HG21 ' A' ' 20' ' ' THR . 2.8 m -70.63 -35.04 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 2.44 108.475 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -59.83 -42.48 93.64 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.992 -1.114 . . . . 3.85 107.992 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.63 -42.29 95.58 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.614 -0.835 . . . . 3.75 108.898 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 62.3 m95 -62.56 -39.64 94.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 5.2 108.519 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CG ' HD23 ' A' ' 8' ' ' LEU . 89.3 t80 -56.23 -44.51 79.67 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.218 -1.03 . . . . 2.74 108.218 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -83.39 -6.07 59.35 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.532 -0.914 . . . . 5.06 108.532 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.42 -60.49 3.74 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.993 -1.243 . . . . 2.92 109.993 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 27.5 p90 -81.52 -27.13 34.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.033 -1.275 . . . . 3.92 110.581 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.6 mm -63.36 -34.2 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 3.57 110.361 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -57.48 -48.98 77.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.78 -1.2 . . . . 6.37 109.486 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 2.8 p30 -63.78 -33.33 75.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.001 . . . . 7.82 108.44 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.583 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 28.8 t -135.32 83.21 38.76 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.871 -0.788 . . . . 5.72 108.871 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.18 -33.83 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.388 2.058 . . . . 4.71 111.987 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -37.44 82.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 5.05 109.073 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.27 0.6 82.5 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 2.56 109.579 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.743 HE22 ' NH2' ' A' ' 79' ' ' ARG . 49.9 tt0 -103.4 122.15 44.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.275 -1.133 . . . . 3.09 109.332 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.7 mt -113.02 150.65 31.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 2.82 110.298 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' C ' ' CE1' ' A' ' 69' ' ' PHE . 88.9 m-20 -95.02 -160.06 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.544 -0.722 . . . . 2.91 109.178 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -65.57 -34.78 79.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 1.72 110.592 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.68 73.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.026 -1.046 . . . . 2.06 110.593 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.35 -50.16 70.73 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.786 -1.197 . . . . 2.03 110.567 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.39 -42.23 99.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.914 -1.345 . . . . 2.65 108.751 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.94 -42.3 79.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 2.8 108.757 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.91 -35.75 79.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.27 -1.011 . . . . 3.4 108.27 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -54.53 -55.08 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.483 -0.932 . . . . 2.99 108.483 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' N ' HG22 ' A' ' 51' ' ' ILE . 2.3 m-30 -58.15 -37.06 73.93 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.616 -1.253 . . . . 5.31 107.616 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -63.1 -35.32 79.88 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.709 -1.244 . . . . 3.63 108.699 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.25 -42.36 86.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.432 -0.793 . . . . 4.23 110.004 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 11.4 m-85 -100.91 -8.68 22.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 4.18 109.466 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 52' ' ' TYR . 68.9 m-85 -140.22 69.14 34.07 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.384 -0.823 . . . . 6.44 109.396 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 59' ' ' GLY . 3.5 Cg_exo -76.1 -1.45 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.364 2.709 . . . . 4.28 112.752 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.29 6.9 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.145 -0.972 . . . . 4.17 110.379 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 57' ' ' PRO . . . 79.86 35.59 27.63 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.239 -1.144 . . . . 3.59 110.239 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 5.3 p-10 -110.74 -4.91 0.1 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.304 -1.115 . . . . 5.63 112.411 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 60' ' ' ASP . 96.3 Cg_endo -81.3 70.4 7.43 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.37 1.38 . . . . 4.4 112.414 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' THR . 0.8 OUTLIER -121.61 -104.02 0.39 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.309 -0.869 . . . . 3.54 109.763 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 66' ' ' THR . 49.0 mtpt -58.85 -43.57 90.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 3.3 110.283 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -62.07 -43.58 98.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 2.12 109.137 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -35.12 77.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.702 . . . . 1.79 110.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 76.6 p -68.71 -41.06 79.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.074 -1.016 . . . . 2.04 110.113 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -65.78 -45.36 82.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.141 -0.975 . . . . 2.31 110.458 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 15.8 m -62.86 -43.43 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.804 -1.185 . . . . 1.71 109.115 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 53.1 t80 -57.33 -43.5 83.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.948 -1.095 . . . . 4.33 110.203 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -73.63 -49.4 26.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.892 -1.13 . . . . 2.75 110.526 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.426 ' CG2' HD12 ' A' ' 110' ' ' LEU . 76.7 t -70.74 -45.05 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -0.993 . . . . 1.91 110.389 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.965 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 51.7 t80 -55.58 -34.75 65.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.484 -0.76 . . . . 2.75 110.023 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.587 ' OD2' ' N ' ' A' ' 78' ' ' GLY . 67.5 t0 -51.95 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.95 -1.094 . . . . 2.3 109.391 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' N ' ' OE2' ' A' ' 84' ' ' GLU . 47.7 tp10 -63.4 -35.21 79.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.449 -0.782 . . . . 5.3 109.856 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -81.8 -4.25 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 3.3 109.493 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 52.91 31.76 11.38 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.362 -0.836 . . . . 5.34 109.12 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' N ' ' OD2' ' A' ' 73' ' ' ASP . 58.0 p30 -92.9 5.26 51.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 3.11 109.668 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.587 ' N ' ' OD2' ' A' ' 73' ' ' ASP . . . 72.84 18.92 79.18 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.783 -1.327 . . . . 2.85 109.783 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.743 ' NH2' HE22 ' A' ' 42' ' ' GLN . 45.0 mtm180 -149.81 145.05 26.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -1.134 . . . . 4.19 109.325 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -89.92 127.02 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.875 -1.157 . . . . 1.76 107.875 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.7 tt0 -102.31 157.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 2.4 109.924 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -41.25 -43.31 2.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 3.27 109.342 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -59.43 -47.38 85.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.082 -1.011 . . . . 2.35 109.393 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' OE2' ' N ' ' A' ' 74' ' ' GLU . 98.1 mt-10 -71.48 -42.57 67.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.981 . . . . 2.09 109.639 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 51' ' ' ILE . 10.3 t80 -55.93 -60.61 3.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 2.22 109.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 86' ' ' ILE . 11.0 tp -61.01 -28.58 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.427 -0.796 . . . . 1.9 109.923 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.2 tt0 -63.02 -55.87 21.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 2.63 109.767 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.965 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.01 -41.19 82.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.986 -1.071 . . . . 1.56 108.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -51.32 -48.96 62.22 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.579 -0.897 . . . . 2.17 108.579 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -63.54 -38.38 90.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.343 -0.848 . . . . 2.01 108.888 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 87' ' ' GLN . 92.5 t -62.35 -39.27 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.855 . . . . 2.2 109.036 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' ALA . 62.6 p -63.61 -36.36 83.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 2.75 108.949 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 t -58.08 -44.49 87.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 3.47 109.01 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.4 mtp180 -158.3 -66.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.371 -0.83 . . . . 8.35 108.914 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.98 170.65 45.38 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.829 -1.308 . . . . 3.29 109.829 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 3.2 m -120.04 156.19 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.492 -1.005 . . . . 3.18 108.727 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.5 mm? -53.94 -36.7 63.11 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.056 -1.027 . . . . 4.22 108.781 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -69.71 -44.56 70.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.983 . . . . 3.59 109.602 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.0 mm-40 -64.18 -39.93 95.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 3.04 109.198 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -62.4 -38.79 91.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.269 -0.894 . . . . 3.12 108.908 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.09 -47.74 84.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.283 -0.886 . . . . 2.31 108.743 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -68.69 -35.49 77.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 3.93 109.162 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.473 ' CH2' HD13 ' A' ' 107' ' ' LEU . 57.1 t90 -64.51 -54.37 33.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 4.4 109.949 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.28 81.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 1.41 109.895 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.2 -53.52 57.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 2.69 110.602 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -64.28 -41.66 96.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.073 -1.017 . . . . 3.23 110.569 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.825 ' O ' HD23 ' A' ' 107' ' ' LEU . 4.5 tt -69.7 -31.51 69.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.029 . . . . 1.99 110.28 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' CE ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -58.26 -34.65 70.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.766 -1.209 . . . . 2.51 110.261 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 65.3 t0 -125.94 120.43 30.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.027 -1.046 . . . . 1.8 109.877 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' A' ' 71' ' ' VAL . 57.4 tp -62.98 -43.48 98.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.528 -0.733 . . . . 3.31 109.749 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 53.8 p30 -88.31 -20.01 25.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 2.09 109.688 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.602 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 30.5 p-10 23.0 55.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.596 0.712 . . . . 3.68 110.831 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -82.34 17.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 2.51 109.184 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.68 -1.01 45.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.876 -1.69 . . . . 2.39 108.876 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 165' ' ' THR . 2.0 m-85 -139.46 143.24 37.46 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -1.042 . . . . 2.76 110.583 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.45 140.68 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.876 -1.157 . . . . 1.6 107.876 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HZ2' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -119.31 158.95 25.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 1.73 108.31 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.755 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -60.14 -39.23 85.57 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.125 -0.984 . . . . 3.17 109.42 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.684 ' ND2' ' N ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -60.96 -39.75 90.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.984 -1.072 . . . . 2.44 109.271 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 96.5 mt-10 -67.95 -39.42 83.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.163 -0.961 . . . . 1.71 109.143 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.805 ' O ' HG23 ' A' ' 125' ' ' VAL . 77.4 mtp -64.65 -37.45 87.63 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -0.953 . . . . 3.66 109.217 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.21 -43.07 87.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 1.77 109.125 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.26 -49.83 72.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 2.01 109.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 124' ' ' ILE . 24.0 mm -67.85 -38.8 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 1.14 109.423 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 121' ' ' MET . 42.3 t -58.94 -48.07 87.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.891 -1.151 . . . . 1.83 107.891 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.18 -35.81 76.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.266 -0.896 . . . . 2.16 109.142 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.0 -54.7 22.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 1.78 110.37 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 183' ' ' LEU . 8.2 pt -73.13 -31.95 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.857 -1.152 . . . . 2.42 109.986 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 -59.66 -49.36 78.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.818 -1.176 . . . . 5.07 107.872 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -62.72 -36.59 83.46 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.612 -1.255 . . . . 3.05 107.612 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.4 ttp -58.97 -29.41 67.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.351 -0.981 . . . . 4.88 108.351 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 128' ' ' ILE . 32.9 m -117.64 14.75 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.638 -0.664 . . . . 3.55 109.271 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -86.42 -75.1 1.26 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.902 -1.279 . . . . 3.52 109.902 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -85.38 6.95 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.122 -1.222 . . . . 4.29 109.445 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.645 ' O ' HD22 ' A' ' 138' ' ' LEU . 9.8 m -84.31 149.63 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 3.68 109.831 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -70.04 -30.56 44.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.392 -0.817 . . . . 5.42 109.554 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 135' ' ' THR . 48.8 tp10 -90.12 87.11 6.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.473 -0.767 . . . . 5.6 110.453 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.826 ' H ' HD23 ' A' ' 138' ' ' LEU . 1.2 pt? -149.11 149.35 29.49 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.835 . . . . 2.5 109.09 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.22 129.94 25.65 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.909 1.74 . . . . 3.55 112.084 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.63 -34.47 78.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 5.65 109.657 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -77.44 2.27 16.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 6.82 109.876 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 59.16 47.19 12.08 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.415 -0.957 . . . . 6.56 108.415 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.527 ' O ' ' C ' ' A' ' 144' ' ' THR . 13.3 t30 -55.48 -21.54 16.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 5.59 109.657 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.527 ' C ' ' O ' ' A' ' 143' ' ' ASN . 61.4 p -25.89 142.0 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 122.071 -0.393 . . . . 3.06 110.849 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.697 ' HD3' HD22 ' A' ' 183' ' ' LEU . 69.4 Cg_endo -85.5 70.61 4.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.649 2.232 . . . . 3.91 113.754 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE1' HG11 ' A' ' 125' ' ' VAL . 47.6 tp10 -102.1 -83.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.885 -1.134 . . . . 3.87 108.661 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -66.35 -28.28 68.54 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.565 -0.902 . . . . 3.64 108.565 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 143' ' ' ASN . 30.9 ttm180 -56.9 -47.03 81.48 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.437 -0.789 . . . . 4.99 109.679 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -71.49 -40.82 72.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 C-N-CA 118.396 -1.321 . . . . 1.57 108.73 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -54.26 -50.02 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.107 -1.037 . . . . 2.71 109.689 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -66.99 -49.35 65.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 4.73 108.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 mp -59.2 -22.5 22.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.991 -1.115 . . . . 2.07 107.991 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.678 ' CZ ' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -71.01 -47.21 60.01 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.209 -1.034 . . . . 2.93 108.209 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.74 -34.09 25.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.8 -1.185 . . . . 1.77 107.8 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.542 ' HA ' ' HZ3' ' A' ' 158' ' ' LYS . 59.5 ttp -87.77 -40.47 14.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.691 . . . . 2.34 110.559 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.3 tpp -71.73 -36.1 70.37 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.303 -0.873 . . . . 3.53 111.941 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 162' ' ' GLY . 18.4 t70 -105.6 16.22 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 2.4 112.646 -176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.542 ' HZ3' ' HA ' ' A' ' 155' ' ' MET . 24.4 mttm -42.35 -29.1 0.24 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.591 -1.318 . . . . 4.18 109.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.762 ' ND2' ' H ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -62.9 1.21 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.379 -0.826 . . . . 2.49 109.581 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.638 ' N ' HD22 ' A' ' 159' ' ' ASN . . . 64.8 9.67 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 3.15 110.199 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.762 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 80.5 m-20 -57.41 -38.3 74.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 3.4 108.915 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.651 ' H ' ' CG ' ' A' ' 157' ' ' ASP . . . 89.12 0.47 80.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.114 -1.595 . . . . 2.83 109.114 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HZ2' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -147.15 155.53 42.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -1.097 . . . . 2.45 109.768 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.678 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 15.8 mt -97.54 146.93 24.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.172 -0.955 . . . . 1.9 108.663 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 115' ' ' TYR . 31.0 m -125.5 161.63 26.71 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.829 -0.804 . . . . 1.8 108.829 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.4 mp -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.915 -1.116 . . . . 2.28 109.881 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -52.69 -49.27 65.65 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.407 -1.433 . . . . 2.92 108.846 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.74 -40.41 61.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.395 -0.816 . . . . 1.85 110.493 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 173' ' ' SER . 0.3 OUTLIER -67.53 -47.57 69.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.141 -0.975 . . . . 2.14 110.033 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 1.5 pp0? -65.47 -42.67 92.03 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.822 -1.174 . . . . 2.35 110.317 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 170' ' ' GLN . 98.8 mt-10 -70.19 -42.7 72.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.889 -1.132 . . . . 2.92 110.259 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.496 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -75.43 -42.15 28.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.784 -1.326 . . . . 1.77 109.784 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 169' ' ' PHE . 77.7 p -58.76 -39.68 81.71 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.334 -1.098 . . . . 2.18 110.131 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -92.89 -1.9 56.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 4.67 109.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -113.14 -51.46 2.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 2.92 109.45 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 177' ' ' PRO . 13.4 t0 -117.77 88.46 30.37 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 2.61 109.189 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 178' ' ' SER . 83.8 Cg_exo -44.93 -179.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.56 2.174 . . . . 2.17 112.492 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.58 -31.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.534 -0.729 . . . . 2.62 109.197 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.496 HD12 ' C ' ' A' ' 172' ' ' GLY . 89.0 mt -58.34 -34.43 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 2.0 109.825 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 173' ' ' SER . 0.2 OUTLIER -127.02 -103.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.26 -0.9 . . . . 3.79 109.863 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 180' ' ' VAL . 94.1 mt-30 43.8 -114.6 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.577 -0.898 . . . . 6.02 108.577 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.599 ' C ' HD23 ' A' ' 183' ' ' LEU . . . -160.92 -165.11 1.3 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.274 -0.892 . . . . 4.48 108.957 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -92.94 4.76 53.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.238 -0.914 . . . . 4.79 109.095 -179.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 0.6 OUTLIER 79.19 91.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 5.27 109.911 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 186' ' ' TYR . 6.2 mp -98.18 117.05 31.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 7.1 108.986 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 185' ' ' LEU . 51.5 p90 42.39 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.431 -0.793 . . . . 9.88 110.025 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -149.94 75.57 1.25 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 8.42 109.806 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.5 14.05 80.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.0 -1.24 . . . . 9.13 110.0 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.6 -34.9 73.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -1.217 . . . . 11.72 109.448 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 117.933 -1.032 . . . . 12.62 109.433 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.259 -0.645 . . . . 15.48 109.259 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.8 55.97 5.13 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.28 . . . . 11.71 109.901 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -71.74 117.93 13.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -1.208 . . . . 12.65 109.316 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 -17.71 65.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -0.803 . . . . 8.16 109.598 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -47.69 -34.94 8.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 7.63 109.908 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.2 p -141.88 152.57 43.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 5.22 109.916 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -88.74 -6.72 57.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 4.94 108.943 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 56.1 tp -103.99 136.01 44.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.997 -0.742 . . . . 2.2 108.997 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 9' ' ' LYS . 4.3 mptp? -47.18 145.43 3.59 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.039 -1.038 . . . . 2.5 108.882 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.96 -35.21 35.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.322 2.015 . . . . 3.23 112.471 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.92 -41.51 95.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 3.91 109.979 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG12 HD21 ' A' ' 8' ' ' LEU . 55.8 t -66.83 -43.37 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 2.17 109.965 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 17' ' ' THR . 24.4 t -58.35 -46.04 89.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 2.64 109.232 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.36 -40.37 96.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 4.15 109.686 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -35.85 81.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 3.01 109.314 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.639 ' O ' HG22 ' A' ' 20' ' ' THR . 6.4 mt -62.33 -45.58 92.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.624 -1.23 . . . . 2.71 108.201 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 13' ' ' VAL . 26.4 p -55.75 -39.18 70.82 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.086 -1.079 . . . . 3.6 108.086 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -63.22 -32.06 73.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.406 -0.809 . . . . 5.04 109.122 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -143.48 93.1 2.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 5.04 109.84 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 16' ' ' LEU . 11.8 t -174.23 -43.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.077 . . . . 2.89 109.427 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 88.39 -22.79 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.575 -0.898 . . . . 6.0 108.575 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 11.7 m-85 -80.25 154.17 28.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.183 -1.043 . . . . 2.94 108.183 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.4 p -73.45 164.89 26.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.935 -1.103 . . . . 3.98 109.102 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.0 -37.64 80.31 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.352 -0.842 . . . . 4.23 109.63 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -66.83 -40.05 87.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 5.1 109.933 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.39 -38.36 89.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 3.8 111.019 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 28' ' ' GLN . 19.6 m -74.12 -39.65 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.705 -1.247 . . . . 2.44 109.43 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 27' ' ' VAL . 63.0 tt0 -62.42 -46.0 90.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 3.85 109.129 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' GLY . 27.5 mt-30 -65.7 -37.78 87.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 3.75 109.739 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.475 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -62.17 -46.98 86.56 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.058 -1.026 . . . . 5.2 109.222 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CD1' ' CE2' ' A' ' 82' ' ' PHE . 49.8 t80 -58.28 -45.12 88.48 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.808 -0.812 . . . . 2.74 108.808 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -82.03 -3.63 54.99 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.379 -0.971 . . . . 5.06 108.379 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -76.61 -63.98 2.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.545 -1.422 . . . . 2.92 109.545 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -77.21 -34.77 56.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.998 -1.295 . . . . 3.92 109.758 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 9.1 mm -56.5 -40.5 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.867 -1.145 . . . . 3.57 109.223 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.96 -44.74 91.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 6.37 109.221 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.37 -37.77 81.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -0.948 . . . . 7.82 108.504 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.36 130.98 7.42 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.237 -1.023 . . . . 5.72 108.237 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.23 17.98 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.981 1.787 . . . . 4.71 112.51 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.1 m -112.4 140.46 47.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 5.05 109.24 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.44 -0.11 11.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.194 -1.563 . . . . 2.56 109.194 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -96.83 112.71 24.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 3.09 109.366 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -105.86 132.27 52.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 2.82 109.555 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.3 173.59 1.14 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.423 -0.798 . . . . 2.91 109.198 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -59.89 -36.94 78.02 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.832 . . . . 1.72 109.541 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.72 -39.83 85.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 2.06 109.806 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.34 91.42 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.304 -1.519 . . . . 2.03 109.304 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.37 -45.77 86.27 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.067 -1.255 . . . . 2.65 108.81 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.579 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 91.6 mt-30 -58.68 -36.03 73.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.81 -1.181 . . . . 2.8 107.81 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -58.44 -45.68 88.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.294 -1.002 . . . . 3.4 108.294 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.37 -51.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.432 -1.322 . . . . 2.99 107.432 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.86 -39.81 86.51 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.454 -0.899 . . . . 5.31 109.815 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.63 -36.16 83.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.655 -1.278 . . . . 3.63 109.784 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -62.26 -37.87 87.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 4.23 111.69 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 17.3 m-85 -115.65 -5.47 12.16 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.866 -1.147 . . . . 4.18 111.739 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 55' ' ' PHE . 13.8 m-85 -136.1 61.83 42.21 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.689 -1.257 . . . . 6.44 110.224 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 94.4 Cg_endo -93.14 8.98 2.49 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.741 2.294 . . . . 4.28 113.567 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 136' ' ' VAL . 99.7 m-85 -90.21 1.05 56.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.741 -1.224 . . . . 4.17 110.876 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.01 161.61 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.771 -1.332 . . . . 3.59 109.771 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.4 p-10 -59.97 112.17 4.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.351 -1.087 . . . . 5.63 109.006 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.661 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 98.1 Cg_endo -87.09 -30.76 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.236 1.957 . . . . 4.4 113.232 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' OG1' ' A' ' 66' ' ' THR . 42.9 m -48.31 -46.82 36.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.11 . . . . 3.54 110.363 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 60.5 mttm -73.72 -64.98 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.996 -1.065 . . . . 3.3 110.373 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 107' ' ' LEU . 46.6 t80 -61.64 -44.2 97.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.12 110.443 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 61' ' ' PRO . . . -64.96 -43.21 93.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.915 -1.116 . . . . 1.79 110.199 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.579 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 75.4 m -67.4 -33.07 74.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.464 -1.397 . . . . 2.04 108.357 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -61.32 -48.01 83.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.593 -0.692 . . . . 2.31 109.818 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 72' ' ' PHE . 4.7 m -64.85 -46.91 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 120.931 -1.106 . . . . 1.71 108.912 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 t80 -54.91 -45.01 74.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 4.33 108.433 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -67.66 -37.7 82.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.088 -1.007 . . . . 2.75 110.243 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 109' ' ' ASP . 59.9 t -95.01 -68.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.029 -1.044 . . . . 1.91 111.708 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -44.6 -44.75 9.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.006 -1.059 . . . . 2.75 110.091 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 27.5 t0 -63.45 145.7 55.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 2.3 109.38 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' CA ' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -129.85 151.63 50.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.255 -0.903 . . . . 5.3 109.838 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER 86.15 80.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.609 1.195 . . . . 3.3 108.661 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 67.05 -36.53 0.28 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.523 -0.736 . . . . 5.34 109.1 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 75' ' ' ASN . 83.7 m-20 56.56 40.37 29.46 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.486 0.66 . . . . 3.11 111.246 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.78 -31.53 12.54 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 106.685 -2.566 . . . . 2.85 106.685 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -143.2 157.39 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.658 -0.867 . . . . 4.19 108.658 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -92.61 125.94 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.893 -1.521 . . . . 1.76 106.893 178.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -90.21 154.1 20.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.088 -1.007 . . . . 2.4 110.716 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -48.54 -49.65 35.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.52 -0.738 . . . . 3.27 109.335 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.5 p -59.04 -39.29 81.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.042 -1.036 . . . . 2.35 108.879 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' OD1' ' A' ' 73' ' ' ASP . 96.7 mt-10 -69.79 -44.39 70.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.403 -0.811 . . . . 2.09 109.399 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CE1' HD23 ' A' ' 89' ' ' LEU . 34.7 t80 -67.5 -55.62 12.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 2.22 110.645 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 -33.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.986 -1.072 . . . . 1.9 108.85 -179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 64.4 tt0 -64.59 -56.36 14.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.205 . . . . 2.63 110.556 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -68.72 -43.8 75.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.83 -1.169 . . . . 1.56 109.197 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -52.71 -45.05 66.74 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 2.17 107.131 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' CD1' ' A' ' 86' ' ' ILE . 32.5 m -62.69 -36.83 84.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.01 108.91 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 67.8 t -58.87 -36.72 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.243 -1.021 . . . . 2.2 108.243 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 88' ' ' ALA . 28.4 p -68.36 -27.47 66.27 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.413 -0.804 . . . . 2.75 108.895 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.573 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 25.6 m -46.25 -31.38 2.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.303 -0.873 . . . . 3.47 109.673 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 93' ' ' SER . 73.5 mtm-85 101.85 82.18 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 121.349 0.595 . . . . 8.35 110.539 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 21' ' ' TYR . . . -109.9 -106.99 3.03 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.009 -1.637 . . . . 3.29 109.009 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 146.15 24.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.254 . . . . 3.18 109.432 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.68 -27.44 68.92 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.433 -0.792 . . . . 4.22 109.668 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -59.84 -43.37 94.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.087 -1.008 . . . . 3.59 110.108 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -63.21 -41.71 99.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.966 . . . . 3.04 108.867 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -62.86 -38.86 92.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.906 -0.775 . . . . 3.12 108.906 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -59.65 -45.42 92.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 2.31 109.772 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -64.44 -40.31 95.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.936 -1.102 . . . . 3.93 109.73 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -43.24 92.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.008 -1.058 . . . . 4.4 108.532 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.49 78.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.41 109.71 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.67 -50.76 72.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 2.69 109.944 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 71' ' ' VAL . 95.2 mttt -62.71 -44.95 94.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 3.23 109.738 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 107' ' ' LEU . 5.6 tt -61.86 -42.37 98.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 1.99 109.494 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -10.22 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.51 108.424 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' O ' HG21 ' A' ' 71' ' ' VAL . 6.9 t0 -111.69 123.78 50.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -0.827 . . . . 1.8 109.441 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.547 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 9.6 tt -63.72 -39.8 95.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 3.31 110.355 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 31.6 p-10 -112.45 -37.03 5.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.091 -1.005 . . . . 2.09 109.526 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER 55.75 31.39 17.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 3.68 110.156 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 34.5 p-10 -57.33 -35.55 70.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.506 -1.371 . . . . 2.51 109.096 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -143.45 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.549 -1.82 . . . . 2.39 108.549 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.413 ' CD1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -136.88 -168.47 2.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.477 -1.014 . . . . 2.76 108.518 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.0 mt -100.08 146.89 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 1.6 110.529 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -120.96 162.94 19.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.575 HH22 ' CG ' ' A' ' 157' ' ' ASP . 22.2 mmt-85 -60.3 -41.47 93.49 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.787 -1.195 . . . . 3.17 110.04 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.49 -41.64 96.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.952 -1.093 . . . . 2.44 109.605 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 109' ' ' ASP . 98.8 mt-10 -66.57 -40.14 88.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 1.71 109.343 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.651 ' O ' HG13 ' A' ' 125' ' ' VAL . 50.1 ttm -62.11 -46.59 88.38 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.327 -0.858 . . . . 3.66 109.085 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.68 -37.6 87.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 1.77 109.877 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -60.37 -40.46 90.89 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.053 -1.029 . . . . 2.01 109.221 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 124' ' ' ILE . 33.1 mm -70.15 -48.03 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 1.14 110.998 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.43 -38.82 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.096 -1.628 . . . . 1.83 107.803 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 89.8 m-20 -61.28 -41.43 96.94 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.828 -1.175 . . . . 2.16 107.828 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.25 78.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.846 -0.798 . . . . 1.78 108.846 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 132' ' ' VAL . 94.1 mt -63.28 -37.46 79.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.788 -0.819 . . . . 2.42 108.788 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.52 -53.33 58.78 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.218 -1.03 . . . . 5.07 108.218 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -59.9 -39.01 83.9 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.594 -1.261 . . . . 3.05 107.594 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 131' ' ' MET . 3.6 tmm? -67.44 -27.14 66.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.943 -0.762 . . . . 4.88 108.943 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -97.47 -0.1 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 3.55 109.29 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.16 121.22 5.81 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.639 -1.784 . . . . 3.52 108.639 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.29 44.24 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -1.173 . . . . 4.29 108.742 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 138' ' ' LEU . 20.1 m -120.48 152.29 38.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.49 -0.756 . . . . 3.68 109.37 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 58' ' ' PHE . 3.4 t -73.95 -4.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 120.797 -1.19 . . . . 5.42 108.961 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.508 ' H ' HG22 ' A' ' 135' ' ' THR . 96.7 mt-10 -108.52 78.55 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 5.6 111.171 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 135' ' ' THR . 4.4 mp -116.25 93.99 40.97 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.262 -1.014 . . . . 2.5 108.262 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.7 Cg_exo -56.5 99.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.721 1.614 . . . . 3.55 111.989 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.36 -33.07 74.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 5.65 109.715 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 187' ' ' ASP . 84.6 tt0 -57.89 -35.48 71.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 6.82 110.137 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 182' ' ' ALA . 46.1 tt0 -130.42 -44.72 1.11 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.171 -0.956 . . . . 6.56 109.793 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 139' ' ' PRO . 24.8 t-20 68.11 50.2 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 5.59 110.622 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.476 ' OG1' ' C ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER 62.05 104.95 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.128 -0.983 . . . . 3.06 110.182 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.18 93.57 0.42 Allowed 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.894 2.396 . . . . 3.91 112.434 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.546 ' O ' HG22 ' A' ' 149' ' ' VAL . 36.8 mp0 -90.16 -75.21 0.46 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.134 -0.979 . . . . 3.87 109.932 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.73 -34.52 73.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.809 -1.182 . . . . 3.64 109.421 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -55.45 -45.93 76.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.411 -0.805 . . . . 4.99 110.107 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 146' ' ' GLU . 29.6 m -72.11 -32.98 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.799 -1.188 . . . . 1.57 108.836 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 22.1 t70 -51.49 -49.55 61.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.373 -1.454 . . . . 2.71 108.343 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.91 -57.1 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 4.73 109.881 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.63 -53.84 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 2.07 110.738 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.74 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -39.08 88.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.85 -1.156 . . . . 2.93 109.227 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -51.36 -39.76 57.73 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.531 -1.285 . . . . 1.77 107.531 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.7 ttp -66.56 -42.23 87.42 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.089 -0.708 . . . . 2.34 109.089 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 158' ' ' LYS . 96.3 mmm -61.86 -34.97 76.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 3.53 109.27 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' HH22 ' A' ' 118' ' ' ARG . 23.5 t70 -77.74 15.92 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.283 -0.885 . . . . 2.4 108.888 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' ALA . 13.0 pttp -48.83 -46.68 42.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.78 0.8 . . . . 4.18 110.098 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.583 ' ND2' ' OE2' ' A' ' 168' ' ' GLU . 20.1 p30 -40.77 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 116.183 -0.462 . . . . 2.49 110.086 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 66.87 27.48 9.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 3.15 109.489 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.559 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 85.6 m-20 -57.47 -32.39 66.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.379 -0.826 . . . . 3.4 108.93 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.2 -34.35 5.67 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.184 -1.966 . . . . 2.83 108.184 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' CB ' ' CD1' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -137.07 -174.53 3.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.932 . . . . 2.45 108.557 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.74 HD21 ' CD1' ' A' ' 153' ' ' PHE . 1.1 mp -104.84 108.55 20.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 1.9 109.856 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -91.96 162.03 14.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 1.8 108.701 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 1.085 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -64.75 -14.56 59.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.888 -1.133 . . . . 2.28 109.957 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.625 ' N ' HD22 ' A' ' 166' ' ' LEU . 15.8 mm100 -57.02 -39.35 74.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.755 -1.216 . . . . 2.92 108.516 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 93.8 mt-10 -74.44 -36.57 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.794 . . . . 1.85 110.103 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.93 -49.28 38.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.906 -1.122 . . . . 2.14 109.876 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.24 -49.91 67.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 2.35 110.157 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -72.31 -42.41 65.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.9 -1.125 . . . . 2.92 109.707 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.09 83.35 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.697 -1.361 . . . . 1.77 109.697 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' HG22 ' A' ' 180' ' ' VAL . 97.7 p -61.01 -36.1 78.59 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.304 -1.115 . . . . 2.18 109.227 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -86.39 -1.51 57.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.293 -0.88 . . . . 4.67 108.784 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.69 -84.38 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.446 -0.784 . . . . 2.92 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.05 136.63 82.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 2.61 109.834 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 178' ' ' SER . 96.3 Cg_endo -79.66 -169.99 0.91 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.484 2.123 . . . . 2.17 112.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 74.71 -40.11 0.43 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 2.62 110.002 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.4 mt -57.6 -47.11 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 2.0 109.631 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -78.24 -39.0 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.943 . . . . 3.79 109.436 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.585 ' NE2' ' OD2' ' A' ' 187' ' ' ASP . 88.0 mt-30 -76.15 37.8 0.16 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.351 -0.843 . . . . 6.02 109.401 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' OE1' ' A' ' 142' ' ' GLU . . . -54.7 -33.78 61.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 4.48 109.435 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -170.48 39.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 4.79 109.869 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -68.96 154.0 42.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.942 -1.099 . . . . 5.27 109.116 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 185' ' ' LEU . 8.2 mp -66.3 -40.58 90.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.964 . . . . 7.1 109.545 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -160.03 154.91 24.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 9.88 109.522 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 7.8 p-10 -142.79 -41.1 0.32 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.192 -0.942 . . . . 8.42 109.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . -97.92 10.13 64.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.839 -1.305 . . . . 9.13 109.839 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 189' ' ' LEU . 1.3 tt 52.14 11.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -1.197 . . . . 11.72 108.806 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.474 ' N ' ' C ' ' A' ' 188' ' ' GLY . 2.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.962 -1.018 . . . . 12.62 109.486 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.288 -0.634 . . . . 15.48 109.288 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.71 0.04 62.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 11.71 109.613 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -58.93 -37.51 76.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -1.165 . . . . 12.65 109.181 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 p -83.83 175.42 9.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 8.16 109.518 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 65.99 55.05 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 7.63 109.99 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.1 m -105.87 144.23 32.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 5.22 108.977 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -147.51 -151.8 0.4 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 4.94 109.572 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 13' ' ' VAL . 66.4 tp -90.57 130.84 36.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 2.2 108.887 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -58.27 148.2 64.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 2.5 109.567 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.61 -35.09 23.54 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.427 2.084 . . . . 3.23 112.06 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.42 -41.55 98.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 3.91 109.585 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -65.47 -41.82 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 2.17 109.33 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.5 ' CG2' HD23 ' A' ' 8' ' ' LEU . 37.0 t -59.41 -39.9 80.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.844 -1.169 . . . . 2.64 107.844 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -61.92 -38.64 89.15 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.622 -0.881 . . . . 4.15 108.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.8 tt0 -66.33 -37.38 85.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.365 -0.834 . . . . 3.01 109.418 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 20' ' ' THR . 79.9 mt -64.12 -47.09 81.31 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.036 -1.04 . . . . 2.71 109.009 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 13' ' ' VAL . 43.0 p -60.04 -38.27 82.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.49 -1.3 . . . . 3.6 107.49 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -74.82 -24.45 58.62 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.71 -0.848 . . . . 5.04 108.71 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 15' ' ' GLU . 23.8 ttpt -151.35 95.32 2.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 5.04 110.239 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.735 HG23 ' H ' ' A' ' 22' ' ' PHE . 6.0 t -176.13 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 2.89 108.852 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 20' ' ' THR . 4.1 m-85 85.78 25.7 0.06 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.088 0.47 . . . . 6.0 110.787 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.735 ' H ' HG23 ' A' ' 20' ' ' THR . 1.5 m-85 -140.08 163.54 32.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.131 -0.981 . . . . 2.94 108.659 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.5 p -74.41 158.92 33.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.05 -1.031 . . . . 3.98 109.009 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.38 -36.24 77.61 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.283 -0.886 . . . . 4.23 109.875 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.85 -37.65 88.19 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.746 -1.221 . . . . 5.1 109.157 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -69.07 -40.58 78.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 3.8 111.206 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' THR . 2.0 m -73.26 -36.29 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.601 -1.312 . . . . 2.44 109.314 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.99 -46.22 85.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 3.85 108.867 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -64.68 -39.31 93.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.863 . . . . 3.75 109.494 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' O ' ' C ' ' A' ' 31' ' ' TYR . 54.5 t-105 -66.18 -47.54 73.63 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.148 -0.97 . . . . 5.2 108.727 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 71.1 t80 -48.41 -64.12 0.89 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.599 -1.26 . . . . 2.74 107.599 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.67 -24.23 63.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.304 -0.998 . . . . 5.06 108.304 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.69 -49.39 27.82 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 111.053 -0.819 . . . . 2.92 111.053 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE1' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.08 -12.11 22.19 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.73 -1.453 . . . . 3.92 112.054 -178.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 35' ' ' ILE . 36.8 mm -68.96 -32.43 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.326 -1.483 . . . . 3.57 109.974 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -57.56 -38.26 74.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.938 -1.102 . . . . 6.37 109.045 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -59.54 -38.9 82.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 7.82 108.948 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -158.97 132.95 5.08 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 5.72 108.924 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.26 -23.24 24.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.108 1.872 . . . . 4.71 112.608 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.8 p -62.23 -32.99 73.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 5.05 110.199 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.56 11.06 85.2 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.227 -1.549 . . . . 2.56 109.227 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -100.6 116.75 33.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -1.033 . . . . 3.09 109.167 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 47' ' ' GLY . 25.0 tp -112.65 121.46 44.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 2.82 109.522 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -71.92 178.39 3.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.188 -0.945 . . . . 2.91 109.484 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 69' ' ' PHE . . . -61.01 -39.62 90.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.405 -0.81 . . . . 1.72 110.318 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.97 73.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.076 -1.015 . . . . 2.06 109.897 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 43' ' ' LEU . . . -56.53 -42.03 89.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.739 -1.344 . . . . 2.03 109.739 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.63 ' CE2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -68.91 -46.38 68.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -1.223 . . . . 2.65 109.158 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 87.3 mt-30 -53.82 -36.9 63.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.372 -1.344 . . . . 2.8 107.372 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -64.72 -41.02 96.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.427 -0.796 . . . . 3.4 109.173 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 ' HE1' ' A' ' 55' ' ' PHE . 33.7 mm -49.1 -55.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.986 -1.071 . . . . 2.99 108.262 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 4.8 m-30 -62.25 -36.82 83.21 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.714 -0.794 . . . . 5.31 110.766 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -81.42 -4.42 55.75 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.869 -1.145 . . . . 3.63 109.015 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.663 ' NE2' ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -84.76 -63.42 1.34 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 4.23 110.572 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.663 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -85.45 -24.77 27.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.843 -1.161 . . . . 4.18 110.583 -178.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -129.99 76.81 77.6 Favored Pre-proline 0 N--CA 1.509 2.484 0 O-C-N 120.596 -1.315 . . . . 6.44 109.399 177.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 59' ' ' GLY . 2.6 Cg_exo -74.61 -3.58 14.09 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.576 2.851 . . . . 4.28 112.685 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.652 ' O ' HG22 ' A' ' 135' ' ' THR . 45.3 m-85 -57.0 -7.46 0.48 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.178 -0.951 . . . . 4.17 109.979 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' A' ' 57' ' ' PRO . . . -80.5 -178.61 52.18 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.535 -1.826 . . . . 3.59 108.535 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -149.6 -64.76 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.875 -1.368 . . . . 5.63 109.835 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.666 ' O ' ' N ' ' A' ' 63' ' ' LYS . 30.5 Cg_endo -63.54 -5.52 8.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.452 2.102 . . . . 4.4 112.068 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 41.22 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.251 0.548 . . . . 3.54 110.017 -179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' N ' ' O ' ' A' ' 61' ' ' PRO . 20.2 tttp -65.62 -42.14 91.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 3.3 109.213 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 65' ' ' ALA . 0.8 OUTLIER -63.72 -37.9 89.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.341 -0.849 . . . . 2.12 109.226 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 49' ' ' GLN . . . -63.93 -46.28 85.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.419 -0.956 . . . . 1.79 108.419 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.587 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 36.7 m -62.66 -40.37 96.84 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.283 -0.885 . . . . 2.04 108.919 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.47 -44.23 80.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 2.31 108.519 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 64' ' ' PHE . 57.5 t -55.95 -50.99 65.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.019 -1.051 . . . . 1.71 108.39 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE2' ' OD1' ' A' ' 70' ' ' ASN . 1.2 t80 -55.25 -57.8 10.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.055 -1.058 . . . . 4.33 109.494 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.595 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 87.5 m-20 -57.1 -37.57 72.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.959 -1.088 . . . . 2.75 110.993 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 110' ' ' LEU . 92.1 t -84.72 -64.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.035 -1.041 . . . . 1.91 111.137 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.901 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 14.0 t80 -59.74 -32.52 70.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 2.75 111.703 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' PHE . 55.4 t0 -63.85 124.37 21.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.42 -1.425 . . . . 2.3 109.526 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.1 mt-10 -107.13 173.96 6.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.465 -0.772 . . . . 5.3 109.118 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 73.02 10.0 5.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.396 -0.815 . . . . 3.3 109.129 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 19.2 pttp 35.48 24.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.834 -0.542 . . . . 5.34 110.514 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 85.8 m-20 -63.36 -34.0 76.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 3.11 109.308 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.65 56.09 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.657 -1.777 . . . . 2.85 108.657 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -151.39 154.64 37.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.543 -0.975 . . . . 4.19 109.217 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 80' ' ' ILE . 3.1 mm -110.65 131.87 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.32 -0.993 . . . . 1.76 108.32 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -105.17 173.93 6.1 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.916 . . . . 2.4 110.487 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -50.19 -64.21 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 3.27 110.542 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 23.2 t -49.59 -44.4 47.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 2.35 110.091 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 96.5 mt-10 -67.12 -48.41 68.19 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.025 -1.047 . . . . 2.09 110.049 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.681 ' CE1' HD23 ' A' ' 89' ' ' LEU . 40.4 t80 -61.69 -51.03 70.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.736 -1.228 . . . . 2.22 110.151 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -28.02 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.965 -1.084 . . . . 1.9 108.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -65.03 -55.96 15.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.014 . . . . 2.63 109.507 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -65.78 -41.64 91.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.914 -1.116 . . . . 1.56 108.257 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.681 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -54.0 -40.52 67.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.716 -1.216 . . . . 2.17 107.716 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.7 m -62.99 -42.13 99.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.671 -0.863 . . . . 2.01 108.671 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.49 -38.76 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 2.2 107.687 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.98 -36.05 83.16 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.349 -0.612 . . . . 2.75 109.349 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 13.6 m -61.73 -61.17 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 3.47 109.623 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 93' ' ' SER . 80.1 mtt-85 -158.49 47.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.375 -0.828 . . . . 8.35 109.034 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 94' ' ' ARG . . . -42.13 151.67 0.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 3.29 109.777 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.635 HG22 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.88 159.12 19.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 3.18 108.75 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 97' ' ' LEU . 1.7 pt? -48.28 -39.34 21.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.024 -1.047 . . . . 4.22 109.726 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 97' ' ' LEU . 57.1 t0 -67.22 -48.17 68.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.99 -1.069 . . . . 3.59 109.617 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.57 -41.01 93.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 3.04 109.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 185' ' ' LEU . 15.7 mtpp -62.72 -36.83 84.28 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.27 -0.893 . . . . 3.12 108.815 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.489 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -61.23 -51.11 70.33 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.767 -0.827 . . . . 2.31 108.767 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.37 -41.37 98.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 3.93 109.641 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -62.33 -52.11 64.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 4.4 110.211 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.44 -38.24 80.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 1.41 110.132 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.584 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 71.5 t80 -60.16 -52.76 63.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 2.69 110.359 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -62.57 -39.8 94.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 3.23 109.867 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.36 -39.14 92.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 1.99 110.472 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -62.41 -27.57 69.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.056 -1.027 . . . . 2.51 111.538 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 10.0 t70 -142.05 109.62 5.69 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.717 -1.239 . . . . 1.8 109.859 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 5.5 tt -57.98 -47.26 83.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.471 -0.768 . . . . 3.31 110.187 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.506 ' OD1' ' OD1' ' A' ' 109' ' ' ASP . 48.6 p30 -97.2 34.79 1.7 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.317 -0.994 . . . . 2.09 108.317 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.608 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.5 p-10 -37.65 -43.21 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.889 -0.507 . . . . 3.68 110.571 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 4.2 p-10 44.29 29.21 0.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.338 -0.986 . . . . 2.51 108.338 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 115' ' ' TYR . . . 82.57 19.82 63.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.884 -1.287 . . . . 2.39 109.884 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' ASN . 14.0 m-85 -153.02 136.81 16.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -1.21 . . . . 2.76 110.445 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.56 135.4 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.367 -0.975 . . . . 1.6 108.367 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 p -120.87 156.55 31.73 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.708 -0.849 . . . . 1.73 108.708 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.641 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -60.99 -37.51 82.77 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.126 -0.984 . . . . 3.17 109.81 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.16 -46.0 85.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 2.44 109.029 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.508 ' OE1' ' OD2' ' A' ' 109' ' ' ASP . 79.0 mt-10 -70.27 -45.74 65.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 1.71 109.124 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.47 ' SD ' HG23 ' A' ' 125' ' ' VAL . 18.6 tmm? -61.13 -38.44 86.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.325 -0.991 . . . . 3.66 108.325 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.97 -39.53 94.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.69 -0.856 . . . . 1.77 108.69 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.77 -43.64 85.63 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.267 -1.012 . . . . 2.01 108.267 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.5 mm -68.18 -37.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.14 109.094 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG23 ' SD ' ' A' ' 121' ' ' MET . 53.9 t -61.06 -45.53 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 1.83 108.017 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -61.76 -38.21 87.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.922 -0.769 . . . . 2.16 108.922 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.86 79.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.89 . . . . 1.78 108.759 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 132' ' ' VAL . 85.4 mt -68.71 -31.52 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.47 -0.769 . . . . 2.42 109.258 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' GLY . 4.8 t80 -61.13 -55.85 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 5.07 109.843 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.98 -40.64 95.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.947 . . . . 3.05 109.661 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.517 ' SD ' ' C ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.76 -30.65 69.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 4.88 109.629 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.645 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -104.72 4.48 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -0.805 . . . . 3.55 109.936 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 135' ' ' THR . . . -71.59 135.42 23.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.727 -1.349 . . . . 3.52 109.727 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 t30 53.19 47.32 24.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 4.29 109.063 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.711 ' O ' HD23 ' A' ' 138' ' ' LEU . 46.4 p -128.08 163.12 25.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 3.68 110.732 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' LEU . 73.4 t -76.65 -27.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 5.42 109.761 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -71.81 21.46 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 5.6 109.518 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 135' ' ' THR . 1.5 mm? -68.91 115.46 31.48 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.981 -1.074 . . . . 2.5 108.847 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -53.0 142.67 52.77 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.631 1.554 . . . . 3.55 112.08 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.67 -42.74 99.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.069 -1.019 . . . . 5.65 109.2 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.621 ' CD ' HD21 ' A' ' 143' ' ' ASN . 86.0 tt0 -68.84 -29.73 68.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 6.82 108.576 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 68.8 59.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.322 0.582 . . . . 6.56 109.859 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.621 HD21 ' CD ' ' A' ' 141' ' ' GLU . 31.1 m120 -80.63 -11.82 59.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.44 -0.787 . . . . 5.59 109.049 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -38.43 -60.22 1.11 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 3.06 110.292 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 144' ' ' THR . 71.4 Cg_exo -31.4 99.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.681 2.254 . . . . 3.91 112.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -42.81 -30.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.681 -0.637 . . . . 3.87 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -58.94 -40.09 83.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.003 -1.061 . . . . 3.64 110.589 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -59.46 -45.74 90.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.072 . . . . 4.99 110.285 -179.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.4 -34.58 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.792 -1.192 . . . . 1.57 109.561 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.36 -57.55 12.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.99 -1.069 . . . . 2.71 110.306 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.39 -44.34 87.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 4.73 109.617 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.9 mt -57.68 -50.71 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 2.07 110.671 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -64.45 -37.49 87.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.814 -1.179 . . . . 2.93 109.611 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.72 66.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.408 -1.33 . . . . 1.77 107.408 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 58.3 ttp -65.11 -32.63 74.42 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.572 -0.899 . . . . 2.34 108.572 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.57 ' CE ' HD11 ' A' ' 179' ' ' ILE . 0.0 OUTLIER -87.48 -20.71 26.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.486 -0.758 . . . . 3.53 109.34 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 153' ' ' PHE . 59.8 t0 -98.64 15.97 23.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 2.4 109.699 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -55.3 -31.52 61.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 4.18 109.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 161' ' ' ASP . 37.5 p-10 -48.76 -29.45 4.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.404 -0.81 . . . . 2.49 109.222 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.582 ' N ' ' OD1' ' A' ' 159' ' ' ASN . . . 64.51 30.05 13.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 3.15 110.007 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 54.8 p30 -63.57 -29.36 70.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.04 -1.038 . . . . 3.4 109.547 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.626 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 126.54 -40.3 1.83 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.626 -1.39 . . . . 2.83 109.626 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.07 177.12 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.227 -1.16 . . . . 2.45 110.122 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 165' ' ' THR . 0.4 OUTLIER -101.1 123.29 45.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.605 -1.257 . . . . 1.9 107.605 178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.642 ' N ' HD13 ' A' ' 164' ' ' LEU . 24.6 p -125.49 168.03 14.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.245 -0.909 . . . . 1.8 110.596 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD23 ' NE2' ' A' ' 170' ' ' GLN . 7.8 mp -57.11 -27.91 62.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.684 -0.635 . . . . 2.28 110.161 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -50.84 -54.42 23.93 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.493 -1.379 . . . . 2.92 109.176 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.583 ' OE2' ' ND2' ' A' ' 159' ' ' ASN . 97.7 mt-10 -75.54 -37.6 59.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 1.85 110.071 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -59.08 4.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 2.14 109.876 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.589 ' NE2' HD23 ' A' ' 166' ' ' LEU . 97.2 mt-30 -63.32 -43.82 96.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 2.35 110.563 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 76.6 mm-40 -68.06 -50.28 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.169 . . . . 2.92 109.584 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -63.14 -38.98 97.42 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.208 -1.557 . . . . 1.77 109.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 180' ' ' VAL . 6.3 t -58.75 -45.98 88.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.51 -0.994 . . . . 2.18 110.59 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -23.9 19.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.098 -1.001 . . . . 4.67 109.759 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -82.3 -37.41 25.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 2.92 110.022 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 172' ' ' GLY . 8.1 t70 -141.14 139.0 18.42 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 2.61 109.564 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 178' ' ' SER . 56.9 Cg_endo -73.65 -170.05 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.026 1.817 . . . . 2.17 112.335 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 81.85 -40.19 0.13 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.654 -0.654 . . . . 2.62 110.137 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 156' ' ' MET . 93.8 mt -65.54 -51.92 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.864 -1.148 . . . . 2.0 108.835 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 182' ' ' ALA . 86.0 t -73.22 -33.08 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 3.79 109.183 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.693 ' NE2' ' CD1' ' A' ' 186' ' ' TYR . 49.7 tp60 -42.34 -20.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.553 -0.906 . . . . 6.02 108.553 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.853 ' C ' HD13 ' A' ' 183' ' ' LEU . . . 48.66 -145.75 0.35 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.612 -0.68 . . . . 4.48 109.418 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.044 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -114.93 -29.73 6.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.591 -0.693 . . . . 4.79 109.578 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 7.1 t -139.3 24.9 2.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 5.27 110.499 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.552 HD23 ' NZ ' ' A' ' 100' ' ' LYS . 8.3 mp -96.32 13.28 28.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.922 -1.111 . . . . 7.1 109.72 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.693 ' CD1' ' NE2' ' A' ' 181' ' ' GLN . 97.1 m-85 -52.75 158.56 1.31 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.085 -1.009 . . . . 9.88 109.674 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -127.99 -101.5 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 8.42 109.343 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.52 97.81 2.32 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.484 -1.446 . . . . 9.13 109.484 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 36.4 tp -59.73 -35.82 75.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -1.179 . . . . 11.72 109.407 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 117.996 -1.002 . . . . 12.62 109.507 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 15.48 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.44 -176.17 46.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.6 -1.4 . . . . 11.71 109.6 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -96.71 134.86 39.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 12.65 109.632 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -118.61 136.7 53.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 8.16 109.246 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.11 114.21 26.92 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.388 -0.82 . . . . 7.63 109.453 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -146.8 7.01 0.93 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 5.22 109.645 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' LEU . 2.6 ttmp? 53.81 82.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 4.94 108.902 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 9' ' ' LYS . 7.1 tt 56.64 107.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.377 -0.971 . . . . 2.2 108.377 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.567 ' O ' HD23 ' A' ' 8' ' ' LEU . 45.0 mtpt -49.24 149.74 3.5 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.262 -0.899 . . . . 2.5 110.483 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.34 -43.94 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.72 2.28 . . . . 3.23 112.314 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -53.44 -38.3 63.4 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.977 -1.12 . . . . 3.91 107.977 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 54.9 t -65.38 -34.01 67.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 98.8 t -61.69 -43.29 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.64 109.234 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.4 -51.3 61.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.866 -1.146 . . . . 4.15 110.057 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -72.93 -27.88 62.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.952 . . . . 3.01 110.488 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 1.8 tm? -78.58 -57.74 3.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.952 -1.092 . . . . 2.71 108.286 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.2 p -57.06 -33.59 67.4 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.659 -1.237 . . . . 3.6 107.659 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -50.55 -29.66 11.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.008 -1.478 . . . . 5.04 107.008 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 16' ' ' LEU . 6.5 ttpt -140.91 105.15 4.82 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.826 -1.176 . . . . 5.04 107.826 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 22' ' ' PHE . 14.7 m -161.76 -23.11 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.906 -1.121 . . . . 2.89 110.864 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 69.36 -7.87 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.482 -0.933 . . . . 6.0 108.482 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 20' ' ' THR . 37.3 m-85 -125.14 162.46 24.58 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 2.94 108.739 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -74.84 165.77 24.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 3.98 109.141 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CG ' HG21 ' A' ' 17' ' ' THR . 3.5 mt-10 -65.77 -35.93 82.12 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.36 -0.837 . . . . 4.23 109.616 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.12 -39.72 91.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 5.1 110.269 -179.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.96 -40.11 96.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.017 -1.052 . . . . 3.8 109.742 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 86' ' ' ILE . 53.3 t -68.42 -38.82 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 2.44 109.505 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.18 -41.35 96.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.939 -1.101 . . . . 3.85 109.071 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.4 -46.13 70.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 3.75 109.406 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 33' ' ' GLY . 1.5 t90 -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 5.2 108.482 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 80.4 t80 -54.92 -45.83 74.82 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 108.472 -0.936 . . . . 2.74 108.472 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -83.48 -2.37 55.77 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.902 -1.148 . . . . 5.06 107.902 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 30' ' ' TRP . . . -72.84 -54.28 7.39 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.623 -0.798 . . . . 2.92 111.26 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' LYS . 2.0 p90 -81.42 -49.29 10.83 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.54 -1.565 . . . . 3.92 111.849 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -62.62 -1.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.581 -1.325 . . . . 3.57 109.672 -178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 34' ' ' PHE . 32.6 ttpt -55.4 -40.64 71.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.024 -1.047 . . . . 6.37 108.239 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -61.17 -39.37 89.86 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 7.82 108.937 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -157.13 153.22 23.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.768 . . . . 5.72 109.15 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.41 -24.81 63.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.582 2.188 . . . . 4.71 112.283 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 35' ' ' ILE . 51.5 p -70.48 144.97 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 5.05 109.186 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.23 80.14 0.26 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.092 -1.203 . . . . 2.56 110.092 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -146.44 119.21 8.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -1.142 . . . . 3.09 109.787 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.8 mp -105.72 145.14 31.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 2.82 109.575 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -80.2 173.44 12.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.54 -0.725 . . . . 2.91 109.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.25 76.99 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.316 -0.865 . . . . 1.72 109.265 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.28 94.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 2.06 109.598 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.39 79.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.485 -1.446 . . . . 2.03 109.485 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 52' ' ' TYR . 39.2 t80 -61.56 -45.88 92.28 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.16 -1.2 . . . . 2.65 108.171 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -36.61 72.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.986 -1.072 . . . . 2.8 108.405 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -61.55 -44.31 97.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.56 -0.713 . . . . 3.4 110.259 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HA ' HE21 ' A' ' 54' ' ' GLN . 0.9 OUTLIER -65.36 -32.8 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.633 -1.292 . . . . 2.99 108.945 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -63.18 -39.39 94.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.27 -1.381 . . . . 5.31 107.27 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -62.77 -37.05 85.11 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.716 -0.846 . . . . 3.63 108.716 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.471 HE21 ' HA ' ' A' ' 51' ' ' ILE . 32.2 mt-30 -58.56 -36.83 74.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 4.23 109.927 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 22.4 m-85 -99.57 -13.63 19.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 4.18 109.518 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -139.78 68.98 37.04 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.874 . . . . 6.44 109.848 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 -55.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.896 2.397 . . . . 4.28 111.669 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -59.67 -24.14 63.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -0.847 . . . . 4.17 109.274 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.15 -177.69 48.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.465 -1.454 . . . . 3.59 109.465 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 131' ' ' MET . 34.0 m-20 -124.35 77.03 61.71 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.361 -1.082 . . . . 5.63 109.274 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 62.8 Cg_endo -79.84 60.83 7.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.722 2.281 . . . . 4.4 112.325 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' THR . 19.2 m -100.46 -79.24 0.5 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 3.54 109.488 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 62' ' ' THR . 48.1 tttp -60.13 -44.4 94.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 3.3 109.234 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.751 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.0 t80 -61.38 -41.21 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.453 -0.779 . . . . 2.12 109.349 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . . . -63.43 -45.56 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 1.79 109.303 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' THR . 69.7 p -64.45 -39.28 93.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.285 -0.884 . . . . 2.04 108.984 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.657 ' CE2' HD22 ' A' ' 110' ' ' LEU . 3.3 m-30 -61.63 -37.55 84.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 2.31 108.877 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 64' ' ' PHE . 59.7 t -64.12 -62.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.365 -0.834 . . . . 1.71 109.318 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.97 -35.92 59.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.85 -1.156 . . . . 4.33 108.665 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -62.46 -39.67 94.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 2.75 110.577 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 72' ' ' PHE . 7.1 p -107.21 -48.74 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 120.996 -1.065 . . . . 1.91 110.728 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.614 ' N ' HG13 ' A' ' 71' ' ' VAL . 10.3 t80 -49.96 -28.81 7.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.919 -1.113 . . . . 2.75 109.689 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.24 112.97 2.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.879 -1.138 . . . . 2.3 108.419 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.7 -39.62 84.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -0.838 . . . . 5.3 111.526 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 38.0 p30 -98.99 -3.04 35.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.751 -1.218 . . . . 3.3 110.629 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.2 mttt 49.84 39.98 19.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.988 -1.07 . . . . 5.34 109.321 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' OD2' ' OE2' ' A' ' 81' ' ' GLU . 47.7 p30 -86.32 1.0 52.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.103 -0.998 . . . . 3.11 109.967 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.58 -23.16 33.63 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.944 -1.122 . . . . 2.85 110.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 77' ' ' ASP . 77.1 mtt85 -129.86 149.54 51.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -1.154 . . . . 4.19 109.857 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -89.83 140.64 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.337 -0.986 . . . . 1.76 108.337 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' OE2' ' OD2' ' A' ' 77' ' ' ASP . 7.6 mp0 -100.23 166.31 11.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.977 -1.077 . . . . 2.4 110.891 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -55.2 -52.94 61.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.709 -0.619 . . . . 3.27 110.205 -179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.512 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 20.4 m -57.1 -42.75 81.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.851 -1.156 . . . . 2.35 109.555 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.16 -41.47 85.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.236 -0.915 . . . . 2.09 109.983 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.452 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 67.9 t80 -73.55 -54.49 8.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 2.22 110.269 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 27' ' ' VAL . 3.6 tp -55.57 -30.65 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.849 -1.157 . . . . 1.9 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 91' ' ' VAL . 61.8 tp60 -71.82 -65.66 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 2.63 110.365 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 72' ' ' PHE . . . -64.77 -40.81 95.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.167 . . . . 1.56 109.606 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.9 tm? -53.7 -47.27 70.66 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.751 -1.203 . . . . 2.17 107.751 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -62.91 -37.49 87.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.096 -1.003 . . . . 2.01 108.75 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 87' ' ' GLN . 96.6 t -62.52 -38.36 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.774 -1.195 . . . . 2.2 107.774 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.41 -35.98 77.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.311 -0.996 . . . . 2.75 108.311 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.504 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 1.7 t -54.31 -43.45 71.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 3.47 108.644 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -154.76 -67.54 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.223 -1.029 . . . . 8.35 108.223 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.71 -179.59 53.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.369 -1.093 . . . . 3.29 110.369 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -124.31 162.42 23.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.591 -0.946 . . . . 3.18 108.741 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.5 mt -56.0 -33.48 64.89 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.605 -1.258 . . . . 4.22 107.605 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -67.58 -50.01 60.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.62 -0.675 . . . . 3.59 109.756 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 96' ' ' THR . 50.9 mt-10 -66.0 -41.14 91.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 3.04 109.573 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -62.0 -38.96 90.59 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.19 -0.944 . . . . 3.12 108.919 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.6 tp -60.51 -45.71 92.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.661 -0.866 . . . . 2.31 108.661 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -66.8 -39.76 87.87 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.52 -0.918 . . . . 3.93 108.52 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -50.3 74.07 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.639 -0.874 . . . . 4.4 108.639 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -37.55 87.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 166' ' ' LEU . 76.1 t80 -59.93 -44.73 94.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.354 -0.841 . . . . 2.69 109.041 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -60.42 -40.97 92.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 3.23 109.455 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.5 -56.15 5.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.038 . . . . 1.99 109.818 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 182' ' ' ALA . 9.8 m-30 -48.48 -37.53 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -0.754 . . . . 2.51 109.302 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -101.29 102.8 13.73 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 1.8 109.626 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.657 HD22 ' CE2' ' A' ' 67' ' ' PHE . 31.4 tp -83.24 -74.84 0.35 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.172 -0.955 . . . . 3.31 109.01 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 26.4 p-10 -66.4 -36.06 81.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 2.09 109.0 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 11.1 p30 45.28 45.34 9.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.582 -0.699 . . . . 3.68 110.06 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 25.7 p-10 -61.09 -35.78 77.9 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.463 -0.94 . . . . 2.51 108.463 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -142.22 -79.69 0.05 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.119 -1.993 . . . . 2.39 108.119 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CD2' HG22 ' A' ' 165' ' ' THR . 0.4 OUTLIER -123.66 -165.86 1.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.535 -0.979 . . . . 2.76 108.409 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 164' ' ' LEU . 51.6 mt -96.18 152.26 3.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.374 -0.829 . . . . 1.6 109.749 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 p -127.42 157.69 39.34 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.311 -0.996 . . . . 1.73 108.311 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.792 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -61.09 -39.76 91.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.933 -1.105 . . . . 3.17 109.776 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -61.63 -43.03 99.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 2.44 109.736 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.13 -42.3 96.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 1.71 109.279 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 86.2 mtp -62.31 -37.6 86.2 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.131 -0.981 . . . . 3.66 108.683 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.99 -42.16 97.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.54 -0.725 . . . . 1.77 109.428 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.0 -39.91 83.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 2.01 109.776 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 124' ' ' ILE . 40.6 mm -63.46 -49.93 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 1.14 110.638 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' TYR . 35.0 m -61.93 -36.5 74.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.959 -1.497 . . . . 1.83 106.959 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 125' ' ' VAL . 54.7 t0 -61.76 -36.78 82.02 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.428 -1.323 . . . . 2.16 107.428 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.8 -65.72 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.649 0.738 . . . . 1.78 109.553 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 64' ' ' PHE . 80.4 mt -53.9 -49.21 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.431 -0.793 . . . . 2.42 109.304 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.559 ' O ' ' N ' ' A' ' 133' ' ' GLY . 44.6 t80 -59.09 -41.4 87.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.149 -1.02 . . . . 5.07 109.711 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -52.08 -43.99 64.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.795 -1.19 . . . . 3.05 108.055 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.419 ' O ' ' OG1' ' A' ' 135' ' ' THR . 19.0 tmm? -62.71 -36.64 83.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.149 -1.056 . . . . 4.88 108.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 132' ' ' VAL . 25.4 t -88.14 -0.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.663 -0.648 . . . . 3.55 109.387 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -60.16 -41.33 98.11 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.399 -0.905 . . . . 3.52 110.855 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -123.03 22.35 9.58 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.177 -1.19 . . . . 4.29 110.257 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 137' ' ' GLU . 48.7 m -81.78 148.06 29.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.013 . . . . 3.68 109.271 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.1 -35.58 66.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.149 -0.969 . . . . 5.42 108.735 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.606 ' H ' HG22 ' A' ' 135' ' ' THR . 78.6 mm-40 -100.87 113.81 27.09 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.577 0.703 . . . . 5.6 109.766 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 135' ' ' THR . 0.5 OUTLIER -148.24 154.43 42.31 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.355 -0.98 . . . . 2.5 108.355 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.52 99.87 1.31 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.46 1.44 . . . . 3.55 112.029 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.78 -36.04 75.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.833 . . . . 5.65 110.019 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -68.47 -58.95 3.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.089 -1.007 . . . . 6.82 109.977 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -73.23 -46.02 52.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.015 . . . . 6.56 109.311 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 144' ' ' THR . 17.2 t-20 55.13 49.69 16.86 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.277 -0.89 . . . . 5.59 108.603 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.471 ' OG1' ' CD1' ' A' ' 129' ' ' TYR . 0.4 OUTLIER 73.73 131.56 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 108.878 -0.786 . . . . 3.06 108.878 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG2' HG11 ' A' ' 125' ' ' VAL . 95.7 Cg_endo -79.89 89.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.843 1.695 . . . . 3.91 111.442 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -100.88 -83.25 0.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 3.87 110.408 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -63.88 -39.05 93.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 3.64 110.832 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -56.76 -48.0 78.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 4.99 110.915 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 149' ' ' VAL . 1.4 m -70.15 -39.54 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.792 -1.193 . . . . 1.57 109.748 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.2 m-20 -51.41 -50.5 59.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.417 -1.427 . . . . 2.71 109.035 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.18 -49.64 12.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.965 . . . . 4.73 110.38 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.41 -54.66 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -0.978 . . . . 2.07 110.641 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.612 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -64.14 -39.49 94.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.858 -1.151 . . . . 2.93 109.04 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -54.99 -38.39 67.78 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.819 -1.176 . . . . 1.77 108.088 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 156' ' ' MET . 9.3 tmm? -68.64 -25.74 64.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.592 -0.692 . . . . 2.34 109.382 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.639 ' SD ' ' SD ' ' A' ' 155' ' ' MET . 96.0 mmm -92.03 -14.46 29.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.145 -0.972 . . . . 3.53 109.807 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.491 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 61.0 t0 -92.94 14.38 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.15 -0.968 . . . . 2.4 110.118 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 160' ' ' ALA . 8.6 mtmp? -56.68 -23.91 45.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.105 -0.997 . . . . 4.18 109.812 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.711 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 24.2 m120 -36.45 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.176 0.512 . . . . 2.49 109.784 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 78.98 -1.99 2.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 3.15 109.577 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.5 p-10 -60.21 -32.87 71.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.252 -0.905 . . . . 3.4 109.113 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.587 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 93.99 -1.69 68.21 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.65 -1.38 . . . . 2.83 109.65 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.493 ' O ' ' OD2' ' A' ' 161' ' ' ASP . 10.9 tttp -142.56 171.49 13.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 2.45 109.041 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -103.83 125.02 49.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 1.9 109.739 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 115' ' ' TYR . 54.6 p -120.0 162.51 19.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 1.8 109.601 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.2 mm? -59.39 -34.75 72.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.251 -0.906 . . . . 2.28 109.703 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 166' ' ' LEU . 53.0 mt-30 -36.17 -72.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.385 -0.822 . . . . 2.92 110.185 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 156' ' ' MET . 5.7 pt-20 -68.57 -26.57 65.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 1.85 110.563 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.568 ' CE1' HG22 ' A' ' 179' ' ' ILE . 0.1 OUTLIER -69.08 -64.96 0.77 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.02 -1.05 . . . . 2.14 110.202 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.18 -41.93 94.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.963 . . . . 2.35 111.021 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.03 -39.45 86.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.834 -1.166 . . . . 2.92 110.418 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -83.6 -41.04 8.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.898 -1.281 . . . . 1.77 109.898 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . 97.7 p -60.58 -33.35 72.58 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.278 . . . . 2.18 109.498 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -86.05 -3.02 58.85 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.283 -0.885 . . . . 4.67 109.809 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.76 -3.74 3.25 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.261 -0.899 . . . . 2.92 109.715 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' O ' ' A' ' 172' ' ' GLY . 5.6 t0 -148.6 89.64 5.02 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.287 -0.883 . . . . 2.61 109.241 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.568 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.45 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.4 2.067 . . . . 2.17 112.244 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 3.0 p 85.39 -40.09 0.05 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.696 -0.627 . . . . 2.62 109.858 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 169' ' ' PHE . 54.7 mt -60.66 -47.88 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.036 -1.04 . . . . 2.0 109.73 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -87.62 -32.13 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.099 -1.0 . . . . 3.79 109.979 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 182' ' ' ALA . 93.4 mt-30 -72.47 44.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 6.02 109.028 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.64 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . . . -34.1 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.924 -0.485 . . . . 4.48 110.055 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -61.91 -26.31 68.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.148 -0.97 . . . . 4.79 109.074 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 183' ' ' LEU . 1.6 p 83.12 110.96 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.74 . . . . 5.27 109.356 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 185' ' ' LEU . 3.0 mm? -79.53 -5.64 55.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 7.1 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.553 ' CB ' ' O ' ' A' ' 185' ' ' LEU . 10.7 t80 87.0 125.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.349 -0.611 . . . . 9.88 109.349 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 188' ' ' GLY . 59.8 t0 -72.03 133.14 45.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 8.42 109.313 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . -40.66 129.2 3.15 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.689 -1.364 . . . . 9.13 109.689 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.523 ' CD2' ' H ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -85.78 -98.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 11.72 109.357 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.469 HG13 ' OXT' ' A' ' 190' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.947 -1.025 . . . . 12.62 109.505 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.284 -0.636 . . . . 15.48 109.284 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.93 -2.67 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.538 -1.425 . . . . 11.71 109.538 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -104.44 140.26 38.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 12.65 109.329 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 91.5 p -126.72 150.34 49.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 8.16 109.387 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' OD1' ' O ' ' A' ' 4' ' ' SER . 83.0 m-20 -158.48 -31.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 7.63 109.429 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 m -58.89 -36.16 74.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 5.22 109.795 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -173.31 -159.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 4.94 109.866 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.87 150.92 27.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 2.2 108.988 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -58.15 150.1 53.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 2.5 109.429 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.51 -33.97 44.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.513 2.142 . . . . 3.23 112.255 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 55.4 mp0 -61.32 -39.62 91.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.146 -0.971 . . . . 3.91 109.059 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 16' ' ' LEU . 55.6 t -65.29 -41.84 92.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -0.87 . . . . 2.17 109.021 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 8' ' ' LEU . 42.7 t -56.44 -46.12 82.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.916 . . . . 2.64 109.604 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HB3' HH12 ' A' ' 18' ' ' ARG . 96.8 mt-10 -61.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.947 -1.095 . . . . 4.15 109.066 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -64.05 -34.94 79.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.141 -0.974 . . . . 3.01 108.793 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.586 ' O ' ' OG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER -58.37 -51.71 68.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.027 -1.101 . . . . 2.71 108.027 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 17' ' ' THR . 27.9 p -52.02 -42.09 62.77 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.77 -1.206 . . . . 3.6 108.452 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.475 HH12 ' HB3' ' A' ' 14' ' ' GLU . 66.8 mtt85 -59.37 -31.3 69.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.206 -0.934 . . . . 5.04 108.978 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -138.88 64.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 5.04 109.56 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.604 ' C ' ' H ' ' A' ' 22' ' ' PHE . 59.0 m -149.03 -25.39 0.3 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.128 -0.983 . . . . 2.89 109.753 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 62.48 -13.46 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.179 -0.951 . . . . 6.0 110.401 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.6 m-30 -105.17 158.5 16.55 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.426 -0.953 . . . . 2.94 108.426 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.1 p -69.65 159.03 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.942 -1.099 . . . . 3.98 108.341 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 99.0 mt-10 -60.63 -35.16 75.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.218 -0.926 . . . . 4.23 109.932 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.27 -41.49 88.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.999 -1.063 . . . . 5.1 109.994 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' OE1' ' CD2' ' A' ' 22' ' ' PHE . 97.5 mt-10 -66.31 -40.72 90.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 3.8 110.954 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG11 HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -65.64 -39.5 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.66 -1.275 . . . . 2.44 108.885 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.55 -39.35 93.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 3.85 109.119 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -63.12 -38.96 93.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 3.75 109.486 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.598 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 78.1 m95 -75.58 -52.52 10.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.994 -1.066 . . . . 5.2 108.879 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -48.4 -65.37 0.58 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.853 -0.795 . . . . 2.74 108.853 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -65.27 -31.45 72.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.507 -0.746 . . . . 5.06 109.146 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.56 -47.14 17.81 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 120.45 -0.881 . . . . 2.92 111.311 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 29.1 p90 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.786 -1.42 . . . . 3.92 111.662 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 41' ' ' GLY . 5.1 mm -71.78 -22.67 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.569 -1.332 . . . . 3.57 110.837 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -52.77 -36.67 58.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.684 -1.26 . . . . 6.37 109.79 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.559 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 92.6 m-20 -56.03 -36.6 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.995 -1.065 . . . . 7.82 108.412 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 37' ' ' ASP . 1.2 m 176.41 155.75 0.41 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 5.72 108.679 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' SER . 11.7 Cg_endo -57.37 145.79 86.07 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.459 2.106 . . . . 4.71 111.336 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 39' ' ' PRO . 3.4 m 43.28 67.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 5.05 108.692 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' H ' HD13 ' A' ' 35' ' ' ILE . . . -64.74 131.72 37.28 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.462 -1.055 . . . . 2.56 110.462 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -105.35 123.78 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.995 . . . . 3.09 109.123 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.77 134.55 48.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 2.82 109.975 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.596 ' OD1' ' NE ' ' A' ' 79' ' ' ARG . 81.7 m-20 -77.3 177.0 8.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.705 -0.85 . . . . 2.91 108.705 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.592 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -57.58 -32.81 67.54 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.12 -0.988 . . . . 1.72 108.726 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.84 91.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.367 -0.833 . . . . 2.06 109.501 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.11 -50.49 66.7 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.314 -1.514 . . . . 2.03 109.314 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -62.09 -42.15 98.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.673 -1.232 . . . . 2.65 107.673 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 62' ' ' THR . 35.7 tt0 -57.91 -38.6 76.14 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.919 -1.141 . . . . 2.8 107.919 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -60.36 -42.14 95.16 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 3.4 108.491 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.6 mm -54.27 -54.06 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 2.99 108.88 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD2' ' SD ' ' A' ' 131' ' ' MET . 5.2 m-30 -62.59 -23.42 67.02 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.517 -0.873 . . . . 5.31 109.449 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -84.87 -27.88 26.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.701 -1.249 . . . . 3.63 108.994 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -62.48 -42.79 99.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.897 . . . . 4.23 110.842 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -114.84 -9.57 12.47 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.98 -1.075 . . . . 4.18 110.333 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -134.48 59.78 38.62 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.051 -1.031 . . . . 6.44 109.72 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 56' ' ' PHE . 56.8 Cg_endo -82.9 -17.36 7.02 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.381 2.054 . . . . 4.28 113.982 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 136' ' ' VAL . 65.2 m-85 -63.42 -3.48 2.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.608 -1.308 . . . . 4.17 109.684 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.59 -151.01 6.36 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.646 -1.382 . . . . 3.59 109.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 130' ' ' GLN . 24.0 t0 56.44 64.7 4.64 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.993 . . . . 5.63 110.082 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.3 Cg_exo -61.42 -53.2 2.52 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.169 1.913 . . . . 4.4 111.337 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.499 ' HA ' HE21 ' A' ' 49' ' ' GLN . 5.8 t -175.07 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.587 -0.696 . . . . 3.54 109.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.87 -53.11 61.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 3.3 110.762 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.907 ' O ' HG23 ' A' ' 68' ' ' VAL . 55.0 t80 -70.62 -50.92 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.962 -1.086 . . . . 2.12 109.916 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . . . -57.74 -54.4 47.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.359 -0.838 . . . . 1.79 109.421 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -60.27 -39.48 87.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.534 -0.913 . . . . 2.04 108.534 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 107' ' ' LEU . 3.2 t80 -57.16 -44.85 83.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.417 -0.802 . . . . 2.31 109.343 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 64' ' ' PHE . 4.9 t -61.98 -53.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.1 t80 -54.25 -38.61 65.98 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.444 -0.785 . . . . 4.33 109.442 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.93 -41.3 91.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 2.75 110.876 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 72' ' ' PHE . 13.4 p -100.89 -49.04 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.849 -1.157 . . . . 1.91 110.849 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.034 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 81.3 t80 -51.01 -34.85 31.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.106 -0.996 . . . . 2.75 110.318 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.92 93.5 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.909 -1.12 . . . . 2.3 108.752 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 72' ' ' PHE . 60.9 mp0 -65.92 -40.05 91.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.249 -0.907 . . . . 5.3 110.386 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -62.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 3.3 109.11 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 mttm 58.83 34.91 24.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.373 -0.603 . . . . 5.34 109.373 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -91.84 0.97 57.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.304 -0.872 . . . . 3.11 108.852 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.61 -3.43 86.26 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.474 -1.45 . . . . 2.85 109.474 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' NE ' ' OD1' ' A' ' 44' ' ' ASP . 46.1 mmm-85 -134.61 153.92 51.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.38 -1.071 . . . . 4.19 109.288 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.51 131.93 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.629 -1.249 . . . . 1.76 107.629 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -105.6 -179.93 4.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 2.4 110.032 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.33 -45.03 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.618 -0.676 . . . . 3.27 110.189 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -58.86 -48.45 81.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.112 -0.992 . . . . 2.35 111.194 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.39 -44.75 50.75 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.82 -1.175 . . . . 2.09 111.347 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.68 ' CE1' HD23 ' A' ' 89' ' ' LEU . 7.9 t80 -61.55 -49.66 75.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.622 -1.299 . . . . 2.22 109.947 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -36.31 77.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.219 -0.925 . . . . 1.9 109.192 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 91' ' ' VAL . 49.1 tt0 -60.58 -49.08 78.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.979 -1.076 . . . . 2.63 110.167 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.034 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -66.42 -32.86 74.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.919 -1.141 . . . . 1.56 107.919 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.68 HD23 ' CE1' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -61.63 -53.65 53.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.098 -0.705 . . . . 2.17 109.098 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.3 m -60.56 -39.74 89.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 2.01 108.841 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 87' ' ' GLN . 70.6 t -63.98 -36.98 78.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.571 -0.9 . . . . 2.2 108.571 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -41.76 88.49 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.93 -0.767 . . . . 2.75 108.93 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 26.9 m -57.82 -50.39 73.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.096 -1.002 . . . . 3.47 108.694 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' SER . 55.7 mtm180 -160.57 -56.41 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.977 -0.749 . . . . 8.35 108.977 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.98 172.89 48.6 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.33 -1.508 . . . . 3.29 109.33 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.96 152.77 18.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.138 -1.213 . . . . 3.18 108.667 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 tp -52.23 -38.88 59.36 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.141 -0.975 . . . . 4.22 108.451 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.09 -43.63 67.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 3.59 109.732 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' CD1' ' A' ' 103' ' ' TRP . 96.7 mt-10 -67.75 -39.02 84.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 3.04 110.121 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -57.71 -45.49 85.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 3.12 109.633 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.33 -37.2 74.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.167 -0.958 . . . . 2.31 109.789 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -63.31 -49.14 75.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.101 -1.0 . . . . 3.93 109.899 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' A' ' 99' ' ' GLU . 58.4 m95 -69.64 -41.17 75.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 4.4 109.548 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.5 89.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.41 109.719 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.88 -54.05 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 2.69 109.55 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -62.12 -40.04 94.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 3.23 108.842 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD11 ' CE1' ' A' ' 64' ' ' PHE . 13.7 tp -64.86 -36.51 84.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.482 -0.761 . . . . 1.99 109.875 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 121' ' ' MET . 0.9 OUTLIER -58.27 -37.32 74.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.805 -1.184 . . . . 2.51 110.794 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 42.2 t0 -107.92 117.96 35.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.956 -1.09 . . . . 1.8 108.946 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 124' ' ' ILE . 8.6 tt -62.14 -38.68 89.91 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.476 -0.89 . . . . 3.31 109.684 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 36.0 p30 -94.92 -33.74 12.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 2.09 110.046 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.604 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 26.0 t-20 48.35 50.91 15.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.968 -1.082 . . . . 3.68 109.535 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.94 13.23 5.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.8 . . . . 2.51 109.672 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.05 9.98 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.194 -1.563 . . . . 2.39 109.194 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.522 ' CE2' HG22 ' A' ' 165' ' ' THR . 4.7 m-85 -120.39 131.93 55.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -1.009 . . . . 2.76 108.871 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.27 144.1 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 1.6 109.319 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 p -121.54 157.76 29.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.554 -0.906 . . . . 1.73 108.554 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.648 ' NE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -62.16 -40.24 95.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.053 . . . . 3.17 110.452 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -52.9 -41.87 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.869 -1.145 . . . . 2.44 108.492 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.24 -35.71 78.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.4 -0.963 . . . . 1.71 108.4 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 66.8 ttp -64.1 -42.66 96.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.555 -0.716 . . . . 3.66 109.669 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 122' ' ' LEU . 4.5 mm? -65.58 -41.87 92.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 1.77 109.425 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -48.87 78.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 2.01 109.132 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 22.5 mm -65.75 -51.31 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.14 109.479 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 121' ' ' MET . 28.5 t -47.34 -52.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 1.83 109.175 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.57 -37.58 70.76 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.505 -1.294 . . . . 2.16 107.505 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -61.68 -34.03 75.03 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.627 -0.879 . . . . 1.78 108.627 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 132' ' ' VAL . 9.3 mm -61.87 -48.94 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.506 -1.294 . . . . 2.42 107.506 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.607 ' CE1' ' OE2' ' A' ' 146' ' ' GLU . 43.0 m-85 -52.03 -44.15 64.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.801 -1.185 . . . . 5.07 107.801 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.517 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 97.2 mm-40 -61.81 -35.08 77.17 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.398 -0.964 . . . . 3.05 108.398 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' ' CD2' ' A' ' 52' ' ' TYR . 16.6 tpt -67.98 -46.49 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 4.88 109.804 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 136' ' ' VAL . 11.1 m -81.02 -0.23 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.072 -1.017 . . . . 3.55 108.99 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.38 167.6 41.93 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.196 -1.162 . . . . 3.52 110.196 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.542 ' C ' HG22 ' A' ' 135' ' ' THR . 22.5 m120 -57.8 -35.13 70.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.406 -1.055 . . . . 4.29 108.695 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.542 HG22 ' C ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -177.32 22.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 3.68 110.27 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 132' ' ' VAL . 5.7 p -54.04 -36.02 30.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.619 -1.301 . . . . 5.42 109.898 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.1 pt-20 -174.21 63.5 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.285 -0.885 . . . . 5.6 110.657 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.7 mt -68.98 161.47 72.12 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.61 -1.306 . . . . 2.5 108.084 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.97 139.72 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.232 1.288 . . . . 3.55 111.571 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -57.64 -42.28 83.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.972 -1.08 . . . . 5.65 108.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.22 -21.36 59.83 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.365 -0.976 . . . . 6.82 108.365 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 62.96 51.96 2.74 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 145' ' ' PRO . 13.8 m120 -54.79 -31.13 58.51 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.475 -0.766 . . . . 5.59 109.186 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.556 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 p -22.92 86.76 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 CA-C-O 121.118 0.485 . . . . 3.06 110.452 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 143' ' ' ASN . 75.0 Cg_endo -90.69 80.03 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.169 2.579 . . . . 3.91 113.651 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.607 ' OE2' ' CE1' ' A' ' 129' ' ' TYR . 96.2 mt-10 -77.42 -76.9 0.16 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.107 -0.996 . . . . 3.87 110.219 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -57.55 -34.62 69.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.03 -1.043 . . . . 3.64 109.722 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -55.92 -45.48 78.7 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.148 -0.97 . . . . 4.99 110.056 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 146' ' ' GLU . 32.9 m -71.73 -32.65 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.615 -1.303 . . . . 1.57 108.792 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.4 m-20 -52.83 -50.76 63.05 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.301 -1.499 . . . . 2.71 108.439 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -80.24 -51.43 8.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 4.73 110.5 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.57 -55.86 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.973 . . . . 2.07 110.887 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -66.91 -38.41 86.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.957 -1.09 . . . . 2.93 110.218 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.39 -42.56 67.05 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.365 -1.459 . . . . 1.77 108.04 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.527 ' C ' ' SD ' ' A' ' 155' ' ' MET . 16.4 tmm? -70.81 -47.77 57.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.442 -0.786 . . . . 2.34 108.916 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.34 -24.22 67.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 3.53 109.15 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 118' ' ' ARG . 48.6 t0 -81.29 11.48 4.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.525 -0.734 . . . . 2.4 110.985 -179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 159' ' ' ASN . 30.9 pttt -74.68 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.58 -1.325 . . . . 4.18 109.986 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.657 ' H ' ' HG3' ' A' ' 158' ' ' LYS . 25.4 m120 39.34 21.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.476 -0.765 . . . . 2.49 109.739 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 56.87 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 3.15 110.693 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.645 ' H ' ' C ' ' A' ' 159' ' ' ASN . 46.2 p-10 -67.15 -38.34 85.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.823 -1.173 . . . . 3.4 110.015 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.88 -12.31 68.69 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.899 -1.281 . . . . 2.83 109.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 69.9 mttt -130.72 177.47 7.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.24 -1.153 . . . . 2.45 109.794 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 165' ' ' THR . 0.3 OUTLIER -103.66 119.96 39.96 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.076 -1.083 . . . . 1.9 108.076 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 164' ' ' LEU . 16.6 p -123.61 164.52 18.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.202 -0.936 . . . . 1.8 109.926 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 166' ' ' LEU . 8.2 mp -58.43 -41.48 85.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 2.28 110.11 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.6 tt0 -33.91 -68.57 0.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.589 -0.694 . . . . 2.92 110.497 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' OE1' ' OD1' ' A' ' 159' ' ' ASN . 10.7 pt-20 -68.92 -24.35 64.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.85 110.318 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -72.78 -65.34 0.81 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.097 -1.002 . . . . 2.14 110.174 -179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 171' ' ' GLU . 21.5 pt20 -62.12 -42.04 98.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 2.35 110.076 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 97.2 mt-10 -67.16 -40.97 86.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.852 -1.155 . . . . 2.92 109.182 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.99 -40.36 93.36 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.343 -1.503 . . . . 1.77 109.343 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.3 p -63.66 -34.55 78.09 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -1.118 . . . . 2.18 109.579 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -98.04 2.41 48.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 4.67 110.334 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.02 -37.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.803 -1.185 . . . . 2.92 110.366 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 172' ' ' GLY . 12.2 t0 -112.15 95.66 31.22 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.21 -0.931 . . . . 2.61 109.514 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' SER . 69.3 Cg_exo -48.23 -176.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.507 2.138 . . . . 2.17 112.551 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.8 OUTLIER 80.21 -40.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.587 -0.695 . . . . 2.62 109.432 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -59.15 -50.98 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 2.0 109.234 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 182' ' ' ALA . 89.9 t -70.49 -29.2 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 3.79 109.234 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -66.48 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 6.02 110.027 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.562 ' O ' ' CD ' ' A' ' 145' ' ' PRO . . . -54.49 -34.48 61.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 4.48 108.52 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -174.43 27.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.979 -0.749 . . . . 4.79 108.979 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 93.0 p -131.49 159.33 38.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 5.27 109.263 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.1 OUTLIER -98.61 85.8 3.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 7.1 109.629 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 26.2 p90 28.3 98.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.587 0.708 . . . . 9.88 111.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -78.31 114.34 17.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.011 -1.056 . . . . 8.42 108.857 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.53 168.2 38.17 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.541 -1.824 . . . . 9.13 108.541 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.99 -32.08 70.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.3 . . . . 11.72 109.372 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.043 -0.979 . . . . 12.62 109.424 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.496 -0.557 . . . . 15.48 109.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.76 -74.76 0.2 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.609 -1.396 . . . . 11.71 109.609 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.14 117.88 30.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -1.187 . . . . 12.65 109.562 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 5' ' ' ASN . 49.6 m -131.06 145.05 51.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 8.16 109.323 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 4' ' ' SER . 20.5 m120 35.73 -107.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.607 -0.683 . . . . 7.63 110.039 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -118.41 145.59 45.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.392 -0.818 . . . . 5.22 109.182 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -138.79 -177.43 4.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.883 . . . . 4.94 109.506 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 9' ' ' LYS . 5.4 tt -85.18 130.6 34.58 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.299 -1.0 . . . . 2.2 108.299 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' N ' HD23 ' A' ' 8' ' ' LEU . 83.0 mttt -55.5 138.45 68.64 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.076 -1.015 . . . . 2.5 110.497 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.31 -32.66 50.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.239 1.959 . . . . 3.23 112.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.69 -40.87 98.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.997 -1.064 . . . . 3.91 109.429 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.8 t -66.06 -40.4 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -0.924 . . . . 2.17 109.303 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 HD22 ' A' ' 8' ' ' LEU . 38.1 t -58.72 -44.86 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -0.926 . . . . 2.64 109.168 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.46 -42.66 96.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.258 -0.901 . . . . 4.15 108.724 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.22 -33.14 75.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.264 -0.897 . . . . 3.01 109.008 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.63 ' O ' HG22 ' A' ' 20' ' ' THR . 10.4 mt -63.36 -43.44 97.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.667 -1.213 . . . . 2.71 108.315 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 13' ' ' VAL . 16.7 p -57.57 -40.71 79.58 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.335 -1.357 . . . . 3.6 107.335 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH11 ' HG1' ' A' ' 17' ' ' THR . 8.0 mpt_? -61.16 -33.47 73.47 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.607 -0.886 . . . . 5.04 108.607 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -151.93 96.46 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 5.04 109.956 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 16' ' ' LEU . 8.5 t -172.39 -34.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.934 -1.104 . . . . 2.89 109.346 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 20' ' ' THR . 8.4 m-85 80.17 -25.47 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.378 0.609 . . . . 6.0 110.0 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' HG13 ' A' ' 27' ' ' VAL . 1.2 m-85 -88.76 132.9 34.42 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.012 -1.107 . . . . 2.94 108.012 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -59.31 165.13 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.784 -1.197 . . . . 3.98 108.986 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -56.65 -37.69 71.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.258 -0.901 . . . . 4.23 109.554 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -66.59 -41.65 88.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.359 -0.838 . . . . 5.1 111.158 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 97.4 mt-10 -66.48 -39.98 89.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.022 . . . . 3.8 110.467 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 22' ' ' PHE . 22.6 m -71.85 -39.33 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.128 . . . . 2.44 109.42 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 27' ' ' VAL . 50.4 tt0 -62.99 -45.91 90.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 3.85 109.711 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -65.39 -41.76 93.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 3.75 109.728 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -64.66 -40.91 96.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.183 -0.948 . . . . 5.2 108.718 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 89.5 t80 -56.32 -51.25 68.92 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.624 -0.88 . . . . 2.74 108.624 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -65.32 -26.63 68.13 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.467 -0.938 . . . . 5.06 108.467 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.93 -65.56 3.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 111.048 -0.821 . . . . 2.92 111.048 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 51.5 p90 -80.82 -25.85 37.48 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.737 -1.449 . . . . 3.92 111.228 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.4 mm -59.86 -28.29 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.686 -1.259 . . . . 3.57 109.673 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -57.43 -48.85 78.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 6.37 109.864 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 38' ' ' CYS . 41.3 p30 -72.05 -25.49 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.968 -1.082 . . . . 7.82 109.055 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 5.0 t -134.75 83.86 40.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.748 -0.834 . . . . 5.72 108.748 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -48.23 -37.81 32.21 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.425 2.083 . . . . 4.71 112.165 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 86.3 p -67.69 -30.22 69.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 5.05 109.326 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . 88.17 0.26 83.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.212 -1.555 . . . . 2.56 109.212 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' NE2' ' CZ ' ' A' ' 79' ' ' ARG . 52.2 tt0 -98.54 115.22 28.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -1.047 . . . . 3.09 108.96 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.0 mt -103.05 136.79 42.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.335 -0.853 . . . . 2.82 109.713 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.58 -178.44 6.39 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.125 -1.065 . . . . 2.91 108.125 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -53.83 -45.34 70.83 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.802 -1.186 . . . . 1.72 108.585 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.69 81.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.992 -1.068 . . . . 2.06 109.104 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.85 -54.31 29.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.731 -1.347 . . . . 2.03 109.731 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 65.1 t80 -62.45 -42.32 99.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.972 -1.311 . . . . 2.65 108.831 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 85.8 mt-30 -59.11 -38.53 79.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.8 -1.187 . . . . 2.8 107.81 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.06 -39.73 90.95 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.729 -1.212 . . . . 3.4 107.729 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -51.32 -55.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.997 -1.112 . . . . 2.99 107.997 178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.9 OUTLIER -63.71 -33.52 75.82 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.298 -1.001 . . . . 5.31 108.298 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.5 -40.1 93.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.927 -1.108 . . . . 3.63 109.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.61 -42.33 98.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 4.23 110.085 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 m-85 -83.08 -38.85 21.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.969 -1.082 . . . . 4.18 109.331 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 1.6 m-85 -126.94 76.73 75.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.741 . . . . 6.44 109.152 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -85.12 -24.84 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.037 2.492 . . . . 4.28 113.649 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.495 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 90.1 m-85 -79.89 -4.66 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.646 -1.284 . . . . 4.17 110.182 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -178.64 42.73 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.074 -1.21 . . . . 3.59 110.074 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD2' ' OE1' ' A' ' 130' ' ' GLN . 1.5 m-20 -55.2 157.02 6.77 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.441 -1.035 . . . . 5.63 109.465 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -37.24 -66.02 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.707 2.272 . . . . 4.4 112.476 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 49' ' ' GLN . 15.3 t -163.85 22.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 3.54 110.518 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 35.6 tttp -63.4 -49.26 74.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.764 -1.21 . . . . 3.3 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 68' ' ' VAL . 52.9 p90 -77.41 -42.6 35.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 2.12 109.148 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.198 -0.938 . . . . 1.79 108.774 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 56.4 m -67.26 -41.92 84.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 2.04 109.094 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.62 ' CD2' HD13 ' A' ' 110' ' ' LEU . 3.1 m-85 -54.91 -45.92 74.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.104 -0.997 . . . . 2.31 108.56 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 64' ' ' PHE . 43.0 t -60.87 -55.95 21.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.197 -1.038 . . . . 1.71 108.197 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -53.87 -33.3 55.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 4.33 109.837 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -62.0 -45.78 92.1 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.928 -1.108 . . . . 2.75 110.575 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 72' ' ' PHE . 10.0 p -99.0 -41.52 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.833 -1.167 . . . . 1.91 109.554 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.525 ' N ' HG13 ' A' ' 71' ' ' VAL . 66.4 t80 -46.95 -32.93 4.2 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.924 -0.485 . . . . 2.75 109.888 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.66 108.58 4.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.985 -1.072 . . . . 2.3 108.494 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.41 -38.78 88.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.807 . . . . 5.3 111.327 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.518 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 13.4 m120 -86.97 -4.49 59.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.808 -1.182 . . . . 3.3 110.379 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 48.97 33.8 4.92 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.07 -1.018 . . . . 5.34 108.547 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -85.35 0.66 51.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 3.11 109.822 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.87 8.51 69.41 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.032 -1.08 . . . . 2.85 111.062 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.639 ' CZ ' ' NE2' ' A' ' 42' ' ' GLN . 32.8 ptt180 -158.87 156.56 29.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.77 -1.429 . . . . 4.19 110.293 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.09 130.71 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -99.96 155.04 17.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.987 -1.071 . . . . 2.4 110.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -46.43 -51.96 14.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 3.27 109.253 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 82' ' ' PHE . 22.3 t -58.24 -40.43 81.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.023 -1.048 . . . . 2.35 108.988 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 91.5 mt-10 -68.5 -42.16 78.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.354 -0.841 . . . . 2.09 109.747 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.785 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 40.9 t80 -72.2 -54.2 10.35 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.229 -0.92 . . . . 2.22 110.816 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -58.18 -46.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.07 . . . . 1.9 109.592 -178.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 86' ' ' ILE . 95.9 mt-30 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.932 -1.105 . . . . 2.63 109.182 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.69 -37.49 73.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 1.56 108.97 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD23 ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -64.77 -37.58 88.08 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.808 -1.182 . . . . 2.17 107.808 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.9 p -66.74 -42.14 86.7 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.331 -0.856 . . . . 2.01 108.745 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.622 HG11 ' NE1' ' A' ' 103' ' ' TRP . 55.5 t -58.81 -36.43 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 106.611 -1.626 . . . . 2.2 106.611 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -56.67 -40.22 75.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.39 -0.967 . . . . 2.75 108.39 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -52.98 -47.24 68.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 3.47 109.513 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -156.16 -75.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 8.35 109.061 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.51 -164.75 49.39 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.56 -1.416 . . . . 3.29 109.56 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 99' ' ' GLU . 43.7 p -120.28 161.69 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.495 -1.003 . . . . 3.18 109.017 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.789 ' H ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -55.14 -34.74 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.328 -1.36 . . . . 4.22 107.328 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.67 -48.55 71.75 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.636 -0.665 . . . . 3.59 109.593 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 96' ' ' THR . 78.3 mm-40 -67.69 -43.73 79.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.138 -0.976 . . . . 3.04 109.331 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -60.77 -38.11 84.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 3.12 108.787 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 -41.06 98.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.432 -0.792 . . . . 2.31 109.303 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -66.68 -43.5 84.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 3.93 110.136 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.622 ' NE1' HG11 ' A' ' 91' ' ' VAL . 85.4 m95 -66.21 -47.62 73.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.875 -1.14 . . . . 4.4 109.732 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.73 -44.9 72.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -0.951 . . . . 1.41 109.955 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -66.32 -53.46 36.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.87 . . . . 2.69 111.031 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.59 -43.17 89.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 3.23 109.968 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.814 ' O ' HD23 ' A' ' 107' ' ' LEU . 2.9 tt -70.73 -29.35 65.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.042 -1.036 . . . . 1.99 109.274 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.674 ' CD1' ' SD ' ' A' ' 121' ' ' MET . 0.1 OUTLIER -51.68 -41.02 61.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 2.51 110.056 -178.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -110.1 143.54 40.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.833 . . . . 1.8 109.445 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 67' ' ' PHE . 54.6 tp -65.34 -40.64 93.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.204 -0.935 . . . . 3.31 109.795 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 49.7 p30 -104.32 -26.76 12.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.148 -0.97 . . . . 2.09 109.873 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.606 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 2.9 p-10 40.91 52.21 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 3.68 110.199 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' OD2' ' OD2' ' A' ' 111' ' ' ASP . 8.8 m-20 -73.85 15.07 0.31 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.111 -1.07 . . . . 2.51 108.111 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 102.3 -7.0 53.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.225 -1.95 . . . . 2.39 108.225 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.623 ' CE1' HG22 ' A' ' 165' ' ' THR . 16.0 m-85 -129.52 139.73 51.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.727 -0.866 . . . . 2.76 109.514 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 mt -118.56 139.81 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.6 109.234 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' ' 163' ' ' LYS . 29.7 p -118.79 159.83 22.99 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.021 -1.103 . . . . 1.73 108.021 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.654 ' NE ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -63.48 -43.01 98.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.904 -1.123 . . . . 3.17 109.144 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -58.72 -43.54 90.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.937 -1.102 . . . . 2.44 109.434 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.92 -37.03 81.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.154 -0.966 . . . . 1.71 108.957 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.674 ' SD ' ' CD1' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -65.94 -46.66 77.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.826 . . . . 3.66 109.485 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.65 -43.01 99.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 1.77 109.424 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -57.74 -44.55 86.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.102 -0.999 . . . . 2.01 108.616 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 124' ' ' ILE . 22.2 mm -68.99 -36.47 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.439 -0.788 . . . . 1.14 109.327 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 145' ' ' PRO . 66.7 t -60.93 -44.83 98.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.058 -1.09 . . . . 1.83 108.058 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.573 ' OD2' ' NE2' ' A' ' 130' ' ' GLN . 20.9 t70 -61.8 -38.75 89.25 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.858 -0.793 . . . . 2.16 108.858 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.02 74.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 1.78 109.131 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 132' ' ' VAL . 80.3 mt -65.28 -41.38 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 2.42 109.374 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 133' ' ' GLY . 0.6 OUTLIER -59.05 -48.1 82.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.415 -0.803 . . . . 5.07 109.453 -179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.573 ' NE2' ' OD2' ' A' ' 126' ' ' ASP . 57.6 mt-30 -61.63 -37.14 82.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 3.05 109.042 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.0 ttp -60.83 -36.98 80.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 4.88 109.403 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 128' ' ' ILE . 33.4 m -108.14 1.22 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.401 -0.812 . . . . 3.55 109.856 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -57.72 -34.81 71.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.459 -1.456 . . . . 3.52 109.459 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 58' ' ' PHE . 14.7 m120 -73.16 -179.35 3.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -1.056 . . . . 4.29 109.366 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 136' ' ' VAL . 28.1 p -82.76 2.31 34.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.111 -0.993 . . . . 3.68 111.126 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 135' ' ' THR . 21.9 t -46.5 -46.2 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.596 -1.315 . . . . 5.42 108.805 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -178.19 73.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.78 -0.575 . . . . 5.6 109.705 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.7 OUTLIER -90.13 147.31 36.75 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.691 -1.256 . . . . 2.5 109.583 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 142' ' ' GLU . 13.8 Cg_endo -60.51 129.44 29.57 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.001 1.8 . . . . 3.55 111.691 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -66.23 -37.05 84.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 5.65 110.477 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 142' ' ' GLU . 7.6 pt-20 -101.1 -59.0 1.77 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.056 -1.028 . . . . 6.82 109.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 139' ' ' PRO . 83.5 tt0 -168.7 -82.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.974 -1.079 . . . . 6.56 108.959 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 20.8 t30 65.5 -49.8 0.38 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.123 -0.695 . . . . 5.59 109.123 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.1 t -41.4 147.94 0.44 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.509 -0.744 . . . . 3.06 109.577 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.702 ' HG2' HG22 ' A' ' 125' ' ' VAL . 92.1 Cg_endo -80.17 31.13 0.49 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.594 2.196 . . . . 3.91 113.451 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.554 ' OE1' HG11 ' A' ' 125' ' ' VAL . 49.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.443 -1.411 . . . . 3.87 110.376 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm -65.18 -32.76 74.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 3.64 109.617 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.764 ' O ' HD13 ' A' ' 152' ' ' ILE . 18.5 mmt85 -59.91 -48.86 79.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 4.99 111.018 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 145' ' ' PRO . 11.8 m -73.87 -35.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.399 -1.438 . . . . 1.57 110.181 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.26 -52.0 67.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.993 -1.067 . . . . 2.71 110.069 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -67.32 -47.75 69.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 4.73 109.284 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.764 HD13 ' O ' ' A' ' 148' ' ' ARG . 1.4 mp -57.02 -30.44 34.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.907 -1.146 . . . . 2.07 107.907 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.792 ' CZ ' HD11 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -65.81 -45.67 81.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.227 -1.027 . . . . 2.93 108.227 178.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.2 -29.58 9.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.043 -1.095 . . . . 1.77 108.043 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -90.27 -48.56 7.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 2.34 110.476 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -64.54 -35.39 80.82 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.122 -0.986 . . . . 3.53 111.748 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.493 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 23.6 t0 -97.44 16.27 20.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.882 -1.136 . . . . 2.4 111.871 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' ASP . 3.6 mmmm -46.86 -27.04 1.11 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.651 -1.28 . . . . 4.18 108.6 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 27.9 m120 -49.57 -30.89 9.4 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.227 -0.657 . . . . 2.49 109.227 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 86.5 -4.98 0.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.851 -0.531 . . . . 3.15 109.653 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 53.8 p30 -64.3 -29.48 70.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 3.4 109.447 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 86.48 11.35 71.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.816 -1.313 . . . . 2.83 109.816 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' ' 117' ' ' THR . 11.4 tttt -142.29 143.47 32.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -1.187 . . . . 2.45 109.023 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.792 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 28.9 mt -98.77 146.36 25.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 1.9 109.32 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 115' ' ' TYR . 6.5 p -123.68 168.1 13.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.927 -0.768 . . . . 1.8 108.927 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.568 ' N ' HD22 ' A' ' 166' ' ' LEU . 3.9 mm? -57.94 -39.98 79.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.834 -1.166 . . . . 2.28 109.866 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -49.61 -39.78 36.85 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.457 -1.402 . . . . 2.92 108.843 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.51 ' OE2' ' OD1' ' A' ' 159' ' ' ASN . 96.4 mt-10 -74.32 -39.96 62.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 1.85 110.356 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' A' ' 173' ' ' SER . 6.2 m-85 -75.92 -50.01 16.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.036 -1.04 . . . . 2.14 110.027 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -61.27 -39.49 90.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.016 -1.052 . . . . 2.35 110.092 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.551 ' CG ' ' N ' ' A' ' 172' ' ' GLY . 17.7 pt-20 -74.86 -48.42 25.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.781 -1.199 . . . . 2.92 109.724 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -64.9 -37.08 93.85 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.933 -1.667 . . . . 1.77 108.933 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 70.6 m -64.44 -38.77 92.18 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.324 -1.104 . . . . 2.18 109.572 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -1.68 46.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 4.67 110.445 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.52 -33.77 1.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.855 -1.153 . . . . 2.92 109.944 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 172' ' ' GLY . 10.8 t70 -117.6 83.31 17.17 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.397 -0.815 . . . . 2.61 109.303 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 178' ' ' SER . 77.4 Cg_exo -47.34 -176.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.768 2.312 . . . . 2.17 112.299 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 80.84 -40.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 2.62 109.291 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.3 -52.08 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.915 . . . . 2.0 109.667 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 181' ' ' GLN . 96.0 t -73.18 -38.56 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 3.79 110.504 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 180' ' ' VAL . 88.9 mt-30 -41.98 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 6.02 109.756 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -66.24 159.78 25.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 4.48 109.267 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.988 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -92.01 8.8 35.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.304 -0.873 . . . . 4.79 108.836 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 m -58.54 -27.73 64.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -0.814 . . . . 5.27 109.945 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 185' ' ' LEU . 5.2 tt 66.78 118.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.482 -0.761 . . . . 7.1 109.204 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -107.99 159.27 16.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 9.88 109.469 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.628 ' OD1' ' N ' ' A' ' 188' ' ' GLY . 52.4 p30 -57.97 -32.49 67.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 8.42 110.096 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.628 ' N ' ' OD1' ' A' ' 187' ' ' ASP . . . 173.99 174.64 41.01 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 9.13 109.613 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.6 mm? -65.44 -33.49 76.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -1.149 . . . . 11.72 109.358 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.299 -1.607 0 CA-C-O 117.947 -1.025 . . . . 12.62 109.559 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 15.48 109.47 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.38 179.75 50.6 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.658 -1.377 . . . . 11.71 109.658 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 5' ' ' ASN . 27.9 mttm -89.04 5.16 45.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 12.65 109.536 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' LYS . 0.8 OUTLIER 72.51 -35.67 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 8.16 109.666 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' LYS . 23.4 t-20 -101.67 86.04 2.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 7.63 109.455 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -176.14 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 5.22 109.181 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -97.6 161.86 13.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 4.94 109.111 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -55.81 157.72 4.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.089 -1.007 . . . . 2.2 109.149 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -54.62 136.71 63.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 2.5 109.605 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.23 -37.71 24.53 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.926 1.751 . . . . 3.23 112.467 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.74 -37.78 85.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.095 -1.003 . . . . 3.91 109.365 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.2 t -65.98 -39.8 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 2.17 109.047 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 17' ' ' THR . 52.9 t -61.07 -44.51 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.35 -0.844 . . . . 2.64 109.398 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.64 -45.35 94.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 4.15 109.227 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -37.53 87.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 3.01 108.821 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' OG1' ' A' ' 20' ' ' THR . 12.0 mt -55.14 -45.97 75.64 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.302 -0.874 . . . . 2.71 109.768 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -64.41 -37.9 89.15 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.02 -1.072 . . . . 3.6 108.117 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -60.25 -33.42 72.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.352 -0.843 . . . . 5.04 108.927 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 21' ' ' TYR . 41.9 pttt -134.24 -142.13 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.277 -0.89 . . . . 5.04 110.28 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.511 ' OG1' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER 62.02 -9.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 2.89 109.77 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 19' ' ' LYS . 36.2 m-85 52.54 21.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 6.0 110.874 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' H ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.73 163.14 31.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.031 . . . . 2.94 109.027 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.2 p -74.51 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 3.98 109.102 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 7.4 pm0 -81.88 -30.55 31.93 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.149 -1.021 . . . . 4.23 109.369 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -64.62 -45.51 86.55 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.576 -0.703 . . . . 5.1 110.431 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -75.1 -42.02 57.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 3.8 110.924 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 HD11 ' A' ' 86' ' ' ILE . 4.1 p -65.52 -41.04 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 2.44 109.572 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 11.7 tm0? -69.04 -46.78 67.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 3.85 109.488 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.44 -42.56 87.63 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 3.75 109.377 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -63.59 -42.29 98.29 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.271 -0.893 . . . . 5.2 109.118 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HD11 ' A' ' 35' ' ' ILE . 60.5 t80 -58.87 -57.39 13.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.489 -0.757 . . . . 2.74 109.396 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' HE22 ' A' ' 28' ' ' GLN . 59.2 tttm -61.93 -29.01 69.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.203 -0.936 . . . . 5.06 108.992 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.71 -66.69 2.62 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.656 -0.783 . . . . 2.92 111.632 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' TYR . 31.4 p90 -76.82 -18.2 58.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.759 -1.436 . . . . 3.92 111.3 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 31' ' ' TYR . 3.8 mm -63.88 -19.22 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.666 -1.271 . . . . 3.57 109.525 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -54.97 -35.25 64.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.084 -1.01 . . . . 6.37 109.668 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.03 -38.48 73.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 7.82 109.251 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.1 p -172.21 134.2 0.79 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 5.72 109.027 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.97 -34.21 16.1 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.648 1.565 . . . . 4.71 111.939 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -40.41 85.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 5.05 109.113 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.64 28.19 69.7 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.924 -1.271 . . . . 2.56 109.924 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 7.2 pt20 -96.94 123.21 40.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.274 . . . . 3.09 109.021 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' H ' HG22 ' A' ' 80' ' ' ILE . 39.2 mt -104.91 133.25 50.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.123 -0.985 . . . . 2.82 109.173 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 45.8 t0 -74.8 -167.76 0.62 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.275 -0.891 . . . . 2.91 108.755 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -67.18 -36.69 82.31 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.54 -0.864 . . . . 1.72 109.05 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.19 92.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 2.06 109.638 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.45 -54.78 21.3 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.275 -1.53 . . . . 2.03 109.275 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.403 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 16.4 t80 -59.14 -45.58 90.57 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.022 -1.281 . . . . 2.65 107.954 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -34.61 73.92 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.995 -1.066 . . . . 2.8 108.539 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -59.64 -43.71 93.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 3.4 109.805 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 6.0 pt -66.37 -36.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.386 -1.326 . . . . 2.99 108.872 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.474 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.1 m-30 -67.28 -42.93 83.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.057 -1.027 . . . . 5.31 108.786 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -61.85 -40.91 96.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 3.63 109.439 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 54' ' ' GLN . 0.8 OUTLIER -60.18 -42.89 95.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 4.23 109.803 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 3.5 m-85 -78.39 -30.8 48.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 4.18 109.207 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.541 ' HA ' HG11 ' A' ' 136' ' ' VAL . 18.6 m-85 -132.69 71.24 78.81 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 6.44 109.938 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.9 -24.18 11.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.829 2.352 . . . . 4.28 113.137 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.22 9.54 22.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.853 -1.154 . . . . 4.17 109.69 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 131' ' ' MET . . . -86.98 -174.09 48.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.152 -1.179 . . . . 3.59 110.152 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.85 157.78 78.31 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 5.63 109.2 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -37.82 -65.88 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.907 2.405 . . . . 4.4 112.854 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -165.78 26.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.022 -1.049 . . . . 3.54 110.782 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 44.0 mtmt -62.73 -55.68 24.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.784 -1.198 . . . . 3.3 110.0 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CE1' HD11 ' A' ' 107' ' ' LEU . 57.9 t80 -69.36 -43.72 73.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.12 110.833 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.89 -51.38 70.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 1.79 109.789 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 m -62.67 -36.48 83.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.069 -1.019 . . . . 2.04 108.813 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' O ' ' A' ' 63' ' ' LYS . 5.0 m-30 -56.56 -43.32 79.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 2.31 108.45 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' PHE . 99.1 t -61.93 -58.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.544 -0.91 . . . . 1.71 108.544 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 10.2 t80 -53.37 -34.65 58.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.348 -0.845 . . . . 4.33 109.538 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.53 HD22 HD11 ' A' ' 110' ' ' LEU . 48.4 t-20 -61.98 -41.69 98.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.975 . . . . 2.75 110.444 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 72' ' ' PHE . 8.5 p -105.19 -48.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.059 -1.026 . . . . 1.91 110.596 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.61 ' N ' HG13 ' A' ' 71' ' ' VAL . 12.0 t80 -55.36 -35.61 65.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.057 -1.027 . . . . 2.75 110.366 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.66 126.8 28.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.796 -1.19 . . . . 2.3 108.802 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 95.8 mt-10 -110.09 167.72 9.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.338 -0.851 . . . . 5.3 110.194 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER 75.28 -9.55 1.38 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.688 . . . . 3.3 109.576 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 mttm 53.94 36.34 24.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.382 -0.824 . . . . 5.34 109.291 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -88.0 -2.21 58.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 3.11 109.96 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.54 11.81 82.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.962 -1.255 . . . . 2.85 109.962 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -151.62 154.25 36.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -1.193 . . . . 4.19 109.794 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.9 tp -91.23 139.06 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.907 -1.146 . . . . 1.76 107.907 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -98.23 158.5 15.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.053 -1.03 . . . . 2.4 110.656 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -52.31 -49.05 64.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.68 -0.637 . . . . 3.27 109.621 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t -60.4 -41.15 93.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.962 . . . . 2.35 110.078 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 99.0 mt-10 -67.24 -42.39 84.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 2.09 110.736 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HE1' HD13 ' A' ' 89' ' ' LEU . 2.0 t80 -70.53 -53.68 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 2.22 111.505 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 HG23 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -64.11 -46.12 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.745 -1.222 . . . . 1.9 109.957 -178.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.3 mt-30 -65.53 -46.88 77.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.6 -1.313 . . . . 2.63 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.14 81.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.082 -1.011 . . . . 1.56 109.414 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 85' ' ' PHE . 17.7 tp -57.01 -43.43 81.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.611 -0.885 . . . . 2.17 108.611 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 p -65.94 -36.56 83.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.277 -0.889 . . . . 2.01 109.064 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 87' ' ' GLN . 58.3 t -59.6 -38.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 2.2 107.336 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -35.84 79.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.431 -0.951 . . . . 2.75 108.431 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.6 t -53.66 -51.03 64.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.185 -0.947 . . . . 3.47 109.203 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 174.11 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.719 -0.845 . . . . 8.35 108.719 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.401 ' HA2' ' CE2' ' A' ' 21' ' ' TYR . . . -78.4 -177.1 48.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.306 -1.117 . . . . 3.29 110.306 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.9 p -78.69 165.11 24.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -1.056 . . . . 3.18 109.546 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.3 -33.72 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.72 -1.215 . . . . 4.22 107.72 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -62.33 -48.83 78.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.736 . . . . 3.59 109.187 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.14 -40.22 94.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 3.04 108.702 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -63.45 -34.32 77.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.377 -0.827 . . . . 3.12 108.892 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.1 tp -64.56 -47.62 78.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 2.31 109.407 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -72.43 -45.84 57.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -0.961 . . . . 3.93 109.611 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -61.82 -45.11 95.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 4.4 109.449 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.8 -42.66 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.831 . . . . 1.41 109.986 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.58 -51.96 67.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.284 -0.885 . . . . 2.69 110.576 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.46 -43.31 99.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 3.23 109.44 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 64' ' ' PHE . 26.2 tp -66.27 -37.54 85.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.865 . . . . 1.99 109.992 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.451 ' CE1' ' SD ' ' A' ' 121' ' ' MET . 0.2 OUTLIER -51.66 -54.3 29.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.307 -0.871 . . . . 2.51 110.408 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' OE2' ' A' ' 120' ' ' GLU . 45.1 t0 -101.32 132.21 46.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.112 -0.992 . . . . 1.8 110.555 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.53 HD11 HD22 ' A' ' 70' ' ' ASN . 15.0 tp -73.45 -74.01 0.19 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.451 -0.78 . . . . 3.31 109.25 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 40.6 p-10 -64.14 -36.96 85.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 2.09 109.489 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 58.5 t30 46.87 56.05 7.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 3.68 109.894 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 22.3 p-10 -73.34 15.26 0.25 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.341 -0.985 . . . . 2.51 108.341 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 112' ' ' ASN . . . 104.49 -8.2 47.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.167 -1.573 . . . . 2.39 109.167 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -135.59 143.47 45.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -1.064 . . . . 2.76 110.224 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.3 mt -117.98 142.45 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.452 -0.944 . . . . 1.6 108.452 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.04 154.19 31.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.307 -0.997 . . . . 1.73 108.307 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -63.96 -44.43 92.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.973 -1.079 . . . . 3.17 110.209 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -58.52 -38.87 78.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.85 -1.156 . . . . 2.44 107.948 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' OE2' ' OD1' ' A' ' 109' ' ' ASP . 82.9 tt0 -65.65 -40.72 92.8 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.28 -1.007 . . . . 1.71 108.28 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 108' ' ' TYR . 35.5 mtm -65.55 -41.85 92.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 3.66 109.749 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 122' ' ' LEU . 57.0 tp -61.33 -42.49 98.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.272 -0.893 . . . . 1.77 109.533 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.35 -41.56 96.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.208 -0.932 . . . . 2.01 109.226 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 124' ' ' ILE . 23.4 mm -63.9 -48.9 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.47 -0.769 . . . . 1.14 110.392 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 97.9 t -58.85 -43.99 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.806 -1.183 . . . . 1.83 108.062 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 130' ' ' GLN . 89.5 m-20 -64.9 -32.91 74.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.744 -0.836 . . . . 2.16 108.744 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.88 95.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.933 . . . . 1.78 109.983 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.596 ' O ' HG23 ' A' ' 132' ' ' VAL . 8.8 pt -70.5 -51.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.04 . . . . 2.42 111.035 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 133' ' ' GLY . 72.3 m-85 -71.61 -37.46 70.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.651 -1.281 . . . . 5.07 110.598 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 32.1 tt0 -59.93 -42.8 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.563 -1.273 . . . . 3.05 107.563 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.427 ' O ' ' CA ' ' A' ' 59' ' ' GLY . 19.6 ttt -66.47 -40.09 89.15 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.314 -0.995 . . . . 4.88 108.314 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' ILE . 23.8 t -87.76 6.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 3.55 108.873 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -58.49 -130.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.966 -1.254 . . . . 3.52 109.966 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.494 ' O ' HD21 ' A' ' 138' ' ' LEU . 23.1 t-20 42.0 -112.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -1.143 . . . . 4.29 109.047 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.588 ' O ' ' N ' ' A' ' 137' ' ' GLU . 22.2 p -139.79 -0.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 3.68 109.727 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -55.98 82.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.113 -0.992 . . . . 5.42 109.481 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 135' ' ' THR . 82.7 tt0 37.72 67.85 0.35 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.665 . . . . 5.6 110.796 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -72.31 162.67 72.63 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 2.5 108.375 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -38.86 146.12 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.85 2.367 . . . . 3.55 112.24 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.58 -93.26 0.48 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.392 -0.818 . . . . 5.65 109.472 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -38.95 85.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 6.82 109.048 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.569 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.5 tt0 -162.13 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.031 -1.1 . . . . 6.56 108.031 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 86.4 m-20 36.86 42.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.787 -0.571 . . . . 5.59 109.663 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.8 ' O ' HG23 ' A' ' 144' ' ' THR . 14.4 t -161.79 72.75 2.42 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.155 -0.966 . . . . 3.06 109.943 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.62 81.1 2.86 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.697 2.265 . . . . 3.91 112.983 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.469 ' OE2' ' CG1' ' A' ' 125' ' ' VAL . 15.5 mm-40 -101.96 -74.78 0.61 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.935 . . . . 3.87 109.465 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -60.6 -36.83 79.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.906 . . . . 3.64 110.237 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.68 ' HG2' HD12 ' A' ' 152' ' ' ILE . 28.7 ttm180 -55.54 -48.72 74.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 4.99 110.105 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -72.33 -45.26 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 1.57 108.625 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 92.9 m-20 -49.35 -45.14 45.29 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.29 -1.506 . . . . 2.71 109.436 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -79.74 -50.91 9.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 4.73 109.958 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.68 HD12 ' HG2' ' A' ' 148' ' ' ARG . 23.1 mt -58.46 -56.5 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.081 -1.012 . . . . 2.07 110.032 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.785 ' CD1' HD21 ' A' ' 164' ' ' LEU . 6.3 m-85 -64.32 -38.58 91.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.032 -1.042 . . . . 2.93 110.712 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -53.18 -34.5 57.2 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 117.577 -1.649 . . . . 1.77 107.633 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.534 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.6 tmm? -84.08 -45.97 12.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.249 -0.649 . . . . 2.34 109.249 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.564 ' SD ' ' O ' ' A' ' 156' ' ' MET . 0.0 OUTLIER -63.27 -33.48 75.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 3.53 110.173 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 158' ' ' LYS . 53.7 t0 -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.194 -0.941 . . . . 2.4 110.852 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' ALA . 34.2 mttm -41.8 -79.2 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.308 -0.87 . . . . 4.18 109.62 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.544 HD21 ' CE ' ' A' ' 156' ' ' MET . 17.9 m120 38.54 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.624 -0.673 . . . . 2.49 109.974 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 62.08 30.52 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.948 . . . . 3.15 110.299 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 48.6 p30 -138.76 -39.16 0.5 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.989 -1.069 . . . . 3.4 110.121 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 83.17 3.36 90.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.008 -1.237 . . . . 2.83 110.008 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -134.42 157.83 45.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -1.181 . . . . 2.45 108.702 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' A' ' 153' ' ' PHE . 7.5 mp -92.96 136.64 33.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.853 -1.155 . . . . 1.9 110.475 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.9 p -127.68 173.55 9.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.972 -1.492 . . . . 1.8 106.972 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -77.66 -11.34 59.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.086 -1.634 . . . . 2.28 108.865 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.13 -41.83 98.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 2.92 109.669 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 168' ' ' GLU . 4.3 pt-20 -78.29 -34.17 48.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.033 -1.042 . . . . 1.85 109.657 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 173' ' ' SER . 26.9 m-85 -68.25 -44.8 74.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.774 -1.204 . . . . 2.14 108.656 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.5 -59.23 3.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.55 -0.718 . . . . 2.35 110.309 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.5 80.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 2.92 109.731 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.56 23.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.07 -1.212 . . . . 1.77 110.07 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 67.9 m -57.82 -40.39 79.89 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -1.173 . . . . 2.18 110.004 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -16.44 53.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 4.67 109.525 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.83 -61.94 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 2.92 109.804 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.13 151.25 61.55 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 2.61 109.607 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 178' ' ' SER . 72.3 Cg_endo -77.62 -172.31 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.71 2.273 . . . . 2.17 112.583 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 2.1 p 79.56 -40.1 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 2.62 110.174 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.7 mt -62.43 -55.91 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.019 . . . . 2.0 109.669 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.416 ' H ' HG12 ' A' ' 180' ' ' VAL . 2.5 p -89.58 -41.65 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 3.79 108.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.588 ' O ' HD12 ' A' ' 183' ' ' LEU . 92.5 mt-30 -60.53 -30.2 69.6 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.248 -1.019 . . . . 6.02 108.248 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 42.93 -97.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 4.48 109.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -72.3 47.29 0.16 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.549 -0.908 . . . . 4.79 108.549 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 p -56.53 144.3 32.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 5.27 109.919 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 1.2 mm? -80.3 -48.64 12.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 7.1 109.217 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -133.46 153.61 51.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 9.88 109.483 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.7 121.36 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 8.42 109.532 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.77 10.56 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.839 -1.304 . . . . 9.13 109.839 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.4 tp -56.38 -36.7 69.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -1.186 . . . . 11.72 109.49 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.464 HG13 ' OXT' ' A' ' 190' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 118.006 -0.997 . . . . 12.62 109.478 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.247 0.546 . . . . 15.48 109.561 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.16 -8.26 59.0 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.958 -1.257 . . . . 11.71 109.958 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -122.17 148.42 44.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.361 -1.082 . . . . 12.65 110.146 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.6 p -97.82 153.4 18.32 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.503 -0.925 . . . . 8.16 108.503 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -103.56 96.98 7.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 7.63 110.036 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.0 p -66.04 -28.28 68.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 5.22 108.889 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -81.03 145.65 31.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.491 -0.756 . . . . 4.94 109.093 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -79.35 134.37 36.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 2.2 108.696 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -62.54 140.4 96.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 2.5 109.436 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -45.05 25.52 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.906 1.737 . . . . 3.23 112.314 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.86 -40.97 90.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 3.91 109.367 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.53 -44.03 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.236 -0.915 . . . . 2.17 109.066 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.669 HG13 ' CD ' ' A' ' 24' ' ' GLU . 12.5 t -56.32 -46.74 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.01 . . . . 2.64 109.698 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.65 -52.08 67.22 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.689 -1.257 . . . . 4.15 109.543 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.17 -32.83 74.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 3.01 110.359 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -69.06 -37.64 78.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.066 -1.021 . . . . 2.71 108.675 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 13' ' ' VAL . 67.9 p -72.49 -26.96 61.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.6 -0.687 . . . . 3.6 110.19 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 18' ' ' ARG . 3.0 mtp-105 -50.66 -33.73 23.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.637 -1.289 . . . . 5.04 107.55 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 20' ' ' THR . 28.0 ttpt -136.05 117.26 14.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.278 -1.008 . . . . 5.04 108.278 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 22' ' ' PHE . 2.8 m -170.47 -27.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 2.89 110.433 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 67.06 -4.87 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.641 -1.244 . . . . 6.0 107.641 -178.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CE2' ' OG ' ' A' ' 93' ' ' SER . 25.2 m-85 -121.15 159.77 25.12 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.102 -1.073 . . . . 2.94 108.102 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -81.37 161.51 23.76 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.881 -1.137 . . . . 3.98 108.826 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.669 ' CD ' HG13 ' A' ' 13' ' ' VAL . 28.7 tp10 -60.8 -36.01 77.94 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.325 -0.86 . . . . 4.23 110.049 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 2.7 mptp? -61.42 -40.95 96.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 5.1 109.513 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -64.93 -39.87 94.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 3.8 109.724 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.64 HG13 ' CD1' ' A' ' 86' ' ' ILE . 41.3 t -66.13 -42.08 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 2.44 109.648 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -63.14 -38.65 92.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.877 -1.139 . . . . 3.85 109.725 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -66.5 -53.26 36.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 3.75 110.074 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 43.0 m0 -68.84 -41.98 77.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 5.2 109.252 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t80 -53.99 -72.64 0.06 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.577 -0.702 . . . . 2.74 109.68 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -58.05 -27.98 64.09 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.305 -0.872 . . . . 5.06 109.165 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.42 -55.79 22.96 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.606 -0.807 . . . . 2.92 111.675 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 30' ' ' TRP . 29.3 p90 -84.71 -20.94 30.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.556 -1.555 . . . . 3.92 111.675 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.409 ' O ' ' O ' ' A' ' 38' ' ' CYS . 23.1 mm -61.58 -28.14 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.59 -1.319 . . . . 3.57 109.91 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -56.74 -40.17 75.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.933 -1.104 . . . . 6.37 109.456 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.37 -38.07 79.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 7.82 108.855 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' ILE . 88.5 m -151.24 133.92 8.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.563 -0.903 . . . . 5.72 108.563 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.2 -30.32 20.41 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.994 1.796 . . . . 4.71 112.297 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.2 p -63.65 -34.75 78.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 5.05 109.75 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.7 15.03 68.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.573 -1.411 . . . . 2.56 109.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.581 HE21 ' C ' ' A' ' 43' ' ' LEU . 3.9 tm0? -99.95 121.55 41.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -1.136 . . . . 3.09 109.517 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.581 ' C ' HE21 ' A' ' 42' ' ' GLN . 5.3 mp -102.95 148.35 25.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 2.82 110.089 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' OD1' ' NE2' ' A' ' 42' ' ' GLN . 94.4 m-20 -91.14 -177.0 4.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.941 -0.763 . . . . 2.91 108.941 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . . . -57.8 -34.03 69.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 1.72 109.345 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.16 93.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 2.06 109.831 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.18 -47.23 89.92 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.338 -1.505 . . . . 2.03 109.338 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -48.47 80.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 2.65 108.44 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.88 -36.12 80.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.512 -0.742 . . . . 2.8 109.386 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -61.03 -46.11 92.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -0.855 . . . . 3.4 110.296 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 52' ' ' TYR . 20.2 pt -66.99 -40.38 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 2.99 109.787 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.451 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -64.13 -37.81 88.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.854 -1.154 . . . . 5.31 108.767 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -63.2 -40.67 98.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 3.63 109.107 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -59.63 -45.01 93.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.803 . . . . 4.23 110.126 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.8 m-85 -79.55 -43.65 22.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 4.18 108.959 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -124.77 80.96 61.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.065 -0.717 . . . . 6.44 109.065 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.8 -35.28 36.79 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.613 2.209 . . . . 4.28 111.964 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HB2' HG23 ' A' ' 136' ' ' VAL . 50.3 m-85 -113.18 7.15 17.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.853 . . . . 4.17 109.188 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.79 65.71 2.63 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.09 -1.204 . . . . 3.59 110.09 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 64' ' ' PHE . 47.4 t0 51.54 64.45 7.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -1.148 . . . . 5.63 109.807 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.73 -8.16 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.704 2.27 . . . . 4.4 111.919 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 66' ' ' THR . 1.4 m -110.86 -72.42 0.72 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.296 -0.877 . . . . 3.54 110.867 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 66.7 mmtt -55.43 -54.34 44.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.969 . . . . 3.3 111.302 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.563 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 46.7 t80 -64.29 -45.6 87.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.045 -1.034 . . . . 2.12 110.52 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.39 84.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 1.79 110.716 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 62' ' ' THR . 71.6 p -70.17 -35.95 74.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.873 -1.142 . . . . 2.04 109.709 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 110' ' ' LEU . 5.9 m-30 -68.28 -46.88 69.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.394 -0.816 . . . . 2.31 110.094 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 17.0 m -63.93 -47.33 91.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.076 -1.015 . . . . 1.71 110.015 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -59.13 -46.09 89.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.14 . . . . 4.33 109.846 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.15 -51.25 59.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.75 110.745 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.4 t -73.61 -44.92 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.088 -1.008 . . . . 1.91 110.769 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.985 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 79.4 t80 -55.79 -35.37 66.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -0.867 . . . . 2.75 110.528 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.02 110.8 2.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.942 -1.099 . . . . 2.3 109.495 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.49 -39.08 93.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 5.3 110.356 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 77' ' ' ASP . 33.6 p-10 -89.69 2.13 55.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 3.3 109.691 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ASN . 4.6 ptpp? 34.51 40.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.626 . . . . 5.34 110.21 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 75' ' ' ASN . 19.4 p-10 -82.92 1.31 40.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 3.11 109.805 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.41 77.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.681 -1.368 . . . . 2.85 109.681 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -138.78 151.62 47.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -1.143 . . . . 4.19 109.089 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -101.41 134.22 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.267 -1.012 . . . . 1.76 108.267 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -92.53 164.21 13.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 2.4 109.959 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.79 -47.08 51.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.449 -0.782 . . . . 3.27 109.787 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.6 t -57.43 -45.74 84.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.038 -1.038 . . . . 2.35 109.826 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.65 -38.55 77.17 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.189 -0.944 . . . . 2.09 109.593 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.54 -56.79 17.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 2.22 110.1 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.64 ' CD1' HG13 ' A' ' 27' ' ' VAL . 6.3 tt -64.89 -32.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.139 -0.975 . . . . 1.9 109.502 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.34 -44.2 83.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.009 . . . . 2.63 109.888 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.985 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -61.49 -37.8 84.98 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.155 -1.424 . . . . 1.56 107.155 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mp -57.87 -43.22 85.86 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.76 -0.83 . . . . 2.17 108.76 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.0 p -61.45 -42.77 99.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.576 -0.703 . . . . 2.01 109.277 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.09 -38.14 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.126 -1.064 . . . . 2.2 108.126 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.68 -22.63 60.88 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.337 -0.616 . . . . 2.75 109.337 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.62 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -83.95 7.18 19.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 3.47 110.793 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' SER . 62.3 mtp180 81.85 74.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.462 0.649 . . . . 8.35 109.984 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' CA ' ' CE2' ' A' ' 21' ' ' TYR . . . -84.34 -168.64 44.43 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.487 -1.445 . . . . 3.29 109.487 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -59.24 147.55 35.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -1.179 . . . . 3.18 109.057 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD11 HG21 ' A' ' 180' ' ' VAL . 36.1 tp -53.06 -33.29 51.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.302 -0.874 . . . . 4.22 109.096 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -58.84 -44.4 90.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.59 109.598 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' NH2' ' A' ' 102' ' ' ARG . 78.2 mm-40 -63.26 -44.64 94.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 3.04 108.774 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -68.44 -34.65 76.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.607 -0.886 . . . . 3.12 108.607 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -53.21 -61.0 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 2.31 109.155 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.582 ' NH2' ' OE1' ' A' ' 99' ' ' GLU . 30.3 ptt180 -64.82 -38.71 91.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -1.0 . . . . 3.93 109.538 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.601 ' CZ3' HD22 ' A' ' 107' ' ' LEU . 32.3 t90 -53.93 -46.55 71.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 4.4 108.797 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.67 74.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.441 -0.787 . . . . 1.41 109.824 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' HD11 ' A' ' 116' ' ' ILE . 81.0 t80 -62.82 -54.8 33.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 2.69 110.196 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -65.87 -36.64 83.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.983 . . . . 3.23 109.206 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.601 HD22 ' CZ3' ' A' ' 103' ' ' TRP . 60.5 tp -62.49 -39.92 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.464 -0.772 . . . . 1.99 110.478 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -58.59 -42.62 88.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.879 -1.138 . . . . 2.51 109.906 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' OD1' ' OD1' ' A' ' 111' ' ' ASP . 58.8 t0 -109.16 116.53 32.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 1.8 110.169 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.714 ' O ' HD23 ' A' ' 110' ' ' LEU . 7.1 tt -60.47 -40.93 93.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.43 -0.794 . . . . 3.31 109.243 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 113' ' ' ASP . 46.7 p30 -94.74 22.44 6.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 2.09 109.291 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' ASP . 45.2 p-10 -23.24 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.057 0.932 . . . . 3.68 111.43 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 111' ' ' ASP . 34.1 p30 -91.12 15.6 11.4 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.535 -0.913 . . . . 2.51 108.535 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.64 54.72 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.744 -1.742 . . . . 2.39 108.744 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -132.88 138.99 47.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -1.034 . . . . 2.76 110.204 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 105' ' ' PHE . 2.2 mt -115.91 144.36 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.724 -0.843 . . . . 1.6 108.724 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 p -123.88 154.05 40.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 1.73 108.86 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.74 ' HE ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -60.47 -34.29 73.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.15 -0.969 . . . . 3.17 109.733 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.881 -1.137 . . . . 2.44 109.24 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.02 -41.98 77.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.96 . . . . 1.71 109.188 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.677 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 57.2 ttm -67.38 -41.96 84.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.795 . . . . 3.66 109.769 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.88 -43.77 97.91 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.343 -0.848 . . . . 1.77 109.346 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.55 -41.81 92.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -0.902 . . . . 2.01 108.873 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 4.5 mm -65.05 -48.42 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.482 -0.761 . . . . 1.14 109.64 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.74 -40.78 77.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 106.691 -1.596 . . . . 1.83 106.691 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -60.62 -34.07 73.7 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.362 -0.977 . . . . 2.16 108.362 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 124' ' ' ILE . . . -60.78 -57.24 13.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.987 . . . . 1.78 108.736 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 132' ' ' VAL . 77.5 mt -62.22 -48.97 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.657 -0.652 . . . . 2.42 109.872 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HA ' HG12 ' A' ' 132' ' ' VAL . 1.2 t80 -60.02 -53.8 53.53 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.892 0.853 . . . . 5.07 110.428 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -49.61 -60.24 3.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.552 -0.717 . . . . 3.05 111.729 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 63.4 mtt -73.92 -40.57 63.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.895 -1.128 . . . . 4.88 111.444 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 128' ' ' ILE . 4.7 p -69.9 -0.49 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.425 -1.422 . . . . 3.55 108.751 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 134' ' ' ASN . . . -53.17 -21.56 11.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.204 -1.558 . . . . 3.52 109.204 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 133' ' ' GLY . 40.4 t30 -53.92 -112.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.429 -1.041 . . . . 4.29 109.876 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 137' ' ' GLU . 12.0 p -142.63 -1.0 1.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.757 -1.214 . . . . 3.68 110.499 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 136' ' ' VAL . 2.8 t -49.2 94.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.835 -1.165 . . . . 5.42 108.875 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 136' ' ' VAL . 52.4 mp0 27.98 74.19 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.032 0.444 . . . . 5.6 110.38 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 135' ' ' THR . 15.5 mt -68.85 111.14 7.42 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.709 . . . . 2.5 109.798 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -83.82 167.21 13.01 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 121.63 1.553 . . . . 3.55 111.846 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -162.13 32.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.311 -0.996 . . . . 5.65 108.311 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.577 ' OE1' ' CD2' ' A' ' 186' ' ' TYR . 51.4 mt-10 -69.16 -45.9 68.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 6.82 110.827 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.639 ' CG ' ' H ' ' A' ' 143' ' ' ASN . 8.7 pt-20 -176.16 -62.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.997 -1.064 . . . . 6.56 110.694 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.679 ' HB3' HD22 ' A' ' 183' ' ' LEU . 82.6 m-20 -61.76 -32.9 73.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.926 -1.109 . . . . 5.59 109.777 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.451 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -49.23 -64.78 1.02 Allowed Pre-proline 0 N--CA 1.493 1.719 0 C-N-CA 119.417 -0.913 . . . . 3.06 110.196 -179.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 144' ' ' THR . 2.8 Cg_endo -51.81 100.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.413 1.409 . . . . 3.91 111.167 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -48.33 -32.84 7.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.546 -0.722 . . . . 3.87 110.312 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -63.66 -40.36 96.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.15 . . . . 3.64 110.281 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -47.0 85.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 4.99 110.72 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.39 -32.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 1.57 109.394 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -61.41 -60.37 3.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 2.71 110.177 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -63.71 -43.04 97.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.004 -1.06 . . . . 4.73 109.381 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.43 -43.71 87.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.488 -0.758 . . . . 2.07 110.248 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.677 ' CE2' ' SD ' ' A' ' 121' ' ' MET . 1.5 m-85 -65.33 -40.92 94.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.913 -1.117 . . . . 2.93 109.76 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . -52.42 -38.83 60.01 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.158 -1.423 . . . . 1.77 107.158 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.9 ttp -70.39 -35.38 73.45 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.969 -0.752 . . . . 2.34 108.969 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 22.2 tpp -74.71 -32.78 62.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.272 -0.893 . . . . 3.53 110.592 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' OD1' ' A' ' 161' ' ' ASP . 55.4 t0 -90.86 16.23 9.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 2.4 110.971 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' ALA . 21.2 mtpp -53.75 -24.99 16.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.938 -1.102 . . . . 4.18 109.751 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.732 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 12.9 m120 -39.42 -26.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.774 -0.579 . . . . 2.49 109.492 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 82.93 -2.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.667 -0.646 . . . . 3.15 109.521 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 55.5 p-10 -60.28 -31.59 70.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 3.4 108.93 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.622 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 94.43 1.19 64.46 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.135 -1.186 . . . . 2.83 110.135 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -148.03 -179.27 6.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.312 . . . . 2.45 110.775 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.546 HD13 ' OE1' ' A' ' 168' ' ' GLU . 0.7 OUTLIER -111.86 132.08 54.95 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.158 -1.053 . . . . 1.9 108.158 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.8 p -127.45 166.6 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 1.8 109.546 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 166' ' ' LEU . 11.0 mp -56.89 -28.55 62.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 2.28 110.196 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -51.17 -43.93 61.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.643 -1.286 . . . . 2.92 109.299 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.546 ' OE1' HD13 ' A' ' 164' ' ' LEU . 87.9 mt-10 -76.8 -44.1 34.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 1.85 111.058 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.37 -47.79 72.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.754 -1.217 . . . . 2.14 109.849 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.436 HE22 ' HG ' ' A' ' 101' ' ' LEU . 87.3 mm-40 -62.93 -46.08 89.47 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.404 -0.81 . . . . 2.35 109.991 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 76.7 mm-40 -70.75 -44.24 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 2.92 110.1 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -66.5 -41.29 94.31 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.665 -1.374 . . . . 1.77 109.665 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 94.2 p -62.79 -39.31 93.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.255 -1.144 . . . . 2.18 109.943 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -96.69 3.96 52.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 4.67 110.535 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -133.13 -43.31 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.16 -0.962 . . . . 2.92 109.474 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.9 t70 -123.61 82.55 53.94 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.793 . . . . 2.61 109.213 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 178' ' ' SER . 78.1 Cg_exo -47.43 -171.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.731 2.287 . . . . 2.17 112.26 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 0.7 OUTLIER 78.38 -12.73 1.04 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 2.62 109.249 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 180' ' ' VAL . 1.4 mp -93.2 -66.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.367 -0.833 . . . . 2.0 109.661 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.605 ' N ' HG22 ' A' ' 179' ' ' ILE . 2.5 p -59.22 -41.36 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 3.79 111.759 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -52.65 136.84 32.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.533 -1.354 . . . . 6.02 109.396 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.89 145.99 54.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 4.48 109.369 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -61.61 -35.85 79.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.409 -0.807 . . . . 4.79 109.039 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.8 p -88.09 6.19 37.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 5.27 109.738 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.4 tp -53.17 -34.26 56.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 7.1 109.644 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CD2' ' OE1' ' A' ' 141' ' ' GLU . 96.4 m-85 -99.16 145.14 27.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 9.88 109.603 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -82.16 14.37 2.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.417 -0.802 . . . . 8.42 109.659 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.47 16.93 38.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.441 -1.464 . . . . 9.13 109.441 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER 59.02 83.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -1.146 . . . . 11.72 109.394 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.433 HG13 ' OXT' ' A' ' 190' ' ' VAL . 5.2 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.956 -1.021 . . . . 12.62 109.469 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.398 -0.594 . . . . 15.48 109.398 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.68 41.54 15.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.46 -1.456 . . . . 11.71 109.46 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -80.93 3.76 21.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -1.139 . . . . 12.65 109.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 t -60.94 159.15 11.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 8.16 109.394 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -67.52 175.25 2.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 7.63 109.686 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -62.31 154.49 27.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 5.22 109.89 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 8' ' ' LEU . 34.2 ttpt -172.16 170.58 5.16 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.826 -0.805 . . . . 4.94 108.826 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.457 HD23 ' CG2' ' A' ' 13' ' ' VAL . 61.9 tp -61.86 130.93 48.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.981 -1.075 . . . . 2.2 109.045 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -61.43 142.38 93.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 2.5 109.536 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.64 -28.18 21.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.281 1.988 . . . . 3.23 112.205 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.83 -49.09 77.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 3.91 109.654 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.56 -39.82 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.885 -1.134 . . . . 2.17 108.947 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' CG2' HD23 ' A' ' 8' ' ' LEU . 24.8 t -59.93 -39.33 79.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.16 -1.052 . . . . 2.64 108.16 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -59.78 -42.26 92.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.918 -1.141 . . . . 4.15 107.918 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 62.0 mm-40 -63.11 -34.88 78.54 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.412 -0.959 . . . . 3.01 108.412 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' O ' ' OG1' ' A' ' 20' ' ' THR . 69.3 mt -61.41 -46.55 89.65 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.412 -1.315 . . . . 2.71 107.91 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 p -52.19 -39.35 60.03 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.582 -1.324 . . . . 3.6 107.641 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.06 -34.28 73.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.48 -1.304 . . . . 5.04 107.48 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 20' ' ' THR . 30.2 ttpt -141.16 111.39 6.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.577 -0.702 . . . . 5.04 109.19 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.598 HG21 ' CG1' ' A' ' 27' ' ' VAL . 92.7 m -171.66 -28.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.332 -0.855 . . . . 2.89 109.268 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' OH ' ' OE1' ' A' ' 99' ' ' GLU . 11.5 m-85 71.23 -4.55 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.071 -1.085 . . . . 6.0 108.071 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CZ ' ' OG ' ' A' ' 93' ' ' SER . 43.5 m-85 -126.36 163.64 22.81 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.223 -1.029 . . . . 2.94 108.223 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.2 p -74.42 164.34 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.911 -1.118 . . . . 3.98 109.545 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.17 -35.16 74.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.433 -0.792 . . . . 4.23 110.269 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.79 -1.194 . . . . 5.1 109.446 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.12 -41.73 90.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 3.8 111.057 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' CG1' HG21 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 -38.63 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.789 -1.194 . . . . 2.44 109.357 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.4 -43.85 96.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.237 -0.914 . . . . 3.85 108.624 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' GLY . 95.2 mt-30 -66.38 -38.21 87.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.499 -0.751 . . . . 3.75 109.794 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.555 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -66.39 -47.51 73.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 5.2 109.496 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 86.0 t80 -55.47 -47.6 75.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 2.74 109.062 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -85.55 -2.56 58.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 5.06 108.742 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -74.61 -57.24 4.65 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.035 -1.226 . . . . 2.92 110.035 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 30' ' ' TRP . 5.1 p90 -87.24 -29.94 21.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.282 . . . . 3.92 110.821 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 8.2 mm -53.86 -40.92 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.726 -1.234 . . . . 3.57 109.932 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -58.2 -39.67 79.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.922 -1.111 . . . . 6.37 109.341 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -58.85 -36.5 74.67 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.213 -1.032 . . . . 7.82 108.213 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.22 125.82 3.71 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.299 -1.0 . . . . 5.72 108.299 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.61 -24.93 34.99 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.774 1.65 . . . . 4.71 112.359 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.8 m -57.95 -37.69 74.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.985 . . . . 5.05 109.122 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.43 4.63 61.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.378 -1.489 . . . . 2.56 109.378 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.38 117.31 33.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -1.066 . . . . 3.09 109.504 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -102.85 142.75 33.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 2.82 109.006 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 43.7 t0 -77.07 -169.44 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.977 -1.077 . . . . 2.91 109.528 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.551 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . -71.41 -37.89 71.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.632 -0.668 . . . . 1.72 110.068 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.77 90.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 2.06 110.03 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.88 79.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.446 -1.462 . . . . 2.03 109.446 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -60.94 -45.89 92.86 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.087 -1.243 . . . . 2.65 108.514 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.591 ' NE2' ' OG1' ' A' ' 66' ' ' THR . 99.1 mt-30 -60.11 -34.04 72.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 2.8 108.645 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -61.06 -44.38 97.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.419 -0.8 . . . . 3.4 109.99 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' N ' ' A' ' 52' ' ' TYR . 10.7 pt -67.66 -38.01 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.685 -1.259 . . . . 2.99 109.796 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.9 m-30 -65.86 -40.44 91.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.893 -1.129 . . . . 5.31 108.881 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.57 -41.07 98.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.136 -0.978 . . . . 3.63 109.366 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.97 -43.52 95.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 4.23 110.099 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.7 m-85 -80.2 -35.95 35.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 4.18 109.647 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 55' ' ' PHE . 10.2 m-85 -128.21 75.22 79.06 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.271 -0.893 . . . . 6.44 110.427 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -24.09 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.79 2.327 . . . . 4.28 112.089 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -60.82 -33.54 73.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 4.17 109.832 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.36 -178.4 52.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.425 . . . . 3.59 109.536 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' OE1' ' A' ' 130' ' ' GLN . 5.1 p-10 -93.02 119.15 67.91 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.34 -1.094 . . . . 5.63 108.931 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' O ' ' OG1' ' A' ' 62' ' ' THR . 58.8 Cg_endo -76.29 74.61 4.58 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.032 1.822 . . . . 4.4 112.122 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 61' ' ' PRO . 25.7 m -166.73 -61.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 3.54 110.012 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 43.9 mmtm -61.32 -63.52 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 3.3 110.524 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.4 p90 -76.06 -33.43 59.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 2.12 109.965 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' HG2' ' A' ' 49' ' ' GLN . . . -66.48 -56.63 10.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 1.79 109.754 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.591 ' OG1' ' NE2' ' A' ' 49' ' ' GLN . 23.0 m -63.79 -38.79 92.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 2.04 109.535 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 4.6 m-30 -55.09 -45.69 75.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 2.31 109.144 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' PHE . 40.0 t -64.93 -53.22 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 1.71 109.081 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -45.18 -66.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.926 -1.109 . . . . 4.33 110.099 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.526 ' N ' ' CG ' ' A' ' 69' ' ' PHE . 19.7 t-20 -59.62 -42.42 92.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 2.75 111.319 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.08 -60.44 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.97 -1.082 . . . . 1.91 110.968 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.999 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 28.7 t80 -54.31 -35.5 62.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 2.75 110.807 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 63.8 t0 -59.98 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.768 -1.208 . . . . 2.3 108.748 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.06 -40.34 93.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 5.3 109.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' OD1' ' OE2' ' A' ' 84' ' ' GLU . 17.8 m120 -63.61 -31.38 72.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.895 . . . . 3.3 109.29 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? 57.86 36.84 26.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.115 -0.698 . . . . 5.34 109.115 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -93.94 4.61 53.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 3.11 109.554 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.49 0.35 76.32 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.685 -1.366 . . . . 2.85 109.685 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -144.56 157.99 43.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -1.111 . . . . 4.19 109.065 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -99.98 134.92 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.092 -1.005 . . . . 1.76 108.651 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' PHE . 85.6 tt0 -98.54 155.86 17.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.815 . . . . 2.4 109.382 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -42.97 -46.58 5.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 3.27 109.278 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -58.38 -43.35 88.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 2.35 109.664 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' OD1' ' A' ' 75' ' ' ASN . 98.0 mt-10 -69.8 -41.94 74.39 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.069 -1.019 . . . . 2.09 109.901 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.616 ' CE1' HD13 ' A' ' 89' ' ' LEU . 16.7 t80 -63.38 -57.25 10.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.763 -1.211 . . . . 2.22 109.307 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.41 -27.81 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.57 -0.707 . . . . 1.9 109.292 -179.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.4 tt0 -65.78 -58.35 5.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.841 -1.162 . . . . 2.63 110.114 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.999 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -63.68 -35.11 79.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.56 108.229 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD13 ' CE1' ' A' ' 85' ' ' PHE . 9.1 tp -55.43 -41.57 73.0 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.74 -1.208 . . . . 2.17 107.74 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 44.6 t -65.91 -49.18 68.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.5 -0.75 . . . . 2.01 110.318 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -68.1 -26.95 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.799 -1.188 . . . . 2.2 109.624 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 88' ' ' ALA . 77.0 p -65.79 -35.83 81.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.102 -0.999 . . . . 2.75 108.94 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.493 ' OG ' ' CZ ' ' A' ' 22' ' ' PHE . 8.4 t -52.54 -40.05 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.052 -1.03 . . . . 3.47 108.367 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 95' ' ' GLY . 20.4 ptp180 -175.95 -39.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.383 -0.969 . . . . 8.35 108.383 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' ARG . . . 58.35 145.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.161 -1.175 . . . . 3.29 110.161 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.7 p -81.79 161.83 23.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -1.091 . . . . 3.18 108.951 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 97' ' ' LEU . 7.0 mp -59.3 -31.94 69.6 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 4.22 108.101 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -64.8 -62.98 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 3.59 110.088 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 10.2 pt-20 -67.01 -39.09 87.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 3.04 109.541 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 99' ' ' GLU . 84.8 tttt -60.81 -42.15 97.08 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.163 -0.96 . . . . 3.12 108.615 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.45 -46.93 85.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 2.31 108.714 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -59.99 -40.8 90.43 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.317 -0.994 . . . . 3.93 108.317 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.62 -41.09 94.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.962 -0.755 . . . . 4.4 108.962 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.96 85.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.423 -0.798 . . . . 1.41 109.547 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 79.9 t80 -57.19 -47.32 81.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 2.69 110.745 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -60.97 -48.1 83.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.869 -1.145 . . . . 3.23 110.075 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 107' ' ' LEU . 6.9 tt -67.97 -33.7 75.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.156 -0.965 . . . . 1.99 110.037 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.408 ' CZ ' ' HG2' ' A' ' 121' ' ' MET . 2.5 t80 -58.62 -16.66 16.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.967 . . . . 2.51 109.78 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 35.9 t0 -129.34 134.49 47.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.257 -0.902 . . . . 1.8 109.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -85.67 -76.48 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.436 -0.79 . . . . 3.31 109.984 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 32.6 p-10 -64.76 -37.04 86.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 2.09 110.048 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 15.0 p30 41.62 41.63 1.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.395 -0.815 . . . . 3.68 109.36 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 114' ' ' GLY . 26.0 p-10 -62.37 -37.31 85.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.405 -0.81 . . . . 2.51 109.654 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 113' ' ' ASP . . . -145.62 -70.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.348 -1.501 . . . . 2.39 109.348 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -126.33 -173.15 2.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.394 -1.063 . . . . 2.76 109.398 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.0 mt -105.43 147.65 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.601 -0.687 . . . . 1.6 109.272 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 p -125.82 160.29 30.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.838 -1.171 . . . . 1.73 107.838 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' H ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -61.66 -39.82 92.75 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.05 -1.031 . . . . 3.17 109.511 -179.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -61.61 -41.26 97.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.001 -1.062 . . . . 2.44 108.96 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.39 -41.33 80.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.161 -0.962 . . . . 1.71 109.124 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.519 ' C ' ' SD ' ' A' ' 121' ' ' MET . 11.7 tmm? -64.43 -43.63 93.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.27 -0.894 . . . . 3.66 108.875 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.457 -0.777 . . . . 1.77 109.047 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.65 -44.84 93.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.173 -0.954 . . . . 2.01 108.518 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 124' ' ' ILE . 29.4 mm -65.52 -37.42 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.562 -0.903 . . . . 1.14 108.562 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 121' ' ' MET . 57.1 t -59.69 -44.17 93.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.505 -1.294 . . . . 1.83 107.505 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -61.38 -35.73 78.28 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 2.16 108.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.1 -61.54 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.787 . . . . 1.78 109.706 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.37 -47.52 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 2.42 109.396 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 133' ' ' GLY . 41.2 t80 -57.89 -41.93 83.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.503 -0.748 . . . . 5.07 109.278 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.443 ' OE1' ' CG ' ' A' ' 60' ' ' ASP . 52.0 tt0 -59.16 -43.08 92.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.963 -1.085 . . . . 3.05 108.167 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.41 ' SD ' ' O ' ' A' ' 131' ' ' MET . 5.0 tpt -65.8 -35.11 79.77 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.614 -0.884 . . . . 4.88 108.614 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . 35.6 t -94.29 -0.06 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.462 -0.774 . . . . 3.55 109.556 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 129' ' ' TYR . . . -97.96 146.1 18.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.244 -1.542 . . . . 3.52 109.244 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 133' ' ' GLY . 8.6 p30 44.54 36.78 1.83 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -1.115 . . . . 4.29 108.191 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -100.21 156.82 17.0 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.602 -0.686 . . . . 3.68 109.569 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 137' ' ' GLU . 7.4 p -48.78 -39.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.389 -0.819 . . . . 5.42 109.967 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 136' ' ' VAL . 20.4 pt-20 -152.61 129.54 11.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.538 -0.726 . . . . 5.6 109.339 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 167.31 11.81 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 107.724 -1.213 . . . . 2.5 107.724 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HB2' HD22 ' A' ' 143' ' ' ASN . 88.5 Cg_endo -87.78 -179.94 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.789 1.659 . . . . 3.55 112.81 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.9 mm-40 -42.66 150.76 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 5.65 109.866 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' OG1' ' A' ' 144' ' ' THR . 78.2 mm-40 -57.09 -37.38 71.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 6.82 109.323 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 144' ' ' THR . 84.4 tt0 -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 6.56 108.94 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.452 HD22 ' HB2' ' A' ' 139' ' ' PRO . 91.2 m-20 -69.36 34.63 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.389 -0.967 . . . . 5.59 108.389 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 142' ' ' GLU . 0.0 OUTLIER -157.74 59.89 1.8 Allowed Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.559 -1.274 . . . . 3.06 107.559 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.644 ' CG ' HD12 ' A' ' 183' ' ' LEU . 76.7 Cg_endo -79.32 93.84 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.899 2.4 . . . . 3.91 113.646 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' O ' HG22 ' A' ' 149' ' ' VAL . 41.5 mp0 -95.72 -73.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.771 -0.826 . . . . 3.87 108.771 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -62.66 -29.17 70.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.916 -1.115 . . . . 3.64 108.746 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -57.94 -45.62 86.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 4.99 109.519 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 146' ' ' GLU . 16.0 m -71.4 -35.02 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.881 -1.137 . . . . 1.57 108.697 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.664 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 93.4 m-20 -52.21 -49.26 64.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.369 -1.457 . . . . 2.71 108.79 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -80.89 -50.64 9.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 4.73 110.306 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.6 mt -58.4 -54.59 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 2.07 110.588 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.806 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -66.63 -36.82 83.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.862 -1.149 . . . . 2.93 109.393 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 150' ' ' ASP . . . -52.26 -40.9 62.33 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.715 -1.241 . . . . 1.77 108.248 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.555 ' C ' ' SD ' ' A' ' 155' ' ' MET . 15.3 tmm? -68.57 -44.98 73.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.53 -0.731 . . . . 2.34 109.52 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 44.4 tpp -63.0 -29.23 70.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 3.53 110.533 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 163' ' ' LYS . 30.0 t0 -88.13 7.02 33.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.083 -1.011 . . . . 2.4 111.256 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.684 ' CG ' ' H ' ' A' ' 159' ' ' ASN . 42.4 pttt -64.23 -67.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.526 -1.359 . . . . 4.18 109.355 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.684 ' H ' ' CG ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER 11.43 52.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 123.056 0.542 . . . . 2.49 111.833 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 158' ' ' LYS . . . 37.69 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 3.15 110.121 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 159' ' ' ASN . 24.7 t0 -120.1 -66.86 1.02 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.274 -0.891 . . . . 3.4 109.591 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 157' ' ' ASP . . . 97.71 1.42 58.8 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.983 -1.247 . . . . 2.83 109.983 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 47.3 mttp -131.79 151.74 51.45 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.166 -1.197 . . . . 2.45 110.076 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.806 HD21 ' CE1' ' A' ' 153' ' ' PHE . 8.4 mp -89.73 117.49 28.63 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.752 -0.833 . . . . 1.9 108.752 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 p -124.77 156.18 38.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 1.8 110.251 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 166' ' ' LEU . 4.4 mp -52.73 -35.39 55.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.643 . . . . 2.28 110.003 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -46.57 -73.13 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.811 -1.18 . . . . 2.92 109.503 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.52 -34.52 54.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.85 110.622 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 105' ' ' PHE . 88.0 t80 -65.48 -51.46 59.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.915 -1.115 . . . . 2.14 110.313 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.544 ' C ' ' NE2' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -70.45 -43.34 70.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.976 -1.078 . . . . 2.35 109.904 -179.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 170' ' ' GLN . 98.2 mt-10 -67.09 -39.78 86.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.712 -1.243 . . . . 2.92 108.975 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 176' ' ' ASP . . . -72.03 -38.33 59.81 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.151 -1.58 . . . . 1.77 109.151 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 66.1 m -60.37 -37.04 79.48 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.115 -1.227 . . . . 2.18 109.574 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -94.12 6.58 48.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.897 . . . . 4.67 110.285 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.48 -44.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.958 -1.089 . . . . 2.92 109.808 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.6 t70 -114.33 90.05 19.53 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.441 -0.787 . . . . 2.61 109.326 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 176' ' ' ASP . 73.8 Cg_exo -46.89 -169.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.828 2.352 . . . . 2.17 112.809 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.479 ' H ' ' HG3' ' A' ' 181' ' ' GLN . 0.8 OUTLIER 74.78 -35.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.799 . . . . 2.62 109.234 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 177' ' ' PRO . 84.3 mt -63.58 -32.28 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.439 -0.788 . . . . 2.0 110.544 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.13 -14.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.108 -0.995 . . . . 3.79 110.225 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HG3' ' H ' ' A' ' 178' ' ' SER . 94.6 mt-30 -45.61 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.931 -1.106 . . . . 6.02 108.843 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 180' ' ' VAL . . . -54.11 152.8 5.63 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 4.48 109.313 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -51.51 -36.36 44.31 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.555 -0.716 . . . . 4.79 109.131 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.6 m -64.76 153.55 39.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 5.27 109.398 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 34.9 mt -101.23 135.24 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 7.1 109.184 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -51.52 126.76 18.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 9.88 109.322 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -57.66 -38.79 75.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 8.42 109.378 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -176.68 49.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.264 -1.534 . . . . 9.13 109.264 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -92.81 0.84 57.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.182 -1.187 . . . . 11.72 109.282 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.975 -1.012 . . . . 12.62 109.452 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.293 -0.632 . . . . 15.48 109.293 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.58 -111.69 4.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.494 -1.442 . . . . 11.71 109.494 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -78.61 140.08 38.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -1.146 . . . . 12.65 109.331 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 5' ' ' ASN . 2.7 t -143.91 -99.91 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 8.16 109.299 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.5 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.9 t30 58.71 48.55 11.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 7.63 109.68 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.3 p -108.95 138.99 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.296 -0.877 . . . . 5.22 109.527 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -176.3 168.58 2.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.585 -0.697 . . . . 4.94 109.131 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 13' ' ' VAL . 26.9 tp -99.71 123.05 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 2.2 109.067 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -78.07 149.36 76.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 2.5 109.756 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.96 -25.34 32.44 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.592 2.195 . . . . 3.23 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.05 -52.86 45.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.047 -1.033 . . . . 3.91 110.205 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 8' ' ' LEU . 1.2 m -63.48 -35.59 73.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 120.989 -1.069 . . . . 2.17 108.373 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 8' ' ' LEU . 38.5 t -61.82 -48.33 89.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.654 -1.239 . . . . 2.64 107.654 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -48.06 -46.92 34.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.715 -1.217 . . . . 4.15 107.715 178.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 96.3 mt-10 -66.0 -32.57 74.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.232 -1.025 . . . . 3.01 108.232 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' OG1' ' A' ' 20' ' ' THR . 8.2 tt -66.18 -42.88 88.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.71 108.954 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.4 p -64.32 -30.37 71.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.305 -0.872 . . . . 3.6 109.273 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -50.17 -33.25 18.54 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.42 -1.326 . . . . 5.04 107.42 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.689 ' NZ ' HE22 ' A' ' 87' ' ' GLN . 11.5 pttp -138.49 117.98 12.93 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.27 -1.011 . . . . 5.04 108.27 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -172.49 -23.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.581 -1.324 . . . . 2.89 111.153 -178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 96' ' ' THR . 26.5 m-85 62.29 -2.13 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.247 -1.02 . . . . 6.0 108.247 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.3 m-85 -127.36 164.99 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.081 -1.081 . . . . 2.94 108.081 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.8 p -76.99 164.36 25.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 3.98 109.579 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 25' ' ' LYS . 14.3 pt-20 -71.62 -36.06 70.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 4.23 109.959 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 45.4 mmtm -61.5 -40.61 95.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 5.1 110.175 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -65.01 -39.15 93.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.049 -1.032 . . . . 3.8 110.032 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 20' ' ' THR . 55.3 t -68.87 -45.08 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.936 -1.103 . . . . 2.44 110.303 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.5 -45.82 91.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 3.85 109.556 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.39 -39.09 92.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 3.75 109.358 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 6.5 m95 -67.89 -40.96 83.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.96 . . . . 5.2 109.222 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 20.8 t80 -55.31 -62.7 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 2.74 109.174 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.608 ' HZ3' ' HA ' ' A' ' 7' ' ' LYS . 66.1 mmtt -66.86 -25.77 66.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 5.06 108.945 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.03 -72.66 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 111.25 -0.74 . . . . 2.92 111.25 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 30' ' ' TRP . 39.3 p90 -74.05 -28.3 61.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.349 . . . . 3.92 111.146 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' CG1' ' O ' ' A' ' 31' ' ' TYR . 5.6 mm -61.88 -35.3 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.816 -1.177 . . . . 3.57 109.957 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -57.98 -48.23 80.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.009 -1.057 . . . . 6.37 109.654 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -64.66 -39.0 92.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 7.82 109.039 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t -130.9 84.86 57.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.917 -0.772 . . . . 5.72 108.917 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.92 -30.1 16.84 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.486 2.124 . . . . 4.71 112.322 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.1 m -60.62 -39.14 87.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 5.05 109.335 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.28 15.99 79.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.606 -1.397 . . . . 2.56 109.606 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -97.55 120.51 38.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -1.181 . . . . 3.09 110.082 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.64 134.33 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.82 109.369 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -74.22 174.99 7.99 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 2.91 109.221 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . . . -60.13 -30.77 69.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 1.72 109.415 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.04 85.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 2.06 109.786 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.13 -56.97 9.14 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.41 -1.476 . . . . 2.03 109.41 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' CG1' ' A' ' 51' ' ' ILE . 15.7 t80 -57.69 -43.87 85.42 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.293 . . . . 2.65 107.873 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.71 -33.1 73.43 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.045 -1.035 . . . . 2.8 108.454 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -60.61 -44.75 95.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.4 109.706 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 52' ' ' TYR . 12.9 pt -65.19 -42.53 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.472 -1.291 . . . . 2.99 108.738 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 51' ' ' ILE . 2.5 m-30 -61.0 -38.72 87.06 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.267 -1.383 . . . . 5.31 107.267 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -60.29 -34.38 73.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.468 -0.938 . . . . 3.63 108.468 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.93 -42.29 89.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 4.23 110.435 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 1.1 m-85 -99.43 -12.17 20.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.86 -1.15 . . . . 4.18 109.519 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.22 69.09 34.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 6.44 109.546 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.68 -28.0 3.69 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.04 2.494 . . . . 4.28 112.334 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -60.84 -26.92 67.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 4.17 109.842 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.94 127.66 35.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 3.59 109.509 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -96.71 -65.41 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.229 -1.159 . . . . 5.63 109.931 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 63' ' ' LYS . 11.2 Cg_endo -56.43 -17.35 21.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.422 2.082 . . . . 4.4 112.277 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 61' ' ' PRO . 12.8 t 43.9 10.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.695 -0.628 . . . . 3.54 110.685 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 61' ' ' PRO . 48.3 mtpt -60.23 -37.13 79.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.005 -1.06 . . . . 3.3 109.748 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD2' ' N ' ' A' ' 65' ' ' ALA . 52.9 p90 -58.45 -43.48 88.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 2.12 108.73 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 64' ' ' PHE . . . -63.9 -35.78 81.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.599 -0.688 . . . . 1.79 109.413 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -68.6 -41.65 79.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.034 . . . . 2.04 109.783 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.603 ' O ' HG22 ' A' ' 71' ' ' VAL . 41.7 m-85 -61.65 -48.0 82.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 2.31 109.9 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' PHE . 9.1 m -59.54 -47.67 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.755 -1.215 . . . . 1.71 108.804 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t80 -56.85 -31.82 65.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.077 -1.015 . . . . 4.33 109.461 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.74 -62.26 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 2.75 110.544 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -71.81 -39.39 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 1.91 110.519 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.994 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 75.3 t80 -54.64 -34.97 62.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 2.75 109.87 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 77' ' ' ASP . 68.3 t0 -69.41 105.68 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.104 -0.998 . . . . 2.3 109.629 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.61 -33.63 76.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.481 -0.762 . . . . 5.3 109.988 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 77' ' ' ASP . 12.6 m120 -84.89 2.12 44.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 3.3 109.824 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 75' ' ' ASN . 16.8 ptpt 36.12 29.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.715 . . . . 5.34 109.885 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 75' ' ' ASN . 25.7 p-10 -85.8 3.8 39.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 3.11 109.832 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.47 4.39 90.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 2.85 109.658 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 -134.66 144.45 47.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -1.148 . . . . 4.19 109.001 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.37 130.7 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.815 -1.18 . . . . 1.76 107.815 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -92.77 167.77 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 2.4 110.439 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -49.6 -46.35 49.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.63 -0.669 . . . . 3.27 109.693 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.0 p -60.62 -44.25 96.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.937 -1.102 . . . . 2.35 110.338 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.62 -42.19 74.67 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.974 -1.079 . . . . 2.09 109.754 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -66.42 -50.83 62.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 2.22 109.849 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -62.39 -27.75 43.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.142 -0.974 . . . . 1.9 108.938 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.689 HE22 ' NZ ' ' A' ' 19' ' ' LYS . 58.4 tp60 -71.89 -63.07 1.21 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.126 -0.983 . . . . 2.63 110.894 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.994 ' HB2' ' CZ ' ' A' ' 72' ' ' PHE . . . -58.58 -44.89 89.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.706 -1.246 . . . . 1.56 108.467 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD22 ' CE1' ' A' ' 85' ' ' PHE . 21.9 tp -52.06 -46.87 65.29 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.422 -0.955 . . . . 2.17 108.422 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 m -61.42 -36.99 81.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.437 -0.949 . . . . 2.01 108.437 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NE1' ' A' ' 103' ' ' TRP . 77.5 t -66.91 -36.97 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 2.2 109.466 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 88' ' ' ALA . 65.3 p -59.72 -36.91 77.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 2.75 109.211 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' THR . 88.0 p -47.81 -54.37 12.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.02 . . . . 3.47 108.924 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 21' ' ' TYR . 29.1 ptt180 173.61 70.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.882 -0.785 . . . . 8.35 108.882 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.57 160.42 28.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.138 -1.185 . . . . 3.29 110.138 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 21' ' ' TYR . 38.7 p -77.47 165.49 24.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -1.057 . . . . 3.18 109.207 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -58.0 -33.41 68.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.61 -1.256 . . . . 4.22 107.61 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.36 -48.35 78.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.578 -0.701 . . . . 3.59 109.187 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.86 -40.57 83.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 3.04 108.839 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.34 -40.45 96.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.574 -0.899 . . . . 3.12 108.574 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.27 -43.34 96.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 2.31 108.96 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.506 HH12 HE21 ' A' ' 170' ' ' GLN . 2.8 mmp_? -64.93 -42.03 95.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 3.93 109.097 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.538 ' NE1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -63.3 -41.32 98.94 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.182 -1.044 . . . . 4.4 108.182 179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.72 76.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.452 -0.78 . . . . 1.41 109.03 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.77 -54.02 50.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.467 -0.771 . . . . 2.69 110.538 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' ASP . 6.0 pttm -64.82 -38.93 92.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.96 -1.087 . . . . 3.23 108.994 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.83 -40.87 98.75 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.323 -0.861 . . . . 1.99 109.391 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -32.17 70.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 2.51 109.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 61.8 t0 -127.09 120.19 28.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 1.8 109.149 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.715 ' C ' HD23 ' A' ' 110' ' ' LEU . 5.9 tt -63.31 -56.49 16.04 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.371 -0.83 . . . . 3.31 109.415 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.625 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 52.5 p30 -73.1 -33.13 65.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 2.09 110.235 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.625 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.3 p-10 41.43 51.49 3.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 3.68 109.326 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -82.68 14.88 2.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 2.51 109.708 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.76 -16.06 51.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.182 -1.567 . . . . 2.39 109.182 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -125.41 133.65 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.493 -1.004 . . . . 2.76 109.681 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.473 HG22 ' HE3' ' A' ' 121' ' ' MET . 17.8 mt -122.46 134.77 64.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.127 -0.694 . . . . 1.6 109.127 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.0 p -108.82 157.19 18.82 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.837 -1.172 . . . . 1.73 107.837 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.694 ' CD ' ' H ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -59.2 -37.41 77.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.899 -1.126 . . . . 3.17 109.464 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -58.81 -42.03 88.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 2.44 109.323 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.65 -39.88 91.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 1.71 108.651 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 153' ' ' PHE . 27.9 mtt -64.58 -42.27 95.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.409 -0.96 . . . . 3.66 108.409 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 122' ' ' LEU . 35.1 tp -66.35 -39.77 89.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.629 -0.67 . . . . 1.77 109.828 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.67 -46.59 88.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 2.01 108.776 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.7 mm -64.78 -36.17 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.356 -0.84 . . . . 1.14 108.797 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 121' ' ' MET . 42.1 t -60.35 -43.75 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.114 -1.069 . . . . 1.83 108.114 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.99 -38.24 85.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.606 -0.887 . . . . 2.16 108.606 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.04 -48.54 78.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 1.78 109.25 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.18 -40.42 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 2.42 109.681 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -58.64 -49.29 78.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.316 -0.865 . . . . 5.07 108.954 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.16 -36.08 82.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 3.05 108.854 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.9 ttp -56.09 -38.03 70.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.268 -1.012 . . . . 4.88 108.268 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.6 m -98.7 -0.05 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.591 -0.892 . . . . 3.55 108.591 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.1 55.01 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.893 -1.683 . . . . 3.52 108.893 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 135' ' ' THR . 21.7 t-20 -74.58 -80.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -1.115 . . . . 4.29 108.665 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 137' ' ' GLU . 45.4 p -159.63 -63.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 3.68 109.991 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER 31.07 35.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 121.742 0.782 . . . . 5.42 109.575 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 135' ' ' THR . 78.0 mm-40 59.02 91.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.677 . . . . 5.6 109.437 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 135' ' ' THR . 7.2 mp -68.98 129.33 92.32 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.522 -0.918 . . . . 2.5 108.522 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.476 ' CG ' ' OD1' ' A' ' 143' ' ' ASN . 85.0 Cg_endo -83.88 -179.97 4.41 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.718 1.612 . . . . 3.55 111.491 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 139' ' ' PRO . 78.0 mm-40 -44.1 148.29 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.001 -1.062 . . . . 5.65 109.264 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.41 -38.6 71.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 6.82 109.715 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.587 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 84.0 tt0 -66.58 -28.65 68.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.074 -1.016 . . . . 6.56 109.57 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 183' ' ' LEU . 27.2 t-20 -68.77 44.03 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 5.59 108.645 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 142' ' ' GLU . 4.0 p -129.83 134.36 26.09 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.745 -0.835 . . . . 3.06 108.745 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 149' ' ' VAL . 91.7 Cg_endo -81.74 31.52 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.231 1.954 . . . . 3.91 113.207 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -101.7 -75.37 0.6 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.828 -1.17 . . . . 3.87 110.149 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -58.73 -38.55 78.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.137 -0.977 . . . . 3.64 109.311 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.587 ' NH2' ' OE2' ' A' ' 142' ' ' GLU . 83.7 mtt-85 -56.13 -68.6 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.427 -0.795 . . . . 4.99 110.043 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 150' ' ' ASP . 2.2 p -46.13 -49.36 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.57 110.247 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 91.1 m-20 -47.02 -64.01 0.89 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.334 -1.479 . . . . 2.71 110.013 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -70.34 -49.01 53.74 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.987 -1.071 . . . . 4.73 111.395 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.46 -59.1 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 2.07 110.624 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.937 ' CE2' HD13 ' A' ' 164' ' ' LEU . 1.9 m-85 -59.66 -41.46 90.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.826 -1.171 . . . . 2.93 110.378 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.56 -32.65 51.67 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.14 -1.424 . . . . 1.77 108.208 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 61.5 ttp -85.06 -43.99 13.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.429 -0.794 . . . . 2.34 110.304 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.3 mmt -59.81 -34.99 73.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.904 -1.122 . . . . 3.53 109.4 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.596 ' OD2' ' NH2' ' A' ' 118' ' ' ARG . 43.5 t0 -79.49 16.16 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 2.4 109.263 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 157' ' ' ASP . 12.4 pttt -30.49 -45.37 0.06 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.713 0.768 . . . . 4.18 110.631 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.724 ' O ' ' HB3' ' A' ' 160' ' ' ALA . 21.3 m120 -38.85 -31.08 0.05 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.927 -0.483 . . . . 2.49 109.856 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 159' ' ' ASN . . . 80.32 2.18 1.93 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 3.15 109.447 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 162' ' ' GLY . 51.0 p30 -62.93 -29.69 70.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.261 -0.899 . . . . 3.4 109.883 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.629 ' N ' ' OD1' ' A' ' 161' ' ' ASP . . . 91.6 1.47 71.2 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.18 -1.568 . . . . 2.83 109.18 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -131.89 146.58 52.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -1.041 . . . . 2.45 109.792 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -109.7 138.53 45.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 1.9 110.105 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.4 p -117.13 159.77 22.07 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.345 -0.983 . . . . 1.8 108.345 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.863 ' H ' HD23 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -62.88 -31.97 73.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.877 -1.139 . . . . 2.28 108.902 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 166' ' ' LEU . 63.0 tt0 -44.63 -39.86 5.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 2.92 108.558 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.8 -36.21 81.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.365 -0.835 . . . . 1.85 108.818 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.6 m-85 -74.47 -52.29 12.41 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 2.14 109.687 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.506 HE21 HH12 ' A' ' 102' ' ' ARG . 95.4 mt-30 -64.13 -50.51 67.95 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.342 -0.849 . . . . 2.35 110.796 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -71.85 -39.44 69.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 2.92 110.143 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 179' ' ' ILE . . . -74.18 -52.35 7.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.964 -1.254 . . . . 1.77 109.964 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 169' ' ' PHE . 59.9 p -59.7 -34.89 73.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.221 -1.164 . . . . 2.18 109.644 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.01 -4.13 59.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 4.67 108.97 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -110.75 -66.55 1.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.301 -0.874 . . . . 2.92 109.814 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.5 150.41 42.11 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.316 -0.865 . . . . 2.61 109.841 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 178' ' ' SER . 86.7 Cg_endo -78.95 -169.94 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.695 2.263 . . . . 2.17 112.207 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 177' ' ' PRO . 1.8 p 80.58 -40.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.59 -0.694 . . . . 2.62 110.171 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 172' ' ' GLY . 94.7 mt -57.06 -49.09 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 2.0 110.544 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -19.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.038 -1.039 . . . . 3.79 109.649 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -82.17 53.58 2.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.275 -0.891 . . . . 6.02 108.957 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CD2' ' A' ' 183' ' ' LEU . . . -49.41 -27.46 4.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 4.48 108.853 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.928 HD23 ' N ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -148.41 35.55 0.8 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.36 -0.837 . . . . 4.79 109.39 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 4.4 p 40.75 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 5.27 109.942 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.83 -34.33 74.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 7.1 109.461 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -61.1 129.28 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 9.88 109.739 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.18 -36.09 76.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 8.42 109.131 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.5 -127.97 1.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 9.13 109.365 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.6 tp -159.01 84.27 0.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -1.197 . . . . 11.72 109.301 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 190' ' ' VAL . 6.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.966 -1.016 . . . . 12.62 109.466 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_